Laboratory Safety Manual

Laboratory Safety Manual
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Contents
S1.001.01 LABORATORY SAFETY POLICY .................................................................................2
S1.002.01 DISASTER ACTIVATION ACTION SUMMARY LABORATORY.................................5
S1.003.01 LABORATORY EVACUATION PLAN......................................................................... 11
S1.004.01 BLOODBORNE PATHOGEN –EXPOSURE CONTROL PLAN .................................... 13
S1.005.01 LABORATORY RISK ASSESSMENT .......................................................................... 19
S1.006.01 INFECTIOUS WASTE MANAGEMENT PLAN ............................................................ 25
S1.007.01 CHEMICAL HYGIENE PLAN....................................................................................... 30
S1.008.01 SAFETY DATA SHEETS ONLINE ............................................................................... 51
S1.009.01 SPILL CLEAN UP PROCEDURE .................................................................................. 56
S1.010.01 Hazardous Waste Training in the Laboratory ................................................................... 61
S1.011.01 LATEX ALLERGY ........................................................................................................ 67
S1.012.01 UV LIGHT SAFETY ...................................................................................................... 69
S1.013.01 GLASSWARE SAFETY ................................................................................................ 72
S1.014.01 CENTRIFUGE SAFETY ................................................................................................ 73
S1.015.01 Glove Safety ................................................................................................................... 75
S1.016.01 ELECTRICAL SAFETY ................................................................................................ 76
S1.017.01 Back Safety .................................................................................................................... 79
S1.018.01 COMPRESSED GASES: STORAGE AND HANDLING ................................................ 81
S1.019.01 NOISE MONITORING .................................................................................................. 85
S1.020.01 EYE AND FACE PROTECTION ................................................................................... 88
S1.021.01
EYEWASH FUNCTION CHECKS ............................................................................ 90
S1.022.01 SAFETY SHOWER FUNCTION VERIFICATION ........................................................ 92
S1.023.01 SAFE SPECIMEN TRANSPORT ................................................................................... 93
S1.024.01 LABORATORY ERGONOMICS ................................................................................... 95
S1.025.01 TUBERCULOSIS EXPOSURE CONTROL PLAN........................................................ 99
S1.026.01 FORMALDEHYDE EXPOSURE CONTROL .............................................................. 103
S1.027.01 XYLENE EXPOSURE CONTROL PLAN .................................................................... 112
S1.028.01 SAFETY GUIDELINES FOR HANDLING OF POSSIBLE .......................................... 114
CREUTZFELDT-JAKOB DISEASE............................................................................................. 114
(SUBACUTE SPONGIFORM ENCEPHALOPATHY) ................................................................. 114
S1.029.01
LABORATORY GUIDELINES FOR HANDLING SPECIMENS FROM PATIENTS
WITH SUSPECTED OR CONFIRMED EBOLA VIRUS DISEASE.............................................. 116
S1.030.01 CHEMICAL EXPOSURE/TERRORISM RESPONSE PLAN........................................ 127
S1.031.01 Safe Work Practices Review......................................................................................... 145
S1.033.01 MANDATORY TRAINING FIRE SAFETY ................................................................. 146
S1.034.01 RADIATION SAFETY IN THE LABORATORY ......................................................... 149
Page 1 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective date: 10.01.2014
S1.001.01 LABORATORY SAFETY POLICY
1.0
POLICY STATEMENT
1.1
1.2
1.3
2.0
The laboratories at Palmetto Health are committed to the safety of the employees and to
the safety of the working environment.
Safe practices and working conditions are the responsibility of both the employer and
the employee.
The Laboratory Safety Manual is intended to address universal safety measures for
achieving a safe and healthy working environment.
1.3.1 It describes good laboratory practices that must be understood and observed by
all individuals involved in the laboratory.
1.3.2 It describes control measures essential for protecting all laboratory occupants
from potential biological, chemical and physical hazards.
1.3.2.1 These controls consist of, but are not limited to, policies, guidelines,
training requirements, procedures, persona l protective equipment,
laboratory inspections, hazard evaluations and engineering controls.
RESPONSIBILITIES
2.1
The Laboratory Director
2.1.1 Review and approve all changes before implementation of safety
policies for the laboratory to ensure that all Federal and state regulations
regarding safe practices are strictly enforced.
2.1.2 Designate a Laboratory Safety/Chemical Hygiene officer.
2.1.3 Establish and maintain adequate standards, policies, procedures, work practices
and maintenance of buildings and equipment to ensure a safe working
environment.
2.1.4 Ensure that a review of all safety policies, procedures and programs and the
Laboratory Safety is done annually.
2.2
The Laboratory Safety/Chemical Hygiene Officer will
2.2.1 Appoint representatives to the Safety Committee
2.2.2 Keep the safety manual up to date, available to all employees on MyPal.
2.2.3 Conduct the Safety Committee meetings.
2.2.4 Advise employees of any OSHA complaints or reports.
2.2.5 Conduct workplace inspections.
2.2.6 Recommend appropriate action on discovered or reported unsafe equipment,
working conditions or practices and on actual or potential health or safety
hazards.
2.2.7 Request for necessary repairs in a timely manner.
2.2.8 Ensure adequate operation of engineering controls.
Page 2 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.3
2.4
2.5
2.6
2.2.9 Review and investigate accidents and revise policies and procedures as needed.
2.2.10 Have chemical hygiene plan for the lab and provide access to SDS sheets.
2.2.11 Prepare and administer an annual safety test and Hands-On Safety training.
2.2.12 Maintain a chemical inventory for the laboratory.
Section Managers and Supervisors are to enforce the Safety Policy.
2.3.1 Retain documentation that all their employees have:
2.3.1.1 Read the Safety Manua l
2.3.1.2 Taken the mandatory Safety Test
2.3.1.3 Participated in the Hands-On-Safety class.
2.3.2 Supervisors will identify areas of risk in their department.
2.3.3 Train staff to use PPE and Engineering controls
2.3.4 Discuss accidents with the employees in their department to prevent
re-occurrence.
2.3.5 Initiate counseling reports when indicated.
2.3.6 Orient new staff to safety in the laboratory.
2.3.7 Train staff in safe work practices and procedures in compliance with established
hospital policies and procedures.
2.3.8 Maintain a list of their employees that wear contact lenses while working in the
Laboratory in the event the employee has a chemical splash to the eyes.
Employees
2.4.1 Read the Safety Manual annually.
2.4.2 Take the mandatory Safety Test each year.
2.4.3 Participate in the Hands-On-Safety class.
2.4.4 Report notifiable conditions to DHEC
2.4.5 Report all accidents to Employee Health/HealthWorks.
2.4.5.1 All accidents are further reported on department QA report, and the PH
Safety Committee.
2.4.3.2 Accidents may then be reported to OSHA and / or JCAHO as applicable.
2.4.4 Follow regulations for shipping and handling of infectious materials or waste.
2.4.4.1 Separate waste into correct containers.
2.4.5 Take every reasonable precaution to maintain a healthy and safe environment.
2.4.6 Take appropriate action to correct any actual or potential health or safety hazard.
2.4.7 Report any actual or potential safety hazards to his/her supervisor.
2.4.8 Prevent loss of or damage to hospital property due to unsafe work practices.
2.4.9 Use personal protective equipment.
2.4.10 Report any chemical spills.
A Laboratory Safety Committee , consisting of at least five members of the laboratory
staff shall periodically monitor and document the compliance to safe work practices.
2.5.1 Periodically evaluate and document the effectiveness of this policy and
proactively develop ways to encourage good safety habits and awareness
throughout the laboratory.
2.5.2 Conduct periodic safety audits of the lab.
2.5.3 Make suggestions for safety improvements to the Lab Director
Violation of safety protocols will result in counseling by
Page 3 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.6.1
2.6.2
2.6.3
The employee’s supervisor, or
The Clinical Manager
The Administrative Director will review the counseling report.
3.0
References
3.1
M29-A4 Protection of Laboratory Workers for Occupationally Acquired
Infections; Approved Guideline- 4TH Edition, Vol. 34, No. 8 Clinical and
Laboratory Standards Institute, Wayne, PA.
3.2
Contact Lenses in a Chemical Environment, Weissman, B.R.,
Occupational Health & Safety, October 2005.
4.0
Initial Author/Date: Mary B. Paoli BS,MT(ASCP)SBB, 11.03.2014
Revised By Author/Date:
Page 4 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.002.01 DISASTER ACTIVATION ACTION SUMMARY LABORATORY
1.0
Principle
The Palmetto Health Emergency Operation Plan (EOP) is designed to assist the hospital
incident commander and hospita l staff in conducting emergency operations during periods of
a declared emergency incident or periods of assist in other healthcare facilities during their
emergency incident through the Hospital Incident Command System (HICS). The EOP
addresses how Palmetto Health will manage preparedness and response, recover, and incident
mitigation.
2.0
Location of EOP
2.1
MyPal
2.2
Policies/Procedures
2.3
Scroll Down to RICHLAND
2.4
Click on Safety Manual
2.5
Click on Emergency Operating Plan
3.0
Activation
3.1
To activate the HICS program, the AOD or Administrator notifies the hospital operators
to contact a pre-determined selection of staff to respond to the activation.
3.2
The Operator will announce over the internal paging system “Code Incident
Command Stand-by” and will initiate the Emergency protocol.
3.3
The activating Administrator will select on-site staff to fill positions as needed until
they are replaced.
3.3.1 Any lab employee present could be designated a Clinical Support Services Unit
Team Leader or member.
3.3.2 Clinical Support Services Unit Leader Job Action Sheet is located on page 185
of the Emergency Operations Plan on MyPal.
3.4
Once verification has been obtained as to the type and extent of the response needed,
“Code Incident Command Activate” is announced along with the additional
announcement of the predetermined code above.
3.5
After all abnormal activities have ceased, the Administrator will direct the Operator to
announce “Code Incident Command Stand-Down” to return to normal operations.
4.0
Code “Incident Command Stand-by”
4.1
Blood Bank should take Blood Inventory and report as follows:
4.1.1 MyPal
4.1.2 Click on Richland
4.1.3 Click On Emergency Incident Bed Staff Report under Services
4.1.4 Unit: Choose Other
Page 5 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
4.1.5
4.1.6
4.1.7
5.0
Type in the inventory for Blood in the Comments section
Click: Submit Comments
Notify Lab Director that Inventory has been sent
Code “Incident Command Activate”
5.1
Laboratory
5.1.1 Blood Bank:
5.1.1.1 Report blood inventory to Incident Command as described in 4.1 if not
already submitted.
5.1.1.2 Notify Red Cross of possible need for additional blood.
5.1.1.3 Notify Laboratory Administrative Director or laboratory Administrator
on Call.
5.1.2 All Laboratory Sections:
5.1.2.1 Continue to function as necessary to support incident.
5.1.2.2 Laboratory personnel not required to support the
incident should report to the Personnel Pool in 9MP-Suite 130.
5.1.3 Laboratory Unit Team Leader:
5.1.3.1 Execute call tree as appropriate
5.1.3.2 Ensure that the most critical jobs are filled with available
employees and less critical jobs by employees returning to
the facility.
5.1.3.3 Continue to function as necessary to support incident.
5.1.3.4 Assist blood bank as necessary
5.1.3.5 Assist Emergency Department Lab as necessary
5.1.3.6 Maintain Activity Log of Events.
5.1.3.7 Evaluate on-hand equipment
5.1.3.8 Evaluate supplies and notify Clinical Support Services Unit
Leader in anticipation of needed supplies
5.1.3.9 Evaluate Laboratory Service’s capacity to perform ER, Hematology,
Chemistry and Blood Bank Services notify Clinical Support Services
Unit Leader with requests for personnel.
5.1.3.10 Evaluate plan of action/cancellation of routine services
5.1.3.11 Inform Clinical Support Services Unit leader of currently
available services.
5.1.3.12 Ascertain the approximate “turn around time” for results
5.1.3.13 Communicate with Clinical Support Services Unit Leader to
ensure accurate routing of test results
5.1.3.14 Observe and assist any staff who exhibit signs of stress and fatigue.
Report concerns to Clinical Support Services Unit Leader. Provide for
staff rest periods and relief.
5.1.3.15 Provide for routine meetings with Clinical Support
Services Unit Leader
Page 6 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
5.0
Clinical Support Services Unit Leader
5.1
Refer to Section 7, Clinical Support Services Unit Leader,
Job Action Sheet for detailed information to be provided to the Clinical
Support Services Unit Leader.
5.2
Lab Unit Team Leader reports to the Clinical Support Services Unit
Leader
6.0 Additional Information
7.1
Incident Command: 6th Floor Conference Room C; Phone 2023
7.2
Public Information Officer: 3MP-PR Conference Room; Phone
6891/3111
7.3
Logistics: Engineering Conference Room; Phone: 2739
7.4
Planning Section: 6th Floor Conference Room A; Phone 8442
7.5
Labor Pool: 9MP-Suite 130
7.6
Finance: Finance Office; Phone 6446
7.7
Operations: 6th Floor Conference Room B; Phone 2022
7.8
Human Services Director: Dining Room B; Phone 7206
7.9
Job Action Sheet in Section 7 (RED) section of EOP “Clinical
Support Services Unit Leader”
7.10 Laboratory requirements for Internal, External Disaster and Recovery
Plans in Section 9 Annex K of EOP (Copy attached).
8.0 Attachments
8.1 Clinical Support Services Unit Leader Job Action Sheet
8.2 Annex K: Laboratory
9.0 Reference
9.1
Palmetto Health Richland, Emergency Operations P lan, 2008.
10.0
Initial Author / Date : Christy Knight MT(ASCP)SC 5/04/06
Revised Author/ Date: Christy Knight BS MT (ASCP) SC 5/ 4/ 06
Mary.B.Paoli BS MT(ASCP)SBB 08.08.2014
Page 7 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Page 8 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Annex K: Laboratory
A. Mitigation/Preparedness


Each department will review its roles within the EOP and HICS.
Each department will also participate in the annual drills with the hospital.
B. Internal Response






Upon notification of internal incident, immediately conduct blood inventory and report levels to
Incident Command.
Notify Red Cross of possible need for additional blood.
Notify Laboratory Administrative Director or Laboratory Administrator on Call.
Continue to function as necessary to support incident.
Laboratory personnel not required to support the incident should report to the Personnel Pool
in the Human Resources classroom.
Maintain Activity Log of events.
C. External Response










Upon notification of internal incident, immediately conduct blood inventory and report levels to
Incident Command.
Notify Red Cross of possible need for additional blood.
Notify Laboratory Administrative Director or Laboratory Administrator on Call.
Execute call tree as appropriate.
Ensure that the most critical jobs are filled with available employees and less critical jobs by
employees returning to the facility.
Continue to function as necessary to support incident.
Assist blood bank as necessary.
Assist Emergency Department lab as necessary.
Laboratory personnel not required to support the incident should report to the Personnel Pool
in the Human Resources classroom.
Maintain Activity Log of events.
D. Recovery


For incidents occurring outside of the Laboratory:
 If incident occurs in a stat lab in another part of the facility, inventory equipment and
supplies.
 Requisition replacement equipment and supplies.
 Return to normal operations.
If incident occurs within the Laboratory:
 Secure area.
 Account for personnel.
Page 9 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________

 Remove equipment and records that can be removed.
 Assess and report damage.
 Relocate operations to assigned location.
 Have area repaired and cleaned.
 Return to the Laboratory when completed and return to normal operations.
Complete After-Action Report and attach the Activity Log and give it to the Safety Officer.
Page 10 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.003.01 LABORATORY EVACUATION PLAN
1.0
PRINCIPLE
There is a comprehensive, documented and workable evacuation plan
for the laboratory, including specific plans for any persons with
disabilities.
NOTE: 1. This plan must cover all employees, patients and visitors, and
should address the special needs of persons with disabilities. Evacuation
routes must be clearly marked (Posting evacuation routes is optional). 2.
Emergency lighting is adequate for safe evacuation of the laboratory.
Hasty evacuation can endanger lives through panic. The decision to evacuate will be made by
the Administrator on Duty or his designate. When this occurs, the Disaster Plan criterion
applies and all should leave the area in an orderly fashion, closing doors as you leave.
All employees should be familiar with the appropriate exit path for their assigned area. Escape
routes: A diagram of escape routes is posted in all Lab areas.
1.1
P.A. System announcements:
Code RED- FIRE
Code GREEN- Internal disaster, evacuate
1.2
The Unified Alert System will also be used to communicate using the PH
network.
1.3
Laboratory administration may call for an evacuation in the event of a
hazardous chemical spill.
2.0
RESPONSIBILITIES
2.1
Laboratory Safety Officer:
2.1.1 Determine the evacuation routes to be used in each area and post
signs.
2.1.2 Designate areas for employees to meet up and be accounted for in
the event of an evacuation.
2.1.3 Periodically walk the evacuation routes posted to determine
emergency exits are working correctly and that they are not
blocked and that lighting is adequate.
2.1.4 Include laboratory evacuation in the annual laboratory safety
training for all employees.
2.2
Laboratory Administration/Section Supervisors:
2.2.1 Include laboratory evacuation training in initial employee
orientation.
Page 11 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.2.2
2.3
Be aware of employees in their section that may need special
assistance in the evacuation process. Make a plan for getting these
employees to safety in the event evacuation is necessary.
2.2.3 Be able to account for their employees at the designated meeting
spot.
Employees:
2.3.1 Promptly stop work and leave the laboratory in an orderly manner
in response to a CODE RED, CODE GREEN, or a fire alarm.
2.3.2 Assist any patients in the area with evacuation.
2.3.4 Assist any special needs co-workers with evacuation.
2.3.5 DO NOT use elevators in the event of an evacuation.
2.3.6 Meet other employees in the agreed upon spot.
Initial Author/Date: Mary B. Paoli MT(ASCP)SBB 01.27.2015
Page 12 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective date: 04.01.2015
S1.004.01 BLOODBORNE PATHOGEN –EXPOSURE CONTROL PLAN
1.0
PURPOSE
1.1
Bloodborne pathogens are infectious microorganisms in human blood that
can cause disease in humans. These pathogens include, but are not limited to,
hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus
(HIV). Other potentially infectious materials (OPIM) is defined as the following:
saliva in dental procedures; semen; vaginal secretions; cerebrospinal,
synovial, pleural, pericardial, peritoneal, and amniotic fluids; body fluids
visibly contaminated with blood; along with all body fluids in situations
where it is difficult or impossible to differentiate between body fluids; unfixed
human tissues or organs (other than intact skin); HIV-containing cell or tissue
cultures, organ cultures, and HIV- or HBV-containing culture media or other
solutions; and blood, organs, or other tissues from experimental animals
infected with HIV or HBV.
1.2
In order to reduce or eliminate the hazards of occupational exposure to
bloodborne pathogens, we have implemented an exposure control plan for the
worksite with details on employee protection measures. The plan will
describe how we use a combination of engineering and work practice controls,
ensure the use of personal protective clothing and equipment, provide training
medical surveillance, hepatitis B vaccinations, and signs and labels, among
other provisions. Engineering controls are the primary means of eliminating or
minimizing employee exposure and include the use of safer medical devices,
such as needleless devices, shielded needle devices, and plastic capillary
tubes.
2.0
RESPONSIBILITY
2.1
Leadership
2.1.1 Perform a risk assessment of the workplace to identify and control
physical and health hazards.
2.1.2 To identify and provide appropriate PPE for employees.
2.1.3 Train employees in the use and care of PPE.
2.1.4 Maintain supply of PPE
2.1.5 Periodically review and update the effectiveness if the PPE program
2.1.6 Counseling will occur when employees fail to follow hospital or
laboratory exposure control and PPE guidelines.
2.1.7 The annual consideration and implementation of appropriate
commercially available and effective safer medical devices designed to
eliminate or minimize occupational exposure.
Page 13 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.2
3.0
Employees
2.2.1 Properly wear PPE
2.2.2 Attend training, take and pass the Laboratory Safety Test.
2.2.3 Select appropriate PPE for the circumstances
2.2.4 Care for and maintain PPE
2.2.5 Inform supervisor of the need to repair or replace PPE
2.2.6 Aid in the identification, evaluation, and selection of effective
engineering and work practice controls.
METHODS OF COMPLIANCE INCLUDE:
3.1
UNIVERSAL/STANDARD PRECAUTIONS: Treating all human blood and OPIM
as if known to be infectious for bloodborne pathogens.
3.2
PERSONAL PROTECTIVE EQUIPMENT: Personal Protective Equipment is
specialized clothing worn by an employee for the protection against a hazard.
They are provided at no cost to employees. General work clothes such as
uniforms and lab coats are not intended to function as protection against
hazards and therefore do not fall into the category of protective equipment.
3.2.1 gloves
3.2.2 disposable lab coats/gowns (resistant to liquids)
3.2.3 masks
3.2.4 face shields
3.2.5 particulate filter respirators
3.2.6 air-mate personal air-powered respirators
3.3
ENGINEERING CONTROLS: Engineering controls are used to control
exposure to occupational hazards by removing a hazard or placing a barrier
between the worker and the hazard.
3.3.1 stationary shields
3.3.2 needle-less transfer devices
3.3.3 self-sheathing needles
3.3.4 clean vs. dirty sink designations
3.3.5 clean vs dirty keyboards and phones
3.3.6 eye washes and safety showers
3.3.7 sealed bags for specimen transport
3.3.8 automatic pipettors
3.3.9 pipette bulbs
3.3.10 Biological Safety Cabinets (BSC)
3.3.11 Negative Pressure rooms, anterooms
3.4
WORK PRACTICE CONTROLS: Work practices are procedures and policies
put in place to reduce exposure.
3.4.1 Frequent hand washing
3.4.2 No eating, drinking, applying cosmetics, or handling contact lenses in
lab areas
3.4.3 No recapping of needles
3.4.4 No mouth pipetting.
Page 14 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
3.5
3.6
3.7
HOUSEKEEPING: includes cleaning of laboratory surfaces and proper
disposal of hazardous waste.
3.5.1 All spills of biohazardous material will be cleaned up immediately. Refer to
SPILL CLEANUP PROCEDURE. Employees working in the department
should clean the biohazardous spills and any splashes of material on
laboratory surfaces.
3.5.2 All benches should be cleaned with freshly-made 10% bleach or
hospital approved disinfectant on a scheduled basis.
3.5.3 Telephones and keyboards should be cleaned with freshly-made 10%
bleach or hospital approved disinfectant
3.5.4 All equipment that may be contaminated must be examined and
decontaminated as necessary before servicing or shipping. If
complete decontamination is not feasible, the equipment must be
labeled with the required biohazard label which also specifically
identifies which portions of the equipment remain contaminated. In
addition, the employer must ensure that this information is conveyed
to the affected employees, the servicing representative, and/or the
manufacturer, as appropriate, before handling, servicing, or shipping.
HEPATITIS B VACCINE: This vaccine is offered to all workers with occupational
exposure.
3.6.1 Vaccine that induces immunity against the hepatitis B virus in 80-95% of those
who take the vaccine (not 100%).
3.6.2 This vaccine is offered free to any PH employees that has contact with blood
and other infectious materials.
3.6.3 It is not mandatory that all employees in this category take the vaccine;
however, employees who elect not to take the vaccine sign a form that
explains that they may change their mind and take the vaccine at any time.
3.6.4 The vaccine consists of a series of 3 shots given over a six month period.
3.6.5 According to Health Works, CDC says that once a person has demonstrated
immunity with the vaccine, they are always immune. No booster shots are
needed.
POST EXPOSURE TO BLOOD BORNE PATHOGEN: What should you do if you
had an exposure to blood or body fluid (needle stick, splash to eyes, nose or mouth;
or blood or body fluid into non-intact skin).
3.7.1 Wash the area with soap and water or flush eyes or mucous membranes with
water.
3.7.2 Report to person in charge.
3.7.3 Go immediately to Health Works if they are open. Health Works is open from
Mon-Fri., 800 to 1630.
3.7.4 If accident occurs when Health Works is closed; report to lab person in
charge. Report immediately to the Nursing Administrator on call. Follow their
directions.
3.7.5 If accident is severe go to the ED immediately.
Page 15 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
3.7.6
3.8
3.9
4.0
Risk assessment will be done and treatment started if indicated. To be most
effective treatment should be started within 2 hours of accident. It is therefore
very important to report accident quickly.
3.7.7 Post-exposure evaluation and follow-up. Refer to Palmetto Health Safety
Policy No. 8262-1041 Employee Accident Reporting and Investigating.
3.7.8 Employee health will report all sharps injuries to OSHA.
TRAINING: all laboratory employees will have training on the Bloodborne Pathogen
Standard initially and annually thereafter.
3.8.1 Regular training covers information on bloodborne pathogens and diseases,
methods used to control occupational exposure.
3.8.2 All laboratory employees will take the current year’s Laboratory Safety Test
with reviews of important material. A passing grade of 80% is required.
3.8.3 All employees will participate in the “Hands-On Safety” class and will have
the opportunity to ask the trainer questions.
LABELS and SIGNS:
3.9.1 Warning labels are affixed to containers of regulated waste; refrigerators and
freezers containing blood or OPIM; contaminated equipment that is being
shipped or serviced.
3.9.2 The Biohazard symbol will be posted in areas where exposure to bloodborne
pathogens occurs.
3.9.3 Universal biohazard label must appear on anything that has blood/body fluids
in or on it that enters or leaves PH laboratories.
TERMS
4.1
OSHA stands for: Occupational Safety and Health Administration
4.2
Bloodborne pathogens: pathogenic microorganisms that are present in human blood,
blood products, other potentially infectious material contaminated with blood, and can
cause disease in humans.
4.3
OPIM Other potentially infectious materials
4.4
Hazard: potential source of harm.
4.5
HIV: Human Immunodeficiency Virus. A virus that attacks the immune system and
causes AIDS. Life threatening Bloodborne pathogen. Less infective than HBV because
it is a more fragile virus.
4.6
HBV: Hepatitis B Virus: A virus infection which invades the liver. Potentially life
threatening Blood borne pathogen. Virus can survive on surfaces at room temperature
for up to 7 days.
4.7
HCV: Hepatitis C Virus: is an infectious disease affecting primarily the liver, caused
by the hepatitis C virus (HCV). The infection is often asymptomatic, but chronic
infection can lead to scarring of the liver and ultimately to cirrhosis, which is generally
apparent after many years. In some cases, those with cirrhosis will go on to
develop liver failure, liver cancer, or life-threatening esophageal and gastric varices.
4.8
Risk Groups for HIV and HBV are: homosexual/bisexual males, IV drug users,
heterosexual contact with someone infected with either virus, rare case of blood/tissue
Page 16 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
4.9
4.10
4.11
4.12
5.0
6.0
transfer to recipient. HCV is spread primarily by blood-to-blood contact associated
with intravenous drug use, poorly sterilized medical equipment, and transfusions.
Modes of transmission: sexual contact involving the sharing of body fluid, needle stick
or contact with blood through mucous membranes and non-intact skin, perinatally,
receiving blood or blood products & organ transplantation.
Standard Precautions: At Palmetto Health we follow standard precautions, which means
that we treat all blood and body fluid as if it has the potential to transmit disease.
Airborne Precautions: applies to patient’s known or suspected to have serious
illnesses transmitted by airborne droplet nuclei. Patients who are either diagnosed as
having TB or who have signs/symptoms of TB may be placed in isolation rooms. An
airborne isolation sign will be on these patients’ door. Employees who enter these
rooms must wear the PPE required by infectious control.
Contact Precautions: applies to patients known or suspected to have serious illnesses
easily transmitted by direct patient contact or by contact with items in the patient’s
environment.
PPE USE GUIDELINES
5.1
PPE should be worn as provided, not modified by the employee.
5.2
Fluid resistant lab coats are long sleeved and knee-length.
Employees are not allowed to shorten lab coats or work with the
sleeves pushed up.
5.3
Fluid resistant lab coats should be worn completely snapped shut.
5.4
Employee ID badges should be worn inside of the
fluid resistant lab coats so that they do not dangle or
come in contact with hazardous material.
5.5
When gloves are worn they should cover the wrist area and meet
the cuff of the fluid resistant lab coat.
5.6
PPE must be removed when leaving the technical work area and
not worn in common (clean) areas or leave the laboratory for other
hospital areas.
5.7
Offices in the laboratory are considered “clean” areas as are bathrooms and
break rooms.
5.8
Do not hang or place dirty PPE in same area as clean PPE.
5.9
Face shield are to be cleaned when visibly dirty with freshly-made
10% bleach or CaviCide.
5.10 Shoes must meet OSHA safety standards.
5.10.1 Shoes must completely cover the entire foot.
5.10.2 Fluid-resistant shoes must be worn. They should not have any
perforations. Canvas athletic/tennis shoes are not permitted.
5.10.3 Shoes that have rubber soles should be worn to prevent slips and
falls.
ASSESSMENT OF LAB JOB CLASSIFICATIONS
6.1
Following this page is a chart of Job Classifications for the Laboratory and
their exposure risks.
Page 17 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
6.2
6.3
The risk assessment of all laboratory procedures is made by the Supervisor/team
leader of each department and approved by Lab Safety Officer and the
Administrative Director of Lab. Safety policies are established for each task
performed, and engineering controls and protective equipment assigned.
As a minimum, all employees handling blood and body fluids must wear
gowns and gloves and face shields when splashes or aerosolization may occur
and eyes are not otherwise shielded.
Job Titles
Lab Director
Lab Manager
Core Lab Manager
Blood Bank Manager
Billing Manager
Quality Information
Coordinator
Division Supervisor
MT IV, III,II,I MLT I,II,III
MT & MLT students
HTI,II, HTN I,II, trainees
Phleb I, II
Lab assist I, II, III
Transporter
Transcriptionist
Administrative coordinator
Pathologist Assist. I, II
Tasks/Procedures of Risk
Occasional handling of all sources of body fluids and/or tissue
specimens, occasional patient contact.
Occasional handling of all sources of body fluids and/or tissue
specimens, occasional patient contact.
Occasional handling of all sources of body fluids and/or tissue
specimens, occasional patient contact.
Occasional handling of all sources of body fluids and/or tissue
specimens, occasional patient contact.
Exposure to contaminated keyboard and lab areas.
Exposure to contaminated keyboard and lab areas.
Handling of all sources of body fluids and/or tissue and /or
formaldehyde.
Handling of all sources of body fluids and/or tissue and /or
formaldehyde.
Exposure to potentially infectious tissue, body fluids and
formaldehyde.
Handling all sources of body fluids and/or tissue. Patient
contact, performs invasive (phlebotomy) procedures,
needlestick risk, exposure to blood, throat/NP collections.
Receives and transports specimens of body fluids with in the
laboratory.
Handling of all sources of body fluids and/or tissue
Exposure to hazardous biological waste. Handling all sources
of body fluids and/or tissue.
Limited exposure to prepared slides.
Limited exposure to prepared slides.
Exposure to potentially infectious tissue, body fluids and
formaldehyde.
Page 18 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective date: 04.01.2015
S1.005.01 LABORATORY RISK ASSESSMENT
1.0
Principle
Upsurges in global population, together with the free movement of goods and people across
national borders, have increased the likelihood for rapid worldwide transmission of infectious
agents. This potential for the rapid transmission of novel agents also increases the risk of
laboratory workers acquiring infections as a result of their occupational exposure to potentially
infectious patient material.
In the preexamination phase, there is an increased risk of percutaneous injury during blood
specimen collection through exposure to infectious aerosols or through direct contact with
patients or specimens during transport. In the examination phase, specimen and culture
manipulations expose the laboratory worker to numerous risks, including laboratory accidents
and equipment. Management of biohazardous waste presents the risk associated with the
postexamination phase. Experience has demonstrated that implementing practices that
decrease the worker’s exposure to potentially infectious materials can minimize the risk of
infection. These practices include designing facilities appropriately, effective training and
consistent application of safe laboratory practices, following standard precautions, using
personal protective equipment and safety devices, and the appropriate handling of biohazardous
waste.
A risk assessment is a process that is used in the laboratory to identify:
1.1
The hazards associated with an infectious agent or material in the laboratory that
is known to be infectious or could potentially be infectious or hazardous.
1.2
The activities that might lead to exposure to the infectious agent, material or
chemical hazard.
1.3
The risk should be assessed by focusing on the appropriate safety practices for
handling infectious material rather than on a specific infectious agent.
2.0
Responsibility of:
2.1
Leadership
2.1.1 Supervisors perform a risk assessment of the workplace activities to
identify and control physical and health hazards.
2.1.2 Train employees in the use and care of PPE.
2.1.3 To identify and provide appropriate PPE for employees.
2.1.4 Enforce the use of PPE; counseling will occur when employees
fail to follow hospital or laboratory exposure control and PPE
guidelines.
2.1.5 Periodically review and update the effectiveness of the PPE
program.
2.1.2 The Laboratory Safety Officer will review risk assessments with the
supervisors and submit them to the section managers for approval.
Page 19 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.1.3
2.2
Once approved the risk assessments will be part of the sections procedure
manual to be reviewed by all employees working in that section.
Employees must:
2.2.1 Properly wear PPE
2.2.2 Attend training in lab
2.2.3 Select appropriate PPE for the circumstances according to the Risk
Assessment.
2.2.4 Care for and maintain PPE, know location
2.2.5 Inform supervisor of the need to repair or replace PPE
3.0
Risk Assessment
3.1
List Procedure or Process- supervisors can be as generic or detailed as they
choose for the procedures.
3.2
Identify Hazards-identify activities and their hazards, considering the agent, the
laboratory procedures and equipment and the personnel. Exposure to Bloodborne
Pathogens and OPIM should be listed for all laboratory procedures.
OPIM-other potentially infectious materials include human body fluids:
semen, vaginal secretions, cerebrospinal fluid, synovial fluid, synovial fluid,
pleural fluid, pericardial fluid, peritoneal fluid, amniotic fluid, any unfixed tissue
or organ.
3.2.1 Consider the predominant probable routes of transmission in the
laboratory:
3.2.1.1 Direct skin, eye or mucosal membrane exposure to an agent;
3.2.1.2 Parenteral inoculation by a syringe needle or other contaminated
sharps.
3.2.1.3 Ingestion of liquid suspension of an infectious agent, or by
contaminated hand to mouth exposure;
3.2.1.4 Inhalation of infectious aerosols.
3.2.2 Consider the Likelihood of an exposure;
Risk Assessment Factors Guide- Likelihood
Score Likelihood Definition
1
Very
Little or no chance of occurrence- would require an extraordinary
unlikely
combination of factors for the situation to result
2
Unlikely
Conceivable- occurrence would require multiple failures of systems and
controls or a rare combination of factors
3
Possible
Possible when additional factors are present, but otherwise unlikely to
occur.
4
Likely
Such an event is known to have occurred and represents a credible scenario.
An additional factor may result in an incident.
5
Probable
Almost inevitable that an incident would result
3.2.2.1 For any procedure or process that has a Likely or Probable
likelihood consider any extra precautions that may reduce the risk
of employee exposure.
Page 20 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
3.3
3.4
3.4
3.5
4.0
Identify Controls and Work Practices- risk mitigation strategies.
3.3.1 Refer to S 1.004.01 Bloodborne Pathogen Exposure Control Plan.
3.3.2 Safety equipment/engineering controls include:
Stationary shields
Pipette bulbs/automatic pipettors
Fume hoods
Biological Safety Cabinets
Negative Pressure/anterooms
Sealed bags for specimen transport
Self-sheathing needles
Needle-less transfer systems
Eye washes/Safety Showers
Housekeeping- daily disinfection of work surfaces.
Recommended PPE: list PPE required to be worn to perform the procedure(s).
Implement Controls- Implement controls in order to reduce risk to an acceptable
level (elimination, substitution, engineering controls, administrative controls and
PPE).
Monitor Improvement to Controls-Monitor the effectiveness of controls and
identify opportunities for improvement.
Microbiology Special Risk Areas: Often there is not sufficient information to make an
appropriate assessment of risk. For example, the hazard of an unknown agent that may be
present in a diagnostic specimen will be unknown until after completing agent identification
and typing procedures. It would be prudent in this case to assume the specimen contains an
agent presenting the hazardous classification that correlates with BSL-2, unless additional
information suggests the presence of an agent of higher risk.
4.1
General Micro exposure control rules:
4.1.1 Never smell cultures
4.1.2 If test tubes are used for cultures, they should have screw type caps,
and not cotton, plastic, foam or loose metal closures.
4.1.3 Do not set up slide cultures or perform scotch-tape preps on isolates
that may be Histoplasma, Blastomyces or Coccidioides.
4.1.4 Decant supernatants into containers or disinfect.
4.1.5 Wipe off work area with 2% Vesphene before and after
each day’s work.
4.1.6 If a culture is dropped or spilled, wear gloves, gown and face shield,
pour 2% Vesphene over contaminated area and cover with paper
towels. Respray with Vesphene. Let stand at least 15 minutes. Wipe
up spill and deposit contaminated material in red biohazard bag.
4.1.7 Mycology petri dishes must be sealed with parafilm or oxygenpermeable tape. Open dishes in hood only.
4.1.8 Microbiology tech should be offered additional vaccines to protect from
meningitis and pneumonia.
Page 21 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Techs reading cultures should be familiar with the “trigger points” that may
indicate the organism is a select agent. All suspected select agents must be
worked up in the biological safety cabinet and not identified using the automated
instruments which may produce aerosols.
General exposure rules for Mycobacteria Lab BSL 3 area:
4.2.1 Surfaces should be cleaned with 2% Vesphene. Contact time of 10 to 30 min. is
adequate.
4.2.2 Before carrying out any transfer procedures in the hood, the tech should cover
the base of the working surface with paper towels that have been thoroughly
moistened with Vesphene. This cover will control inadvertent surface
contamination from droplets or spillage from containers.
4.2.3 A vesphene soaked gauze sponge should be used to wipe the edge of centrifuge
tubes and other containers after potentially contaminated solutions have been
transferred.
4.2.4 The transfer of specimens from one container to another, mixing of specimens
for concentration, preparation of smears, and inoculation and transfer of
culture must be done under HEPA-filter hood.
4.2.5 The Mycobacteria work room should be kept scrupulously clean. The work
surface of the hood should be swabbed with Vesphene before and after
work, and it should be irradiated with UV light when not in use.
4.2.6 If a filter change on the hood is needed, it must be done with due precaution by
an individual who is specially trained.
4.2.7 It should be recognized that working in a hood with the exhaust turned off and
vented to the outside may cause airflow into the face of the operator,
constituting a greater hazard than working in an open laboratory.
4.2.8 For material subjected to shaking or centrifugation, use containers sealed with
plastic screw caps. Closed centrifuge tubes containing clinical specimens
should be placed in sealed centrifuge cups under the hood, and then carried to
the centrifuge.
4.2.9 Masks should not be touched with contaminated hands.
4.2.10 When finished processing specimens, gloves, gowns and masks should be
removed using proper technique and placed in a red biohazard bag before
leaving the Mycobacterial processing room.
Spills in the Mycobacteriology Lab:
4.3.1 Accidents that occur in the Mycobacteriology lab may be of two types: those
that generate minimal aerosol and those that produce large quantities of
potentially infectious aerosol.
4.3.2 A minimal aerosol may be created by a single tube of solid medium being
broken , dropping a plastic petri dish, or spilling the contents of a sputum
specimen. In these cases, the solid medium and the thick mucoid nature of the
sputum specimen greatly limit large numbers of bacilli from
being aerosolized. When a minor accident occurs, the following procedure
should be done:
4.1.9
4.2
4.3
Page 22 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
4.3.2.1 Cover spill immediately to prevent further aerosolization .
4.3.2.2 Soak the cloth covering the spill with disinfectant (bleach or
vesphene).
4.3.2.3 Leave the room for at least 2 hours.
4.3.2.4 Wearing protective clothing (gown, mask, gloves) reenter the
room to clean up the spill.
4.3.2.5 Place materials in appropriate containers and autoclave.
4.3.2.6 Clean all surfaces (floors, counters, equipment) with disinfectant.
4.3.2.7 Document through Health Works all employees potentially exposed.
5.0
Autopsy Special Risk Area: Routine autopsy procedure and protocol is such that, in
addition to Standard blood and body fluid precautions all persons performing or
assisting in postmortem, procedures should use:
5.1
Double-gloves
5.2
Respirator: Racal Personal Air-powered Respirator or UVEX if fit tested.
5.3
Face shield with UVEX
5.4
Gowns
5.5
Waterproof apron
5.6
Instruments and surfaces contaminated during postmortem procedures
should be decontaminated with an appropriate chemical germicide.
5.7
Instruments and dissecting tables are kept flushed with running water
during the gross dissection.
5.8
Disposable items and linens are wrapped according to standard
procedure and autoclaved for contaminated and significant infectious
cases.
5.9
The funeral director receiving the body after autopsy is notified and
given appropriate advice relative to their body preparation procedures.
5.10 Special precautions are taken for cases of Jakob-Creutzfeldt disease.
5.10.1 Gowns, respirators and gloves are worn.
5.10.2 All tissues, organs and fluids are hand-processed with separate disposal of all
solutions and containers involved in the procedure.
5.10.3 All instruments, tissues and fluids for disposal are autoclaved for 1 hour at 121
p.s.i., prior to disposal.
5.10.4 Following the gross dissection, the morgue table is cleaned with copious
amounts of 5% hypochlorite solution (bleach) and copious amounts of
hypochlorite are flushed down the sink drain..
5.10.5 Radioactive Substances: For bodies contaminated by radioactive
substances, the radiation safety office or equivalent is called for advice
prior to handling of the body.
6.0
Novel Disease Laboratory- Special Risk Area.
The Novel Disease laboratory was opened to provide a laboratory area in which testing
on specimens from patients under investigation for Ebola Virus Disease may be carried
Page 23 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
out safely. This laboratory may be used for testing specimens from patients in the
Novel Disease Unit of Palmetto Health Richland no matter what disease they may have.
Risk mitigation strategies include:
6.1
Limiting the number of staff engaged in specimen testing.
6.2
Segregating the equipment used for testing.
6.3
Performing testing in a dedicated space.
6.4
Using POC equipment in the Novel Disease Unit.
6.5
Specimen management and transport, including the path of the sample from the
Novel Disease Unit to the laboratory avoiding high-traffic areas and pneumatic
tubes.
6.6
All testing is to be performed in a certified Biological Safety Cabinet, class II.
6.7
Solid front wrap around gowns that are fluid-resistant or fluid impermeable.
6.8
A surgical mask that covers all of the nose and mouth.
6.9
Eye protection such as a full face shield.
6.10 Two pairs of disposable gloves.
6.11 Use of centrifuges with sealed buckets, opened inside the BSC.
6.12 Use of disinfectant as recommended b y the CDC.
6.13 Autoclaving of all waste including used PPE
6.14 Special training on donning and doffing PPE
7.0
Reference:
7.1
CDC Public Health Mycobacteriology A Guide for the Level III Laboratory
7.2
CLSI M29-A4 Protection of Laboratory Workers From Occupationally Acquired
Infections; Approved Guideline – Fourth Edition, Volume 34 number 8, Clinical and
Laboratory Standards Institute, Wayne, PA 19087.
7.3
Guidance for U.S. Laboratories for Managing and Testing Routine Clinical Specimens
When There is a Concern About Ebola Virus Disease. Center for Disease Control and
Prevention. March 19,2015.
7.0
Initial Author / Date : Mary.B.Paoli BS MT(ASCP)SBB 03.11.2015
Page 24 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.006.01 INFECTIOUS WASTE MANAGEMENT PLAN
(LABORATORY ADDENDUM TO HOSPITAL PLAN)
1.0
PURPOSE AND/OR PRINCIPLE
To describe the procedures for the systematic control of the collection, identification,
packaging, storage, transportation, treatment and disposal of infectious wastes generated within
the confines of Palmetto Health Laboratory. Waste that is not properly handled can create
conditions that may cause severe adverse effects on public health and the environment.
2.0
GENERAL INFORMATION:
2.1
Infectious waste (described in SC Infectious Waste Management Act, Act
Number 134 of 1989) is defined as any waste, solid, or liquid that is
generated in the health care community in the diagnosis, treatment,
immunization, or care of human beings; generated in autopsy or necropsy;
generated in research pertaining to the production of biologicals which
have been exposed to human pathogens; generated in research using
human pathogens. It is broadly defined as waste capable of producing
infectious disease.
2.2
All persons required to handle infectious wastes or materials will be
provided with appropriate orientation, equipment, and on-the-job training.
3.0
IDENTIFICATION
3.1
Infectious waste will be classified as infectious in accordance with CDC
recommendations and DHEC regulations, and at a minimum, the
following will be classified as infectious.
3.1.1 Bulk blood and body fluids including supersaturated absorbent
materials (i.e. items so saturated with blood or body fluids that
they will allow pooling or dripping of these liquids during the
normal handling process).
3.1.2 It may include serum, plasma, and other components of blood,
visibly bloody body fluids such as suctioned fluids, excretions, and
secretions.
3.1.3 Pathological and microbiological waste (i.e. Pathologicals) - all
tissues, organs, limbs, and other body parts removed from the
whole body, excluding tissues which have been preserved with
formaldehyde or other approved preserving agents.
3.1.4 Microbiologicals - specimens, cultures and culture dishes/devices
used to transfer, inoculate and mix cultures.
Page 25 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
3.1.5
3.2
4.0
All sharp items that may cause puncture or cuts such as needles,
capillary tubes, and scalpel blades must be placed in puncture
proof- red sharps containers.
3.1.6 Class IV wastes (i.e. all waste generated from patients in isolation
for Class IV communicable diseases - smallpox, Lassa fever, Tickborne encephalitis virus complex, Marburg fever).
The classification of infectious waste will be reviewed/revised as
regulations are modified or updated.
PACKAGING, STORAGE, AND TRANSPORTATION:
4.1
Infectious waste will not be placed in a trash.
4.2
Infectious waste will be segregated from other waste by containing in
disposable red or orange plastic bags which are impervious to moisture
and have sufficient strength to prevent tearing.
4.3
Needles and sharps will be discarded immediately or as soon as feasible
into containers that are:
4.3.1 Closable
4.3.2 Puncture resistant
4.3.3 Leakproof on sides and bottom
4.3.4 Labeled or color-coded as a biohazard
4.3.5 Easily accessible
4.3.6 Maintained upright throughout use
4.3.7 Replaced routinely and not be allowed to overfill containers which
can either be taped closed or sealed with a tight fitting lid.
4.4
Infectious waste contained in disposable red bags and sharps containers
will be placed in sturdy, red plastic biohazard bins.
4.5
These collection containers will be placed in the designated area until
picked up by the contractor. They are then sent out for incineration.
4.6
Other regulated wastes should be placed in containers that are:
4.6.1 Closable
4.6.2 Constructed to contain all contents and prevent leakage of fluids
during handling, storage, transport or shipping
4.6.3 Labeled or color-coded as a biohazard
4.6.4 Closed prior to removal to prevent spillage or protrusion of
contents during handling, storage, transport or shipping.
4.7
All spills of infectious waste will be cleaned up immediately and then
Environmental Services will be contacted to clean the area.
4.7.1 Blood spills will be cleaned immediately by a person wearing
gloves and using a hospital approved disinfectant or a 1:10 dilution
of household bleach.
4.7.2 Any spillage, or injury from handling infectious wastes will be
reported through Health Works. They will be responsible for the
SERO and reporting to other appropriate areas.
Page 26 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
4.8
Infectious waste will be transported from areas where generated to the
storage area fully enclosed in the collection container by the most direct
route that minimizes exposure to patients, visitors, staff, and community.
5.0
OFF-SITE DISPOSAL:
In the event infectious waste cannot be disposed of on-site, it will be collected, transported,
and stored in the manner previously described in preparation for delivery to the container
provided and maintained by the Contractor.
The Contractor will pick up and transport the infectious waste in a leak-proof, fully
enclosed container, to a site approved by all regulatory bodies for handling and disposing of
infectious wastes.
It is the responsibility of the Contractor to maintain all valid permits relevant to disposing of
infectious waste.
6.0
DISPOSAL OF MICROBIOLOGY PLATES
6.1
According to new guidelines published in South Carolina Infectious Waste
Management Regulations, R.61-105, all positive culture plates should be
decontaminated before disposal.
6.2
Decontamination of this potentially infectious material in PHR laboratory
is accomplished by steam sterilization. The autoclave uses moist heat at
greater than atmospheric pressure to kill infectious agents. (See the
Autoclave manual for details of operation.)
6.3
SUPPLIES AND REAGENTS:
6.3.1 Gloves
6.3.2 Autoclave Bags (CMS)
6.3.3 Autoclave tape
6.3.4 Biological Indicators (ATTEST)
6.4
PRECAUTIONS:
6.4.1 To avoid burns by the rush of steam that escapes through the crack
in the autoclave door, open the door slowly. Crack the door and let
stand for several minutes before opening fully.
6.4.2 Read autoclave procedure thoroughly before attempting procedure.
6.4.3 Gloves should be worn when you are placing material in the
autoclave and when removing.
6.4.4 Positive AFB specimens should be autoclaved for 1 hour.
6.5
PROCEDURE:
6.5.1 All positive plates from the workbenches are to be placed in
autoclave bags. The plates should be double bagged.
6.5.2 All material to be autoclaved should be loosely packed so that the
steam can circulate freely.
6.5.3 The bag should be closed with autoc lave tape so that there is a
visible hole in the gathering of the top of the bag. This is to release
any pressure that may build up and prevent spewing of the
contents.
Page 27 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
6.5.4
The bags should be labeled as positive plates and the date. This
can be written on autoclave tape across the front of the bag.
6.5.5 A biological indicator should be placed inside the autoclave with
the positive plates. This should be performed weekly on Sunday.
6.5.6 The biological indicator should be incubated after steam
sterilization and checked for a change of the indicator. (See
autoclave procedure for more details about biological indicator.)
6.5.7 All positive plates and positive AFB slants should be autoclaved at
250°F for 60 minutes.
6.5.8 After treatment, is easier and less messy if the autoclaved plates
are allowed to solidify before disposal. Waste should be double
bagged and placed in the red biohazard bin.
6.5.9 Alwayswear autoclave gloves when opening autoclave or
disposing of autoclaved materials.
6.5.10 Wash hands thoroughly after handling the autoclaved materials.
6.5.11 Notify the CLS or tech-in-charge if there is a problem with the
autoclave (i.e., proper temperature not attained).
7.0
LABORATORY POLICY-INFECTIOUS WASTE
PH Microbiology lab is in accordance with S.C. Disposal of Infectious Waste Management
Regulations.Page 14: S.C. Infectious Waste Management Regs.
7.1
Biological indicators (Bacillus stearothermophilus) will be used weekly
to monitor the autoclave. The indicator will be placed at the center of the
load to be processed under standard operating conditions.
7.2
The printout record of the temperature and time duration will be checked
at the completion of the autoclave cycles to ensure that each load has
attained 121°C (250°F) for 45 minutes. Note: TB specimens will be
autoclaved for 1 hour.
7.3
Sterilizer tape will be used on each bag and checked at the completion of
the cycle for changes indicating that the proper temperature has been
reached.
7.4
In the event that the proper time and temperature was not attained, the
supervisor will be notified, the load run again, and if still not adequate,
Engineering will be notified to service the autoclave.
7.5
Records of all testing results (printouts, biological indicators) will be
maintained by the laboratory and kept on file in the laboratory for at least
3 years. Maintenance records are kept in the Engineering Department.
7.6
Quarterly reports will be made to the Infection Control Committee.
7.7
All laboratory personnel responsible for handling and autoclaving of
infectious waste will receive training and supervision in these procedures
in accordance with the preceding procedures.
Page 28 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
8.0
REFERENCES:
8.1
8.2
8.3
8.4
8.5
8.6
8.7
8.8
8.9
U.S. Department of Health and Human Services, Public Health Services,
CDC, Guidelines for the Prevention and Control of Nosocomial
Infectious, Atlanta, Georgia, February 1981.
U.S. EPA Infectious Waste Management Guidelines, 1986. Springfield,
Virginia, National Technical Information Services.
U.S. Department of Health and Human Services, CDC, Disposal of Solid
Wastes from Hospitals, 2nd Revision, Atlanta, Georgia Bureau of
Epidemiology, June 1980.
"Hazardous-Infectious Waste Management for Hospitals and Healthcare
Facilities", American Environmental Systems, Torrance, California 1985.
U.S. Department of Health and Human Services, Center for Disease
Control (CDC); Isolation Techniques for Use in Hospitals, 1983.
Joint Commission on Accreditation of Hospitals, Accreditation Manual for
Hospitals, 1988 Edition. Chicago, Illinois 1986.
CDC, "Recommendations for Prevention of HIV Transmission in
Healthcare Settings", MMWR 1987; 36:25-185.
South Carolina Infectious Waste Management Regulations, R.61-105.
Protection of Laboratory Workers from Instrument Biohazards and
Infectious Disease Transmitted by Blood, Body Fluids and Tissue;
Approved Guideline. NCCLS, M29-A, Dec. 1997.
Initial Author/Date: Mary Sue Sawyer MBA, MT(ASCP) before 1998
Revised By Author/Date: Fay Parker-Brown MBA, SM(ASCP) 1/12/01, 5/14/03, 8/12/06, 9/20/07,
8/24/09, 9/2/10. Mary B. Paoli MT(ASCP)SBB 6/17/14
Page 29 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.007.01 CHEMICAL HYGIENE PLAN
1.0 PURPOSE: The Chemical Hygiene Plan was developed to inform employees who work with
hazardous chemicals of the risks associated with those chemicals.
The Laboratories at Palmetto Health are committed to providing a safe working environment. The purpose
of this plan is to minimize all chemical exposures and set procedures, equipment, personal protective
equipment, engineering controls and work practices to protect employees from the health hazards presented
by hazardous chemicals used in the laboratory and comply with the requirements of the Occupational
Safety and Health Administration (OSHA) and “Occupational Exposure to Hazardous Chemicals in
Laboratories for laboratory employees 29 CFR 1910.1450 by:



Prescribing equipment to include personal protective equipment, implementing
procedures and work practices that protect employees from the health hazards
associated with hazardous chemicals used in the lab.
Maintaining employee exposures below Permissible Exposure Limits for OSHA
regulated substances.
Training employees.
This plan will be readily available to employees in the safety manual and will be reviewed and
updated annually. Laboratory operations and work procedures are reviewed to ensure that
personnel are following safe procedures and are being protected properly. Changes are made to
procedures as necessary. The policies and procedures set forth in this plan are applicable to all
laboratory operations and personnel.
2.0 RESPONSIBILITIES
The responsibility for chemical hygiene rests at all levels including the following:
2.1
The Medical Director of the laboratory assumes ultimate responsibility for chemical
hygiene and provides continuing support for institutional chemical hygiene.
2.2
The Safety Officer of the Laboratory is assigned the duty of Chemical Hygiene Officer
and is responsible for the chemical hygiene in the laboratory. They must have the
authority to implement and enforce the plan.
2.2.1 The Chemical Hygiene Officer’s duties are to:
2.2.1.1 Develop and implement appropriate chemical hygiene policies and
practices.
2.2.1.2 Monitor procurement, use, and disposal of chemicals used in the
laboratory.
2.2.1.3 Establish audit procedures.
2.2.1.4 Develop guidelines for safety precautions and ensure adequate facilities.
Page 30 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.3
2.4
2.2.1.5 Know the current legal requirements concerning regulated substances.
2.2.1.6 Seek new ways to improve the Chemical Hygiene Program.
2.2.1.7 Review and update CHP annually.
The Laboratory Supervisors have overall responsibility for daily chemical hygiene in
the laboratory.
2.3.1 Specific duties include:
2.3.1.1 Ensure that laboratory employees know and follow the chemical hygiene
rules that protective equipment is available and in working order, and
that appropriate training had been provided.
2.3.1.2 Ensure all new hires are informed and trained on specific chemical
hazards present in the lab.
2.3.1.3 Provide regular, formal chemical hygiene inspection including routine
inspections of emergency equipment.
2.3.1.4 Know current legal requirements concerning regulated substances.
2.3.1.5 Determine the required levels of protective apparel and equipment.
2.3.1.6 Ensure that facilities and training for use of any material being ordered
are adequate.
2.3.1.7 Make an assessment of hazards and controls in place is necessary to limit
employee exposures to these agents.
2.3.1.8 Identify and use safer chemical alternatives if possible.
2.3.1.9 Conduct periodic cleanouts to prevent accumulation of unnecessary
chemicals.
2.3.1.10
Procure and use the minimum amount of material
required for the procedures
2.3.1.11
Keep working quantities of chemicals to a minimum. Do not
stock pile chemicals.
2.3.1.12
Responsible for supporting and promoting safe and compliant
work practices in the laboratory.
The Laboratory employee is responsible for the following:
2.4.1 Planning and conducting each operation in accordance with the Palmetto Health
Richland Laboratory chemical hygiene procedures.
2.4.2 Developing good personal chemical hygiene habits.
2.4.3 Utilizes equipment necessary for safe conduct of work.
2.4.4 Participating in laboratory safety training sessions.
2.4.5 Reporting unsafe conditions to their supervisor or Safety Officer.
2.4.6 Know the provisions of and comply with the Chemical Hygiene Plan.
3.0 GENERAL PRINCIPALS
To provide for the safety of Palmetto Health, the following general principles apply to all
performing work in laboratories:
3.1 Perform Hazard Assessment: Prior to initiation of new experiments or procedures,
assessment of potential hazards must be performed. Appropriate protective measures,
including personal protective equipment and engineering controls, must be identified and
Page 31 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
3.2
3.3
3.4
3.5
3.6
implemented. Laboratories should develop process-or experiment-specific guidelines and
protective procedures.
Minimize Chemical Exposures: Since few laboratory chemicals are without hazards,
general precautions for chemical handling, storage and disposal should be implemented in
all laboratories. Use of less hazardous materials, implementation of engineering controls
whenever feasible, and use of personal protective equipment to avoid skin contact with or
inhalation of chemicals is encouraged.
Avoid Underestimation of Risk: Even for substances with no known significant hazard,
exposure should be minimized. For work with particularly hazardous substances, special
precautions must be taken. All substances of unknown toxicity should be considered toxic.
Provide Adequate Ventilation: The best way to prevent exposure to airborne substances is
to prevent their escape into the working atmosphere by using chemical fume hoods or other
ventilation devices.
Observe Established Standards: The permissible exposure limits and threshold limit
values established by OSHA and other organizations should be observed. Where a
regulatory standard does not exist, other recognized exposure limits should be followed.
Follow the Chemical Hygiene Plan: Procedures described in this Chemical Hygiene Plan
are designed to minimize or prevent exposure to hazardous chemicals. Implementation of
the CHP should be a regular continuing effort.
4.0 INFORMATION AND TRAINING
Palmetto Health Laboratories will provide laboratory personnel with information and training
to ensure that they are apprised of the hazards of the chemicals present in their work area. The
purpose of information and training is to ensure that all individuals at risk are adequately
informed about the work being performed in the laboratory associated hazards and actions to be
taken to protect themselves during normal operations as well as emergencies.
4.1 Laboratory Safety Manual which includes Chemical Hygiene Plan.
4.2 OSHA Lab Standard
4.3 Location of SDS Sheets
4.4 Initial training for department orientation
4.5 Annual review with Lab Mandatory training
4.6 Records are kept in the Lab files.
5.0 BASIC TERMINOLOGY
5.1 Corrosives (caustics): strong acids or bases that cause severe burns to living tissue. If
inhaled or ingested, causes severe damage to the gastrointestinal and respiratory tracts. Ex.
Sulfuric acid.
5.2 Irritants: cause reversible inflammatory effects on living tissue. Ex. Formaldehyde
5.3 Carcinogens: actual or potential cancer-causing chemicals. Ex. Benzene, toluene.
5.4 Toxic substances (poisons): substances that cause serious biological effects if relatively
small amounts are inhaled, ingested, or absorbed through skin contact. Ex. Mercury
5.5 Ignitables: chemicals that can burn. This includes both combustible and flammable liquids.
5.6 Flammable liquids: have flashpoints below 100 degrees F. Ex. Acetone, ethanol.
Page 32 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
5.7 Combustible liquids: have flash points at or above 100 degrees F but below 200 degrees F.
Ex. Acetic acid.
5.8 Oxidizers: agents that initiate or promote combustion in other materials, thereby causing
fire either of itself or through the release of oxygen or other gases. Ex potassium
permanganate, sodium chlorate
5.9 Hepatotoxic: agents that cause damage to the liver. Ex. Tetrachloroethane.
5.10 Nephrotoxic: agents that cause damage to the kidneys. Ex. Halogenated
hydrocarbons.
5.11 Neurotoxic: agents that cause damage to the nervous system.
5.12 Compressed gas: a gas mixture of having in a container, and absolute pressure
exceeding 40psi at 70o F.; or an absolute pressure exceeding 104psi at130o F
regardless of the pressure at 70o F; or a liquid having a vapor pressure exceeding 40psi
at 100o F.
5.13 Hazardous chemical: a chemical which there is evidence that acute or chronic
health effects may occur in exposed employees. They include carcinogens, toxic
agents, reproductive toxins, irritants, corrosives, sensitizers, hepatotoxins, neurotoxins,
agents which act on the hematopoietic systems, and agents which damage the lungs,
skin, eyes or mucous membranes.
5.14 Water reactive materials: react violently with water to produce heat and flammable or
toxic gas.
5.15 Incompatible chemicals : Chemicals that should never be stored together. They are
oxidizing agents that can initiate combustion. They should never be stored in the same
area with fuel, such as flammable, organic chemicals, dehydrating agents, or reducing
agents.
5.16 Select carcinogens: Substances that meet any of the following criteria:
5.16.1 Regulated by OSHA as a carcinogen.
5.16.2 Listed under the category “known carcinogen” in the Annual Report on
Carcinogens published by the National Toxicological Program (NTP).
5.16.3 Listed under Group 1 (Carcinogenic to humans) by the International Agency for
Research on Cancer (IARC) Monographs.
5.16.4 Listed in either Group 2A or 2B by IARC or under the category “reasonably
anticipated to be carcinogens” by NTP.
5.17 Reproductive toxins: Chemicals that adversely affect the reproductive process. These
toxins include mutagens that can cause chromosomal damage and teratogens, the effects
of which include retarded fetal growth, birth defects, fetal malformations and fetal
death.
5.18 Acutely toxic substances: Substances that produce adverse effects when exposed
individuals receive only small doses of that substance for a short period of time.
6.0 BASIC RULES AND PROCEDURES FOR WORKING WITH CHEMICALS
6.1 GENERAL RULES: All laboratory employees will be familiar with the general rules listed
below:
6.1.1 Avoid “Routine” Exposure to chemicals
Page 33 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
6.1.2
6.1.3
6.1.4
6.1.5
6.1.6
6.1.7
6.1.8
6.1.9
6.1.10
6.1.11
6.1.12
6.1.13
6.1.14
6.1.15
Develop and encourage safe habits; avoid unnecessary exposure to chemicals by
any route.
Identify the physical properties of the chemical and its hazards using safety data
sheets (SDS).
Do not smell, inhale or taste chemicals. Apparatus that can discharge toxic
chemicals (vacuum pumps, distillation columns, etc) should be vented into local
exhaust devices.
Do not allow release of toxic substances in cold or warm rooms, since these
have contained re-circulated atmospheres.
Inspect gloves before use. The person opening a new box is to inspect gloves.
Always add acid to water, never water to acid.
Keep flammables away from open flames or sparks.
Chemical inventory is maintained and revised at least annually from
departments.
Use minimum quantities of the chemicals.
Use ventilation and engineering controls. Always use chemicals with adequate
ventilation or in a chemical fume hood.
Use appropriate personal protection and good laboratory practices.
Limit access to the laboratory to authorized personnel.
Use only those chemicals for which the quality of the available ventilation system
is appropriate.
When possible avoid working alone in a building; do not work alone if procedures
being conducted are hazardous. If it is unavoidable to work alone, have method in
place to contact appropriate personnel in the event of an accident.
Be alert to unsafe conditions and see that they are corrected when detected.
6.1.16
6.1.17
6.2 Eating, Smoking, Etc.
6.2.1 Do not eat, drink, smoke, chew gum, or apply cosmetics or lip balm in areas where
laboratory chemicals or specimens are present. Employees must do these activities
in designed areas and must wash hands before performing these activities.
6.2.2 Do not store, handle, or consume food or beverages in lab storage areas, or in
laboratory refrigerators.
6.2.3 Glassware, or utensils that are also used for laboratory operation cannot be used for
eating or drinking.
6.2.4 Microwave ovens within the lab areas are not to be used for heating food or drinks.
6.3 Equipment and Glassware
6.3.1 Handle and store laboratory glassware with care to avoid damage; do not use
damaged glassware. Use extra care with Dewar flasks and other evacuated glass
apparatus; shield or wrap them to contain chemicals and fragments should
implosion occur.
6.3.2 Use equipment only for its designed purpose.
6.3.3 All emergency equipment is maintained in proper working order and is must be
periodically checked.
Page 34 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
6.3.4
Access to emergency equipment such as fire extinguishers, electrical panels, and
emergency eye washes should not be obstructed.
6.4 Exiting the lab after improper exposure to chemicals
6.4.1 Wash areas of exposed skin thoroughly and notify your supervisor before leaving
the laboratory.
6.5 Horseplay
6.5.1 Avoid practical jokes or other behavior that might confuse, startle, or distract
another worker.
6.6 Mouth Suction
6.6.1 Do not use mouth suction for pipetting or starting a siphon.
6.7 Personal Apparel
6.7.1 Confine long hair and loose clothing.
6.7.2 Wear a lab coat, closed toe and heel shoes (vinyl or leather) at all times in the
laboratory, do not wear sandals, perforated shoes, or any shoes made of canvas.
6.7.3 Follow Laboratory Dress Code found in the lab policy manual.
6.8 Personal Housekeeping
6.8.1 Keep the work area clean and uncluttered.
6.8.2 Chemicals and equipment must be properly labeled and stored.
6.8.3 Clean up the work area on completion of an operation or at the end of each day.
6.8.4 Decontaminate benches if there are spills and daily.
6.9 Hand washing
6.9.1 Hands shall be washed immediately after removal of gloves (15 sec) or other
personal protective equipment, even if no visible contamination has occurred.
6.9.2 Hands must be washed before leaving the laboratory
6.9.3 Hands must be washed before and after contact with patients and hazardous
materials, before eating.
6.9.4 Hands must be washed before eating, drinking, fixing eye contacts, or applying
makeup.
6.9.5 Each section of the lab shall have a specified sink for hand washing or have one
available nearby in which no chemicals or biological hazardous materials are
placed. These sinks will be labeled with a "CLEAN SINK" sign.
6.10 Waste minimization
6.10.1 Make process/equipment adjustments or modifications when possible.
6.10.2 Make substitutions for toxic material
6.10.3 Properly segregate and separate waste
6.10.4 Recycle when possible
6.10.5 Exercise prudence in ordering new chemicals
7.0 PERSONAL PROTECTION
7.1 Ensure that appropriate eye protection, where necessary, is worn by all persons, including
visitors in areas where chemicals are stored or handled.
7.2 Wear appropriate gloves when the potential for contact with toxic materials exists; inspect the
gloves before each use; replace periodically; wash hands after removal of gloves.
Page 35 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
7.3 Use appropriate respiratory equipment when air contaminant concentrations are not
sufficiently restricted by engineering controls. Inspect the respirator before each use. All
respiratory selections must be made by Safety Officer and used following the requirements of
29 CFR 1910.134.
7.4 Use any other protective and emergency apparel and equipment as appropriate.
7.5 Avoid use of contact lenses in the laboratory unless necessary; if they are used, inform
supervisor so special precautions can be taken.
7.6 Remove laboratory coats immediately upon significant contamination.
7.7 Use heat resistant gloves when handling dry ice.
7.8 Use protective carrier equipment when moving corrosives.
7.9 Use a funnel designed to prevent air blocking when pouring chemicals.
8.0 PLANNING
8.1 Seek information and advice about hazards, plan appropriate protective procedures, and plan
positioning of equipment before beginning any new operation.
8.2 Inform Lab Safety Officer of any new procedures. Have Chemical company fax or send an
SDS before ordering and have Lab Safety Officer approve.
8.3 Make sure the chemical with its inherent hazards are reviewed by Lab Safety Officer before
bringing in-house to be sure it can be handled safely in our lab.
8.4 Use and look for less hazardous alternatives for hazardous chemicals.
8.5 Purchase the minimum quantity needed.
9.0 TRAINING
9.1 All personnel are trained in emergency procedures and know the location of emergency
equipment such as emergency eyewashes, showers, fire extinguishers, fire alarms, emergency
exits, telephones, and personal protective equipment.
10.0
UNATTENDED OPERATIONS/PROCEDURES WITH TOXIC CHEMICALS
10.1 Leave lights on, place an appropriate sign on the door, and provide for containment of
toxic substances in the event of failure of a utility service
(such as cooling water) in an
unattended operation.
11.0
USE OF HOODS
11.1 Use a hood for operations that might result in release of toxic chemical vapors or dust.
11.2 As a rule of thumb, use a hood or other local ventilation device when working with any
appreciably volatile substance with a TLV of less than 50 ppm.
11.3 Confirm adequate hood performance before use: keep hood closed at all times except
when adjustments within the hood are being made. Keep materials stored in hoods to a
minimum, and do not allow materials to block vents or air flow.
11.4 Leave the hood "on" when it is not in active use if toxic substances are stored in it or if it is
uncertain whether adequate general laboratory ventilation will be maintained when it is
"off."
Page 36 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
12.0
WASTE DISPOSAL
12.1 Carefully follow hazardous waste disposal procedures of the Laboratory in this manual.
12.2 Deposit chemical waste in appropriately labeled receptacles and follow all other waste
disposal procedures of the CHP plan.
12.3
As a general rule, do not discharge to the sewer concentrated acids or bases;
highly toxic, malodorous, or lachrymatory substances; or any substances which might
interfere with the biological activity of waste water treatment plants, create fire or
explosion hazards, cause structural damage or obstruct flow.
13.0
SUMMARY OF RULES OF 29 CFR 1910.1450, paragraph E. 29 FR 1910.1450
can be found in this manual.
13.1 Rules for working with Allergens and embryotoxins
13.1.1 Allergens : ex. diazomethane, isocyanates, bichromates
Wear suitable gloves to prevent hand contact with allergens or substances of
unknown allergenic activity.
13.1.2 Embryotoxins : ex. organomercurials, lead compounds, formamide
Women of childbearing age must handle these substances only in a hood whose
satisfactory performance has been confirmed, using appropriate protective apparel
(especially gloves) to prevent skin contact.
13.1.3 Reviews of procedures with allergens and or embryotoxins should be done
annually by the supervisor and whenever procedural changes are made.
13.1.4 Store these substances, properly labeled, in an adequately ventilated area in an
unbreakable secondary container.
13.1.5 Notify supervisor of all incidents of exposure or spills; consult qualified physician
when appropriate.
13.2 Rules for working with chemicals of moderate chronic or high acute toxicity.
13.2.1 Examples include but not limited to: diisopropylflurophosphate, hydrofluoric acid,
hydrogen cyanide.
13.2.2 Follow chemical handling rules described above and in this plan.
13.2.3 Use and store these substances only in areas of restricted access with special
warning signs.
13.2.4 Always use a hood (previously evaluated to confirm adequate performance with a
face velocity of at least 60 linear feet per minute) or other containment device for
procedures which may result in the generation of aerosols or vapors containing the
substance. Trap released vapors to prevent their discharge with the hood exhaust.
13.2.5 Always avoid skin contact by use of gloves and long sleeves. Always wash
hands and arms immediately after wards.
13.2.6 Maintain records of materials on hand, amounts used, and the names of workers
involved.
13.2.7 Assure that at least 2 people are present at all times if a compound in use is highly
toxic or of unknown toxicity.
13.2.8 Store breakable containers of these substances in chemically resistant trays: also
work and mount apparatus above such trays or cover work and storage surfaces
with removable, absorbent, plastic backed paper.
Page 37 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
13.3
13.2.9 If a major spill occurs outside the hood, evacuate the area: assure that cleanup
personnel wear suitable protective apparel and equipment.
13.2.10 Thoroughly decontaminate or incinerate contaminated clothing or shoes. If
possible, chemically decontaminate by chemical conversion.
13.2.11 Store contaminated waste in closed, suitably labeled, impervious containers.
Rules for working with chemicals of high chronic toxicity
13.3.1 Examples include but are not limited to: dimethylmercury and nickel carbonyl,
benzo-a-pyrene, N-nitrosodiethylamine, other human carcinogens or substances
with high carcinogenic potency in animals.
13.3.2 Follow chemical handling rules described above and in this plan.
13.3.3 Conduct all transfers and work with these substances in a "controlled area": a
restricted access hood, glove box, or portion of a lab, designated for use of highly
toxic substances, for which all people with access are aware of the substances
being used and necessary precautions.
13.3.4 Before use, prepare plan for use and disposal of these materials and obtain
approval of the Laboratory Safety Officer.
13.3.5 Decontamination /non-contamination
13.3.6 Protect vacuum pumps against contamination by scrubbers or HEPA filters and
vent them into the hood.
13.3.7 Decontaminate vacuum pumps or other contaminated equipment, including
glassware, in the hood before removing them from the controlled area.
13.3.8 Decontaminate the controlled area before normal work is resumed there.
13.3.9 On leaving a controlled area, remove any protective apparel (placing it in an
appropriate, labeled container) and thoroughly wash hands, forearms, face, and
neck.
13.3.10 Use a wet mop or a vacuum cleaner equipped with a HEPA filter instead of dry
sweeping if the toxic substance was a dry powder.
13.3.11 Medical Surveillance may be necessary if using toxicologically significant
quantities of such a substance on a regular basis (e.g. 3 times/week).Consult a
qualified physician concerning desirability of regular medical surveillance.
13.3.12 Keep accurate records of the amounts of these substances stored and used, the
dates of use, and names of users.
13.3.13 Signs and labels must be used. Assure that the controlled area is conspicuously
marked with warning and restricted access signs and that all containers of these
substances are appropriately labeled with identity and warning labels.
13.3.14 In the event of spills, assure that contingency plans, equipment, and materials to
minimize exposures of people and property in case of accident are available.
13.3.15 Store only in ventilated, limited access area in appropriately labeled, unbreakable,
chemically resistant, secondary containers.
13.3.16 For a negative pressure glove box, ventilation rate must be at least two (2) volume
changes/hour and pressure at least 0.5 in. of water. For a positive pressure glove
box, thoroughly check for leaks before each use. In either case, trap the exit gases
or filter them through a HEPA filter and then release them into the hood.
Page 38 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
13.3.17 For waste treatment, use chemical decontamination whenever possible; Ensure
that containers of contaminated waste (including washings from contaminated
flasks) are transferred from the controlled area in a secondary container under the
supervision of authorized personnel.
14.0
SEGREGATION AND STORAGE WITH RESPECT TO HAZARD CLASS
14.1 Acids
14.1.1 Segregate from reactive metals such as sodium, potassium or magnesium.
14.1.2 Segregate from oxidizing acids from organic acids, flammable and combustible
materials.
14.1.3 Segregate acids from bases.
14.2 Bases
14.2.1 Segregate from acids, metals, explosives, organic peroxide and easily ignitable
materials.
14.2.2 Do not store aqueous sodium and potassium hydroxide solutions on aluminum drip
trays. This will corrode aluminum.
14.3 Flammable Combustible Liquids
14.3.1 Store in approved flammable cabinets.
14.3.2 Segregate from oxidizing acids and oxidizers.
14.3.3 Keep away from any source of ignition: heat, sparks or open flames.
14.4 Oxidizers
14.4.1 Keep away from combustible and flammable materials.
14.4.2 Keep away from reducing agents such as zinc, alkali metals and acids.
14.5 Water Reactive
14.5.1 Store in a cool, dry place, away from any water source.
14.6 Light Sensitive
14.6.1 Store in amber bottles in a cool, dry, dark place.
14.7 Toxic Chemical
14.7.1 Store according to the nature of the chemical.
15.0
CHEMICAL PROCUREMENT, DISTRIBUTION AND STORAGE
15.1 Procurement:
15.1.1 Inform Lab Safety Officer of any new procedures. Have chemical company fax
SDS before ordering and have Lab Safety Officer approve. No container shall be
accepted without adequate identifying label and SDS. Purchase only what is
needed to avoid storage issues.
15.2 Storage
15.2.1 All chemicals must be stored properly, according to compatibility and the
manufacturers’ recommendation. Chemicals which pose significant risk are
limited to minimum quantities required. Toxic substances will be segregated in a
well- identified area with local exhaust ventilation. Chemicals which are
highly toxic or other chemicals whose containers have been opened will be in
unbreakable secondary containers. Stored chemicals will be examined periodically
(at least annually) for replacement, deterioration, and container integrity.
Page 39 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
15.3
16.0
Chemicals should be stored in appropriate chemical storage cabinets, not on floors
or in hoods.
15.2.2 Acids and bases are stored in separate chemical storage cabinets or are separated
with a plastic container near floor level, and also away from other incompatible
chemicals.
15.2.3 Acids and bases should not be stored in chemical storage cabinets with
flammables.
15.2.4 All secondary containers are properly labeled.
15.2.5 Flammable liquids are stored in flammable storage cabinets with proper ventilation
according to NFPA standards.
15.2.6 Compressed gas cylinders will be stored in a secured upright position.
15.2.7 Avoid exposure of chemicals to heat or direct sunlight. This may lead to
deterioration of storage containers and labels, as well as the degradation of the
chemicals.
15.2.8 Ensure that caps and lids on all chemical containers are tightly closed to prevent
evaporation of contents.
15.2.9 Do not store chemicals under sinks.
15.2.10 Avoid stock piling chemicals.
15.2.11 Conduct periodic cleanouts to prevent accumulating unnecessary chemicals.
Transporting
15.3.1 When hazardous chemicals are hand-carried, and the volume is larger than 500
mL, the container shall be placed in an outside container or bucket designed for
chemical transportation.
15.3.2 Freight- only elevators should be used if possible.
15.3.3 Compressed gas cylinders will not be left unattended until secured.
15.3.4 Safety cans with a spring loaded spout are used for transporting flammable liquids.
15.3.5 Carry glass containers in specially designed bottle carriers or leak resistant,
unbreakable secondary containers.
15.3.6 When possible, transport chemicals by traveling routes not frequently used by
others.
15.3.7 When transporting chemicals on a cart, use a cart that is suitable for the load and
one that has high edges to contain leaks or spills.
CHEMICAL INVENTORY
16.1 The chemical inventory is reviewed/updated annually by the section supervisors. All
the chemicals used in the laboratory are listed, hazardous and non-hazardous.
Hazardous chemicals will have the hazardous ingredients listed with CAS numbers,
signal words and pictograms.
16.2 Chemicals are listed by laboratory section and the test that uses them so that they may
be easily updated when test methodology changes.
16.3 Upon completion of the chemical inventory, request letters are sent to
manufacturers if SDS are missing or can’t be found on line.
Page 40 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
17.0
SAFETY DATA SHEETS
17.1 SDS are available in some laboratory sections in a 3-ring SDS binder.
The SDS are in alphabetical order along with a chemical inventory of the
section.
17.2 In most PH laboratory sections they can be found online using the internet retrieval
program. Annual safety training will address finding SDS.
17.3 The laboratory relies on the chemical manufacturer's information to ascertain
whether or not the chemical is hazardous.
17.4 Manufacturer's send updates at various times throughout the year. Each
supervisor is
responsible for keeping the latest SDS in their section's book or with making sure the SDS
is available in the online service.
18.0
GLOBALLY HARMONIZED SYSTEM (GHS) SYSTEM OF CLASSIFICATION AND
LABELING OF CHEMICALS
The OSHA Hazard Communication Standard has been revised. Material Safety Data Sheets
(MSDS) are now called Safety Data Sheets or SDS. The headings of information and the
order in which they are provided are consistent for every chemical manufacturer or distributor.
Section 1.
Identification- will include the product identifier, how the
chemical is to be used and any restrictions, the supplier’s contact
information plus an emergence phone number.
Section 2.
Hazard Information- will include the GHS classification of the
substance and the pictogram or the name of the symbol.
Section 3.
Composition and Information on Ingredients - will include
the chemical identity, its common name and synonyms and the
chemical abstract service (CAS) number.
Section 4.
First-Aid Measures- will describe routes of exposure such as
inhalation, skin and eye contact and ingestion. It will also indicate
any immediate medical attention and special treatment needed.
Section 5.
Fire-fighting Measures- will include extinguishing media and
special protective equipment and precautions for fire fighters.
Section 6.
Accidental Release Measures- will include emergency procedures
and environmental precautions, including methods and material for
containment and cleaning up.
Section 7.
Handling and Storage - will include the safe handling and storage
of the chemical including any incompatibilities.
Section 8.
Exposure Controls/Personal Protection- will include
occupational or biological exposure limit values, engineering
controls and personal protective equipment.
Section 9.
Physical and Chemical Properties - will include the chemical
appearance, melting or freezing point, boiling range, flash point,
Page 41 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
evaporation rate, flammability, vapor pressure and density,
solubility, autoignition and decomposition temperatures.
Section 10. Stability and Reactivity –will describe the chemicals stability. It
will also indicate conditions to avoid such as static discharge,
shock or vibration, incompatible materials and hazardous
decomposition products.
Section 11. Toxicological Information- will include a description of the
toxicological effects of a chemical, including routes of exposure,
symptoms related to the physical, chemical and toxicological
characteristics, as well as effects from short and long term
exposure.
The following sections may be included in the SDS but are not required by OSHA;
Section 12. Ecological Information- will include ecotoxicity, persistence and
degradability, bioaccumulative potential, mobility in soil and any
other adverse effects.
Section 13. Disposal Considerations- will include a description of the waste
residues, their safety handling and a disposal of any contaminated
packaging.
Section 14. Transport Information- will include the United Nations (UN)
number, the United States proper shipping name, hazard classes,
packing groups, if applicable, if it is a marine pollutant and any
special precautions.
Section 15. Regulatory Information- will include safety, health and
environmental regulations for the chemical.
Section 16. Other Information- may include any relevant information that is
not covered by the other 15 sections and may include the date of
preparation or last revision of the SDS.
Page 42 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
GHS Pictograms and Hazard Classes

Oxidizers






Flammab les
Self Reactives
Pyrophorics
Self-Heating
Emits Flammable Gas
Organic Peroxides



Explosives
Self Reactives
Organic Peroxides

Acute toxicity (severe)

Corrosives

Gases Under Pressure






Carcinogen
Respiratory Sensitizer
Reproductive Toxicity
Target Organ Toxicity
Mutagenicity
Aspiration Toxicity

Environmental Toxicity






Irritant
Dermal Sensitizer
Acute toxicity (harmful)
Narcotic Effects
Respiratory Tract
Irritation
18.0
CHEMICAL LABELS
18.1 Chemical manufacturers, importers, and distributors make sure that each container of
hazardous chemicals is labeled, tagged, or marked with the following information:
18.1.1 Identity of the chemical and appropriate hazard warning must be shown on the
label.
Page 43 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
18.2
18.3
18.1.2 The hazard warning must provide users with an immediate understanding of the
primary health and/or physical hazard(s) of the hazardous chemical through the use
of words, pictures, symbols, or any combination of these elements.
18.1.3 Name and address of the manufacturer, importer or other responsible party must be
included on the label.
18.1.4 The hazard label message must be legible, permanently displayed and written in
English.
Expiration Dates: Some chemicals will come from the manufacturer with an
expiration date on the label. These chemicals will be discarded once the expiration date
has pasted.
18.2.1 If the chemical label does not have an expiration date the shelf life of
the chemical has not been established.
18.2.2 Once a chemical with no expiration date has been opened for use an
expiration date of five (5) years from the date of opening will be
assigned. This should be written on the label under the open date.
18.2.3 All chemical solutions prepared by the laboratory should be assigned
an expiration date according to the procedure involved. This
expected time period should be supported by literature or the
procedure validation studies.
Secondary (portable) Container Labels- often, laboratory operations require
transferring chemicals from the original labeled container into a secondary
container (e.g. beaker, flask or bottle). A label needs to be applied to the
secondary container containing the identity of the hazardous chemical(s) in
the container and the hazards present.
18.3.1
18.3.2
18.3.3
18.3.4
Enter name of chemical (Product ID:)
Check the signal word –if one was on the original container.
Select the pictogram corresponding to the original container.
Enter the special hazard information from the original container.
Page 44 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
18.3
18.4
Replacement Container Label- The existing label on a container entering the
workplace from a supplier must not be removed, altered or defaced. If a
chemical container’s original label must be replaced, the new label must
contain the same information as the original.
Prominent signs and labels of the following types shall be posted:
18.4.1 Warning signs at the entrance to all regulated areas as defined by 29 CFR
1910.1450 and where all special or unusual hazards exist.
18.4.2 Emergency telephone numbers of all emergency personnel/facilities,
supervisors and laboratory workers.
18.4.3 Location signs for safety showers, eyewash stations, other first aid equipment,
exits and where food and beverage consumption is permitted.
19.0
ENVIRONMENTAL MONITORING
19.1 Hoods
19.1.1 Hoods will be tested initially and annually by a certified company.
19.1.2 They shall be reevaluated after repairs or alterations.
19.1.3 Airborne contaminant monitoring will be performed if necessary after repairs.
19.1.4 Hoods shall have a continuous flow indicator device such as magnehelic gauge,
swinging vane anemometer or manometer to indicate adequate performance.
19.1.5 Hood evaluation shall include:
19.1.5.1
Face velocity measurements (typically 60 -100 fpm).
19.1.5.2
Air flow and turbulence visualization (smoke tubes).
19.2 Formaldehyde and xylene
19.2.1 Formaldehyde and xylene exposure will be monitored annually by a qualified
company. Immediate action will be taken if OSHA personal exposure standard
limits are exceeded.
19.2.2 Histology will also monitor formaldehyde exposure via Personal Monitoring
Badges from Gas Monitoring Inc. quarterly this year. The usefulness of this
monitoring will be reevaluated after one year.
19.3 Irradiator
19.3.1 The irradiator is completely encased in lead to prevent exposure; therefore, it does
not require a restricted area.
19.3.2 The Medical Physicist/Radiation Officer of the Hospital performs leak checks
every 6 months.
19.3.3 There are sensors placed in the lab and sent out periodically by the Radiation
Officer.
20.0
HOUSEKEEPING, MAINTENANCE, AND INSPECTIONS
20.1 Floors shall be cleaned regularly by housekeeping.
20.2 Formal housekeeping and chemical hygiene inspections will be done quarterly.
20.3 Eyewashes will be tested weekly and showers shall be inspected and tested monthly.
20.4 All safety equipment and personal protective equipment will be checked semiannually by the Lab Safety Officer or designee for condition and effectiveness.
20.5 Hoods will be tested as indicated in Section 19.1 above.
Page 45 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
20.6
Stairways and hallways (passages) shall not be used as storage areas. Access to exits,
emergency equipment and utility controls shall never be locked.
21.0
SPILLS AND ACCIDENTS
21.1 Chemical Spills – refer to S0.73 Spill Clean-up Procedure.
21.2 Spills of blood and blood-contaminated fluids shall be promptly cleaned
following
Infection Control policies:
21.2.1 Wipe up spill using paper towel and discard in waste can. (If dripping or
supersaturated, place in red, infectious waste bag.
21.2.2 Disinfect area with an infection control approved disinfectant (Cavicide or freshly
made solution of 1:10 of bleach and water).
21.2.3 Wipe up disinfectant with paper towels.
21.2.4 For large spills on carpeting, notify Environmental Services.
21.3 After all spill type clean ups employees should remove gloves and wash hands.
21.4 All accidents or near accidents shall be analyzed and documented by the Chemical
Hygiene/Safety Officer and a report of the finding shall be distributed to all who might
benefit.
22.0
POSSIBLE SIGNS AND SYMPTOMS OF CHEMICAL EXPOSURE
22.1 Skin that has become dried, whitened, reddened, swelled, blistered, and itchy or exhibits a
rash.
22.2 A chemical odor. Many chemicals can be smelled at concentrations well below
harmful levels. On the other hand, a chemical may be present without a detectable odor.
22.3 A chemical taste. Some chemicals have characteristic tastes.
22.4 Tearing or burning of the eyes.
22.5 Burning sensations of the skin, nose or throat.
22.6 Cough
22.7 Headache or dizziness
23.0
MEDICAL PROGRAM
23.1 Medical consultation to at-risk employees will be provided via Healthworks or the
Emergency Room when:
23.1.1 An employee develops signs or symptoms of exposure to a hazardous chemical.
23.1.2 When exposure monitoring discussed in Part 17 above reveals hazardous chemical
concentrations at or above the Permissible Exposure Limit (PEL).
23.1.3 Whenever an event such as a spill, leak, or explosion takes place and increases the
likelihood of exposure.
23.2 Medical consultation and surveillance will be given at no cost or loss of pay to the
employee by a licensed physician chosen by Healthworks or the Emergency Room after
hours.
23.3 The physician will be provided with pertinent information about the hazardous chemical.
23.4 The physician will give the Medical Director of the laboratory a written
opinion
stating:
23.4.1 The results of the examination.
Page 46 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
23.5
24.0
23.4.2 Any medical condition that increases the employee's risk if exposed to a hazardous
chemical.
23.4.3 Recommendations for any further medical follow- up.
23.4.4 A statement that the employee has been informed of all the preceding information.
Lab Chemical Hygiene Officer must be notified of any needs for consultation.
PROTECTIVE CLOTHING AND EQUIPMENT
24.1 Protective clothing and equipment shall be provided at no cost to personnel.
24.2 Hands are the most likely part of the body to come in contact with chemicals. Skin contact
with chemicals may result in irritation, burns, or absorption of the chemical into the blood
stream. Glove materials must be compatible with the chemicals used.
24.3 Face shields should be worn when eye hazards are possible.
24.4 Eyewashes and all-drench type safety showers are provided at necessary intervals:
24.4.1 Emergency water showers must meet the minimum volume requirement of 30
gallons per minute water pressure (ANSI standard 4.1).
24.4.2 Water pressure for eye/face washes must be 3 gallons per minute (ANSI standard
7.1.4).
24.5 Accessibility to showers and eye/face washes:
24.5.1 Emergency showers: Shower heads should be located between 82 and 92 inches
from the surface on which the user stands. The center of the spray pattern
delivered by the shower head should be 16 inches from any obstruction (ANSI
standard 4.1).
24.5.2 Eye and eye/face wash units: outlet heads should be located between 33 and 45
inches from floor (ANSI 5.4.1 and 7.4.1).
24.5.3 At least one eye wash station should be installed in each laboratory work area,
unencumbered by walls. There should be no more than a 25-foot radius from a eye
wash station to any place in the laboratory.
21.3.4 These are inspected and tested regularly.
24.6 Fire equipment is provided as required by DHEC, OSHA, NFPA, Columbia Fire
Department, and other pertinent regulatory agencies. This includes all alarms,
panels, fire extinguishers, fire doors, etc.
24.6.1 The Palmetto Health Safety Officer is responsible for all inspections of fire
protection equipment.
24.6.2 Check cards are on each extinguisher indicating last inspection.
24.6.3 The laboratory has Class ABC extinguishers that can be used with combustible
materials, flammable liquids and electrical fires.
24.7 Telephones are located throughout the lab for use in emergencies and in all elevators.
24.8 Hoods are provided where necessary and will be evaluated annually.
24.9 Employees requiring first aid will immediately report to Employee Health or
Emergency Department for treatment per PHR procedures.
24.10 Personal Protective equipment (gloves, gowns, visors,) is provided in each
lab
area. Employees are instructed as to when to use them in their area when
performing
certain duties. This equipment is evaluated periodically by Lab
Safety Officer as to
its condition and effectiveness.
Page 47 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
24.10.1 Refer to Personal Protective Equipment section of this Manual.
25.0
RECORDS
25.1 Accident records are written and retained.
25.2 Inventories of all chemicals shall be maintained and updated yearly. Records shall
include:
25.2.1 Chemical name.
25.2.2 Trade name.
25.2.3 Manufacturer.
25.3 All employee medical records shall be retained for each employee with occupational
exposure for at least the duration of employment plus 30 years. The records are kept
confidential and separate from other personnel records by Employee Health and, therefore,
may not be disclosed or reported to any person without the employee's written consent,
unless required by local, state or federal regulations. All medical examinations, testing and
follow-up procedures as well as a copy of the employee's Hepatitis vaccination status
must be included in an employee's medical record.
Medical records must be made available to OSHA, the Director of the National Institute
for Occupational Safety and Health (NIOSH), and the Assistant Secretary of Labor and to
anyone having written consent of the subject employee.
25.4 In addition to medical records, PH maintains on- site, training records which include:
25.4.1 The dates of all training sessions.
25.4.2 The contents or a summary of training sessions.
25.4.3 The names and qualifications of persons conducting the training
sessions.
25.4.4 The names and job titles of all persons attending the training sessions.
25.5 Training records must be maintained for 3 years from the date on which training occurred.
25.6 Training records are not considered confidential and, unlike medical records, may be
maintained in any file.
25.7 Training records may be provided upon request to employees, employee
representatives, and to OSHA.
25.8 Training records must be made available to Director of NIOSH, OSHA and to
the Assistant Secretary of Labor.
26.0
TRAINING
26.1 All personnel shall receive information and training at initial assignment to the laboratory
and upon assignment to areas involving new exposure situations.
26.2 Personnel shall receive annual training on hazardous material used in the laboratory.
26.3 The initial, reassignment and annual training shall include:
26.3.1 Information on the contents of 29 CFR 1910.1450.
26.3.2 Information on location and availability of the Chemical Hygiene Plan.
26.3.3 Information on the Permissible Exposure Limits for regulated chemicals or
recommended limits for other chemicals.
26.3.4 Information on the signs and symptoms associated with exposure to hazardous
chemicals used in the laboratory.
Page 48 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
26.3.5 Information on location and availability of Safety Data Sheets and other reference
material concerning the hazards, safe handling, storage and disposal of hazardous
chemicals used in the laboratory.
26.3.6 Information on methods and observations that may be used to detect the exposure
or release of hazardous chemicals.
26.3.7 Information on the physical and health hazards of chemicals in the work area.
26.3.8 Information on measures employees can take to protect themselves from these
hazards.
26.3.9 Information on specific details of the Chemical Hygiene Plan.
26.3.10 All training shall be documented with employee signature and records retained for
3 years past date of training.
27.0
WASTE DISPOSAL
27.1 At no time shall waste chemicals be disposed of in a manner that could cause harm to
people, other organisms or the environment.
27.2 See the attached Waste Disposal Program for specifics on how waste is collected,
segregated, stored and transported. This program will be evaluated by the Chemical
Hygiene Officer initially and annually.
27.3 Unlabeled containers of chemicals shall be disposed of promptly.
27.4 Pouring certain chemicals into drain or mixing with non-hazardous waste is prohibited.
27.5 Disposing of volatile chemicals under laboratory hood is prohibited.
27.6 Disposal by recycling or chemical decontamination will be used when possible.
28.0
SELECT BIOTOXINS
The Department of Health and Human Services (DHHS) has identified a select group of biotoxins
which are considered particularly hazardous and acutely toxic. There are strict rules and
regulations from DHHS for use and transfer of these agents. Users and transporters of these
agents must also register with the Centers for Disease Control and Prevention (CDC).
28.1 Abrin
28.2 Aflatoxins
28.3 Botulism toxins
28.4 Clostridium perfringens epsilon toxin
28.5 Conotoxins
28.6 Diacetoxyscirpenol
28.7 Ricin
28.8 Saxitoxin
28.9 Shigatoxin
28.10 Staphylococcal entertoxins
28.11 Tetrodotoxin
28.12 T-2 toxin
Page 49 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Initial author/Date: Mary Sue Sawyer MBA MT(ASCP) before 2001
Revised by Author/Date:
Mary Sue Sawyer MBA, MT(ASCP) 9/1/01
Mary Sue Sawyer 8/10/02 MBA, MT(ASCP)
Mary Sue Sawyer 8/6/03 MBA,MT(ASCP)
Fay Parker-Brown MBA, SM(ASCP) 8/2/04
Fay Parker-Brown MBA, SM(ASCP) 7/28/05
Fay Parker-Brown MBA, SM(ASCP) 10/11/06
Fay Parker-Brown MBA, SM(ASCP) 6/6/07
Fay Parker-Brown MBA, SM(ASCP)8/21/08
Fay Parker-Brown MBA, SM(ASCP) 8/14/09
Fay Parker-Brown MBA, SM(ASCP) 2/3/10
Fay Parker-Brown MBA, SM(ASCP) 4/29/11
Mary B. Paoli MT(ASCP)SBB 6/17/14,1/28/15
Page 50 of 150
CARCINOGENS 2015
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7001
7001
7001
7001
7001
7001
7001
7001
7001
Bilirubin,Direct
SIEMENS
DBIL FLEX
CKMB
SIEMENS
PHOSPHORUS
SIEMENS
K2125
4/15/2015
DEDM0329
HYDROGEN CHLORIDE
7647-01-0
CARCINOGEN
CKMB FLEX
DEDM0250
GLYCEROL
56-81-5
CARCINOGEN
PHOS FLEX
DEDM0266
SULPHURIC ACID
7664-93-9
IRRITANT
SODIUM BISULFITE
7631-90-5
TOXIC MATERIAL
DISODIUM MOLYDBATE
7631-95-0
SENSITIZING MATERIAL
CARTRIDGE
CORROSIVE
CARCINOGEN
TARGET ORGAN EFFECTS
SALICYLATE
SIEMENS
SAL FLEX
K5020
DEDM0269
CARTRIDGE
IRON (III) NITRATE, NONAHYDRATE
7782-61-8
SENSITIZING MATERIAL
NITRIC ACID
7697-37-2
CORROSIVE
NEOMYCIN, SULFATE
1405-10-3
CARCINOGEN
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
TIBC
SIEMENS
TIBC FLEX
K3084
DEDM0276
CARTRIDGE
TARGET ORGAN EFFECTS
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
55965-84-9
ASCORBIC ACID
50-81-7
IRRITANT
TROMETAMOL
77-86-1
TOXIC MATERIAL
2-AMINO-2-(HYDROXYMETHYL)PROPANE-
SENSITIZING MATERIAL
1,3-DIOL HYDROCHLORIDE
1185-53-1
CORROSIVE
SODIUM ACETATE
127-09-3
CARCINOGEN
ACETIC ACID
64-19-7
TARGET ORGAN EFFECTS
POLYETHYLENE GLYCOL #1540
25322-68-3
THIOUREA
62-56-6
NEOMYCIN, SULFATE
1405-10-3
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
SIEMENS
CHEM 3
CALIBRATOR
SIEMENS
LOCI 8
KC130
KC646
DEDM0072
DEDM0286
CALIBRATOR
GENERAL
55965-84-9
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
MALLINCKRODT
PARAFORMALDEHYDE
P0154
2/1/2007
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
55965-84-9
SENSITIZING MATERIAL
ETHANOL
64-17-5
CARCINOGEN
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
55965-84-9
TARGET ORGAN EFFECTS
NEOMYCIN, SULFATE
1405-10-3
SENSITIZING MATERIAL
ETHANOL
64-17-5
CARCINOGEN
30525-89-4
FLAMMABLE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
Paraformaldehyde (100%)
BAKER, INC
IRRITANT
CARCINOGEN
TARGET ORGAN EFFECTS
GENERAL
POLYSCIENCES
FORMALDEHYDE
4018
11/28/2006
Formaldehyde
000050000
IRRITANT
CARCINOGEN
50-00-0
FLAMMABLE
METHANOL FREE
INVITROGEN FIX & PERM A
GAS001
10/15/2008 FORMALDEHYDE
IRRITANT
CARCINOGEN
1
CARCINOGENS 2015
7001
POLYSCIENCES
FORMALDEHYDE
4018
7001
METHANOL FREE
7001
MALLINCKRODT
PARAFORMALDEHYDE
P0154
7001
BAKER, INC
7001
7001
7001 MARKERS
BECTON DICKINSON
MULTITEST 10 LYSING SOL
340503C
7001
7001
FACS LYSING SOLN
349202
7001
7001
DESICCANT
22-0448
7001
7017
ALK PHOS SIGMA ALDRICH SODIUM NITRITE
914
7017
ALK PHOS
7017
LEUKOCYTE
7017
KIT
7017
7017
SEME
FERTILITY
7017
7017
7017
BMAS
SOLUTIONS
THERMO
7018
II
7018
7018
7018 MALDI-TOF
7018 O&P
7018
SDL
SPERM COUNT
CONTROL
10% NEUTRAL
BUFFERED
ZINC FORMALIN
INDIA INK
AQC103
22050259
756-1
MERIDIAN
S7625
50-00-0
Paraformaldehyde (100%)
30525-89-4
FLAMMABLE
CARCINOGEN
TARGET ORGAN EFFECTS
12/2/11 DIETHYLENE GLYCOL
FORMALDEHYDE
1/11/12 DIETHYLENE GLYCOL
FORMALDEHYDE
12/2/11 SILICA
1/19/2012
111-46-6
IRRITANT
50-00-0
CARCINOGEN
111-46-6
IRRITANT
50-00-0
CARCINOGEN
COBALT DICHLORIDE
112926-00-8 IRRITANT
TOXIC CARCINOGEN
7646-79-9
SODIUM NITRITE
7632-00-0
CARCINOGEN
TARGET ORGAN
12/1/2007
3/2/2012
Formaldehyde
50-00-0
CARCINOGEN
Methyl Alcohol
FORMALDEHYDE
METHYL ALCOHOL
ZINC SULFATE
67-56-1
50-00-0
67-56-1
7733-02-0
TOXIC
CARCINOGEN
TARGET ORGAN
IRRITANT
FORMALDEHYDE
50-00-0
CARCINOGEN
SODIUM ACETATE
127-09-3
IRRITANT
METHYL ALCOHOL
67-56-1
TARGET ORGAN EFFECT
7646-79-9
CARCINOGEN
50-00-0
CARCINOGEN
67-56-1
IRRITANT
FORMALDEHYDE
900412
IRRITANT
IRRITANT
10/20/2009 COLBALT DICHLORIDE
PARA-PAK 10%
FORMALIN
Formaldehyde
CARCINOGEN
2/1/2007
9/31/08
NEGATIVE CTL
SIGMA-ALDRICH
SILICA GEL
11/28/2006
4/15/2015
3/9/2009 METHYL ALCOHOL
2
7001-MOLECULAR PATHOLOGY AND FLOW CYTOMETERY
DEPT
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
TEST NAME
PIPETTE CALIB
VENDOR
ARTEL, INC.
REAGENT
PCS BLANK
SOLUTION
PCS CALIB
SOLUTIONS
PCS SAMPLE
RANGE
SOLUTIONS
COBAS AMPLIPREP ROCHE
COBAS TAQMAN DIAGNOSTICS
HCV
CORPORATION
MGP
LYSIS REAGENT
PRODUCT # MSDS
HAZARDOUS INGREDIANT
PCS-231
5/20/09 POLYETHYLENE GLYCOL
Copper (II) chloride dihydrate
Methyl 4-hydroxybenzoate
2-phenoxyethanol
EDTA
PCS-600
5/20/09 NONE- LESS THAN1% OF ANY HAZADOUS
PCS-221
03568555190
PROTEASE
HCV VIRAL LOAD
ELUTION BUFFER
MASTER MIX
COBAS AMPLIPREP ROCHE
COBAS TAQMAN DIAGNOSTICS
CORPORATION
CMV VIRAL LOAD
MGP
LYSIS REAGENT
COBAS AMPLIPREP ROCHE
COBAS TAQMAN DIAGNOSTICS
CORPORATION
COBAS AMPLIPREP ROCHE
COBAS TAQMAN DIAGNOSTICS
HIV 2.0
CORPORATION
WASH
SOLUTION
03587797190
MGP
LYSIS REAGENT
05212308190
PROTEASE
ELUTION BUFFER
MASTER MIX
PROTEASE
HIV VIRAL LOAD
04902025190
ELUTION BUFFER
MASTER MIX
5/20/09 Aqueous phthalate buffer
Ponceau S (Acid red 112)
Methyl 4-hydroxybenzoate
2-phenoxyethanol
EDTA
9/18/09 Isopropanol
Polydocanol
Guanidine thiocyanate
Glycerol
SUBTILISINS
METHYLPARABEN
DIMETHYL SUFOXIDE
GLYCEROL
TRICINE
POTASSIUM ACETATE
3/2/12 DITHIOTHREITOL
POLIDOCANOL
Guanidine thiocyanate
Glycerol
SUBTILISINS
DIMETHYL SUFOXIDE
GLYCEROL
TRICINE
POTASSIUM ACETATE
10/12/10 NONE- LESS THAN1% OF ANY HAZADOUS
9/7/11 Isopropanol
Polydocanol
Guanidine thiocyanate
Glycerol
SUBTILISINS
METHYLPARABEN
DIMETHYL SUFOXIDE
GLYCEROL
TRICINE
POTASSIUM ACETATE
Page 3 of 9
4/15/2015
CAS #
25322-68-3
10125-13-0
99-76-3
122-99-6
64-02-8
HAZARD
IRRITANT
N/A
6226-79-5
99-76-3
122-99-6
64-02-8
67-63-0
5274-68-0
593-84-0
56-81-5
9014-01-1
99-76-3
67-68-5
56-81-5
5704-04-1
127-08-2
3483-12-3
3055-99-0
593-84-0
56-81-5
9014-01-1
67-68-5
56-81-5
5704-04-1
127-08-2
IRRITANT
67-63-0
5274-68-0
593-84-0
56-81-5
9014-01-1
99-76-3
67-68-5
56-81-5
5704-04-1
127-08-2
FLAMMABLE
IRRITANT
HARMFUL
FLAMMABLE
IRRITANT
HARMFUL
IRRITANT
HARMFUL
7001-MOLECULAR PATHOLOGY AND FLOW CYTOMETERY
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
HSV
HSV
GC/CT
ACROMETRIX
OPTIQUAL
HSV-1, 2 DNA
LOW POS
HSV2 HIGH CTL
REMEL
MICROTEST
M4 MEDIA
ROCHE
HSV
DIAGNOSTICS
PRIMER
CORPORATION
PAIR
ROCHE
HSV PROBE 1
DIAGNOSTICS
HSV PROBE 2
CORPORATION
HSV PROBE C3
ROCHE
HSV 1/2 RECOVERY
DIAGNOSTICS
TEMPLATE
CORPORATION
HSV 1/2
TEMPLATE DNA
ROCHE
LIGHTCYCLER
DIAGNOSTICS
FASTSTART DNA
CORPORATION
MASTER MIX
BD DIAGNOSTIC FOX EXTRACTION
SYSTEMS
TUBES
95-1301
95-1301
4/15/2015
NONE- LESS THAN1% OF ANY HAZADOUS
904510
R12500
7/22/11 NONE- LESS THAN1% OF ANY HAZADOUS
4/11/11 NONE- LESS THAN1% OF ANY HAZADOUS
05883466001
2/5/10 NONE- LESS THAN1% OF ANY HAZADOUS
05883440001
05883458001
0588342001
03355624001
2/5/10
2/5/10
2/5/10
2/12/08
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
03355616001
2/12/08 NONE- LESS THAN1% OF ANY HAZADOUS
03003248001
8/22/06 NONE- LESS THAN1% OF ANY HAZADOUS
441129
2/11/11 NONE- LESS THAN1% OF ANY HAZADOUS
7001M
7001M
NEUTRALIZATION
POUCH
441354
3/3/11 Tris base
77-86-1
IRRITANT
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
BINDING ACID
LYSIS TROUGH
CT-QX AMPLIF
MICROWELLS
CT/GC-QX NEG
CONTROL SET
CT/GC-QX POS
CONTROL SET
CT-QX PRIMING
MICROWELLS
441128
2/11/11 Sulfuric acid
7664-93-9
CORROSIVE
441126
2/11/11 NONE- LESS THAN1% OF ANY HAZADOUS
441125
2/11/11 NONE- LESS THAN1% OF ANY HAZADOUS
441125
2/11/11 NONE- LESS THAN1% OF ANY HAZADOUS
441126
2/11/11 NONE- LESS THAN1% OF ANY HAZADOUS
7001M
7001M
7001M
7001M
7001M
7001M
ELUTION
BUFFER 1
ELUTION
BUFFER 2
441128
2/11/11 Potassium hydroxide
1310-58-3
CORROSIVE
441128
2/11/11 Glycerol
Bicine
Dimethyl sulfoxide
2/11/11 NONE- LESS THAN1% OF ANY HAZADOUS
56-81-5
150-25-4
67-68-5
IRRITANT
HARMFUL
GC-QX AMPL
441124
Page 4 of 9
7001-MOLECULAR PATHOLOGY AND FLOW CYTOMETERY
7001M
7001M
7001M
MICROWELLS
GC-QX PRIMING
MICROWELLS
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
GC/CT
441124
2/11/11 NONE- LESS THAN1% OF ANY HAZADOUS
LBC SPECIMEN
DILUTION
LYSIS SOLUTION
441444
2/11/11 Tris base
77-86-1
IRRITANT
441128
2/11/11 Potassium hydroxide
1310-58-3
CORROSIVE
QX ENDO SWAB KIT
441357
QX MALE SWAB KIT
441358
67-68-5
56-81-5
1310-58-3
67-68-5
56-81-5
1310-58-3
QUEST V-C-M
MEDIUM
SWAB DILUENT
220223
8/12/09 Dimethyl sulfoxide
Glycerol
Potassium hydroxide
8/12/10 Dimethyl sulfoxide
Glycerol
Potassium hydroxide
2/11/11 NONE- LESS THAN1% OF ANY HAZADOUS
441362
2/11/11 Dimethyl sulfoxide
Glycerol
Potassium hydroxide
2/9/09 NAP guard
67-68-5
56-81-5
1310-58-3
XI;R 36/37/38
00127
3/11/10 NONE- LESS THAN1% OF ANY HAZADOUS
UPT COLLECTION
TRANSPORT KIT,
CT/GC QX
BIO RAD LAB
AMPLICLEAR
DIAGNOSTIC GROUP
TB
CEPHEID
BORD
CLONTECH
COPAN
ERAGEN
BIOSCIENCES
LUMINEX
ERAGEN
BIOSCIENCES
LUMINEX
ERAGEN
BIOSCIENCES
4/15/2015
AMPLITROL CT/GC
XPERT MTB/RIF
TITANIUM TAQ
COPAN ESWAB
BORDETELLA (3901)
PERTUSSIS PRIMERS
441361
00126
GXMTB/RIF
639209
482C
3901
BORDETELLA
PARAPERTUSSIS
3902
COLOR COMPENS.
REAGENT SET
3580
3/11/10 5-chloro-2-methyl-2H-isothiazol-3-one
300-6081
Tween 20
HEPES Acid and Salt
Magnesium Chloride
Bovine Serum Albumin
ISOPROPANOL
SODIUM HYDROXIDE
NONE- LESS THAN1% OF ANY HAZADOUS
1/1/06 NONE- LESS THAN1% OF ANY HAZADOUS
1/14/10 3-N-morpholino propansulfonic acid (MOPS)
Ethylenediamine tetraacidic acid (EDTA)
Deoxyribonucleic Acid (DNA, oligonucleotides)
1/14/10 3-N-morpholino propansulfonic acid (MOPS)
Ethylenediamine tetraacidic acid (EDTA)
Deoxyribonucleic Acid (DNA, oligonucleotides)
8/4/10 Deoxyribonucleic Acid (DNA, oligonucleotides)
3-N-morpholino propansulfonic acid (MOPS)
Page 5 of 9
HARMFUL
HARMFUL
HARMFUL
HARMFUL
IRRITANT
26172-55-4
IRRITANT
9005-64-5
FLAMMABLE
7365-45-9 (Acid)
7786-30-3
CORROSIVE
9048-48-6
67-63-0
497-19-8
1132-61-2
6381-92-6
170274-78-9
1132-61-2
6381-92-6
170274-78-9
170274-78-9
1132-61-2
IRRITANT
IRRITANT
IRRITANT
7001-MOLECULAR PATHOLOGY AND FLOW CYTOMETERY
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
LUMINEX
ERAGEN
BIOSCIENCES
ERAGEN
BIOSCIENCES
LUMINEX
ERAGEN
BIOSCIENCES
ERAGEN
BIOSCIENCES
LUMINEX
ERAGEN
FVL
PGM
FVL/PGM
HSV
MAGNA PURE
LC DNA
ISOLATION KIT 1
ERAGEN
ROCHE
DIAGNOSTICS
CORPORATION
ROCHE
DIAGNOSTICS
CORPORATION
ROCHE
DIAGNOSTICS
CORPORATION
ROCHE
DIAGNOSTICS
CORPORATION
FVL/PGM
BORD
MAGNA PURE
LT LOTAL
NUCLEIC ACID
ISOLATION KIT 1
HSV
HIV
GENOTYPING
CLEANING
ROCHE
DIAGNOSTICS
CORPORATION
Ethylenediamine tetraacidic acid (EDTA)
8/9/10 NONE- LESS THAN1% OF ANY HAZADOUS
DNA SAMPLE
PROCESSING
MULTICODE-RTX
CONTROL PRIMERS 2
3700
MULTICODE-RTx
DNA REAGENT SET
MULTICODE
ISOLUTION
3660
1/14/10 3-N-morpholino propansulfonic acid (MOPS)
Ethtlenediamine tetraacidic acid (EDTA)
Deoxyribonucleic acid (DNA, oligonucleotides)
7/1/08 NONE- LESS THAN1% OF ANY HAZADOUS
3691
8/4/10 NONE- LESS THAN1% OF ANY HAZADOUS
NUCLEASE FREE
WATER
5X ISOLUTION
FACTOR V
LEIDEN KIT
1468
8/4/10 NONE- LESS THAN1% OF ANY HAZADOUS
1482
03610179001
8/4/10 NONE- LESS THAN1% OF ANY HAZADOUS
9/17/09 Tris hydrochloride
04618955001
9/17/09 NONE- LESS THAN1% OF ANY HAZADOUS
2158850
8/22/06 NONE- LESS THAN1% OF ANY HAZADOUS
3003990
6/2/11 ETHANOL
Guanidine thiocyanate
ETHANOL
Guanidine thiocyanate
Triton X-100
Proteinase K
Isopropanol
TRIS HYDROCHLORIDE
6/2/11 ETHANOL
Guanidine thiocyanate
ETHANOL
Guanidine thiocyanate
Triton X-100
Proteinase K
Isopropanol
TRIS HYDROCHLORIDE
CITRIC ACID, TRISODIUM SALT
1/28/06 Tris (hydroxymethyl) aminomethane free base
Boric acid
Ethylenediaminetetraacetic acid disodium hydrate
12/1/01 Ethyl Alcohol
1,1 diflouroethane
FACTOR II
(PROTHROMBIN)
G20210A KIT
LIGHTCYCLER
COLOR COMPENS.
SET
WASH BUFFER 1
WASH BUFFER 2
LYSIS/BINDING
BUFFER
Proteinase K
Magnetic glass particles
ELUTION BUFFER
WASH BUFFER 1
WASH BUFFER 2
LYSIS/BINDING
BUFFER
Proteinase K
Magnetic glass particles
ELUTION BUFFER
WASH BUFFER 3
SIGMA-ALDRICH TRIS-BORATE
EDTA 5X
BUFFER
STERIS
ALCARE PLUS
3803
3038505
T4448
6399
Page 6 of 9
4/15/2015
6381-92-6
1132-61-2
6381-92-6
170274-78-9
IRRITANT
7732-18-5
IRRITANT
64-17-5
50-01-1
64-17-5
593-84-0
9002-93-1
39450-01-6
67-63-0
1185-53-1
64-17-5
50-01-1
64-17-5
593-84-0
9002-93-1
39450-01-6
67-63-0
1185-53-1
68-04-2
77-86-1
10043-35-3
6381-92-6
64-17-5
75-37-6
FLAMMABLE
IRRITANT
HARMFUL
SENSITIZER
FLAMMABLE
IRRITANT
HARMFUL
SENSITIZER
IRRITANT
FLAMMABLE
IRRITANT
7001-MOLECULAR PATHOLOGY AND FLOW CYTOMETERY
7001M
7001M
7001M
7001M
7001M
CLEANING
CLEANING
CLEANING
CLEANING
STERIS
TEXWIPE CO
THERMO
MILLIPORE
7001M
7001M
CLEANING
CLEANING
CLOROX COMPANY
CLOROX
CURTIN MATHESON
SUPER FRIENDLY
6810
6830
CLEANING
SCIENTIFIC INC AIR IT
MALLINCKRODT ISOPROPYL
BAKER, INC
ALCOHOL 90-100%
I8840
CLEANING
3M COMPANY
3M AVAGARD
FOAM
ANTISEPTIC
9251
3/27/09
CLEANING
MEDLINE
ALCOHOL PREP
51088
2/21/02
CLEANING
INDUSTRIES
METREX
RESEARCH
PADS
CAVICIDE
CAVIWIPES
7/1/07
CLEANING
CORPORATION
MOLECULAR
DNA AWAY
10/9/06
CLEANING
BIO-PRODUCTS,
OKO-TEC
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
CLEANING
GENERAL
SOFT N SURE
MICRODUSTER
SOFTGUARD
NUCLEOCLEAN
UNI-SAFE/
UNIVERSIAL GEL
SORBENT
PROCTER &
SWIFFER
GAMBLE COMPANY
SWEEPER
WET CLOTHS
STRECK
TEMP-CHEX
LABORATORIES RED SPIRIT
1119
TX2500
11002-24-001
3097
1/1/01
4/1/94
3/27/08
8/16/02
Isobutane
NONE- LESS THAN1% OF ANY HAZADOUS
CHLORODIFLUOMETHANE
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
10/1/00 Sodium Hypochlorite
2/21/96 1,1,1,2 TETRAFLUOROETHANE
240043
240046
75-28-5
75-45-6
MAY CAUSE FROSTBITE
7681-52-9
811-97-2
CORROSIVE
IRRITANT
Ethyl alcohol
water
emollients
64-17-5
7732-18-5
trade secret
MAY CAUSE FROSTBITE
FLAMMABLE
IRRITANT
NERVOUS SYSTEM
FLAMMABLE
NERVOUS SYSTEM
IRRITANT
Dimethicone Surfactant
Isopropyl Alcohol
102783-01-7
67-63-0
FLAMMABLE
Isoproponal
Ethylene glycol monobutyl ether
67-63-0
111-76-2
IRRITANT
FLAMMABLE
IRRITANT
Alkali hydroxide
proprietary
BLINDNESS
IRRITANT
5/4/07 ISOPROPYL ALCOHOL
1/7/06
RQ0810303
4/15/2015
67-63-0
Diatomite
2-propenoic acid with starch
Polyethylene glycol
7/8/08 NONE- LESS THAN1% OF ANY HAZADOUS
68855-54-9
60323-79-7
25322-68-3
IRRITANT
5/7/10
108-88-3
8052-41-3
FLAMMABLE
IRRITANT
Toluene
VARSOL fluid
Page 7 of 9
7001-MOLECULAR PATHOLOGY AND FLOW CYTOMETERY
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
7001M
240049
GENERAL
GENERAL
GENERAL
GENERAL
GENERAL
GENERAL
RVP
WD-40 COMPANY WD-40
AAPER ALCOHOL Ethyl
- ETHYL
Alcohol
ALCOHOL
AND CHEMICAL USP 190 PROOF
COMPANY
DRUMMOND
REPELL
A LAWSON BRAND
RICCA
CHEMICAL
COMPANY
AMBION, INC.
BAXTER
HEALTHCARE
CORPORATION
BIOFIRE
WD-40
Methanol
Propylene Glycol
5/16/07 Aliphatic hydrocarbon
Petroleum base oil
LVP aliphatic hydrocarbon
Carbon dioxide
004
Ethyl Alcohol
DA6172
DENATURED
ALCOHOL
SOLUTION
WATER,
NUCLEASE-FREE
STERILE WATER
FOR IRRIGATION,
USP
FA REAGENT POUCH
HYDRATION SOLN
SAMPLE BUFFER
3/29/11 Petroleum distillates, hydrotreated heavy naphthenic
Tetrachloroethylene
Carbon Dioxide
7/12/00 Ethanol (60-72%)
Methanol (3-4%)
Isoproponal, 2-proponal (3-4%)
1/10/06 NONE- LESS THAN1% OF ANY HAZADOUS
2546
9938
2F7114
RFITASY-0001
1/21/13 NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
GUANIDINE
OCTOXYNOL
RVP
GENERAL
GENERAL
MAINE MOLECULAR
CONTROLS
BD
BD VIRAL TRANSPORT
LUMINEX
NUCLEASE-FREE
7001M
7001F
67-56-1
57-55-6
64742-47-8
64742-65-0
64742-47-8
124-38-9
64-17-5
FLAMMABLE
IRRITANT
FLAMMABLE
NERVOUS SYSTEM
64742-52-5
127-18-4
124-38-9
64-17-5
67-56-1
67-63-0
IRRITANT
50-01-1
IRRITANT
9002-93-1
FLAMMABLE
64-17-5
FLAMMABLE
75-37-6
FLAMMABLE
7681-52-9
MAY CAUSE FROSTBITE
CORROSIVE
FLAMMABLE
IRRITANT
NONE- LESS THAN1% OF ANY HAZADOUS
7001M
7001M
7001M
7001M
4/15/2015
M210
9/11/12 ETHYL ALCOHOL
11/4/08 NONE- LESS THAN1% OF ANY HAZADOUS
8/4/10 NONE- LESS THAN1% OF ANY HAZADOUS
3692-22
WATER,
CLEANING
FALCON SAFETY AIR, CANNED
7001F
7001F
PRODUCTS,
(COMPUCESSORY)
CLOROX COMPANY
CLOROX
7001F
7001F
7001F
7001F
7001F
7001F
METREX
RESEARCH
CORPORATION
NICE PAK
PRODUCTS,
CCS24300
10/28/09 Ethane, 1,1-difluoro
6810
10/1/00 Sodium Hypochlorite
CAVICIDE
SANI-CLOTH PLUS
7/1/07
0002
SODIUM HYDROXIDE
Isoproponal
Ethylene glycol monobutyl ether
2-propanol
Ethanol, 2-butoxy-
Page 8 of 9
1310-73-2
67-63-0
111-76-2
67-63-0
111-76-2
FLAMMABLE
IRRITANT
BLINDNESS
IRRITANT
7001-MOLECULAR PATHOLOGY AND FLOW CYTOMETERY
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
STERIS
DECON
MARKERS
GENERAL
SOFT N SURE
CONTRAD 70
LABORATORIES
IMMUNOTECH
IMMUNOTECH
INVITROGEN
DAKO
1119
CD34 PE
CD138 PE
FETAL HGB FITC
POLYCOLONAL
RABBIT
ANTI HUMAN KAPPA
LIGHT CHAIN FITC
DAKO
POLYCOLONAL
RABBIT
ANTI HUMAN KAPPA
LIGHT CHAIN RPE
SUPERTECHS
ANTI-HTdT FITC
IMMUNOTECH
7-AAD VIABILITY
BECTON DICKINSON
7-AAD VIABILITY
IM1871
IM2759
MHFH01
F0434
Benzyl-C12-18-alkyldimethyl ammonium chlorides
Quarternary ammonium compounds, chlorides
5/16/07 NONE- LESS THAN1% OF ANY HAZADOUS
8/1/11 POTASSIUM HYDROXIDE
IRRITANT
26628-22-8
ALL CONTAIN 0.1%
SODIUM AZIDE
67-63-0
trade secret
IRRITANT
9048-46-8
26628-22-8
IRRITANT
ALL CONTAIN 0.1%
SODIUM AZIDE
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
FORMALDEHYDE
50-00-0
FLAMMABLE
IRRITANT
10/15/08 NONE- LESS THAN1% OF ANY HAZADOUS
11/28/06 Formaldehyde
50-00-0
3/14/07
12/24/01
5/9/07
1/30/09
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
1/30/09 NONE- LESS THAN1% OF ANY HAZADOUS
6600
IM3422
559925
2/20/06 NONE- LESS THAN1% OF ANY HAZADOUS
5/19/08 NONE- LESS THAN1% OF ANY HAZADOUS
6/6/03 NONE- LESS THAN1% OF ANY HAZADOUS
BECKMAN-COULTERdiff A T PAK
8547134
BECKMAN-COULTERA T RINSE
8547113
5/11/07 ISOPROPYL ALCOHOL
QUATERNARY AMMONIUM SALT
3/28/06 NONE- LESS THAN1% OF ANY HAZADOUS
SHUTDOWN
BD DIAGNOSTIC BD PHARM LYSE
555899
4/13/10 NONE- LESS THAN1% OF ANY HAZADOUS
0002331
26010066
9/15/06 Bovine Serum Albumin
9/24/08 NONE- LESS THAN1% OF ANY HAZADOUS
STRECK
STRECK
BOVINE ALBUMIN 22%
NEW BORN
CALF SERUM
CD-CHEX PLUS
CELL PRESERVATIVE
BECKMAN-COULTERCOULTER CLENZ
BECKMAN-COULTERCYTO-COMP
TRILLIUM
INVITROGEN
FETALTROL
FIX & PERM A
POLYSCIENCES
FIX & PERM B
FORMALDEHYDE
SF10A1000-6
SF10A4000-1
8546931
6607023
13012090
GAS001
GAS002
4018
68391-01-5
68956-79-6
1310-58-3
R0437
IMMUCOR
INVITROGEN
4/15/2015
12/29/08
2/21/08
5/20/08
3/18/08
1/1/07
10/15/08
Page 9 of 9
CARCINOGEN
IRRITANT
7001-MOLECULAR PATHOLOGY AND FLOW CYTOMETERY
7001F
7001F
7001F
7001F
METHANOL FREE
MALLINCKRODT PARAFORMALDEHYDE
BAKER, INC
P0154
2/1/07
Paraformaldehyde (100%)
4/15/2015
30525-89-4
7001F
TARGET ORGAN EFFECTS
7001F
ACROS ORGANIC GLUTARALDEHYDE
AC410970000
7001F
8% SOLUTION
7001F
BECTON DICKINSON
PHARM LYSE
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
INVITROGEN
PBS PH 7.2
20012050
SIGMA-ALDRICH RPMI 1640
R8758
BECKMAN-COULTERS-CAL
179310
BECTON DICKINSON
BD PRE-FILLED
FLUSH SYRINGES
PHOENIX FLOW TdT CONTROL CELLS
CRTDP
INVITROGEN
1% TRITON X-100
HFH10
BECKMAN-COULTER4C ES CELL CONTROL
7547187
BECTON DICKINSON
CD3(LEU 4)
349201
ANTI-KAPPA FITC
643774
ANTI-LAMBDA PE
642924
MPO PE
341632
BECTON DICKINSON
V450 MOUSE ANTIHUMAN CD11
560369
FITC IGM ISOTYPE
551448
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
CARCINOGEN
FLAMMABLE
IRRITANT
CARCINOGEN
MARKERS
MARKERS
7-COLOR SETUP BEAD
FACS SETUP DILUENT
CD1A PE
CD2 V450
CD4 APC
CD5PE
CD5PE-CY7
CD7 (M-T701)PE
CD8 PERCP-CY5.5
3/5/60 GLUTARALDEHYDE
111-30-8
IRRITANT
TARGET ORGAN EFFECTS
555899
91-0660
336565
341641
644486
340672
340697
348800
340656
341049
4/13/10 NONE- LESS THAN1% OF ANY HAZADOUS
5/18/07 NONE- LESS THAN1% OF ANY HAZADOUS
2/3/06 NONE- LESS THAN1% OF ANY HAZADOUS
8/24/07 NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
7/15/07
5/9/07
11/20/07
8/28/12
11/16/11
11/16/11
12/2/11
12/11/08
10/16/00
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
11/3/11
11/17/11
12/2/11
11/16/11
12/2/11
12/2/11
12/2/11
12/2/11
12/2/11
POLYETHYLENE GLYCOL
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
Page 10 of 9
26628-22-8
ALL CONTAIN 0.1%
SODIUM AZIDE
26628-22-8
ALL CONTAIN 0.1%
SODIUM AZIDE
37255-26-6
IRRITANT
26628-22-8
ALL CONTAIN 0.1%
SODIUM AZIDE
7001-MOLECULAR PATHOLOGY AND FLOW CYTOMETERY
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
7001F
MARKERS
CD10 PE-CY7
341102
CD10(HI10A)
340922
CD11b APC
340936
CD13 PE-CY7
338432
CD14 FITC
340682
CD15 FITC
340703
CD16 PERCP-CY5.5
338433
CD19 (SJ25C1)PERCP-CY5.5
340950
CD20 V450
642283
CD20 PERCP-CY5.5
340954
CD22 FITC
340707
CD23 APC
340934
CD25 PE-CY7
335807
CD33 PE
340679
CD34(8G12) PE
340669
CD34 PER CP-CY5.5
347213
CD38 APC
340677
CD45 APC H7
641408
CD56 PE-CY7
335809
CD61 FITC
340715
CD64 (10.1)PE
644386
CD71 APC
341029
CD79A PE
340654
CD103 PE
340997
CD117 PE-CY7
339206
CD138 RPE
347206
CD138 PERCP-CY5.5
341097
FMC7 FITC
340918
GLYCOPHORIN A PE
340946
ANTI-HLA DR FITC
340688
IgG1 V450
642277
TRITEST CD3/CD4/CD45 340383
MULTITEST CD3/CD16+56/CD45/CD19
340500
MULTITEST CD3/CD8/CD45340499
MULTITEST CD3/CD8/CD45/CD4
340503A
BECTON DICKINSON
MULTITEST CD3/CD16+56/CD45/CD19
340503B
MULTITEST 10 LYSING SOL
340503C
12/2/11
12/2/11
6/25/12
11/17/11
12/21/11
12/2/11
11/17/11
12/2/11
11/16/11
12/2/11
12/2/11
12/2/11
11/17/11
12/2/11
12/2/11
5/28/02
12/2/11
11/16/11
11/17/11
12/2/11
11/16/11
12/2/11
12/2/11
12/2/11
11/17/11
12/2/11
12/2/11
12/2/11
12/2/11
12/2/11
11/16/11
12/2/11
12/2/11
12/2/11
12/2/11
12/2/11
12/2/11
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
GLYCEROL
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
DIETHYLENE GLYCOL
4/15/2015
56-81-5
HARMFUL IF SWALLOWED
111-46-6
IRRITANT
7001F
7001F
7001F
CARCINOGEN
641319
349202
FORMALDEHYDE
11/16/11 NONE- LESS THAN1% OF ANY HAZADOUS
1/11/12 DIETHYLENE GLYCOL
50-00-0
BD CST KIT
FACS LYSING SOLN
111-46-6
IRRITANT
7001F
7001F
7001F
FORMALDEHYDE
6/26/12 NONE- LESS THAN1% OF ANY HAZADOUS
11/17/11 NONE- LESS THAN1% OF ANY HAZADOUS
50-00-0
CARCINOGEN
BD FACSFLOW SHEATH 342003
FACS SHUTDOWN SOLN 334224
Page 11 of 9
7001-MOLECULAR PATHOLOGY AND FLOW CYTOMETERY
7001F
BD FACS CLEAN
7001F
7001F
POUCHED ABSOLUTE COUNT
91-0390
TUBES
DESICCANT
22-0448
7001F
7001F
7001F
MARKERS
SPILL KITS
BECTON DICKINSON
STAIN BUFFER
PND CORP
UNI-SAFE
340345
554657
4/15/2015
12/2/11 Sodium Hypochlorite
7681-52-9
IRRITANT
12/2/11 POLYETHYLENE GLYCOL
12/2/11 SILICA
37255-26-6
112926-00-8
IRRITANT
IRRITANT
COBALT DICHLORIDE
1/22/09 NONE- LESS THAN1% OF ANY HAZADOUS
2/3/2011 NONE- LESS THAN1% OF ANY HAZADOUS
7646-79-9
TOXIC CARCINOGEN
Page 12 of 9
7017- IMMUNOLOGY
DEPT
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
TEST NAME
CLEANING
VENDOR
PDI
REAGENT
Adhesive Remover
CLEANING
MALLINCKRODT
BAKER, INC
ISOPROPYL
ALCOHOL 90-100%
I8840
CLEANING
CLEANING
CLEANING
CLEANING
CLEANING
SOFT N SURE
MICRODUSTER
SOFTGUARD
CLOROX
SUPER FRIENDLY
AIR IT
3M AVAGARD
FOAM
ANTISEPTIC
1119
TX2500
11002-24-001
6810
6830
1/1/2001
4/1/1994
3/27/2008
10/1/2000
2/21/1996
CLEANING
STERIS
TEXWIPE CO
THERMO
CLOROX COMPANY
CURTIN MATHESON
SCIENTIFIC INC
3M COMPANY
9251
3/27/2009
CLEANING
MEDLINE
ALCOHOL PREP
51088
2/21/2002
INDUSTRIES
METREX
RESEARCH
CORPORATION
ARTEL, INC.
PADS
CAVICIDE
CAVIWIPES
7017
7017 CLEANING
7017
7017
7017 PIPETTE CALIB
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017 SPILL KITS
MANUAL
TESTING
7017 RPR
7017
7017 VDRL
7017
7017 MYCM
7017 HITR
PCS-231
PCS CALIB
SOLUTIONS
PCS SAMPLE
RANGE
SOLUTIONS
PCS-600
UNI-SAFE
BD
WAMPOLE
BD
RPR ANTIGEN
RPR CONTROL
VDRL ANTIGEN
VDRL CONTROL
MYCOPLASMA IgM
PF4 HIT
MSDS
HAZARDOUS INGREDIANT
2/25/2009 NAPHYHA
FATTY ACIDS C14-18 ISOPROPYL ESTERS
ISOPROPANOL
SOLVENT NAPTHA
XYLENE
5/4/2007 ISOPROPYL ALCOHOL
Jul-07
PCS BLANK
SOLUTION
PND CORP
IMMUNOCARD
GTI DIAGNOSTICS
PRODUCT #
40000-260
NONE- LESS THAN1% OF ANY HAZADOUS
CHLORODIFLUOMETHANE
NONE- LESS THAN1% OF ANY HAZADOUS
Sodium Hypochlorite
1,1,1,2 TETRAFLUOROETHANE
4/15/2015
CAS #
64742-48-9
70750-32-2
67-63-0
64742-89-8
1330-20-7
67-63-0
HAZARD
FLAMMABLE
IRRITANT
75-45-6
MAY CAUSE FROSTBITE
7681-52-9
811-97-2
CORROSIVE
IRRITANT
MAY CAUSE FROSTBITE
FLAMMABLE
NERVOUS SYSTEM
IRRITANT
Ethyl alcohol
water
emollients
Dimethicone Surfactant
Isopropyl Alcohol
64-17-5
7732-18-5
trade secret
102783-01-7
67-63-0
Isoproponal
Ethylene glycol monobutyl ether
67-63-0
111-76-2
FLAMMABLE
IRRITANT
NERVOUS SYSTEM
FLAMMABLE
IRRITANT
FLAMMABLE
IRRITANT
BLINDNESS
IRRITANT
5/20/2009 POLYETHYLENE GLYCOL
Copper (II) chloride dihydrate
Methyl 4-hydroxybenzoate
2-phenoxyethanol
EDTA
5/20/2009 NONE- LESS THAN1% OF ANY HAZADOUS
25322-68-3
10125-13-0
99-76-3
122-99-6
64-02-8
PCS-221
5/20/2009 Aqueous phthalate buffer
Ponceau S (Acid red 112)
Methyl 4-hydroxybenzoate
2-phenoxyethanol
EDTA
2/3/2011 NONE- LESS THAN1% OF ANY HAZADOUS
N/A
6226-79-5
99-76-3
122-99-6
64-02-8
IRRITANT
270333
61C3
240764
235201
709030
XHAT45
2/11/2011
9/27/2007
2/11/2011
2/11/2011
1/1/1994
1/7/2011
7647-14-5
201-064-4
HARMFUL IF SWALLOWED
IRRITANT
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
SODIUM CHLORIDE
TRIS
Page 13 of 66
7017- IMMUNOLOGY
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
HITGR
HITG
PF4 IgG
HAT45G
CR2003
CRYB
IMMY
CRYPTOCOCCUS AG
ROTAV
FISHER SCIENTIFIC
MO
CFHIV
FISHER SCIENTIFIC
BIO-RAD
SURE VUE ROTA
ROTA CONTROLS
SURE-VUE MONO
MULTISPOT
HIV-1/HIV-2
WASH SOLN
DEV .REAGENT
STOP SOLUTION
ELECTROPHORESIS
SIK
STRECK
HBEL
ACID HGB
SEBIA
ALK HGB
SEBIA
SPE
SEBIA
AUTOMATED
TESTING
ANAPR
ANARF
ANASC
ZEUS SCIENTIFIC
SA069111-F
SA069101
2303817
25228
SODIUM HYDROXIDE
DIETHANOLAMINE
SODIUM AZIDE
HCL
SODIUM CHLORIDE
9/7/2012 DISODIUM EDTA
BOVINE SERUM ALBUMIN
12/1/2008 NONE- LESS THAN1% OF ANY HAZADOUS
11/30/2000 NONE- LESS THAN1% OF ANY HAZADOUS
13/3/97
NONE- LESS THAN1% OF ANY HAZADOUS
6/1/2012
UREA
PROPYLENE GLYCOL
AMP BUFFER
SULFURIC ACID
SICKLEDEX
773500
9/21/2007 SODIUM HYDROSULFITE
SAPONIN
SICKLE-CHEK
AMIDOBLACK STAIN
217654
4108
STAIN DILUENT
DESTAIN SOLN
ACID HGB KIT
BUFFER STRIPS
HEMOLYZING SOLN
WASH SOLUTION
WET STORAGE SOLN
HEMOGLOBIN BUFFER
CAP- HEMOLYZING
CAP-WASH SOLN
CAPICLEAN
CLEAN PROTECT
4108
4540
4108
4108
4108
4541
1294
2007
2007
2007
2058
2059
2/19/2009 NONE- LESS THAN1% OF ANY HAZADOUS
7/17/2013 ETHYLENE-GLYCOL
AMIDO BLACK
7/17/2013 CITRIC ACID
7/17/2013 CITRIC ACID
7/17/2013 NONE- LESS THAN1% OF ANY HAZADOUS
7/17/2013 NONE- LESS THAN1% OF ANY HAZADOUS
7/17/2013 NONE- LESS THAN1% OF ANY HAZADOUS
7/17/2013 NONE- LESS THAN1% OF ANY HAZADOUS
7/17/2013 NONE- LESS THAN1% OF ANY HAZADOUS
9/26/2013 NONE- LESS THAN1% OF ANY HAZADOUS
7/17/2013 NONE- LESS THAN1% OF ANY HAZADOUS
7/17/2013 SODIUM HYDROXIDE
7/22/2013 PROTEOLYTIC ENZYMES
7/17/2013 2-METHYL-2H-ISOTHIAZOL-3-ONE
PROTEIN BUFFER
2043
7/17/2013 NONE- LESS THAN1% OF ANY HAZADOUS
ATHENA ANA II KIT
CALIBRATION KIT
DAILY
MAINTENANCE KIT
A21001
AX100
2/11/2009
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
AX9001
8/26/2009
SODIUM CHLORIDE
ISOPROPAL ALCOHOL
TETRAETHYLAMMONIUM HYDROXIDE
TRITON X-100
Page 14 of 66
4/15/2015
215-185-5
203-868-0
247-852-1
231-595-7
231-598-3
60-00-4
9048-46-8
CAUSTIC
HARMFUL IF SWALLOWED
57-13-6
57-55-6
124-68-5
7664-93-9
IRRITANT
7775-14-6
8047-15-2
FLAMMABLE
TOXIC
IRRITANT
107-21-1
1064-48-8
77-92-9
77-92-9
IRRITANT
TOXIC
IRRITANT
IRRITANT
1310-73-2
NA
2682-20-4
CORROSIVE
IRRITANT
CORROSIVE,TOXIC
IRRITANT
7647-14-5
67-63-0
IRRITANT
FLAMMABLE
9002-93-1
IRRITANT
7017- IMMUNOLOGY
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
SHEATH FLUID
A200S
MUMPS
RUBE
VARG
VARM
HPA
HSM
WAMPOLE
MUMPS ELISA
MEASLES ELISA
VARICELLA IgG
VARICELLA IgM
H.PYLORI IGG
HSV 1/2 IgM
426000CE
425900CE
425600CE
425650CE
446400CE
HSV1G
HSV2G
DIASORIN
HSV-1 IGG
HSV-2 IGG
CALIBRATORS &
CONTROLS
310831
310621
TREP
DIASORIN
TREPONEMA SCREEN
TREP CONTROL
EBVG
DIASORIN
EBVM
DIASORIN
CMVG
DIASORIN
CMVM
DIASORIN
LYME
DIASORIN
LIAISON
GENERAL
REAGENTS
DIASORIN
IMMUNOCAP
GENERAL
REAGENTS
PHADIA
PHADIA
ALL
IMMUNOCAPS
PHADIA
PHADIA
PHADIA
EBV VCA IgG
EBV VCA CONTROL
EBV IgM
EBV IgM CONTROL
CMV IgG
CMV IgG CONTROL
CMV IgM
CMV IgM CONTROL
BORRELIA LYME
BORRELIA CONT.
CLEANING KIT
LIGHT CHECK
STARTER SET
WASH
MAINTENANCE
SOLUTION
DEVELOPMENT
SOLUTION
SAMPLE DILUENT
WASHING SOLUTION
STOP SOLUTION
ALLERGEN
IMMUNOCAP
ANTI-IgE
B1032-480
B1032-842
310510
310511
310500
B-1032-373
B1032-382
B1032-385
B1032-384
B1032-386
B1032-870
B1032-871
B1032-383
B1032-9101
B1032-9102
319100
10-9476-01
10-925-01
10-9361-01
10-9435-01
10-9422-01
34-2271-51
IMMUNOCAP
SODIUM CHLORIDE
SODIUM PHOSPHATE
10/24/2005 GLYCEROL
HCL
SODIUM AZIDE
SODIUM CHLORIDE
TWEEN 20
9/1/2014
9/1/2014
9/1/2011
7/15/2010
7/15/2010
7/15/2010
7/15/2010
7/15/2010
7/15/2010
REQUESTED
NA
11/29/2010
9/1/2011
7/3/2007
4/15/2015
764-14-5
7782-85-6
56-81-5
7647-01-0
26628-22-8
764-14-5
9005-64-5
PROCLIN
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
PROCLIN
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NONE- LESS THAN1% OF ANY HAZADOUS
SODIUM HYDROXIDE
NONE- LESS THAN1% OF ANY HAZADOUS
COCOASLKYBENZYLDIMETHYLAMMOIUM CHLORIDE
BIS(3-AMINOPROPYL)-DODECYLAMIN
COCOSPROPYLENDIAMINBISGUANIDINIUM DIACETAT
DIMETHYL-POLYSILOXANE
5/7/2007 NONE- LESS THAN1% OF ANY HAZADOUS
4/6/2005 NONE- LESS THAN1% OF ANY HAZADOUS
5/7/2007 SODIUM CARBONATE
12/19/2006 NONE- LESS THAN1% OF ANY HAZADOUS
Page 15 of 66
IRRITANT
IRRITANT
CAUSTIC
HARMFUL IF SWALLOWED
TOXIC
IRRITANT
55965-84-9
SENSITIZING MATERIAL
TOXIC, CORROSIVE
IRRITANT
SENSITIZING MATERIAL
TOXIC, CORROSIVE
SENSITIZING MATERIAL
TOXIC, CORROSIVE
SENSITIZING MATERIAL
TOXIC, CORROSIVE
SENSITIZING MATERIAL
TOXIC, CORROSIVE
SENSITIZING MATERIAL
TOXIC, CORROSIVE
SENSITIZING MATERIAL
TOXIC, CORROSIVE
1310-73-2
CORROSIVE
8001-54-5
2372-82-9
CORROSIVE
HARMFUL IF SWALLOWED
IRRITANT
55965-84-9
55965-84-9
55965-84-9
55965-84-9
55965-84-9
55965-84-9
85681-60-3
63148-42-9
24551-51-7
IRRITANT
7017- IMMUNOLOGY
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
SPECIFIC IgE
PHADIA
TOTAL IgE
PHADIA
ANTI CCP
ANTI-TTG IgA
ANTIGLIADEN
IgA +IgG
PHADIA
QF TB GOLD
CELLESTIS
CURVE CONTROL
SPECIFIC CONTROL
10-9312-01
10-9449-01
SPECIFIC CONJUGATE
10-9419-01
SPECIFIC CALIB
10-9386-01
CURVE CONTROL
10-9325-01
TOTAL CONTROL
10-9267-01
TOTAL CONJUGATE
10-9319-01
TOTAL CALIB
10-9387-01
ELIA IGG CALIBRATORS83-1015-01
ELIA IGG CURVE CONTROL
83-1016-01
ELIA IGG CONJUGATE 5083-1017-01
ELIA IGG CONJUGATE 83-1022-01
200
ELIA SAMPLE DILUENT 83-1023-01
ELIA IGA CAL WELL
14-5516-01
ELIA IGA CALIBRATORS83-1019-01
ELIA IGA CURVE CONTROL
83-1020-01
ELIA IGA CONJUGATE 5083-1021-01
ELIA IGA CONJUGATE 200
83-1022-01
ELIA CCP WELL
14-5515-01
ELIA CCP CONTROL
83-1035-01
ELIA CELIKEY IGA WELL
14-5517-01
ELIA CELIKEY IGG WELL
14-5518-01
ELIA GLIADIN IGA dp WELL
14-5538-01
ELIA GLIADIN IGG dp WELL
14-5539-01
ELIA CELIA CONTROL 83-1036-01
ELIA NEG CONTROL
83-1037-01
ELIA IgG CALIBRATOR WELL
14-5509-01
TB GOLD ELISA KIT
0594-0201
BLOOD COLLECTION
TUBES
T0590-0301
7/25/2005
4/6/2005
2/10/2006
2/10/2006
7/25/2005
4/6/2005
4/6/2005
4/6/2005
12/8/2011
12/8/2011
12/8/2011
12/8/2011
12/8/2011
12/8/2011
12/8/2011
12/8/2011
12/8/2011
12/8/2011
12/8/2011
12/8/2011
12/8/2011
12/8/2011
12/8/2011
12/8/2011
12/8/2011
12/8/2011
12/8/2011
2/1/2013
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
11/1/2007 NONE- LESS THAN1% OF ANY HAZADOUS
Page 16 of 66
4/15/2015
7017- HEMATOLOGY/COAGULATION/URINALYSIS
DEPT
TEST NAME
VENDOR
REAGENT
7017
CLEANING
METREX
CAVICIDE
7017
RESEARCH
7017
CORPORATION
7017
CLEANING
PROTOCOL
PRODUCT #
4/15/2015
MSDS
HAZARDOUS INGREDIANT
CAS #
HAZARD
Jul-07
Isoproponal
67-63-0
FLAMMABLE
Ethylene glycol monobutyl ether
111-76-2
IRRITANT
BLINDNESS
SAFE CLEAR
23-314-629
8/28/2009
ALKANES, C9-11 ISO
68551-16-6
7017
FLAMMABLE
IRRITANT
7017
7017
CLEANING
CLOROX COMPANY
CLOROX
6810
10/1/2000
Sodium Hypochlorite
7681-52-9
CORROSIVE
7017
CLEANING
3M COMPANY
3M AVAGARD
9251
3/27/2009
Ethyl alcohol
64-17-5
FLAMMABLE
7017
FOAM
water
7732-18-5
NERVOUS SYSTEM
7017
ANTISEPTIC
emollients
trade secret
IRRITANT
Dimethicone Surfactant
102783-01-7
7017
7017
CLEANING
ALCONOX
LIQUINOX
7017
CLEANING
STERIS
ALCARE PLUS
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
CLEANING
CLEANING
ASP
ASP
CLEANING
THERMO
CLEANING
ALCONOX
CLEANING
BAXTER
CLEANING
CBC
AGION TECH
SYSMEX
XE5000
CBC
CONTROLS
CBC
SYSMEX
XE5000
SYSMEX
XE5000
SYSMEX
XE5000
SYSMEX
CBC
CBC
CBC
6399
2/24/2005
SODIUM DODECYLBENZENESULFONATE
25155-30-0
IRRITANT
12/21/2009
Ethyl alcohol
64-17-5
FLAMMABLE
1,1 Difluoroethane
Isobutane
NONE- LESS THAN1% OF ANY HAZADOUS
GLYCINE
SODIUM SULFITE
P-CHLORO-M-XYLENOL
75-37-6
75-28-5
IRRITANT
CIDEX OPA
CIDEX OPA
TEST STRIPS
SOFTCIDE
HAND SOAP
TERGAZYME
09588-0-001
BXPQG
9/27/2010
9/9/1994
12-544-09
7/14/2005
C6302-2A
3/15/2005
SP BRAND LENS
CLEANER
AGION SILVER CLENE
CELLPACK
CELLSHEATH
RET SEARCH (II)DIL
STROMATOLYSER 4DL
STROMATOLYSER FB
STROMATOLYSER NR
SUFOLYSER
e-CHECK XE
SCS-1000
STROMATOLYSER-NR
DYE
STROMATOLYSER-IM
M6015
5/2/2008
72977
PK-30L
SE-90L
RED-300
FFD-200A
FBA-200A
SNR-200
SLS-220A
201-6001-0
5/24/2006
EXEMPT
2/23/2010
EXEMPT
NONE- LESS THAN1% OF ANY HAZADOUS
SNR-800
12/31/2010
ETHYLENE GLYCOL
107-21-1
SIM-220A
6/12/2009
SODIUM HYDROXIDE
1310-73-2
FFS-8001
2/22/2011
RED-800
11/12/2010
ETHYLENE GLYCOL
METHANOL
ETHYLENE GLYCOL
107-21-1
67-56-1
107-21-1
STROMATOLYSER -4DS
DYE
RET-SEARCH (II) DYE
Page 17 of 66
SODIUM DODECYLBENZENESULFONATE
SODIUM CARBONATE
SODIUM PHOSPHATE
ISOPROPANOL
ACETIC ACID
CITRIC ACID
NONE- LESS THAN1% OF ANY HAZADOUS
56-40-6
7757-83-7
88-04-0
25155-30-0
497-19-8
7758-29-4
67-63-0
64-19-7
77-92-9
IRRITANT
IRRITANT
IRRITANT
FLAMMABLE
IRRITANT
IRRITANT
COMBUSTIBLE
TOXIC
CORROSIVE
IRRITANT
COMBUSTIBLE
TOXIC
COMBUSTIBLE
7017- HEMATOLOGY/COAGULATION/URINALYSIS
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
CBC
EOSA
SEO
XE5000
PROTOCOL
METHANOL
GLYCERIN
METHYL ALCOHOL
67-56-1
56-81-5
67-56-1
11/16/2012
GLYCERIN
METHYL ALCOHOL
56-81-5
67-56-1
161-6005
9/1/2007
8889-215003
1/30/2004
67-56-1
68988-92-1
9002-86-2
6422-86-2
GIEMSA STAIN
GS500
6/24/2014
METHANOL
WRIGHT STAIN
POLVINYL CHLORIDE
BIS-(2-ETHYLHEXYL)TEREPHTHALATE
PROPRIETARY INGREDIENTS
Methyl alcohol
67-56-1
IRRITANT
TOXIC
FLAMMABLE
THERMO
METHANOL
9600-1
9/5/2006
METHANOL
67-56-1
THERMO
RESOLVE IMMERSION
OIL
HIGH VISCOSITY
LOW VISCOSITY
M5004
2/2/2012
12-365-20
2/15/2012
BOVINE ALBUMIN
SOLUTION 22%
PHOSPHATE BUFFER
PH 7.2
SICKLEDEX
0002327
8042-47-5
68956-74-1
61788-32-7
9003-29-6
26140-60-3
9048-46-8
26628-22-8
P3288
IO17-10
4/9/2012
7/10/2014
WHITE MINERAL OIL
POLYPHENYLS
HYDROGENATED TERPHENYLS
POLYBUTENE
TERPHENYLS
BOVINE ALBUMIN
SODIUM AZIDE
NONE- LESS THAN1% OF ANY HAZADOUS
IRRITANT
FLAMMABLE
TOXIC
FLAMMABLE
IRRITANT
773500
9/21/2007
SODIUM HYDROSULFITE
SAPONIN
7775-14-6
8047-15-2
FLAMMABLE
TOXIC
IRRITANT
6009-70-7
4/3/6132
TOXIC
TARGET ORGAN
IRRITANT
1310-73-2
7758-98-7
CORROSIVE
IRRITANT
1310-58-3
67-68-5
CORROSIVE
7681-52-9
CORROSIVE
WRIGHT-GIEMSA
STAIN
264-983
9/10/2012
HARLECO
WRIGHT-GIEMSA
STAIN
742
CBC
SYSMEX
HCT
TYCO
KENDALL
SAS-100 WRIGHT STAIN
& BUFFER
CRITOSEAL
CBC
SIGMA ALDRICH
CBC
CBC
CBC
IMMUCOR
CBC
SIGMA ALDRICH
SIK
STRECK
WBC/PLT
BIOMEDICAL
POLYMERS
STRECK
STRECK
STRECK
SIEMENS
SICKLE-CHEK
LEUKOCHEK
217654
N834
2/19/2009
2/24/2010
NONE- LESS THAN1% OF ANY HAZADOUS
AMMONIUM OXALATE
ESR VACUUM TUBES
ESR -CHEX
CELL-CHEX
CLINITEST TABLETS
SF10A1001-1
SF10A1000-7
SF10A1000-7
2157
6/14/2006
2/19/2009
2/19/2009
2/21/1997
KOH
BAYER
SIEMENS
MICROGENICS
BD DIAGNOSTICS
LABSTIX
N-MULTISTIX SG
MAS UA CONTROL
KOH PREP
2181
2176
UAB-115
261191
12/6/1998
1/12/2011
3/16/2007
3/1/2011
UA
IRIS
IRIS DILUENT
IRIS SYSTEM CLEANER
800-3202
800-3203
10/5/2011
10/5/2011
SODIUM CITRATE DIHYDRATE
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
SODIUM HYDROXIDE
CUPRIC SULFATE
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
POTASSIUM HYDROXIDE
DIMETHYL SULFOXIDE
NONE- LESS THAN1% OF ANY HAZADOUS
SODIUM HYPOCHLORIDE
SED
SED
FLD
UA
UA
4/15/2015
Page 18 of 66
TOXIC
FLAMMABLE
TOXIC
IRRITANT
FLAMMABLE
TOXIC
IRRITANT
FLAMMABLE
TOXIC, IRRITANT
IRRITANT
IRRITANT
7017- HEMATOLOGY/COAGULATION/URINALYSIS
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
FCC
CCSP
UA
IRIS
SWCHL
WESCOR
SWCHL
LABCONCO
SWCHL
LABCONCO
SWCHL
G6PD
QUANTIMEX
TRINITY
BIOTECH
ALK PHOS
SIGMA ALDRICH
ALK PHOS
LEUKOCYTE
KIT
IQ CALIBRATOR
800-3103
IRISPEC CA
800-0074
IRISPEC CB
800-0074
IRISPEC CC
800-7702
IQ FOCUS
800-3104
IQ LAMINA
800-3102
WASH SOLN CONC
AX-4280
SG CALIBRATOR LOW
AX-2480
SG CALIBRATOR HIGH
AX-4280
VELOCITY CHEMISTRY STRIPS 800-7212
IQ NEGATIVE CONTROL
800-3104
IQ POSITIVE CONTROL
800-3104
IQ BODY FLUID LYSE
800-3213
VELOCITY CALCHECK
800-7703
VELOCITY WASH SOLN
800-7704
MACRODUCT
PILOCARPINE
SLP2125
CHLORIDOMETER
ACID REAGENT
1039100
CHLORIDE
442-5304
STANDARD
SWEAT CONTROL
1190-01
G-6-PD REAGENT
400K-100-5
G-6-PD NORMAL CTL
G6888
G-6-PD DEF.CTL
G5888
NEUTRAL RED
N6264
NAPHTHOL AS-BI
861
FRV-ALKALINE
862
FBB-ALKALINE
863
SODIUM NITRITE
914
CITRATE SOLUTION
HEMATOXYLIN
915
GHS316
10/5/2011
7/1/2011
7/1/2011
7/1/2011
10/5/2011
10/5/2011
2/1/2004
2/1/2004
2/1/2004
11/14/2011
10/5/2011
10/5/2011
11/14/2011
10/5/2011
10/29/2009
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
ACETONE
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
PILOCARPINE HCL
SEME
SEME
54-71-7
ACETIC ACID
64-19-7
11/18/2009
IRRITANT
IRRITANT
BLINDNESS
IRRITANT
NONE- LESS THAN1% OF ANY HAZADOUS
2/20/2008
3/9/2010
2/1/11
2/1/11
1/19/12
9/7/2010
1/19/2012
1/19/2012
1/19/2012
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
DIETHYLENE GLYCOL
HYDROCHORIC ACID
SODIUM NITRITE
1/17/2012
01/19/12
NONE- LESS THAN1% OF ANY HAZADOUS
ETHYLENE GLYCOL
ACETIC ACID
SEME
67-64-1
10/10/2005
ALUMINIUM SULPHATE HEXADECAHYDRATE
MEDICAL CHEMICAL
CORPORATION
FERTILITY
SOLUTIONS
CONCEPTION TECH
4/15/2015
111-46-6
7647-01-0
7632-00-0
TOXIC
CORROSIVE
CARCINOGEN
TARGET ORGAN
107-21-1
16828-11-8
64-19-7
BLINDNESS
IRRITANT
CORROSIVE
TERATOGEN
IRRITANT
FLAMMABLE
CARCINOGEN
TOXIC
ACETONE
100B
8/6/2009
ACETONE
67-64-1
SPERM COUNT CONTROL
AQC103
12/1/2007
50-00-0
67-56-1
FISHER
FISHER
ENHANCE W
VISCOSITY TREATMENT
NIGROSIN
EOSIN Y
EW-100
VTS-20
S25447
22-220-104
9/22/2000
1/1/1993
7/20/2009
7/24/2006
JT BAKER
SODIUM HYDROXIDE
7772
6/2/2014
Formaldehyde
Methyl Alcohol
NONE- LESS THAN1% OF ANY HAZADOUS
A-CHYMOTRYPSIN TYPE II
NONE- LESS THAN1% OF ANY HAZADOUS
ETHYL ALCOHOL
METHYL ALCOHOL
SODIUM HYDROXIDE
Page 19 of 66
9004-07-3
IRRITANT
64-17-5
67-56-1
1310-73-2
IRRITANT
CORROSIVE
7017- HEMATOLOGY/COAGULATION/URINALYSIS
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
SEMW
(AVANTOR)
QWIKCHEK
FCC
COAG
CINH
SIGMA ALDRICH
GEORGE KING
BIOMEDICAL
PTTHZ
APCR
DADE
CHROMOGENIX
DRVV
DIAGNOSTICA
STAGO
DIAGNOSTICA
STAGO
AT3
DDI
CINH
F2
F5
F7
F8
F9
F10
F11
FIB
FSP
LMWH
PRTC
PRTS
PTINR
PTT
THRO
VWFAG
PELLETS
BEADS
TEST STRIPS
LIQUEFACTION KIT
DILUTION KIT
HYALURONIDASE
POOLED NORMAL
NORMAL DONOR
CORE SET
SYSCOR SET
HEPZYME
COATEST APC VS
APC CONTROL 1
APC CONTROL2
STACLOT SCREEN
STACLOT CONFIRM
FDP PLASMA
LIATEST ATIII
STA CaCl2
STA CALIB HBPL/LMWH
STA CLEANER SOLN
STA COAG CONT N&ABN
STA DEF II
STA DEF V
STA DEF VII
STA DEF VIII
STA DEF IX
STA DEF X
STA DEF XI
STA FIBRINOGEN
STA LIATEST N&P
STA LIATEST D-Di
STA LIATEST VWF:AG
STA NEOPLASTINE CL
STA OWREN-KOLLER
STA PTT A
STA QUALITY LMWH
ROTACHROM HEPARIN
STACLOT PROTEIN C
STACLOT PROTEIN S
SYSTEM CTL N&P
STA THROMBIN
STA UNICALIBRATOR
VWF:AG CALIBRATOR
STA DESORB U
0200
0700
0900
0800
H3506
0010-1
0070-50
0070-30
0065-30
B4240-10
823138
822650-63
822668-63
00339
00334
00540
00568
00367
00685
00973
00676
00745
00744
00743
00725
00724
00738
00723
00674
00526
00515
00518
00667
00360
00595
00686
00612
00747
00746
00678
00611
00675
00520
00975
8/21/2014
2/22/2007
6/29/2012
8/17/2014
11/3/2011
1/26/2012
5/1/2000
NA
NA
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
6/7/2010
Page 20 of 66
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
ALPHA-CHYMOTRYPSIN
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
POTASSIUM HYDROXIDE
SODIUM HYPOCHLORIDE
4/15/2015
7/3/9004
1310-58-3
7681-52-9
IRRITANT
CORROSIVE
IRRITANT
7017- HEMATOLOGY/COAGULATION/URINALYSIS
7017
7017
7017
7017
7017
BMAS
STAR/COMPAC
FRIGIPORTEUR T1
38640
9/15/2011
THERMO
10% NEUTRAL
BUFFERED
ZINC FORMALIN
22050259
3/2/2012
PURPLE TOP
367861
1/14/2010
GREEN TOP
367960
365958
306513
P8165
T3128
PCS-231
4/18/2006
11/17/2009
4/9/2008
5/20/2009
PCS CALIB
SOLUTIONS
PCS SAMPLE
RANGE
SOLUTIONS
PCS-600
5/20/2009
PCS-221
5/20/2009
CYTOLYT SOLN
85092-001
7017
BD DIAGNOSTICS
7017
7017
7017
BD DIAGNOSTICS
7017
7017
BD DIAGNOSTICS
7017
MALP
SIGMA ALDRICH
7017
MALFI
7017 PIPETTE CALIBARTEL, INC.
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
7017
CYTOLOGY
CYTYC
7017
7017 SPILL KITS
PND CORP
HEPARIN SYRINGE
PHOSPATE BUFFER 6.6
TRIZMA MALEATE
PCS BLANK
SOLUTION
UNI-SAFE
ETHANEDIOL
METHANOL
FORMALDEHYDE
METHYL ALCOHOL
ZINC SULFATE
DIPOTASSIUM EDTA
7/1/2002
LITHIUM HEPARIN
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
POLYETHYLENE GLYCOL
Copper (II) chloride dihydrate
Methyl 4-hydroxybenzoate
2-phenoxyethanol
EDTA
NONE- LESS THAN1% OF ANY HAZADOUS
Aqueous phthalate buffer
Ponceau S (Acid red 112)
Methyl 4-hydroxybenzoate
2-phenoxyethanol
EDTA
METHANOL
2/3/2011 NONE- LESS THAN1% OF ANY HAZADOUS
Page 21 of 66
4/15/2015
107-21-1
67-56-1
50-00-0
67-56-1
7733-02-0
TOXIC
FLAMMABLE
CARCINOGEN
TARGET ORGAN
IRRITANT
25102-12-9 IRRITANT
9045-22-1
NOSE BLEEDS
IRRITANT
25322-68-3
10125-13-0
99-76-3
122-99-6
64-02-8
IRRITANT
N/A
6226-79-5
99-76-3
122-99-6
64-02-8
67-56-1
IRRITANT
FLAMMABLE
TOXIC
7018-MICROBIOLOGY LAB
DEPT
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
TEST NAME
VENDOR
REAGENT
CEPHEID
XPERT GBS-LB
BD
LIM BROTH
PRODUCT #
MSDS
HAZARDOUS INGREDIANT
4/15/2015
CAS #
HAZARD
GENEXPERT
GBS-LB
GXGBS-LB-10
7/1/2014 SODIUM HYDROXIDE
1310-73-2
CORROSIVE
IRRITANT
MRSA
CEPHEID
XPERT
296266
GXMRSA
3/26/2014 NONE- LESS THAN1% OF ANY HAZADOUS
9/2/2011 SODIUM HYDROXIDE
MRSA SCREEN
CDIFF
CEPHEID
XPERT
GXCDIFFICLE
CEPHEID
CORROSIVE
593-84-0
IRRITANT
1310-73-2
CORROSIVE
GUANIDINE THIOCYANATE
593-84-0
IRRITANT
BES SODIUM SALT
10191-18-1
5/22/2012 SODIUM HYDROXIDE
C.DIFFICILE
GBS
1310-73-2
GUANIDINE THIOCYANATE
XPERT GBS
GXGBS-100N
6/8/2010 SODIUM HYDROXIDE
1310-73-2
CORROSIVE
IRRITANT
FILMARRAY
BCID
BIOFIRE
GI PCR
BLOOD CULTURE ID
RFIT-ASY-0114
GI PANEL
RFIT-ASY-01165
SAMPLE BUFFER
GI PCR
MMQCI
BCID
GI PCR
5/1/2014
50-01-1
TOXIC,IRRITANT
M238
5/21/2014 ETHYL ALCOHOL
64-17-5
FLAMMABLE
BCID CONTROL PANELM235
6/10/2014 ETHYL ALCOHOL
64-17-5
FLAMMABLE
10043-52-4
IRRITANT
67-63-0
IRRITANT,FLAMMABLE
67-56-1
FLAMMABLE
67-68-5
TOXIC
GI CONTROL PANEL
GUANIDINIUM CHLORIDE
MERIDAN
PARA-PAK C&S
900612
8/2/2013 CALCIUM CHLORIDE
BD
STERILE SWABS
446250
2/11/2011 NONE- LESS THAN1% OF ANY HAZADOUS
SAMPLE TUBES
446250
11/9/2009 NONE- LESS THAN1% OF ANY HAZADOUS
REAGENT CASSETTES
446252
9/1/2011 NONE- LESS THAN1% OF ANY HAZADOUS
SUBSTRATE SOLN
446252
9/1/2011 ISOPROPANOL
BUFFER SOULTION
446252
9/1/2011 NONE- LESS THAN1% OF ANY HAZADOUS
LYSIS SOLUTION
446252
9/1/2011 NONE- LESS THAN1% OF ANY HAZADOUS
PROBE CARDS
446252
TRANSPORT REAGENT
446255
AFFIRM
VAPA
9/1/2011 NONE- LESS THAN1% OF ANY HAZADOUS
12/6/2013 METHANOL
DIMETHYL SULFOXIDE
MALDI-TOFF
BIOMERIEUX
TRANSPORT BAGS
446250
11/9/2009 NONE- LESS THAN1% OF ANY HAZADOUS
VITEK MS-CHCA
411071
4/18/2011 ALPHA-CYANO-4-HYDROXY-CINNAMIC ACID
VITEK MS-FA
GRAM STAIN
SIGMA-ALDRICH
SILICA GEL
EKI
GRAM SAFRANINE
GRAM DECOLORIZER
411072
S7625
28166-41-8
FLAMMABLE
TRIFLUOROACETIC ACID
76-05-1
TOXIC
ETHANOL
64-17-5
IRRITANT
ACETONITRILE
75-05-8
4/18/2011 FORMIC ACID
64-18-6
CORROSIVE
7646-79-9
CARCINOGEN
64-17-5
IRRITANT
67-64-1
IRRITANT
ETHYL ALCOHOL
64-17-5
IRRITANT
METHANOL
67-56-1
IRRITANT
10/20/2009 COLBALT DICHLORIDE
11120
1185
6/2/2010 ETHYL ALCOHOL
12/10/2009 ACETONE
Page 22 of 66
4/15/2015
7018-MICROBIOLOGY LAB
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018 AFB
7018 TB STAIN
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
ISOPROPANOL
GRAMS IODINE
6050
67-63-0
IRRITANT
7553-56-2
IRRITANT
7681-11-0
IRRITANT
64-17-5
FLAMMABLE
CRYSTAL VIOLET
548-62-9
IRRITANT
AMMONIUM OXALATE, MONOHYDRATE
6009-70-7
IRRITANT
4/26/2004 POTASSIUM OXALATE
6487-48-5
IRRITANT
5/30/2009 METHANOL
67-56-1
FLAMMABLE
6153-56-6
IRRITANT, TOXIC
67-68-5
IRRITANT, TOXIC
4/20/2004 IODINE
POTASSIUM IODIDE
GRAMS GENTIAN
4633
6/2/2010 ETHYL ALCOHOL
VIOLET STAIN
NEW METHYLENE
7443
4/15/2015
BLUE N STAIN
ELI TECH
AEROSPRAY
WESCOR
NOZZLE CLEANER
ELI TECH
AEROSPRAY
WESCOR
STAIN RESIDUE SOLV
BIOMERIEUX
IODINE-B
SS-029
OXALIC ACID, DIHYDRIDE
SS-230
5/30/2009 DIMETHYL SULFOXIDE
29523
FUCHSIN SOLUTION
29585
10/24/2008 POLYVINYLPRROLIDONE (PVP)
9003-39-8
IRRITANT
IODINE
7553-56-2
IRRITANT
POTASSIUM IODIDE
7681-11-0
IRRITANT
67-63-0
FLAMMABLE
67-56-1
IRRITANT, TOXIC
64-17-5
IRRITANT
6153-56-6
IRRITANT, TOXIC
1/20/2010 ISOPROPANOL
METHANOL
BD
CRYSTAL VIOLET C
29587
NOZZLE CLEANER
29588
TB DECOLORIZER TM
TB FLUORESCENT TB POTASSIUM
STAIN SET M
212519A
2/11/2011 ISOPROPANOL
67-63-0
CORROSIVE,FLAMMABLE
212519B
2/11/2011 POTASSIUM PERMANGANATE
7722-64-7
IRRITANT
2/11/2011 ISOPROPANOL
67-63-0
IRRITANT
2/11/2011 ISOPROPANOL
67-63-0
IRRITANT
PHENOL
108-95-2
IRRITANT, TOXIC
ETHYL ALCOHOL
64-17-5
IRRITANT, TOXIC
BASIC FUCHSIN
569-61-9
HARMFUL
64-17-5
FLAMMABLE
METHANOL
67-56-1
IRRITANT
HYDROCHLORIC ACID
7647-01-0
212519C
TB CARBOLFUCHSIN
212522
TB DECOLORIZER
212522
TB BRILLIANT GREEN
SCIENTIFIC
212522
SNAP N'DIGEST
667
DEVICE LABORATORY
MALLINCKRODT
GENPROBE
3/9/2010
PERMANGANATE
TB AURAMINE M
TB STAIN SET K
1/20/2010 ETHYL ALCOHOL
2/11/2011 ETHYL ALCOHOL
2/11/2011 BRILLIANT GREEN
10/1/2011 SODIUM HYDROXIDE
N-ACETYL CYSTEINE
HARMFUL
1310-73-2
CORROSIVE
616-91-1
IRRITANT
10043-35-3
IRRITANT
PHOSPHATE
BUFFER SOULTION
U033
5/26/2009 NONE- LESS THAN1% OF ANY HAZADOUS
PROBE REAGENT
0082
11/30/2010 NONE- LESS THAN1% OF ANY HAZADOUS
REAGENT 1
0076
11/15/2010 NONE- LESS THAN1% OF ANY HAZADOUS
REAGENT 2
0077
11/15/2010 NONE- LESS THAN1% OF ANY HAZADOUS
REAGENT 3
0078
11/15/2010 BORIC ACID
Page 23 of 66
4/15/2015
7018-MICROBIOLOGY LAB
7018
7018
7018
7018
7018 AFBB
7018
7018
7018
7018
7018
7018
CLEANING
7018
7018
7018 O&P
7018 O&P
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
TRITIUM
0084
11/30/2010 TOLUENE
4/15/2015
108-88-3
STANDARD
FLAMMABLE
IRRITANT
TARGET ORGAN EFFECT
BD
BOVINE ALBUMIN
211968
3/3/2011 NONE- LESS THAN1% OF ANY HAZADOUS
BIOMERIEUX
BACT T/ALERT
251011
7/28/2011 NONE- LESS THAN1% OF ANY HAZADOUS
259760
2/19/2011 AMPHOTERICIN B
BOTTLES
ANTIBIOTIC
SUPPLEMENT
METREX
CAVICIDE
Jul-07
RESEARCH
1397-89-3
NALIDIXIC ACID
389-08-2
POLYMIXIN B
1405-20-5
GLYCEROL
56-81-5
IRRITANT
Isoproponal
67-63-0
FLAMMABLE
Ethylene glycol monobutyl ether
111-76-2
IRRITANT
CORPORATION
ALERE
BLINDNESS
GIARIDA/CRYPTO
T30407
9/1/2011 NONE- LESS THAN1% OF ANY HAZADOUS
QUIK CHEK
SCIENTIFIC
TRICHROME STAIN
782
10/1/2011 CHROMOTROPE 2R
4197-07-03
IRRITANT
DEVICE
FAST GREEN
2353-45-9
LABORATORY
PHOSPHOTUNGSTIC ACID
12501-23-4
LIGHT GREEN
5141-20-8
GLACIAL ACETIC ACID
64-19-7
FORMALDEHYDE
50-00-0
CARCINOGEN
67-56-1
IRRITANT
4/17/2012 ISOPROPYL ALCOHOL
67-63-0
IRRITANT
ACETIC ACID
64-19-7
TOXIC
POLYVINYL ALCOHOL
9002-89-5
MERCURIC CHLORIDE
7487-94-7
GLYCERIN
56-81-5
HYDROGEN CHLORIDE
7647-01-0
MERIDIAN
PARA-PAK 10%
FORMALIN
900412
PARA-PAK
400212
LV-PVA
MACRON
ETHYL ACETATE
4992
3/9/2009 METHYL ALCOHOL
8/26/2011 ETHYL ACETATE
141-78-6
TERATOGEN
FLAMMABLE
IRRITANT
SPECTRUM
TRITON X-100
TR135
POLY( OXY-1,2-ETHANEDYL),ALPHA-[4-(1,1,3,3,3/1/2012 TETRAMETHYLBUTYL)PHENYL]-OMEGA-HYDRO> 9002-93-1
POLYETHYLENE GLYCOL
THERMO
MACRON
CYTOSEAL-60
GLACIAL ACETIC
8310-16
9508
7/24/2007 TOLUENE
IRRITANT
25322-68-3
108-88-3
IRRITANT
ACRYLIC RESIN
28262-63-7
IRRITANT
BUTYL BENZYL PHTHALATE
85-68-7
IRRITANT
64-19-7
CORROSIVE
1/17/2012 ACETIC ACID GLACIAL
ACID
FLAMMABLE
TARGET ORGAN EFFECT
Page 24 of 66
4/15/2015
7018-MICROBIOLOGY LAB
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
MACRON
IODINE CRYSTALS
1008-06
1/8/2013 IODINE
4/15/2015
7553-56-2
OXIDIZER
CORROSIVE
IRRITANT
MACRON
POTASSIUM
1115
8/20/2008 POTASSIUM IODIDE
7681-11-0
3791
3/23/2011 ETHYL ALCOHOL
64-17-5
FLAMMABLE
108-10-1
IRRITANT
100-41-4
FLAMMABLE
1330-20-7
TARGET ORGAN EFFECT
IODIDE CRYSTALS
MACRON
TARGET ORGAN EFFECT
ETHYL ALCOHOL
DENATURED
THERMO
XYLENE
IRRITANT
METHYL ISOBUTYL KETONE
9900-1
11/5/2007 ETHYL BENZENE
XYLENES
IRRITANT
STPL
GBLD
FBLD
APT
EKI
METHYLENE BLUE
BECKMAN
GASTROCULT
COULTER
DEVELOPER
BECKMAN
HEMOCULT SENSA
COULTER
DEVELOPER
MACRON
SODIUM
7161
4/26/2004 ETHYL ALCOHOL
66115
METHYL ALCOHOL
67-56-1
ISOPROPYL ALCOHOL
67-63-0
8/5/2001 HYDROGEN PEROXIDE
395009
IRRITANT
7722-84-1
FLAMMABLE
CITRIC ACID
77-92-9
IRRITANT
OCTYLPHENOXYPOLY
9036-19-5
ETHANOL-METHANOL MIX
8013-52-3
1/30/2003 HYDROGEN PEROXIDE
ETHANOL-METHANOL MIX
7001
64-17-6
8/29/2011 SODIUM HYDROXIDE
7722-84-1
FLAMMABLE
8013-52-3
IRRITANT
1310-73-2
CORROSIVE
HYDROXIDE
IRRITANT
RAPID TESTS
GROUP A STREP
QUIDEL
SOFIA STREP A FIA
RAFLU
QUIDEL
SOFIA INFLUENZA
PURITAN
UNI-TRANS-RT
RSV
QUIDEL
SOFIA RSV FIA
ADENO
FISHER
SURE VUE
LEGU
ALERE
20253
6/12/2013 SODIUM NITRITE
20218
1/15/2014 NONE- LESS THAN1% OF ANY HAZADOUS
REAGENT SOLUTION
ACETIC ACID
7632-00-0
TOXIC
64-19-7
CORROSIVE
A+B
UT-116
11/13/2013 NONE- LESS THAN1% OF ANY HAZADOUS
20242
8/6/2012 NONE- LESS THAN1% OF ANY HAZADOUS
SA 067020
7/15/2002 NONE- LESS THAN1% OF ANY HAZADOUS
ADENOVIRUS
LEGIONELLA
3/6/2013 NONE- LESS THAN1% OF ANY HAZADOUS
EIA WASH
NONE- LESS THAN1% OF ANY HAZADOUS
LEGIONELLA
9/8/2010 NONE- LESS THAN1% OF ANY HAZADOUS
CONTROL SWABS
LEGIONELLA
NONE- LESS THAN1% OF ANY HAZADOUS
TEST CARD
HIVS
ALERE
HIV1/2 AG/AB CARD
7D2648
CHASE BUFFER
7D2648
9/17/2013 NONE- LESS THAN1% OF ANY HAZADOUS
HIV 1 CTL
7D2628
03
NONE- LESS THAN1% OF ANY HAZADOUS
HIV 2 CTL
7D2628
02
NONE- LESS THAN1% OF ANY HAZADOUS
9/17/2013 NONE- LESS THAN1% OF ANY HAZADOUS
Page 25 of 66
4/15/2015
7018-MICROBIOLOGY LAB
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
FRS
MILES
P24 AG CTL
7D2628
NON REAC CTL
7D2628
CLINITEST TABS
2126
02
NONE- LESS THAN1% OF ANY HAZADOUS
02
NONE- LESS THAN1% OF ANY HAZADOUS
12/20/1990 SODIUM HYDROXIDE
1310-73-10
EXPLOSIVE
7758-98-7
FLAMMABLE
7722-84-1
IRRITANT
6/23/2011 HYDROGEN CHLORIDE
7647-01-0
IRRITANT
2/11/2011 2-METHOXYETHANOL
109-86-4
TOXIC
ACETIC ACID
64-19-7
IRRITANT
FORMAMIDE
75-12-7
COPPER SULFATE
CAT
COAG
OWENS &
3% HYDROGEN
MINOR
PEROXIDE
BD
COAGULASE PLASMA
3306HP0304
240827
4/15/2015
7/12/2011 HYDROGEN PEROXIDE
9/9/2011 NONE- LESS THAN1% OF ANY HAZADOUS
RABBIT
SPAGU
ALERE
SPAGC
STLAC
EHEC
TECH LAB
MERIDIAN
STREP TEST CARD
710-000
3/7/2013 NONE- LESS THAN1% OF ANY HAZADOUS
REAGENT A
NONE- LESS THAN1% OF ANY HAZADOUS
NEGATIVE CTL
NONE- LESS THAN1% OF ANY HAZADOUS
POSITIVE CTL
NONE- LESS THAN1% OF ANY HAZADOUS
LEUKO EZ VUE
T5019
10/1/2011
DILUENT
NONE- LESS THAN1% OF ANY HAZADOUS
CASETTES
NONE- LESS THAN1% OF ANY HAZADOUS
POS CONTROL
NONE- LESS THAN1% OF ANY HAZADOUS
IMMUNOCARD
STAT EHEC
POS CONTROL
751630
2/21/2009 NONE- LESS THAN1% OF ANY HAZADOUS
SAMPLE DILUENT
751630
2/21/2009 NONE- LESS THAN1% OF ANY HAZADOUS
261181
2/11/2011 NONE- LESS THAN1% OF ANY HAZADOUS
OXIDASE
BD
OXIDASE
INDOLE
REMEL
BACTIDROP
SPOT INDOLE
PYR
BD
BBL DRY SLIDE PYR
R21550
231747
SRX
REMEL
STAPHAUREX
R30859901
4/11/2011 NONE- LESS THAN1% OF ANY HAZADOUS
PHAA or PHAB
MKL
PHADEBACT
10-5583-12
3/26/2012 NONE- LESS THAN1% OF ANY HAZADOUS
STREP TEST
STRG
PNSP
BD
BD
STREPTOCARD
LATEX A-G
240951
2/11/2011 NONE- LESS THAN1% OF ANY HAZADOUS
EXTRACTION 1
240951
2/11/2011 SODIUM NITRITE
7632-00-0
TOXIC
EXTRACTION 2
240951
2/11/2011 HYDROCHLORIC ACID
7647-01-0
CORROSIVE
EXTRACTION 3
240951
2/11/2011 NONE- LESS THAN1% OF ANY HAZADOUS
POS CONTROL
240951
2/11/2011 SODIUM NITRITE
7632-00-0
TOXIC
PNEUMOSLIDE
240840
2/11/2011 NONE- LESS THAN1% OF ANY HAZADOUS
LATEX
NONE- LESS THAN1% OF ANY HAZADOUS
POS CONTROL
NONE- LESS THAN1% OF ANY HAZADOUS
NEG CONTROL
SAGG
BD
SALMONELLA O
NONE- LESS THAN1% OF ANY HAZADOUS
225341
2/11/2011 NONE- LESS THAN1% OF ANY HAZADOUS
Page 26 of 66
4/15/2015
7018-MICROBIOLOGY LAB
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
ANTISERA
SHIGELLA
ANITSERA A
SHIGELLA
ANITSERA B
SHIGELLA
ANITSERA C
SHIGELLA
ANITSERA D
241025
11/2/2011 GLYCEROL
228351
11/2/2011 NONE- LESS THAN1% OF ANY HAZADOUS
228361
11/2/2011 NONE- LESS THAN1% OF ANY HAZADOUS
228371
11/2/2011 NONE- LESS THAN1% OF ANY HAZADOUS
BACR
BD
BACITRACINE B-10
231268
2/11/2011 NONE- LESS THAN1% OF ANY HAZADOUS
OPT
BD
OPTOCHIN
231048
2/11/2011 NONE- LESS THAN1% OF ANY HAZADOUS
3798
5/10/2001 NONE- LESS THAN1% OF ANY HAZADOUS
231750
2/11/2011 NONE- LESS THAN1% OF ANY HAZADOUS
4/15/2015
56-81-5
IRRITANT
64-19-7
IRRITANT
203-713-7
TOXIC
SENSITIVITY
HP
GI SUPPLY
HPFAST
NOVB
BD
NOVOBIOCIN DISC
MXCA
REMEL
C.ALBICANS
30168501
SCREEN
API
BIOMERIEUX
9/8/2003 ACETIC ACID
2-METHOXYETHANOL
API E
20100
11/16/2009 NONE- LESS THAN1% OF ANY HAZADOUS
API NE
20050
11/17/2009 NONE- LESS THAN1% OF ANY HAZADOUS
API C
20210
11/17/2009 NONE- LESS THAN1% OF ANY HAZADOUS
API A
20300
11/20/2009 NONE- LESS THAN1% OF ANY HAZADOUS
API NE
10400
11/20/2009 METHANOL
67-56-1
FLAMMABLE
DIMETHYL SULFOXIDE
67-68-5
IRRITANT
HYDROCHLORIC ACID
7647-01-0
CORROSIVE
BCP
70510
11/20/2009 BROMERESOL PURPLE
115-40-2
IRRITANT
JAMES
70542
12/13/2012 HYDROCHLORIC ACID
7647-01-0
CORROSIVE
EHRLICHS
70520
12/13/2012 HYDROCHLORIC ACID
7647-01-0
HARMFUL
p-DIMETHYLAMINOBENZALDEHYDE
100-10-7
CORROSIVE
ETHYL ALCOHOL
64-17-5
FLAMMABLE
MINERAL OIL
70100
12/28/2009 MINERAL OIL
8042-47-5
IRRITANT
XYL
70530
11/18/2009 XYLENE
1330-20-7
FLAMMABLE
ZINC DUST
70380
9/27/2007 ZINC DUST
7440-66-6
FLAMMABLE
TDA
70402
9/25/2012 FERRIC CHLORIDE
7705-08-0
IRRITANT
VP1
70422
12/13/2012 POTASSIUM HYDROXIDE
1310-58-3
CORROSIVE
VP2
70422
11/17/2009 ETHANOL
64-17-5
FLAMMABLE
90-15-3
IRRITANT
64-19-7
CORROSIVE
SULFANILIC ACID
121-57-3
IRRITANT
N,N-DIMETHYL-ALPHA-NAPHTHYLAMINE
86-56-6
ALPHA-NAPHTHOL
NIT1 & NIT2
70442
10/16/2012 ACETIC ACID
VPA
70572
12/3/2009 POTASSIUM HYDROXIDE
1310-58-3
CORROSIVE
VPB
70572
12/3/2009 2-METHOXYETHANOL
109-86-4
FLAMMABLE
90-15-3
IRRITANT
ALPHA-NAPHTHOL
Page 27 of 66
4/15/2015
7018-MICROBIOLOGY LAB
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
ZYM A
70494
ZYM B
EMD
KOVAC'S REAGENT
70493
R01720
12/13/2012 HYDROCHLORIC ACID
4/15/2015
7647-01-0
TRIS
77-86-1
SODIUM LAURYL SULFATE
151-21-3
IRRITANT
11/18/2009 DIMETHYL SULFOXIDE
67-68-5
FLAMMABLE
METHANOL
67-56-1
IRRITANT
3/4/2003 ISOAMYL ALCOHOL
123-51-3
IRRITANT
HYDROCHLORIC ACID
7647-01-0
CORROSIVE
BENZALDEHYD4, 4 DIMETHYLAMINO
100-10-7
FLAMMABLE
8047-15-2
IRRITANT
FORMALDEHYDE
50-00-0
CARCINOGEN
SODIUM ACETATE
127-09-3
IRRITANT
METHYL ALCOHOL
67-56-1
TARGET ORGAN EFFECT
1310-58-3
CORROSIVE
BLOOD
RT2BC
BIOMERIEUX
BACT T/ALERT
251011
7/28/2011 NONE- LESS THAN1% OF ANY HAZADOUS
BOTTLES
FA,FN,PF,SA,SN
ALERE
ISOLATER
BD
INDIA INK
SDL
INDIA INK
50C5
7/13/2010 SAPONIN
MYCO
II
261194
756-1
1/31/2009 NONE- LESS THAN1% OF ANY HAZADOUS
9/31/08
NEGATIVE CTL
KOH
BD
10% POTASSIUM
261191
2/11/2011 POTASSIUM HYDROXIDE
HYDROXIDE
FUNG
BD
LACTOPHENOL
DIMETHYL SULFOXIDE
261188
2/11/2011 GLYCEROL
COTTON BLUE
67-68-5
56-81-5
CORROSIVE
PHENOL
108-95-2
TOXIC
LACTIC ACID
50-21-5
MACRON
SULFURIC ACID
21201
8/25/2011 SULFURIC ACID
7664-93-9
CORROSIVE
BD
CARBOFUCHSIN
212518
2/11/2011 ISOPROPANOL
67-63-0
TOXIC
PHENOL
108-95-2
IRRITANT
ETHANOL
64-17-5
BASIC FUCHSIN
569-61-9
IRRITANT
MISC
SPILL KITS
PND CORP
UNI-SAFE
MISC
THERMO
BLOOD BANK SALINE
2/3/2011 NONE- LESS THAN1% OF ANY HAZADOUS
MISC
BACHARACH
FYRITE FLUID
11-0069
MISC
THERMO
RESOLVE IMMERSION
M5004
OIL
M2004
8504
HIGH VISCOSITY
LOW VISCOSITY
MISC
BD
MCFARLAND
7/2/2009 NONE- LESS THAN1% OF ANY HAZADOUS
4/10/2000 POTASSIUM HYDROXIDE
2/2/2012
1310-58-3
8042-47-5
FLAMMABLE
POLYPHENYLS
68956-74-1
IRRITANT
HYDROGENATED TERPHENYLS
61788-32-7
M2000
POLYBUTENE
9003-29-6
M5000
TERPHENYLS
26140-60-3
297298
CORROSIVE
WHITE MINERAL OIL
2/11/2011 NONE- LESS THAN1% OF ANY HAZADOUS
TURBIDITY
Page 28 of 66
4/15/2015
7018-MICROBIOLOGY LAB
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
7018
4/15/2015
STANDARD
MISC
BD
BD GASPAK
260683
3/2/2011
MISC
BD
BIOBAG CFJ
261211
2/11/2011 POTASSIUM BOROHYDRIDE
CHARCOAL
HYDROCHLORIC ACID
MISC
3M
3M ATTEST
1276
7440-44-0
IRRITANT
13762-51-1
CORROSIVE
7647-01-0
FLAMMABLE
9/13/2012 NONE- LESS THAN1% OF ANY HAZADOUS
STEAN BIOLOGICAL
INDICATOR
MISC
MISC
BD
AIRGAS
PORT-A-CUL
221,606,221,608
CARBON DIOXIDE
7/22/2013 SODIUM CHLORIDE
7647-14-5
IRRITANT
SODIUM THIOGLYCOLLATE
367-51-1
IRRITANT
L-CYSTINE
52-90-4
IRRITANT
124-38-9
IRRITANT
1/20/2012 CARBON DIOXIDE
CLEANING
CLEANING
TARGET ORGAN EFFECT
STERIS
VESPHENE II SE
CLEANING
CLOROX COMPANYCLOROX
CLEANING
MEDLINE
ALCOHOL PREP
INDUSTRIES
PADS
MEDI-FLEX
CHLORAPREP 2.0%
CLEANING
6461
6810
1/7/2009 2-PHENYLPHENOL
8/1/2009
51088
90-43-7
IRRITANT
P-TERTIARY AMYLPHENOL
80-46-6
IRRITANT
POTASSIUM HYDROXIDE
1310-58-3
IRRITANT
SODIUM HYDROXIDE
1310-73-2
IRRITANT
Sodium Hypochlorite
7681-52-9
CORROSIVE
2/21/2002 Isopropyl Alcohol
MEDI-FLEX
2% IODINE
4/6/2006
Isopropyl Alcohol
14-910-36
4/24/2006 ETHANOL
IODINE
CLEANING
7018 CLEANING
7018
7018 CLEANING
7018
7018 CLEANING
7018
BAXTER
SP BRAND LENS
M6015
CLEANER
DEARDORF
FITZSIMMONS
CORP
FLAMMABLE
IRRITANT
NA
Chlorhexidine Gluconate
CLEANING
67-63-0
ACTIVATE 5.25%
BLEACH
77062
5/2/2008
S-KLENZ
1J81
INTERNATIONAL
SCALE REMOVER PLUSNA
FLAMMABLE
18472-51-0 IRRITANT
64-17-5 FLAMMABLE
7553-56-28 IRRITANT
ISOPROPANOL
67-63-0
FLAMMABLE
ACETIC ACID
64-19-7
IRRITANT
6/1/2011 SODIUM HYPOCLORITE
SODIUM HYDROXIDE
STERIS
67-63-0
9/9/2014 PHOSPHORIC ACID
7681-52-9
IRRITANT
1310-73-2
IRRITANT
7664-38-2
CORROSIVE
IRRITANT
CHEMTEX CO
9/29/1998 HYDROCHLORIC ACID
HYDROFLORIC ACID
Page 29 of 66
7647-01-0
CORROSIVE
7664-39-3
4/15/2015
7019-PHLEBOTOMY
DEPT
TEST NAME
VENDOR
REAGENT
PRODUCT #
MSDS
7019
CLEANING
Triad
Adhesive Remover
NA
4/6/2008
HAZARDOUS INGREDIANT
4/15/2015
CAS #
HAZARD
Isoparrafin
64742-48-9 FLAMMABLE
7019
Petroleum Naptha
64742-89-8 IRRITANT
7019
Isopropyl Alcohol
7019
CLEANING
METREX
CAVICIDE
7019
RESEARCH
CAVIWIPES
7019
CORPORATION
Jul-07
67-63-0
FLAMMABLE
Ethylene glycol monobutyl ether
111-76-2
IRRITANT
7681-52-9
CORROSIVE
64-17-5
FLAMMABLE
BLINDNESS
7019
CLEANING
CLOROX COMPANY
CLOROX
6810
10/1/2000
Sodium Hypochlorite
7019
CLEANING
3M COMPANY
3M AVAGARD
9251
3/27/2009
Ethyl alcohol
7019
FOAM
7019
ANTISEPTIC
7019
7019
water
7732-18-5
NERVOUS SYSTEM
emollients
trade secret
IRRITANT
Dimethicone Surfactant
CLEANING
STERIS
ALCARE PLUS
6399
12/21/2009 Ethyl alcohol
7019
1,1 Difluoroethane
7019
Isobutane
7019
67-63-0
Isoproponal
102783-01-7
64-17-5
FLAMMABLE
75-37-6
IRRITANT
75-28-5
CLEANING
STERIS
CAL STAT
1181
11/7/2011
Isopropyl Alcohol
67-63-0
PHLEBOTOMY
MEDI-FLEX
CHLORAPREP 2.0%
NA
4/6/2006
Isopropyl Alcohol
67-63-0
7019
7019
IRRITANT
7019
7019
Chlorhexidine Gluconate
PHLEBOTOMY
7019
7019
MEDLINE
INDUSTRIES
PHLEBOTOMY
7019
7019
INVERNESS
ALCOHOL PREP
51088
2/21/2002 Isopropyl Alcohol
COOPER SURGICAL
50C5
10/23/2007 SAPONINS
WARMGEL
20418
11/30/2005 HYDROXYETHYL CELLULOSE
CELLULOSE
7019
PHLEBOTOMY
BIOMERIEUX
BACT/ALERT
251011
7/28/2011
NONE- LESS THAN1% OF ANY HAZADOUS
7019
PHLEBOTOMY
GREINER BIO-ONE
BLUE TOP
9NC
3/7/2011
CITRIC ACID TRISODIUM DIHYDRATE
7019
PHLEBOTOMY
BD DIAGNOSTICS
ACD-YELLOW
364606
1/24/2005
SODIUM CITRATE
7019
DEXTROSE
7019
CITRIC ACID MONOHYDRATE
7019
BD DIAGNOSTICS
BLUE TOP
363080
9/29/2005
TRISODIUM CITRATE
7019
BD DIAGNOSTICS
GREY TOP
367921
9/29/2005
POTASSIUM OXALATE
7019
SODIUM FLUORIDE
BD DIAGNOSTICS
67-63-0
FLAMMABLE
IRRITANT
ISOSTAT
MEDICAL
PHLEBOTOMY
FLAMMABLE
18472-51-0 IRRITANT
PADS
SODIUM ACETATE
7019
FLAMMABLE
GREEN TOP
7019
367960
4/18/2006
LITHIUM HEPARIN
365958
7019
BD DIAGNOSTICS
WHITE TOP
362788
7/15/2005
DIPOTASSIUM EDTA
7019
BD DIAGNOSTICS
PURPLE TOP
367861
1/14/2010
DIPOTASSIUM EDTA
7019
MICROTAINER
365974
7019
PINK TOP
367899
Page 30 of 66
8047-15-2 IRRITANT
TOXIC
9004-62-0 IRRITANT
127-09-3
9004-34-6
4/3/6132
68-04-2
68131-37-3
5949-29-1
68-04-2
583-52-8
7681-49-4
9045-22-1
IRRITANT
IRRITANT
IRRITANT
IRRITANT
CORROSIVE
NOSE BLEEDS
IRRITANT
25102-12-9 IRRITANT
25102-12-9 IRRITANT
7019-PHLEBOTOMY
7019
BD DIAGNOSTICS
GOLD TOP
BD DIAGNOSTICS
RED TOP
367812
DK BLUE TOP
368380
RED MICROTAINER
365963
7019
7019
7019
7019
11/10/2011 SILICA
367983
7019
7019
367986
BD DIAGNOSTICS
SPILL KITS
PND CORP
UNI-SAFE
PYRUVIC ACID
ARUP
PYUVIC ACID TUBES
TRANSPORT
ASHLAND
DRY ICE
PAP
HOLOGIC
THINPREP
CYTOLOGY
CYTYC CORP
24 HR URINES
RICCA
11/22/2006 SILICA
EXEMPT
NONE- LESS THAN1% OF ANY HAZADOUS
16567
2/19/2013
PERCLORIC ACID
6/22/1999
SOLID CARBON DIOXIDE
85093
2/1/2010
METHANOL
CYTOLYT
85092
2/1/2005
METHANOL
HYDROCHLORIC ACID
3750-32
4/19/1999
HYDROCHLORIC ACID
7019
7019
7019
7019
7019
PRESERVCYT
7019
7019
60676-86-0 IRRITANT
SILICOSIS
14808-60-7 IRRITANT
SILICOSIS
2/3/2011 NONE- LESS THAN1% OF ANY HAZADOUS
7019
7019
4/15/2015
7019
7019
7019
7019
7019
Page 31 of 66
7601-90-3 CORROSIVE
STRONG OXIDIZER
124-38-9 IRRITANT
BURNS & FROSTBITE
SUFFOCATION
67-56-1 IRRITANT
FLAMMABLE
67-56-1 IRRITANT
FLAMMABLE
7647-01-0 CORROSIVE
7020-ANCILLARY /POCT
4/15/2015
ANCILLARY/POCT
DEPT
TEST NAME
VENDOR
REAGENT
7020
CLEANING
METREX
CAVICIDE
7020
RESEARCH
CAVIWIPES
7020
CORPORATION
PRODUCT #
MSDS
Jul-07
CAS #
HAZARD
Isoproponal
HAZARDOUS INGREDIANT
67-63-0
FLAMMABLE
Ethylene glycol monobutyl ether
111-76-2
IRRITANT
7681-52-9
CORROSIVE
67-63-0
FLAMMABLE
BLINDNESS
7020
CLEANING
CLOROX COMPANY
CLOROX
6810
10/1/2000
Sodium Hypochlorite
7020
PHLEBOTOMY
MEDI-FLEX
CHLORAPREP 2.0%
NA
4/6/2006
Isopropyl Alcohol
7020
7020
Chlorhexidine Gluconate
PHLEBOTOMY
7020
7020
MEDLINE
INDUSTRIES
PHLEBOTOMY
COOPER SURGICAL
ALCOHOL PREP
51088
2/21/2002 Isopropyl Alcohol
PADS
20418
11/30/2005
7020
CELLULOSE
GREEN TOP
7020
7020
HYDROXYETHYL CELLULOSE
SODIUM ACETATE
BD DIAGNOSTICS
367960
4/18/2006
LITHIUM HEPARIN
365958
i-STAT
ABBOTT
CARTRIDGES
NA
EXEMPT
NONE- LESS THAN1% OF ANY HAZADOUS
7020
BIONOSTICS
CONTROLS
131000
3/3/2010
NONE- LESS THAN1% OF ANY HAZADOUS
7020
TRINITY BIOTECH
ACT CONTROL
50100
11/13/2007
NONE- LESS THAN1% OF ANY HAZADOUS
PT CONTROL
50407
6/23/2003
NONE- LESS THAN1% OF ANY HAZADOUS
7020
7020
MORE DIAGNOSTICS
CARDIAC CONT
NA
EXEMPT
NONE- LESS THAN1% OF ANY HAZADOUS
7020
CLINIQA
CARDIAC CONT
016646-01
2/20/2006
NONE- LESS THAN1% OF ANY HAZADOUS
7020
EUROTROL
CUESEE VERISTAT QC
221001010
11/5/2012
NONE- LESS THAN1% OF ANY HAZADOUS
VERISTAT LVM
220000005
10/31/2012
NONE- LESS THAN1% OF ANY HAZADOUS
HEMOCULT
395009
1/30/2003
HYDROGEN PEROXIDE
7020
7020
AFBD
7020
AFOBS
BECKMAN COULTER
SENSA
7020
ETHANOL-METHANOL MIX
DEVELOPER
7020
AUCHM
BAYER
LABSTIX
2181
12/6/1998
NONE- LESS THAN1% OF ANY HAZADOUS
7020
OBUA
SIEMENS
N-MULTISTIX SG
2176
1/12/2011
NONE- LESS THAN1% OF ANY HAZADOUS
MICROGENICS
MAS UA CONTROL
UAB-115
3/16/2007
NONE- LESS THAN1% OF ANY HAZADOUS
ABBOTT
GLUCOSE CONTROL
EXEMPT
7020
7020
SC
67-63-0
FLAMMABLE
IRRITANT
WARMGEL
7020
7020
18472-51-0 IRRITANT
NONE- LESS THAN1% OF ANY HAZADOUS
Page 32 of 66
9004-62-0 IRRITANT
127-09-3
9004-34-6
9045-22-1 NOSE BLEEDS
IRRITANT
BIOHAZARD
BIOHAZARD
BIOHAZARD
7722-84-1 FLAMMABLE
8013-52-3 IRRITANT
7021-BLOOD BANK
DEPT
TEST NAME
VENDOR
REAGENT
7021
ABO
IMMUCOR
MURINE
PRODUCT #
7021
MONOCLONAL
7021
ANTI-A
0006400
7021
ANTI-B
0006406
7021
ANTI-A,B
0006408
ANTI-M
0004145
ANTI-A1
0131-0015
7021
AG TYPING
4/15/2015
MSDS
HAZARDOUS INGREDIANT
CAS #
HAZARD
IO17-10
BOVINE ALBUMIN
9048-46-8
IRRITANT
4/9/2012
SODIUM AZIDE
26628-22-8
7021
7021
ABO
IMMUCOR
7021
7021
DAT
IMMUCOR
COMPLEMENT
7021
CONTROL
7021
CELLS
7021
7021
DAT
IMMUCOR
7021
7021
GLYCINE
56-40-6
SODIUM AZIDE
26628-22-8
0007930
7/12/2010
DEXTROS(GLUCOSE)
50-99-7
BIOHAZARD
I001-12
CHLORAMPHENICOL
56-75-7
IRRITANT
NEOMYCIN SULFATE
1405-10-3
DAT POSITIVE
0066122
ANTI-C3b-C3d
0004068
GENTAMYCIN SULFATE
1405-41-0
9/26/2011
GAMMA-CLONE
DAT
IMMUCOR
7021
7021
9/5/2006
LECTIN
ANTI-IgG
0409203
9/26/2011
GAMMA-CLONE
ABO
IMMUCOR
GLYCINE
56-40-6
SODIUM AZIDE
26628-22-8
GLYCINE
56-40-6
SODIUM AZIDE
26628-22-8
IRRITANT
IRRITANT
IRRITANT
REFERENCELLS-4
0006421
7/12/2010
DEXTROS(GLUCOSE)
50-99-7
BIOHAZARD
7021
GROUP
0006422
I001-12
CHLORAMPHENICOL
56-75-7
IRRITANT
7021
A1,A2,B
NEOMYCIN SULFATE
1405-10-3
7021
GENTAMYCIN SULFATE
1405-41-0
PANOSCREEN
0002381
7/12/2010
DEXTROS(GLUCOSE)
50-99-7
BIOHAZARD
7021
PANOCELL
'0003032
I001-12
CHLORAMPHENICOL
56-75-7
IRRITANT
7021
CHECKCELL(WEAK)
0002226
NEOMYCIN SULFATE
1405-10-3
7021
CAPTURE R READY
GENTAMYCIN SULFATE
1405-41-0
7021
7021
ABS
ABS
IMMUCOR
IMMUCOR
7021
7021
INDICATOR CELLS
0006427
BOVINE ALBUMIN
0002327
SOLUTION 22%
ABS
IMMUCOR
IMMUADD
0002007
7021
7021
ABS
IMMUCOR
GAMMA PEG
0705010
7021
IO17-10
BOVINE ALBUMIN
9048-46-8
4/9/2012
SODIUM AZIDE
26628-22-8
I018-3
BOVINE ALBUMIN
9048-46-8
4/19/2010
THIMEROSAL
54-64-8
G013-5
GLYCINE
56-40-6
12/3/2007
POLYETHYLENE GLYCOL
25322-68-3
SODIUM AZIDE
26628-22-8
7021
7021
AG TYPING
IMMUCOR
7021
7021
7021
AG TYPING
IMMUCOR
7021
GAMMA-CLONE
ANTI-E
0066422
ANTI-C
0066421
7021
AG TYPING
IMMUCOR
GLYCINE
56-40-6
9/26/2011
SODIUM AZIDE
26628-22-8
GLYCINE
56-40-6
G011-9
SODIUM AZIDE
26628-22-8
6/13/2011
BOVINE ALBUMIN
9048-46-8
IO17-10
BOVINE ALBUMIN
9048-46-8
4/9/2012
SODIUM AZIDE
26628-22-8
GAMMA-CLONE
ANTI-e
0066424
ANTI-c
0066425
7021
7021
G012-9
SERIES 1
Page 33 of 66
IRRITANT
IRRITANT
IRRITANT
IRRITANT
IRRITANT
IRRITANT
7021-BLOOD BANK
7021
7021
MONOCLONAL
AG TYPING
IMMUCOR
7021
I010-5
BOVINE ALBUMIN
9048-46-8
SLIDE/TUBE
ANTI-c
0012310
10/18/2010
FICOLL
26873-85-8
SODIUM AZIDE
26628-22-8
MODIFIED TUBE
G017-7
BOVINE ALBUMIN
9048-46-8
6/13/2011
SODIUM AZIDE
26628-22-8
7021
7021
4/15/2015
AG TYPING
IMMUCOR
7021
ANTI-Cw
0007406
7021
ANTI-Kpa
0007540
7021
ANTI-Kpb
0007550
7021
ANTI-Fya
0007591
7021
ANTI-Fyb
0007594
7021
ANTI-Jka
0007601
7021
ANTI-Jkb
0007604
7021
ANTI-S
0007454
IRRITANT
IRRITANT
7021
7021
AG TYPING
IMMUCOR
7021
ANTI-D
SERIES 4
7021
ANTI-D
7021
SERIES 5
7021
ANTI-K
7021
7021
AG TYPING
IMMUCOR
0006412
AG TYPING
IMMUCOR
BOVINE ALBUMIN
9048-46-8
SODIUM AZIDE
26628-22-8
G017-7
BOVINE ALBUMIN
9048-46-8
6/13/2011
SODIUM AZIDE
26628-22-8
SERIES 2
0004210
ANTI-k
0007537
ANTI-Lea
0004861
G016-6a
DEXTRAN
9004-54-0
ANTI-Leb
0004864
6/13/2011
BOVINE ALBUMIN
9048-46-8
7021
ANTI-P1
0004501
SODIUM AZIDE
26628-22-8
7021
GAMMA-CLONE
7021
7021
AG TYPING
IMMUCOR
7021
0007702
GROUP
7021
7021
LEWIS BLOOD
IRRITANT
0006414
7021
7021
IO17-10
4/9/2012
G004-6
IRRITANT
IRRITANT
NONE- LESS THAN1% OF ANY HAZADOUS
6/14/2010
SUBSTANCE
AG TYPING
ALBA
MONOCLONAL
BIOSCIENCE
ANTI-Leb
Z217
7021
ANTI-Lea
Z217U
7021
ANTI-E
Z073U
7021
ANTI-c
Z083U
7021
ANTI-k
Z137U
7021
ANTI-Lub
Z223U
7021
7021
7021
7021
7021
7021
7021
ANTI-M
ANTI-N
ANTI-N
GAMMA-CLONE
ANTI-s
ANTI-S
ANTI-c
Z171U
Z176
0007807
7021
AG TYPING
IMMUCOR
AG TYPING
BIO-RAD
AG TYPING
QUOTIENT
MNS4
MNS3
Z083U
3/1/2008
NONE- LESS THAN1% OF ANY HAZADOUS
G019-5
12/3/2007
May-11
MAGNESIUM SULFATE
SODIUM AZIDE
NONE- LESS THAN1% OF ANY HAZADOUS
10/13/2013
NONE- LESS THAN1% OF ANY HAZADOUS
Page 34 of 66
7487-88-9
26628-22-8
IRRITANT
7021-BLOOD BANK
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
DIAGNOSTICS
SIK
STRECK
ANTI-Le A
ANTI-Le B
SICKLEDEX
ABI
IMMUCOR
SICKLE-CHEK
ELU-KIT II
AUTOMATION
IMMUCOR
AUTOMATION
IMMUCOR
Z212U
Z217U
773500
4/15/2015
9/21/2007
SODIUM HYDROSULFITE
SAPONIN
7775-14-6
8047-15-2
FLAMMABLE
TOXIC
IRRITANT
217654
0007861
2/19/2009
G011-9
6/13/2011
0006419
0006445
0089000
I012-5
4/19/2010
I029-11
6/15/2009
56-40-6
26628-22-8
9048-46-8
56-40-6
26628-22-8
50-99-7
9048-46-8
IRRITANT
CAPTURE LISS
NONE- LESS THAN1% OF ANY HAZADOUS
GLYCINE
SODIUM AZIDE
BOVINE ALBUMIN
GLYCINE
SODIUM AZIDE
DEXTROS(GLUCOSE)
BOVINE ALBUMIN
50-99-7
56-75-7
1405-10-3
1405-41-0
26628-22-8
9000-70-8
56-75-7
1405-10-3
1405-41-0
9048-46-8
26628-22-8
BIOHAZARD
IRRITANT
IRRITANT
AUTOMATION
IMMUCOR
CAPTURE R SELECT
CMT PLATES
CAPTURE -R
READY SCREEN 3
CAPTURE -R
READY ID EXTEND
corQC TEST SYSTEM
BIOHAZARD
AUTOMATION
IMMUCOR
WB corQC
0066090
I034-2
AUTOMATION
IMMUCOR
0066236
IO17-10
4/9/2012
AUTOMATION
IMMUCOR
CAPTURE-R POSITIVE
CONTROL SERUM
WEAK/NEGATIVE
pHIX
DEXTROS(GLUCOSE)
CHLORAMPHENICOL
NEOMYCIN SULFATE
GENTAMYCIN SULFATE
SODIUM AZIDE
PORCINE GELATIN
CHLORAMPHENICOL
NEOMYCIN SULFATE
GENTAMYCIN SULFATE
BOVINE ALBUMIN
SODIUM AZIDE
0005070
I003-3
4/19/2010
POTASSIUM PHOSPHATE DIBASIC
POTASSIUM PHOSPHATE MONOBASIC
7758-11-4
7778-77-0
IRRITANT
MISC
MISC
SIGMA
THERMO
SCIENTIFIC
G5516
8504
3/10/2011
7/2/2009
GLYCEROL
NONE- LESS THAN1% OF ANY HAZADOUS
56-81-5
IRRITANT
MISC
SP
GLYCEROL
BUFFERED
SALINE
NERL
BLOOD BANK
0066802
0006456
0002400
I027-7a
12/14/2009
NONE- LESS THAN1% OF ANY HAZADOUS
Page 35 of 66
BIOHAZARD
IRRITANT
IRRITANT
7021-BLOOD BANK
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
7021
CLEANING
DUPONT
CLEANING
PDI
CLEANING
THERMO
CLEANING
FISHER
SCIENTIFIC
4/15/2015
SALINE
RELY ON
CLEANING
TABLETS
Adhesive Remover
B3158-2
ANREC05
4/13/2010
40000-260
2/25/2009
SOFTCIDE
HAND SOAP
ISOPROPYL
ALCOHOL 70%
12-544-09
7/14/2005
POTASSIUM PEROXYMONOSULFATE
SULFAMIC ACID
SODIUM CHLORIDE
NAPHYHA
FATTY ACIDS C14-18 ISOPROPYL ESTERS
ISOPROPANOL
SOLVENT NAPTHA
XYLENE
P-CHLORO-M-XYLENOL
A459-1
10/19/2010
ISOPROPYL ALCOHOL
NONE- LESS THAN1% OF ANY HAZADOUS
70693-62-8
IRRITANT
5329-14-6
7647-14-5
64742-48-9
FLAMMABLE
70750-32-2
IRRITANT
67-63-0
64742-89-8
1330-20-7
88-04-0
IRRITANT
67-63-0
FLAMMABLE
IRRITANT
NERVOUS SYSTEM
75-45-6
MAY CAUSE FROSTBITE
7021
CLEANING
STERIS
SOFT N SURE
1119
1/1/2001
7021
CLEANING
TEXWIPE CO
MICRODUSTER
TX2500
4/1/1994
CHLORODIFLUOMETHANE
7021
CLEANING
THERMO
SOFTGUARD
11002-24-001
3/27/2008
NONE- LESS THAN1% OF ANY HAZADOUS
7021
CLEANING
CLOROX COMPANY
CLOROX
6810
10/1/2000
Sodium Hypochlorite
7681-52-9
7021
CLEANING CURTIN MATHESON
SUPER FRIENDLY
6830
2/21/1996
1,1,1,2 TETRAFLUOROETHANE
811-97-2
7021
7021
CLEANING
SCIENTIFIC INC
AIR IT
3M COMPANY
3M AVAGARD
CORROSIVE
IRRITANT
MAY CAUSE FROSTBITE
Ethyl alcohol
64-17-5
7021
FOAM
9251
3/27/2009
water
7732-18-5
FLAMMABLE
NERVOUS SYSTEM
7021
ANTISEPTIC
emollients
trade secret
IRRITANT
Dimethicone Surfactant
102783-01-7
7021
7021
7021
7021
7021
CLEANING
2-propanol
67-63-0
Ethanol, 2-butoxy-
111-76-2
7021
Benzyl-C12-18-alkyldimethyl ammonium chlorides
68391-01-5
7021
Quarternary ammonium compounds, chlorides
68956-79-6
7021
7021
NICE PAK
SANI-CLOTH PLUS
PRODUCTS,
CLEANING
7021
MEDLINE
ALCOHOL PREP
INDUSTRIES
PADS
METREX
CAVICIDE
7021
RESEARCH
CAVIWIPES
7021
CORPORATION
7021
7021
CLEANING
CLEANING
BAXTER
7021
7021
0002
51088
2/21/2002
PND CORP
67-63-0
FLAMMABLE
IRRITANT
Jul-07
Isoproponal
67-63-0
FLAMMABLE
Ethylene glycol monobutyl ether
111-76-2
IRRITANT
BLINDNESS
SP BRAND LENS
M6015
5/2/2008
CLEANER
SPILL KITS
Isopropyl Alcohol
IRRITANT
UNI-SAFE
ISOPROPANOL
67-63-0
FLAMMABLE
ACETIC ACID
64-19-7
IRRITANT
2/3/2011 NONE- LESS THAN1% OF ANY HAZADOUS
Page 36 of 66
7021-BLOOD BANK
Page 37 of 66
4/15/2015
7023- CLINICS AND ACC LAB
DEPT
TEST NAME
VENDOR
REAGENT
PRODUCT #
MSDS
7023
CLEANING
Triad
Adhesive Remover
NA
4/6/2008
HAZARDOUS INGREDIANT
4/15/2015
CAS #
HAZARD
Isoparrafin
64742-48-9
FLAMMABLE
7023
Petroleum Naptha
64742-89-8
IRRITANT
7023
Isopropyl Alcohol
67-63-0
7023
METREX
CAVICIDE
7023
CLEANING
RESEARCH
CAVIWIPES
7023
CORPORATION
07/01/07
Isoproponal
67-63-0
FLAMMABLE
Ethylene glycol monobutyl ether
111-76-2
IRRITANT
7681-52-9
CORROSIVE
64-17-5
FLAMMABLE
BLINDNESS
7023
CLEANING
CLOROX COMPANY
CLOROX
6810
10/1/2000
Sodium Hypochlorite
7023
CLEANING
3M COMPANY
3M AVAGARD
9251
3/27/2009
Ethyl alcohol
7023
FOAM
7023
ANTISEPTIC
7023
7023
water
7732-18-5
NERVOUS SYSTEM
emollients
trade secret
IRRITANT
Dimethicone Surfactant
Ethyl alcohol
64-17-5
FLAMMABLE
7023
1,1 Difluoroethane
75-37-6
IRRITANT
7023
Isobutane
7023
CLEANING
STERIS
ALCARE PLUS
6399
12/21/2009
102783-01-7
75-28-5
CLEANING
STERIS
CAL STAT
1181
11/7/2011
Isopropyl Alcohol
67-63-0
PHLEBOTOMY
MEDI-FLEX
CHLORAPREP 2.0%
NA
4/6/2006
Isopropyl Alcohol
67-63-0
7023
7023
IRRITANT
7023
7023
Chlorhexidine Gluconate
PHLEBOTOMY
7023
7023
PHLEBOTOMY
7023
7023
51088
2/21/2002 Isopropyl Alcohol
ALCOHOL PREP
INDUSTRIES
PADS
INVERNESS
ISOSTAT
50C5
10/23/2007
SAPONINS
8047-15-2
WARMGEL
20418
11/30/2005
HYDROXYETHYL CELLULOSE
9004-62-0
127-09-3
9004-34-6
MEDICAL
PHLEBOTOMY
COOPER SURGICAL
SODIUM ACETATE
CELLULOSE
PHLEBOTOMY
7023
PHLEBOTOMY
BIOMERIEUX
BACT/ALERT
251011
7/28/2011
NONE- LESS THAN1% OF ANY HAZADOUS
GREINER BIO-ONE
BLUE TOP
9NC
3/7/2011
CITRIC ACID TRISODIUM DIHYDRATE
BD DIAGNOSTICS
ACD-YELLOW
364606
1/24/2005
SODIUM CITRATE
7023
DEXTROSE
7023
CITRIC ACID MONOHYDRATE
7023
BD DIAGNOSTICS
BLUE TOP
363080
9/29/2005
TRISODIUM CITRATE
7023
BD DIAGNOSTICS
GREY TOP
367921
9/29/2005
POTASSIUM OXALATE
7023
7023
67-63-0
SODIUM FLUORIDE
BD DIAGNOSTICS
GREEN TOP
7023
FLAMMABLE
IRRITANT
FLAMMABLE
IRRITANT
7023
7023
18472-51-0
MEDLINE
7023
7023
FLAMMABLE
367960
4/18/2006
LITHIUM HEPARIN
4/3/6132
68-04-2
68131-37-3
5949-29-1
68-04-2
583-52-8
7681-49-4
9045-22-1
365958
7023
BD DIAGNOSTICS
WHITE TOP
362788
7/15/2005
DIPOTASSIUM EDTA
7023
BD DIAGNOSTICS
PURPLE TOP
367861
1/14/2010
DIPOTASSIUM EDTA
7023
MICROTAINER
365974
7023
PINK TOP
367899
Page 38 of 66
25102-12-9
25102-12-9
IRRITANT
TOXIC
IRRITANT
IRRITANT
IRRITANT
IRRITANT
IRRITANT
CORROSIVE
NOSE BLEEDS
IRRITANT
IRRITANT
IRRITANT
7023- CLINICS AND ACC LAB
7023
60676-86-0
11/22/2006
SILICA
14808-60-7
BD DIAGNOSTICS
RED TOP
367812
DK BLUE TOP
368380
BD DIAGNOSTICS
RED MICROTAINER
365963
EXEMPT
NONE- LESS THAN1% OF ANY HAZADOUS
SIEMENS
A1C KIT
5035C
1/13/2011
NONE- LESS THAN1% OF ANY HAZADOUS
A1C CONTROLS
5068A
9/22/2011
NONE- LESS THAN1% OF ANY HAZADOUS
HEMOCULT
395009
1/30/2003
HYDROGEN PEROXIDE
7023
7023
AA1C
7023
7023
AFBD
7023
AFOBS
BECKMAN COULTER
SENSA
7023
7023
SILICA
GOLD TOP
367983
7023
7023
11/10/2011
BD DIAGNOSTICS
7023
367986
4/15/2015
ETHANOL-METHANOL MIX
INVERNESS
SIGNIFY STREP A
01P46-50
8/12/2009
DIPSTICK
TRIS AMINOMETHANE
SODIUM CARBONATE
7023
SODIUM NITRATE
7023
ACETIC ACID
7023
AUCHM
BAYER
LABSTIX
2181
12/6/1998
NONE- LESS THAN1% OF ANY HAZADOUS
7023
OBUA
SIEMENS
N-MULTISTIX SG
2176
1/12/2011
NONE- LESS THAN1% OF ANY HAZADOUS
MICROGENICS
MAS UA CONTROL
UAB-115
3/16/2007
NONE- LESS THAN1% OF ANY HAZADOUS
7023
7023
AUMA
ROCHE
MICRAL
EXEMPT
NONE- LESS THAN1% OF ANY HAZADOUS
7023
AUPRG
Genzyme Diagnostics
OSOM Card
EXEMPT
NONE- LESS THAN1% OF ANY HAZADOUS
7023
7023
7023
7722-84-1
8013-52-3
FLAMMABLE
IRRITANT
77-86-1
497-19-8
7632-00-0
64-19-7
IRRITANT
DEVELOPER
ASTRP
7023
7023
IRRITANT
SILICOSIS
IRRITANT
SILICOSIS
TOXIC
Pregnancy Test
ACPT
SG
KOH
ALERE
TEST STRIPS
0100071
ABBOTT
GLUCOSE CONTROL
EXEMPT
BD DIAGNOSTICS
KOH PREP
261191
3/7/2011
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
3/1/2011
7023
7023 SPILL KITS
POTASSIUM HYDROXIDE
DIMETHYL SULFOXIDE
PND CORP
UNI-SAFE
2/3/2011 NONE- LESS THAN1% OF ANY HAZADOUS
Page 39 of 66
1310-58-3
67-68-5
CORROSIVE
CHEMICAL LIST
DEPT TEST NAME
VISTA REAGENTS
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
4/15/2015
7027-CENTRAL LAB CHEMISTRY
VENDOR
REAGENT
A1C-GHGB
GHGBB
SIEMENS
Acetaminophen
ACETA
SIEMENS
HA1C KIT
FLEX CARTRIDGE
CALIBRATOR
ACTM FLEX
CARTRIDGE
AFP
SIEMENS
ALB
ALB
MSDS
HAZARDOUS INGREDIANT
CAS #
HAZARD
DEDM0388
TETRADONIUM BROMIDE
1119-97-7
IRRITANT
K5088
DEDM0623
DEDM0322
AFP FLEX
CARTRIDGE
K6454
DEDM0052
77-86-1
25322-68-3
95-48-7
7647-14-5
1310-73-2
1405-10-3
IRRITANT
TOXIC MATERIAL
CORROSIVE
CORROSIVE
SIEMENS
ALB FLEX
CARTRIDGE
K1013
DEDM0292
ALB-SENSITIVE
ALP
ALP
ALPF
SIEMENS
s ALB FLEX
ALPI FLEX
CARTRIDGE
K2115
MRDV0040
DEDM0414
NONE- LESS THAN1% OF ANY HAZADOUS
TROMETAMOL
POLYETHYLENE GLYCOL #1540
O-CRESOL
SODIUM CHLORIDE
SODIUM HYDROXIDE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
SODIUM ACETATE
ACETIC ACID
2-CHLORACETAMIDE
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
ALT
AMMONIA
SIEMENS
SIEMENS
ALP CALIBRATOR
ALT FLEX
AMON FLEX
KC330
K2043
K3019
DEDM0125
DEDM0295
DEDM0296
AMYLASE
AMY
SIEMENS
AMY FLEX
CARTRIDGE
K3017
DEDM0297
AST
AST
SIEMENS
AST FLEX
CARTRIDGE
K1021
DEDM0298
B12
SIEMENS
LOCI B12 FLEX
CARTRIDGE
PRODUCT #
K3105
KC6442
DEDM0131
B12
LOCI B12 FLEX
CARTRIDGE
REVISED
Bilirubin,Direct
SIEMENS
DBIL FLEX
DEDM0396
K2125
DEDM0329
NONE- LESS THAN1% OF ANY HAZADOUS
2-CHLORACETAMIDE
GLYCERIN
MANNITOL,DPOTASSIUM THIOCYANATE
SODIUM CHLORIDE
SODIUM AZIDE
DISODIUM L-ASPARTATE
2-AMINO-2-(HYDROXYMETHYL)PROPANE1,3-DIOL HYDROCHLORIDE
TROMETAMOL
POLYETHYLENE GLYCOL #135
SODIUM CHLORIDE
SODIUM HYDROXIDE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
"-1,4-DIMERCAPTOBUTANE-2,3-DIOL
SODIUM CHLORIDE
SODIUM HYDROXIDE
DISODIUM HYDROGENORTHOPHOSPHATE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
HYDROGEN CHLORIDE
Page 40 of 66
55965-84-9
127-09-3
64-19-7
79-07-2
79-07-2
56-81-5
69-65-8
333-20-0
7647-14-5
22628-22-8
5598-53-8
1185-53-1
77-86-1
25322-68-3
7647-14-5
1310-73-2
1405-10-3
55965-84-9
6892-68-8
7647-14-5
1310-73-2
7558-79-4
1405-10-3
55965-84-9
7647-01-0
IRRITANT
IRRITANT
IRRITANT
IRRITANT
IRRITANT
CORROSIVE
IRRITANT
TOXIC MATERIAL
SENSITIZING MATERIAL
CARCINOGEN
CHEMICAL LIST
7027 BID
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
CARTRIDGE
BILI
CALIBRATOR
Bilirubin,Total
BID
SIEMENS
BUN
SIEMENS
T/DBIL CALIB
TBIL FLEX
CARTRIDGE
BUN FLEX
CARTRIDGE
KC210
K1167
K1021
BUN
βhCG
SIEMENS
BHCG FLEX
CARTRIDGE
K6430
BHCG CALIBRATOR
KC632
HCG
HCGQ
C125
C125
SIEMENS
CA15-3
SIEMENS
LOCI CA125 II
CARTRIDGE
LOCI CA 15-3
K6456
Calcium/CA
Carbamazepine
SIEMENS
SIEMENS
CA FLEX CART.
CRBM FLEX
CARTRIDGE
K1023
K4087
CEA
CEA
SIEMENS
CEA FLEX
CARTRIDGE
K6453
Chloride
Cholesterol
CHOL
CK
SIEMENS
SIEMENS
SIEMENS
4/15/2015
7027-CENTRAL LAB CHEMISTRY
CHOL FLEX
CARTRIDGE
CK FLEX
CARTRIDGE
K1027
K2038
DEDM0073
SODIUM NITRITE
NEOMYCIN, SULFATE
GENTAMICIN, SULFATE
ACETAMIDE,2,2-DICHLORO-N-(BETA-HYDROXYALPHA-(HYDROXYMETHYL)-P-NITROPHENETHYL),D-(-)-THREO
DEDM0184 NONE- LESS THAN1% OF ANY HAZADOUS
DEDM0273 SODIUM ACETATE
CAFFEINE
DEDM0301 GLYCERIN
MANNITOL,DPOLY(OXY-1,2-ETHANEDIYL),ALPHA,-HYDRO-,
OMEGA,-HYDROXYDEDM0138 SODIUM CHLORIDE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0198 NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0307 SODIUM CHLORIDE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0306 SODIUM CHLORIDE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0302 SODIUM GLYCINATE
DEDM-0252 NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0347 SODIUM CHLORIDE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
SEE V-LYTE
DEDM0248 SODIUM CHLORIDE
LITHIUM HYDROXIDE
DEDM0249 SOUIUM 4-MORPHOLIN-1-YLETHYLSULPONATE
D-GLUCITOL
ACETIC ACID, MAGNESIUM SALT, HYDRATE
POLYETHYLENE GLYCOL #1540
(R*,S*)-1,4 DIMERCAPTOBUTANE-2,3-DIOL
GLYCINE,N,N'-1,2-ETHANEDIYLBIS
Page 41 of 66
7632-00-0
1405-10-3
1405-41-0
56-75-7
SENSITIZING MATERIAL
127-09-3
58-08-2
56-81-5
69-65-8
IRRITANT
25322-68-3
7647-14-5
1405-10-3
55965-84-9
1405-10-3
IRRITANT
IRRITANT
SENSITIZING MATERIAL
IRRITANT
SENSITIZING MATERIAL
55965-84-9
7647-14-5
1405-10-3
SENSITIZING MATERIAL
55965-84-9
7647-14-5
1405-10-3
SENSITIZING MATERIAL
55965-84-9
6000-44-8
1405-10-3
IRRITANT
SENSITIZING MATERIAL
55965-84-9
7647-14-5
1405-10-3
IRRITANT
SENSITIZING MATERIAL
55965-84-9
7647-14-5
1310-65-2
71119-23-8
50-70-4
16674-78-5
25322-68-3
6892-68-8
10378-23-1
IRRITANT
TOXIC MATERIAL
IRRITANT
TOXIC MATERIAL
SENSITIZING MATERIAL
CHEMICAL LIST
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
CKI
CKMB
SIEMENS
SIEMENS
K6420
DEDM0340
DEDM0238
MASS CKMB
ISOENZYME
CALIBRATOR
MBI FLEX
CARTRIDGE
CO2 FLEX
CARTRIDGE
KC672
DEDM0141
2-CHLORACETAMIDE
SUCROSE
AMMONIUM SULPHATE
NONE- LESS THAN1% OF ANY HAZADOUS
GLYCEROL
POLYETHYLENE GLYCOL #1540
MAGNESIUM DI(ACETATE)
SODIUM CHLORIDE
GLYCINE,N,N'-1,2-ETHANEDIYLBIS
ETHANOL
TROMETAMOL
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NONE- LESS THAN1% OF ANY HAZADOUS
K3032
DEMD0288
NONE- LESS THAN1% OF ANY HAZADOUS
K1137
DEDM0251
107-21-1
7791-18-6
26628-22-8
IRRITANT
ECREA FLEX
CARTRIDGE
ECREA CALBRATOR
K1270
DEDM0230
ETHANEDIOL
MAGNESIUM CHLORIDE,HEXAHYDRATE
SODIUM AZIDE
NONE- LESS THAN1% OF ANY HAZADOUS
1405-10-3
SENSITIZING MATERIAL
CREA FLEX
CARTRIDGE
CRP FLEX CARTRIDGE
hs CRP FLEX
CARTRIDGE
hs CRP CON L
hs CRP CON H
DIG FLEX
CARTRIDGE
K1033
DEDM0253
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
SODIUM HYDROXIDE
55965-84-9
1310-73-2
CORROSIVE
K7032
K7046
MRDV0009
MRDV0008
SUCROSE
SUCROSE
57-50-1
57-50-1
KC755
KC757
K4036
MRDV0011
MRDV0012
DEDM0258
DIGXN FLEX
LOCI DIGOXIN
K6435
DEDM0369
ETOH FLEX
K5022
DEDM0201
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
CHROMIN DIOXIDE
ETHANEDIOL
POLYETHYLENE GLYCOL #1540
SODIUM CHLORIDE
STREPTOMYCIN SULPHATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
SODIUM CHLORIDE
STREPTOMYCIN SULPHATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
TROMETAMOL
CK CALIBRATOR
DEDM0126
CKI FLEX
CKMB FLEX
CARTRIDGE
DEDM0287
DEDM0250
CKMB VERIFIER
MMB FLEX
CARTRIDGE
CO2
SIEMENS
Creatinine
SIEMENS
CRP
SIEMENS
HS-CRP
DIGOXIN
ETOH-Alcohol
SIEMENS
SIEMENS
4/15/2015
7027-CENTRAL LAB CHEMISTRY
DEDM0056
Page 42 of 66
79-07-2
57-50-1
7783-20-2
56-81-5
25322-68-3
142-72-3
7647-14-5
10378-23-1
64-17-5
77-86-1
1405-10-3
IRRITANT
CARCINOGEN
IRRITANT
IRRITANT
SENSITIZING MATERIAL
55965-84-9
12018-01-8
107-21-1
25322-68-3
7647-14-5
3810-74-0
55965-84-9
7647-14-5
3810-74-0
55965-84-9
77-86-1
SENSITIZING MATERIAL
IRRITANT
SENSITIZING MATERIAL
SENSITIZING MATERIAL
IRRITANT
CHEMICAL LIST
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
FERRITIN
SIEMENS
FOLATE
SIEMENS
CARTRIDGE
FERR FLEX
CARTRIDGE
FOL FLEX
CARTRIDGE
K2045
DEDM0264
SODIUM 4-MORPHOLIN-1-YLETHYLSULPONATE
SODIUM CHLORIDE
STREPTOMYCIN SULPHATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
ASCORBIC ACID
(R*,R*)-1,4 DIMERCAPTOBUTANE-2,3-DIOL
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
SODIUM HYDROXIDE
SODIUM CHLORIDE
SODIUM CHLORIDE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
SODIUM CHLORIDE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
SODIUM CHLORIDE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
SODIUM CHLORIDE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
BORIC ACID
2-CHLORACETAMIDE
K1039
DEDM262
NONE- LESS THAN1% OF ANY HAZADOUS
K3048A
DEDM0284
NONE- LESS THAN1% OF ANY HAZADOUS
K7044
MSDV0026
NONE- LESS THAN1% OF ANY HAZADOUS
K3085
DEDM0231
KC240
K3016
DEDM0229
DEDM0232
CITRIC ACID, MONOHYDRATE
THIOUREA
NONE- LESS THAN1% OF ANY HAZADOUS
GLYCERN
HYDRAZINE, SULFATE
1,3-PROPANEDIOL,2-AMINO-2-HYDROXYMETHYL
AMMONIUM HYDROGEN SULPHATE
POLY(OXY-1,2-ETHANEDIYL),ALPHA,-HYDRO-,
OMEGA,-HYDROXYNEOMYCIN, SULFATE
1,3-PROPANEDIOL,2-AMINO-2-HYDROXYMETHYL
K6440
DEDM0071
K6444
DEDM0143
FREE T3
SIEMENS
FT3 FLEX
CARTRIDGE
K6416
DEDM0144
FREE T4
SIEMENS
FT4 FLEX
CARTRIDGE
K6410
DEDM0081
FSH
SIEMENS
FSH FLEX
CARTRIDGE
K6460
DEDM0371
GENTAMICIN
SIEMENS
GGT
SIEMENS
GLUCOSE
SIEMENS
HDL
SIEMENS
Homocysteine
SIEMENS
IRON
SIEMENS
LACTIC ACID
SIEMENS
LDH
SIEMENS
4/15/2015
7027-CENTRAL LAB CHEMISTRY
GENT FLEX
CARTRIDGE
GGT FLEX
CARTRIDGE
GLUCOSE FLEX
CARTRIDGE
HDLC FLEX
CARTRIDGE
HCYS FLEX
CARTRIDGE
IRON FLEX
CARTRIDGE
IRON CALIBRATOR
LA FLEX
CARTRIDGE
LDH FLEX
K4012
K2054
DEDM0187
DEDM0234
Page 43 of 66
71119-23-8
7647-14-5
3810-74-0
55965-84-9
50-81-7
27565-41-9
1405-10-3
55965-84-9
1310-73-2
7647-14-5
7647-14-5
55965-84-9
7647-14-5
55965-84-9
7647-14-5
55965-84-9
1405-10-3
7647-14-5
55965-84-9
1405-10-3
10043-35-3
79-07-2
5949-29-1
62-56-6
56-81-5
13464-80-7
77-86-1
7783-20-2
25322-68-3
1405-10-3
77-86-1
SENSITIZING MATERIAL
IRRITANT
SENSITIZING MATERIAL
CORROSIVE
IRRITANT
SENSITIZING MATERIAL
IRRITANT
SENSITIZING MATERIAL
IRRITANT
SENSITIZING MATERIAL
IRRITANT
SENSITIZING MATERIAL
IRRITANT
SENSITIZING MATERIAL
HARMFUL
IRRITANT
TOXIC MATERIAL
IRRITANT
TOXIC MATERIAL
SENSITIZING MATERIAL
IRRITANT
CHEMICAL LIST
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
CARTRIDGE
LDLC
LH
LIPASE
SIEMENS
SIEMENS
SIEMENS
4/15/2015
7027-CENTRAL LAB CHEMISTRY
LDI FLEX
CARTRIDGE
LDLC FLEX
CARTRIDGE
LH FLEX
CARTRIDGE
LIPL FLEX
CARTRIDGE
LIP FLEX
CARTRIDGE
DEDM0328
K3131
K6461
K3056
DEDM0233
DEDM0370
DEDM0219
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
SODIUM CHLORIDE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
NONE- LESS THAN1% OF ANY HAZADOUS
LITHIUM
SIEMENS
LI FLEX
CARTRIDGE
K4132
DEDM0235
MAGNESIUM
SIEMENS
K3057
DEDM0237
MICROALBUMIN
SIEMENS
MRDV0001
NONE- LESS THAN1% OF ANY HAZADOUS
PHENOBARBITAL
SIEMENS
MG FLEX
CARTRIDGE
MALB FLEX
CARTRIDGE
PHNO FLEX
CARTRIDGE
1,3-PROPANEDIOL,2-AMINO-2-HYDROXYMETHYL
1,3-PROPANEDIOL,2-AMINO-2-HYDROXYMETHYL
HYDROCHLORIDE
POLY(OXY-1,2-ETHANEDIYL),ALPHA,-HYDRO-,
OMEGA,-HYDROXYSUCROSE
DIMETHYL SULFOXIDE
POTASSIUM HYDROXIDE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
SODIUM METABORATE,ANHYDROUS
DEDM0244
SODIUM CHLORIDE
POTASSIUM CHLORIDE
BORIC ACID
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
SODIUM AZIDE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
SULPHURIC ACID
SODIUM BISULFITE
DISODIUM MOLYDBATE
PHENYTOIN
SIEMENS
PTN FLEX
CARTRIDGE
PHOSPHORUS
SIEMENS
PHOS FLEX
CARTRIDGE
Potassium
PREALBUMIN
SIEMENS
SIEMENS
PREALB FLEX
CARTRIDGE
DEDM0188
1,3-PROPANEDIOL,2-AMINO-2-HYDROXYMETHYL
HYDROCHLORIDE
SODIUM CHLORIDE
K4060
K4064
DEDM0268
DEDM0266
K7064
SEE V-LYTE
MRDV0007 NONE- LESS THAN1% OF ANY HAZADOUS
Page 44 of 66
1185-53-1
7647-14-5
TARGET ORGAN EFFECTS
SENSITIZING MATERIAL
55965-84-9
7647-14-5
TARGET ORGAN EFFECTS
SENSITIZING MATERIAL
55965-84-9
1405-10-3
77-86-1
IRRITANT
1185-53-1
TARGET ORGAN EFFECTS
25322-68-3
57-50-1
67-68-5
1310-58-3
1405-10-3
CORROSIVE
TARGET ORGAN EFFECTS
SENSITIZING MATERIAL
55965-84-9
7775-19-1
IRRITANT
IRRITANT
TARGET ORGAN EFFECTS
7647-14-5
7447-40-7
10043-35-3
1405-10-3
IRRITANT
55965-84-9
26628-22-8
1405-10-3
55965-84-9
7664-93-9
7631-90-5
7631-95-0
TARGET ORGAN EFFECTS
SENSITIZING MATERIAL
IRRITANT
SENSITIZING MATERIAL
IRRITANT
TOXIC MATERIAL
SENSITIZING MATERIAL
CORROSIVE
CARCINOGEN
TARGET ORGAN EFFECTS
CHEMICAL LIST
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
PROLACTIN
SIEMENS
PROLACTIN LOCI
CARTRIDGE
PRL
K6462
PSA
SIEMENS
PSA CALIBRATOR
KC602
(FREE)
FPSA FLEX
CARTRIDGE
(TOTAL)
TPSA FLEX
CARTRIDGE
K6451
RF FLEX
CARTRIDGE
SAL FLEX
CARTRIDGE
K7068
RF
RHEUMATOID
SALICYLATE
SIEMENS
SODIUM
T4
THYROXINE
SIEMENS
SIEMENS
THEOPHYLINE
TIBC
SIEMENS
SIEMENS
SIEMENS
4/15/2015
7027-CENTRAL LAB CHEMISTRY
T4 FLEX
CARTRIDGE
THEO FLEX
CARTRIDGE
TIBC FLEX
CARTRIDGE
TIBC CALIBRATOR
K5020
K6065
K4071
K3084
KC230
SODIUM CHLORIDE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0208 5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
DEDM0216 SODIUM CHLORIDE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM 0100 SODIUM CHLORIDE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
MRDV0010 POLYETHYLENE GLYCOL #1540
SODIUM CHLORIDE
DEDM0269 IRON (III) NITRATE, NONAHYDRATE
NITRIC ACID
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
SEE V-LYTE
DEDM0272 POLYETHYLENE GLYCOL #1540
SODIUM CHLORIDE
SODIUM HYDROXIDE
2-AMINO-2-(HYDROXYMETHYL)PROPANE1,3-DIOL HYDROCHLORIDE
SODIUM AZIDE
DEDM0275 SODIUM CHLORIDE
DIMETHYL SULFOXIDE
DISODIUM HYDROGENORTHOPHOSPHATE
ALBUMINS, HUMAN
NEOMYCIN, SULFATE
DEDM0276 ASCORBIC ACID
TROMETAMOL
2-AMINO-2-(HYDROXYMETHYL)PROPANE1,3-DIOL HYDROCHLORIDE
SODIUM ACETATE
ACETIC ACID
POLYETHYLENE GLYCOL #1540
THIOUREA
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0130 NONE- LESS THAN1% OF ANY HAZADOUS
Page 45 of 66
7647-14-5
1405-10-3
IRRITANT
SENSITIZING MATERIAL
55965-84-9
55965-84-9
1405-10-3
7647-14-5
1405-10-3
IRRITANT
SENSITIZING MATERIAL
55965-84-9
7647-14-5
1405-10-3
55965-84-9
25322-68-3
7647-14-5
7782-61-8
7697-37-2
1405-10-3
TARGET ORGAN EFFECTS
SENSITIZING MATERIAL
SENSITIZING MATERIAL
CORROSIVE
CARCINOGEN
TARGET ORGAN EFFECTS
55965-84-9
25322-68-3
7647-14-5
1310-73-2
1185-53-1
26628-22-8
7647-14-5
67-68-5
7558-79-4
70024-90-7
1405-10-3
50-81-7
77-86-1
1185-53-1
127-09-3
64-19-7
25322-68-3
62-56-6
1405-10-3
55965-84-9
IRRITANT
TARGET ORGAN EFFECTS
CORROSIVE
IRRITANT
TARGET ORGAN EFFECTS
SENSITIZING MATERIAL
IRRITANT
TOXIC MATERIAL
SENSITIZING MATERIAL
CORROSIVE
CARCINOGEN
TARGET ORGAN EFFECTS
CHEMICAL LIST
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
TOBRAMYCIN
SIEMENS
TOTAL PROTEIN
SIEMENS
TP FLEX
CARTRIDGE
K1073
DEDM0277
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
SODIUM CHLORIDE
BORIC ACID
COPPER SULPHATE
URINARY/CSF
PROTEIN
SIEMENS
UCFP FLEX
CARTRIDGE
K3026
DEDM0190
METHANOL
TOTAL T3
SIEMENS
UCFP CALIBRATOR
T3 CALIBRATOR
KC260
KC250
DEDM0247
DEMD0271
T3 FLEX
CARTRIDGE
K6414
DEDM0270
TRIG FLEX
CARTRIDGE
CTNI FLEX
CARTRIDGE
K2069
DEDM0278
NONE- LESS THAN1% OF ANY HAZADOUS
SODIUM AZIDE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
ETHANDIOL
CHROMIN DIOXIDE
STREPTOMYCIN SULPHATE
GENTAMICIN, SULFATE
NEOMYCIN, SULFATE
SODIUM AZIDE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NONE- LESS THAN1% OF ANY HAZADOUS
K6421
DEDM0256
TRIGLYERIDE
SIEMENS
TROPONIN
SIEMENS
TOBR FLEX
CARTRIDGE
CTNI
CALIBRATOR
TSH
SIEMENS
4/15/2015
7027-CENTRAL LAB CHEMISTRY
TSH FLEX
CARTRIDGE
K4014
KC678
K6412
TSH SDIL
T-UPTAKE
SIEMENS
TU FLEX
CARTRIDGE
K6075
URIC ACID
SIEMENS
K1077
VALPROIC
ACID
SIEMENS
URCA FLEX
CARTRIDGE
VALP FLEX
CARTRIDGE
K4078
DEDM0189
1405-10-3
IRRITANT
55965-84-9
7647-14-5
10043-35-3
7758-98-7
TARGET ORGAN EFFECTS
SENSITIZING MATERIAL
67-56-1
26628-22-8
SENSITIZING MATERIAL
55965-84-9
107-21-1
12018-01-8
3810-74-0
1405-41-0
1405-10-3
26628-22-8
IRRITANT
7647-14-5
1405-10-3
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0084 SODIUM CHLORIDE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0077vs NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0279 POLYETHYLENE GLYCOL 135
BARBITAL SODIUM
SODIUM AZIDE
DEDM0280 GLYCERIN
BORIC ACID
DEMD0281 SODIUM CHLORIDE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
1405-10-3
Page 46 of 66
TARGET ORGAN EFFECTS
SENSITIZING MATERIAL
55965-84-9
SODIUM CHLORIDE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0255
IRRITANT
TOXIC MATERIAL
TARGET ORGAN EFFECTS
IRRITANT
TOXIC MATERIAL
TARGET ORGAN EFFECTS
TARGET ORGAN EFFECTS
SENSITIZING MATERIAL
55965-84-9
55965-84-9
7647-14-5
SENSITIZING MATERIAL
IRRITANT
55965-84-9
1405-10-3
TARGET ORGAN EFFECTS
SENSITIZING MATERIAL
55965-84-9
25322-68-3
144-02-5
26628-22-8
56-81-5
10043-35-3
7647-14-5
TARGET ORGAN EFFECTS
SENSITIZING MATERIAL
TARGET ORGAN EFFECTS
IRRITANT
CHEMICAL LIST
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
VANCOMYCIN
SIEMENS
SIEMENS
ELECTROLYTES
DIMENSION
VISTA
SIEMENS
SIEMENS
SYSTEM
REAGENTS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
4/15/2015
7027-CENTRAL LAB CHEMISTRY
VANC FLEX
CARTRIDGE
V-LYTE IMT
CARTRIDGE
V-LYTE
STANDARD A
V-LYTE
STANDARD B
V-LYTE
V-LYTE DILUENT
V-LYTE
DILUENT CHECK
VISTA ENZ 5
CALIBRATOR
VISTA ENZ 6
CALIBRATOR
LIPID
CALIBRATOR
MULTI 1
K800A
DEDM0390
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
SODIUM CHLORIDE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
BORIC ACID
NONE- LESS THAN1% OF ANY HAZADOUS
K820
DEMD0115
NONE- LESS THAN1% OF ANY HAZADOUS
K825
DEMD0116
NONE- LESS THAN1% OF ANY HAZADOUS
K835
DEDM0118
NONE- LESS THAN1% OF ANY HAZADOUS
K840
DEDM0220
KC350
KC360
DEDM0312
DEDM0350
NONE- LESS THAN1% OF ANY HAZADOUS
NEOMYCIN, SULFATE
GENTAMICIN, SULFATE
SUCROSE
KC220-A
DEDM0129
NONE- LESS THAN1% OF ANY HAZADOUS
KD693
DEDM0391
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
ETHANOL
K4086
MULTI 2
SAMPLE DILUENT
KD694
CHEM 1
CALIBRATOR
KC110
DEDM0191
DEDM0393
DEDM0112
CHEM 2
CALIBRATOR
KC120
DEDM0246
CHEM 3
CALIBRATOR
KC130
DEDM0072
KC140
KS805
DEDM0128
DEDM0120
CHEM 4
CALIBRATOR
CUVETTE
WASH SOLUTION
DRUG 1
CALIBRATOR
DRUG 2
CALIBRATOR
KC410
DEDM0259
NONE- LESS THAN1% OF ANY HAZADOUS
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NONE- LESS THAN1% OF ANY HAZADOUS
KC420
DEDM0075
GENTAMICIN, SULFATE
Page 47 of 66
55965-84-9
1405-10-3
7647-14-5
TARGET ORGAN EFFECTS
SENSITIZING MATERIAL
IRRITANT
55965-84-9
1405-10-3
10043-35-3
TARGET ORGAN EFFECTS
SENSITIZING MATERIAL
1405-10-3
1405-41-0
57-50-1
SENSITIZING MATERIAL
55965-84-9
1405-10-3
IRRITANT
SENSITIZING MATERIAL
55965-84-9
1405-10-3
IRRITANT
SENSITIZING MATERIAL
55965-84-9
1405-10-3
IRRITANT
SENSITIZING MATERIAL
55965-84-9
1405-10-3
IRRITANT
SENSITIZING MATERIAL
55965-84-9
64-17-5
SENSITIZING MATERIAL
CARCINOGEN
55965-84-9
IRRITANT
SENSITIZING MATERIAL
1405-41-0
SENSITIZING MATERIAL
TARGET ORGAN EFFECTS
CHEMICAL LIST
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
4/15/2015
7027-CENTRAL LAB CHEMISTRY
DRUG 4
CALIBRATOR
ENZYME 1
CALIBRATOR
ENZYME 2
CALIBRATOR
ENZYME
DILUENT
PROT3 CAL
LOCI 1
CALIBRATOR
KC460
DEDM0152
NONE- LESS THAN1% OF ANY HAZADOUS
KC310
DEDM0123
NONE- LESS THAN1% OF ANY HAZADOUS
KC320
DEDM0124
AMMONIUM SULPHATE
7783-20-2
ED
DEDM0260
SODIUM CHLORIDE
7647-14-5
KC770
KC660
MRDV0018
DEDM0109
LOCI 4
CALIBRATOR
KC640
LOCI 5
CALIBRATOR
KC600
LOCI 6
CALIBRATOR
KC604
LOCI 7
CALIBRATOR
KC605
LOCI 8
CALIBRATOR
KC646
MMB
CALIBRATOR
PROT1
CON H
PROT1
CON L
PROT1
CON M
PROT 2
CALIBRATOR
PROT 2
CON H
PROT 2
CON L
PROT 3
CON
PROT 1
CALIBRATOR
KC672
DEDM0141
NONE- LESS THAN1% OF ANY HAZADOUS
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
ETHANOL
NONE- LESS THAN1% OF ANY HAZADOUS
KC717
MRDV0016
KC715
MRDV0014
KC706
MRDV0015
KC780
MRDV0020
KC787
MRDV0021
KC785
MRDV0022
KC775C
MRDV0019
KC710C
MRDV0013
DEDM0136
DEDM0207
DEDM0317
DEDM0320
DEDM0286
IRRITANT
TARGET ORGAN EFFECTS
IRRITANT
TARGET ORGAN EFFECTS
55965-84-9
1405-10-3
IRRITANT
SENSITIZING MATERIAL
55965-84-9
1405-10-3
IRRITANT
SENSITIZING MATERIAL
55965-84-9
1405-10-3
IRRITANT
SENSITIZING MATERIAL
55965-84-9
1405-10-3
IRRITANT
SENSITIZING MATERIAL
55965-84-9
1405-10-3
IRRITANT
SENSITIZING MATERIAL
55965-84-9
1405-10-3
64-17-5
TARGET ORGAN EFFECTS
SENSITIZING MATERIAL
CARCINOGEN
SODIUM CHLORIDE
SODIUM AZIDE
SODIUM CHLORIDE
SODIUM AZIDE
SODIUM CHLORIDE
SODIUM AZIDE
2-PYRROLIDONE
SODIUM AZIDE
2-PYRROLIDONE
SODIUM AZIDE
2-PYRROLIDONE
SODIUM AZIDE
NONE- LESS THAN1% OF ANY HAZADOUS
7647-14-5
26628-22-8
7647-14-5
26628-22-8
7647-14-5
26628-22-8
616-45-5
26628-22-8
616-45-5
26628-22-8
616-45-5
26628-22-8
TARGET ORGAN EFFECTS
SODIUM CHLORIDE
SODIUM AZIDE
7647-14-5
26628-22-8
TARGET ORGAN EFFECTS
Page 48 of 66
TARGET ORGAN EFFECTS
TARGET ORGAN EFFECTS
TOXIC MATERIAL
TOXIC MATERIAL
TOXIC MATERIAL
CHEMICAL LIST
7027
7027
7027
7027
7027
7027
7027
7027 Ci4100
7027 SYSTEM
7027 REAGENTS
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
SIEMENS
REAGENT
PROBE CLEANER
SAMPLE
PROBE CLEANER
KS806
DEDM0121
NONE- LESS THAN1% OF ANY HAZADOUS
KS807
DEDM0122
SODIUM HYPOCHLORIDE CL ACTIVE
KS804
DEDM0119
NONE- LESS THAN1% OF ANY HAZADOUS
ABBOTT
SYSTEM
DILUENT
CONCENTRATED
WASH BUFFER
PROBE
CONDITIONING
TRIGGER
SOLUTION
PRE-TRIGGER
SOLUTION
MULTI CONST
CALIBRATOR 1
CALIBRATOR 2
MULTI-ASSAY
MANUAL DILUENT
DOA
CALIBRATOR 1
CALIBRATOR 2
CALIBRATOR 3
CALIBRATOR 4
DOA MG NEG
DOA MC I CONT
DOA MC II CONT
SPECIFIC PROTEINS
CALIBRATORS 1-5
QUANTIA
PROTEIN
CALIBRATORS 1-5
ALKALINE WASH
ABBOTT
ACID WASH
6K01-20
ABBOTT
WATER BATH
ADDITIVE
9D29-20
SIEMENS
SIEMENS
ABBOTT
ABBOTT
ABBOTT
ABBOTT
ABBOTT
ABBOTT
ABBOTT
ABBOTT
ABBOTT
ABBOTT
4/15/2015
7027-CENTRAL LAB CHEMISTRY
DETERGENT A
DETERGENT B
6C54-48
1L56-40
6C55-60
6E23-65
1E65-04
9/30/2010 SODIUM AZIDE
11/23/2009 5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
3/3/2011 TRITON X-100
SODIUM HYDROXIDE
12/30/2009 NONE- LESS THAN1% OF ANY HAZADOUS
8/25/2010 SODIUM AZIDE
7D82-50
12/23/2009 NONE- LESS THAN1% OF ANY HAZADOUS
3L43-01
3L43-02
3L43-03
3L43-04
3L43-05
3L43-10
3L42-11
1E78-02
5/6/2009
5/6/2009
5/6/2009
5/6/2009
5/6/2009
2/28/2011
2/28/2011
11/30/2009
6K45
11/17/2012 NONE- LESS THAN1% OF ANY HAZADOUS
9D31-20
11/13/2006 SODIUM HYDROXIDE
POLYETHYLENE GLYCOL
11/10/2006 METHANOL
CITRIC ACID, MONOHYDRATE
POLYETHYLENE GLYCOL
OXALIC ACID
8/12/2011 MAGNESIUM NITRATE HEXAHYDRATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
2-METHYL-4-ISOTHIAZOLIN-3-ONE
5/14/2009 2-AMINOETHANOL
4/22/2009 POLYETHOXYETHYLENE NONYLPHENYLETHER
SODIUM HYDROXIDE
1J72-20
2J94-20
7681-52-9
CORROSIVE
IRRITANT
TARGET ORGAN EFFECTS
26628-22-8
HARMFUL IF SWALLOWED
55965-84-9
9002-93-1
1310-73-2
SENSITIZING MATERIAL
IRRITANT
IRRITANT
CORROSIVE
26628-22-8
HARMFUL IF SWALLOWED
INFECTOUS
1310-73-2
25322-68-3
67-56-1
5949-29-1
25322-68-3
144-62-7
13446-18-9
CORROSIVE
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
Page 49 of 66
55965-84-9
2682-20-4
141-43-5
NA
1310-73-2
TOXIC MATERIAL
MAY CAUSE BLINDNESS
SENSITIZING MATERIAL
IRRITANT
IRRITANT
CORROSIVE
CHEMICAL LIST
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
URINE
CREATININE
ABBOTT
METHOTREXATE
ABBOTT
CREATININE
REAGENT 1
REAGENT2
PROPOXPHENE
OPIATES
METHADONE
BENZODIAZEPINES
COCAINE
AMIKACIN
CANNABINOIDS
BARBITURATE
ABBOTT
ABBOTT
ABBOTT
ABBOTT
ABBOTT
ABBOTT
ABBOTT
ABBOTT
ABBOTT
3L81-22
8/5/2010
SODIUM HYDROXIDE
PICIRIC ACID
8/15/2011
METHOTREXATE
PRETREATMENT
ANTISERM
FLUORESCEIN
TRACER
WASH
PHENCYCLIDINE
4/15/2015
7027-CENTRAL LAB CHEMISTRY
7A12P
7A12S
7A12T
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
7A12W
NONE- LESS THAN1% OF ANY HAZADOUS
PHENCYCLIDINE
REAGENT 1
REAGENT 2
PROPOXPHENE
REAGENT 1
REAGENT 2
OPIATES
REAGENT 1
REAGENT 2
LOW CONTROL
1000 CAL
METHADONE
REAGENT 1
REAGENT 2
6L96/R1
6L96/R2
6/27/2009 NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
6L97/R1
6L97/R2
5/5/2009 NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
3L34/R1
3L34/R2
3L34-10
3L34-04
6/1/2009 NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
6/1/2009 NONE- LESS THAN1% OF ANY HAZADOUS
6/1/2009 NONE- LESS THAN1% OF ANY HAZADOUS
3L35/R1
3L35/R2
6/24/2009 NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
3L39/R1
3L39/R2
6/19/2009 NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
3L40/R1
3L40/R2
6L35-01
6L35-01/1
6L35-01/2-6
6/19/2009 NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
BENZODIAZEPINES
REAGENT 1
REAGENT 2
COCAINE
REAGENT 1
REAGENT 2
CALIBRATOR KIT
CAL 1
CAL 2-6
AMIKACIN
REAGENT 1
REAGENT 2
CANNABINOIDS
REAGENT 1
REAGENT 2
CANNABINOIDS 100
CALIBRATOR
CANNABINOIDS 50
CALIBRATOR
CANNABINOIDS 20
CALIBRATOR
BARBITURATE
REAGENT 1
4/7/2009 NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
6L35/R1
6L35/R2
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
3L41/R1
3L41/R2
3L41-03
5/8/2009 NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
5/8/2009 NONE- LESS THAN1% OF ANY HAZADOUS
3L41-02
5/8/2009 NONE- LESS THAN1% OF ANY HAZADOUS
3L41-01
5/8/2009 NONE- LESS THAN1% OF ANY HAZADOUS
5/24/2006
3L38-20/R1
NONE- LESS THAN1% OF ANY HAZADOUS
Page 50 of 66
1310-73-2
88-89-1
CORROSIVE
IRRITANT
TARGET ORGAN EFFECTS
CHEMICAL LIST
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
ETHANOL
AMPHETAMINE
ABBOTT
ABBOTT
REAGENT 2
ETHANOL
REAGENT 1
REAGENT 2
NEG CALIBRATOR
100 CALIBRATOR
3L38-20/R2
3L36/R1
3L36/R2
36L36-01
3L36-02
TACROLIMUS
REAGENT 1
REAGENT 2
MICROPARTICLES
1E14-20/R1
1E14-20/R2
1L77G
CONJUGATE
1L77H
ASSAY DILUENT
1L77J
TACROLIMUS
ABBOTT
PRECIPITATION
REAGENT
1L77-55
CYCLOSPORINE
ABBOTT
MICROPARTICLES
1L75G
CONJUGATE
1L75H
ASSAY DILUENT
ABBOTT
CYCLOSPORINE
ABBOTT
TRANSFERRIN
ABBOTT
ASO
ABBOTT
IgG
ABBOTT
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
2/28/2011 NONE- LESS THAN1% OF ANY HAZADOUS
2/28/2011 NONE- LESS THAN1% OF ANY HAZADOUS
AMPHETAMINE
METHAMPHETAMINE
CYCLOSPORINE
NONE- LESS THAN1% OF ANY HAZADOUS
2/28/2011
METHAMPHETAMINE
ABBOTT
4/15/2015
7027-CENTRAL LAB CHEMISTRY
SOLUBILIZATION
REAGENT
1L75X
PRECIPITATION
1L75Y
CALIBRATOR A
CALIBRATOR B-F
TRANSFERRIN
REAGENT 1
REAGENT 2
ASO R1 BUFFER
ASO R2 REAGENT
ASO CONTROL 1
ASO CONTROLII
ASO CALIBRATOR
IGG REAGENT1
IGG REAGENT2
1L75A
1L75B
1E04-80
1E04/R1
1E04/R2
6K38/R1
6K38/R2
6K54-21
6K55/II
6K46-02
9D99/R1
9D99/R2
7/25/2006 4-(2-HYDROXYETHYL)PIPERAZINE
-1ETHENESULPHONIC ACID
11/23/2009 EDTA DISODIUM SALT
2-METHYL-4-ISOTHIAZOLIN-3-ONE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
MORPHOLINOETHANESULFONIC ACID
2-METHYL-4-ISOTHIAZOLIN-3-ONE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
11/23/2009 METHANOL
ETHYLENE GLYCOL
ZINC SULFATE HEPTAHYDRATE
12/30/2009 EDTA DISODIUM SALT
2-METHYL-4-ISOTHIAZOLIN-3-ONE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
12/30/2009 SAPONIN ( FROM Qillaja bark)
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
METHANOL
ETHYLENE GLYCOL
ZINC SULFATE HEPTAHYDRATE
12/30/2009 NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
6/24/2009 POLYETHYLENE GLYCOL
PROPRIETARTY INGREDIENT N-7
TRIS HYDROXYMETHYL AMINOMETHANE
10/25/2010 NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
10/26/2010 NONE- LESS THAN1% OF ANY HAZADOUS
10/26/2010 NONE- LESS THAN1% OF ANY HAZADOUS
10/26/2010 5-BROMO-5-NITRO-1,3 DIOXANE
10/2/2009 POLYETHYLENE GLYCOL
PROPRIETARTY INGREDIENT N-7
TRIS HYDROXYMETHYL AMINOMETHANE
Page 51 of 66
7365-45-9
IRRITANT
6381-92-6
2682-20-4
SENSITIZING MATERIAL
55965-84-9
145224-94-8
2682-20-4
55965-84-9
67-56-1
107-21-1
7446-20-0
6381-92-6
2682-20-4
55965-84-9
55965-84-9
8047-15-2
SENSITIZING MATERIAL
IRRITANT
SENSITIZING MATERIAL
IRRITANT
TOXIC MATERIAL
FLAMMABLE
MAY CAUSE BLINDNESS
SENSITIZING MATERIAL
SENSITIZING MATERIAL
IRRITANT
SENSITIZING MATERIAL
IRRITANT
55965-84-9
67-56-1
107-21-1
7446-20-0
SENSITIZING MATERIAL
IRRITANT
TOXIC MATERIAL
FLAMMABLE
MAY CAUSE BLINDNESS
25322-68-3
IRRITANT
77-86-1
TARGET ORGAN EFFECTS
30007-47-7
25322-68-3
TARGET ORGAN EFFECTS
IRRITANT
77-86-1
TARGET ORGAN EFFECTS
CHEMICAL LIST
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
IgA
IgM
C3
ABBOTT
ABBOTT
ABBOTT
IGA REAGENT1
IGA REAGENT 2
9D98/R1
9D98/R2
IGM REAGENT 1
IGM REAGENT 2
1E01/R1
1E01/R2
C3 REAGENT 1
C3 REAGENT 2
9D96/R1
9D96/R2
C4
ABBOTT
C4 REAGENT 1
C4 REAGENT 2
9D97/R1
9D97/R2
HAPTOGLOBIN
ABBOTT
A1-ANTRYPSIN
A1AT
ABBOTT
9D91-21
9D91/R1
9D91/R2
6K99-40
6K99/R1
6K99/R2
OXYCODON
MICROGENICS
HAPTOGLOBIN
REAGENT 1
REAGENT 2
A1-ANTRYPSIN
REAGENT 1
REAGENT 2
OXYCODON
REAGENT 1
CONJUGATE
CAILBRATOR
CONTROL KIT
MICROPARTICLES
CONJUGATE
ASSAY DILUENT
POS CALIBRATOR
NEG CONTROL
POS CONTROL 1
POS CONTROL 2
POS CONTROL 3
POS CONTROL 4
METHOTREXATE
PRETREATMENT
ANTISERM
FLUORESCEIN
TRACER
WASH SOLUTION
CALIBRATOR A
CALIBRATOR B-F
CONTROLS
PIPET CHECK
DILUTION BUFFER
PCS BLANK
SOLUTION
9519-02
PCS-231
HIV Ag/Ab COMBO
ABBOTT
METHOTREXATE
FLEX
ABBOTT
FLEX
ABBOTT
PIPETTE CALIB
ARTEL, INC.
4/15/2015
7027-CENTRAL LAB CHEMISTRY
100248
100249
100250-53
100254,-55
2P36G
2P36H
2P36J
2P36K
2P36L
2P36M
2P36N
2P36R
2P36S
7A12P
7A12S
7A12T
7A12W
7A12-A
7A12-B-F
7A12-10
9531-02
9/14/2010 PROPRIETARTY INGREDIENT N-7
TRIS HYDROXYMETHYL AMINOMETHANE
SODIUM AZIDE
9/13/2010 PROPRIETARTY INGREDIENT N-7
TRIS HYDROXYMETHYL AMINOMETHANE
SODIUM AZIDE
9/14/2010 PROPRIETARTY INGREDIENT N-7, N-12
TRIS HYDROXYMETHYL AMINOMETHANE
SODIUM AZIDE
10/22/2009 POLYETHYLENE GLYCOL
PROPRIETARTY INGREDIENT N-7
TRIS HYDROXYMETHYL AMINOMETHANE
9/13/2010 SODIUM AZIDE
TRIS HYDROXYMETHYL AMINOMETHANE
77-86-1
26628-22-8
TARGET ORGAN EFFECTS
HARMFUL IF SWALLOWED
77-86-1
26628-22-8
77-86-1
26628-22-8
25322-68-3
TARGET ORGAN EFFECTS
HARMFUL IF SWALLOWED
IRRITANT
TARGET ORGAN EFFECTS
HARMFUL IF SWALLOWED
IRRITANT
77-86-1
26628-22-8
77-86-1
TARGET ORGAN EFFECTS
TARGET ORGAN EFFECTS
HARMFUL IF SWALLOWED
77-86-1
9002-93-1
TARGET ORGAN EFFECTS
IRRITANT
124-90-3
7647-14-5
IRRITANT
SENSITIZING MATERIAL
10101-89-0
26628-22-8
10101-89-0
25322-68-3
10125-13-0
IRRITANT
10/29/2010
TRIS HYDROXYMETHYL AMINOMETHANE
TRITON X-100
Jun-04 NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
11/11/2008 OXYCODONE-HCL
SODIUM CHLORIDE
9/1/2010 NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
8/15/2011 NONE- LESS THAN1% OF ANY HAZADOUS
8/15/2011 NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
8/15/2011 NONE- LESS THAN1% OF ANY HAZADOUS
8/15/2011 NONE- LESS THAN1% OF ANY HAZADOUS
8/15/2011 NONE- LESS THAN1% OF ANY HAZADOUS
8/15/2011 NONE- LESS THAN1% OF ANY HAZADOUS
8/15/2011 NONE- LESS THAN1% OF ANY HAZADOUS
8/22/2011 TRISODIUM PHOSPHATE DODCAHYDRATE
SODIUM AZIDE
3/15/2010 TRISODIUM PHOSPHATE DODCAHYDRATE
5/20/2009 POLYETHYLENE GLYCOL
Copper (II) chloride dihydrate
Page 52 of 66
IRRITANT
IRRITANT
CHEMICAL LIST
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
PCS CALIB
SOLUTIONS
PCS SAMPLE
RANGE
SOLUTIONS
Adhesive Remover
PCS-221
5/20/2009 Aqueous phthalate buffer
Ponceau S (Acid red 112)
Methyl 4-hydroxybenzoate
2-phenoxyethanol
EDTA
N/A
6226-79-5
99-76-3
122-99-6
64-02-8
64742-48-9 FLAMMABLE
64742-89-8 IRRITANT
7027
Isopropyl Alcohol
CAVICIDE
7027
RESEARCH
CAVIWIPES
7027
CORPORATION
4/6/2008
IRRITANT
Petroleum Naptha
METREX
NA
99-76-3
122-99-6
64-02-8
Isoparrafin
CLEANING
Triad
PCS-600
Methyl 4-hydroxybenzoate
2-phenoxyethanol
EDTA
5/20/2009 NONE- LESS THAN1% OF ANY HAZADOUS
7027
7027
CLEANING
4/15/2015
7027-CENTRAL LAB CHEMISTRY
Jul-07
67-63-0
FLAMMABLE
Ethylene glycol monobutyl ether
111-76-2
IRRITANT
7681-52-9
CORROSIVE
64-17-5
FLAMMABLE
BLINDNESS
7027
CLEANING
CLOROX COMPANY
CLOROX
6810
10/1/2000
Sodium Hypochlorite
7027
CLEANING
3M COMPANY
3M AVAGARD
9251
3/27/2009
Ethyl alcohol
7027
FOAM
7027
ANTISEPTIC
7027
7027
water
7732-18-5
NERVOUS SYSTEM
emollients
trade secret
IRRITANT
Dimethicone Surfactant
CLEANING
STERIS
ALCARE PLUS
6399
12/21/2009 Ethyl alcohol
7027
1,1 Difluoroethane
7027
Isobutane
7027
CLEANING
67-63-0
Isoproponal
STERIS
CAL STAT
1181
11/7/2011
Isopropyl Alcohol
DECON LABS
PND CORP
CONTRAD 70
UNI-SAFE
1002
7/18/2014 NONE- LESS THAN1% OF ANY HAZADOUS
2/3/2011 NONE- LESS THAN1% OF ANY HAZADOUS
102783-01-7
64-17-5
FLAMMABLE
75-37-6
IRRITANT
75-28-5
67-63-0
7027
CLEANING
7027 SPILL KITS
7027 CENTAUR
7027 BNP
7027
7027
7027
7027
7027 TG
7027
7027
7027 ATA
7027
FLAMMABLE
IRRITANT
SIEMENS
SIEMENS
SIEMENS
BNP
BNP 1,2,3 QC KIT
2816634
02817045
BNP CALIBRATOR
02817266
ANTI-TG
ANTI-TG CONTROL
ANTI-TG DILUENT
ANTI-TPO
ATPO CONTROL SET
10492398
10630917
128280
10630886
10630936
1/6/2011 NONE- LESS THAN1% OF ANY HAZADOUS
1/3/2013 PHOSPHORIC ACID, MONOSODIUN SALT,MONOHYDRATE
10049-21-5
SODIUM CHLORIDE
7647-14-5
DIPOTASSIUM HYDROGENORTHOPHOSPHATE
7758-11-4
SODIUM AZIDE
26628-22-8
1/3/2013 PHOSPHORIC ACID, MONOSODIUN SALT,MONOHYDRATE
10049-21-5
SODIUM CHLORIDE
7647-14-5
DIPOTASSIUM HYDROGENORTHOPHOSPHATE
7758-11-4
SODIUM AZIDE
26628-22-8
1/7/2011 NONE- LESS THAN1% OF ANY HAZADOUS
1/25/2013 NONE- LESS THAN1% OF ANY HAZADOUS
1/25/2013 NONE- LESS THAN1% OF ANY HAZADOUS
1/25/2013 SODIUM CHLORIDE
7647-14-5
1/25/2013 NONE- LESS THAN1% OF ANY HAZADOUS
Page 53 of 66
IRRITANT
TARGET ORGAN EFFECTS
IRRITANT
TARGET ORGAN EFFECTS
TARGET ORGAN EFFECTS
CHEMICAL LIST
7027
7027 B12
7027
7027
7027 CORTL
7027
7027 CPEP
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
SIEMENS
ATPO DILUENT
125733
VB12
110748
T3/T4/B12 ANC REAGENT 110329
VB12 DILUENT
02531958
CORTISOL
04610049
1/23/2013
9/28/2011
1/21/2013
4/2/2012
1/8/2011
SIEMENS
C-PEPTIDE
12026
1/25/2013
DHEAS
SIEMENS
CPEP CLAIBRATOR
DHEA-SO4
129021
6489701
1/14/2013
1/15/2013
FOL8
SIEMENS
FOLATE
124838
9/28/2011
FOLATE DILUENT
FOL8 RELEASING AGENT
125500
124974
1/23/2013
1/13/2013
128434
129883
128433
10492368
1/25/2013
1/25/2013
1/25/2013
1/25/2013
INTACT PTH1,2,3
IPTH CALIBRATOR
PROGESTERONE
SHBG
SHBG CALIBRATOR
RUBELLA
RUB G QC
TOTAL T3
T3 DILUENT
TOX G
TOX G QC
TOX M
TOX M QC
TESTOSTERONE
10492378
10492387
125362
6520781
04819274
117710
117711
04779671
06998311
120154
120382
120153
120383
125363
1/25/2013
1/25/2013
1/3/2013
1/17/2013
1/14/2013
1/23/2013
1/23/2013
1/14/2013
4/4/2012
1/23/2013
1/23/2013
1/23/2013
1/23/2013
1/15/2013
TOTAL VIT D
VIT D TOTAL QC
VIT D CALIBRATOR
ANTI-HAV TOTAL
10631021
10632229
10630911
05498862
4/12/2012
4/12/2012
1/30/2012
1/15/2013
ANTI-HAV QC
01313752
SIEMENS
INSU
SIEMENS
IPTHD
SIEMENS
PRG
SHBG
SIEMENS
SIEMENS
RUBG
SIEMENS
TT3
SIEMENS
TOXOG
SIEMENS
TOXOM
SIEMENS
TES
SIEMENS
VD25
SIEMENS
HAVAB
SIEMENS
4/15/2015
7027-CENTRAL LAB CHEMISTRY
INSULIN
INSULIN DILUENT
INSULIN CALIBRATOR
IPTH
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
SODIUM HYDROXIDE
1310-73-2
DISODIUM HYDROGENORTHOPHOSPHATE
7558-79-4
SODIUM SALICYLATE
54-21-7
DIPOTASSIUM HYDROGENORTHOPHOSPHATE
7758-11-4
DISODIUM HYDROGENORTHOPHOSPHATE
7558-79-4
SODIUM CHLORIDE
7647-14-5
POLY(OXY-1,2-ETHANEDIYL),ALPHA,-HYDRO-,
9036-19-5
NONE- LESS THAN1% OF ANY HAZADOUS
PHOSPHORIC ACID, MONOSODIUN SALT,MONOHYDRATE
10049-21-5
AMMONIUM SULPHATE
7783-20-2
DISODIUM TETRABORATE DECAHYDRATE
1303-96-4
SODIUM CHLORIDE
7647-14-5
DIPOTASSIUM HYDROGENORTHOPHOSPHATE
7758-11-4
ABSORBIC ACID
50-81-7
PHOSPHORIC ACID, MONOSODIUN SALT,MONOHYDRATE
10049-21-5
DIPOTASSIUM HYDROGENORTHOPHOSPHATE
7758-11-4
1,4 DIMERCAPOBUTANE
27565-41-9
SODIUM HYDROXIDE
1310-73-2
SODIUM CHLORIDE
7647-14-5
POTASSIUM THIOCYANATE
333-20-0
POTASSIUM THIOCYANATE
333-20-0
DISODIUM HYDROGENORTHOPHOSPHATE
7558-79-4
POLY(OXY-1,2-ETHANEDIYL),ALPHA,-HYDRO-,
9036-19-5
SODIUM CHLORIDE
7647-14-5
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
SODIUM CHLORIDE
7647-14-5
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
SODIUM SALICYLATE
54-21-7
ETHANEDIOL
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
SODIUM CHLORIDE
L-CYSTEIN
1/3/2013 NONE- LESS THAN1% OF ANY HAZADOUS
Page 54 of 66
107-21-1
7647-14-5
52-90-4
IRRITANT
TARGET ORGAN EFFECTS
IRRITANT
TARGET ORGAN EFFECTS
TARGET ORGAN EFFECTS
TARGET ORGAN EFFECTS
IRRITANT
TARGET ORGAN EFFECTS
TARGET ORGAN EFFECTS
CORROSIVE
TARGET ORGAN EFFECTS
TARGET ORGAN EFFECTS
TARGET ORGAN EFFECTS
TARGET ORGAN EFFECTS
TARGET ORGAN EFFECTS
TARGET ORGAN EFFECTS
TARGET ORGAN EFFECTS
IRRITANT
TARGET ORGAN EFFECTS
TARGET ORGAN EFFECTS
IRRITANT
CHEMICAL LIST
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
HAVM
SIEMENS
ANTI-HAV IgM
HAVM QC KIT
05004126
05004800
HBSAB
SIEMENS
ANTI-HBS
01463789
AHBCM
SIEMENS
ANTI-HBS QC KIT
ANTI- HBc IgM
'01453546
00504619
HBCT
SIEMENS
ANTI-HBcM QC KIT
HBc TOTAL
00504945
07566733
HBSGB
SIEMENS
HBc TOTAL QC KIT
HBsAg
07569996
003393362
7027
ICA+
HCV
SIEMENS
GENERAL
CENTAUR
REAGENTS
4/15/2015
7027-CENTRAL LAB CHEMISTRY
SIEMENS
HBsAg CONFIRMATORY03393818
HBsAg QC KIT
03394660
ANTI-HCV
03438099
HCV QC KIT
03439141
SOLN CLEANING
112748
ANC PROBE WASH 1
03395373
ANC PROBE WASH 2
02416113
MULTI DIL 1
110313
MULTI DIL 2
110314
MULTI DIL 3
110315
MULTI DIL 10
129880
MULTI DIL 11
111088
CALIBRATOR A
03147078
CALIBRATOR B
00652707
CALIBRATOR C
672182
CALIBRATOR D
07176714
CALIBRATOR E (ECOR) 04634762
CALIBRATOR O
10310392
CALIBRATOR 1
10310424
ACID/BASE REAGENT
112219
CENTAUR WASH 1
3773025
NOVA
1/15/2013 SODIUM CHLORIDE
7647-14-5
1/15/2013 5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
55965-84-9
1/3/2013 DODECAN-1-OL,ETHOXYLATED
9002-92-0
DISODIUM HYDROGENORTHOPHOSPHATE
7558-79-4
1/3/2013 NONE- LESS THAN1% OF ANY HAZADOUS
1/3/2013 GLYCINE, NN-1,2 ETHANEDIYLBIS,SODIUM SALT,HYDRATE
6381-92-6
SODIUM CHLORIDE
7647-14-5
1/3/2013 NONE- LESS THAN1% OF ANY HAZADOUS
1/17/2013 SODIUM CHLORIDE
7647-14-5
POTASSIUM THIOCYANATE
7647-14-5
2-AMINO-2-(HYDROXYMETHYL)PROPANE1185-53-1
1/17/13 NONE- LESS THAN1% OF ANY HAZADOUS
1/14/2013 SODIUM CHLORIDE
7647-14-5
POLY(OXY-1,2-ETHANEDIYL),ALPHA,-HYDRO-,
9036-19-5
1/14/2013 NONE- LESS THAN1% OF ANY HAZADOUS
1/14/2013 NONE- LESS THAN1% OF ANY HAZADOUS
1/14/2013 SODIUM CHLORIDE
7647-14-5
1/14/2013
NONE- LESS THAN1% OF ANY HAZADOUS
1/21/2013 SODIUM HYPOCHLORITE SOLUTION
7681-52-9
1/14/2013 SODIUM HYDROXIDE
1310-73-2
1/3/2013 NONE- LESS THAN1% OF ANY HAZADOUS
1/21/2013 NONE- LESS THAN1% OF ANY HAZADOUS
1/21/2013 NONE- LESS THAN1% OF ANY HAZADOUS
1/21/2013 NONE- LESS THAN1% OF ANY HAZADOUS
4/12/2012 NONE- LESS THAN1% OF ANY HAZADOUS
1/21/2013 NONE- LESS THAN1% OF ANY HAZADOUS
4/2/2012 NONE- LESS THAN1% OF ANY HAZADOUS
1/3/2013 NONE- LESS THAN1% OF ANY HAZADOUS
5/15/12 SODIUM CHLORIDE
7647-14-5
DIPOTASSIUM HYDROGENORTHOPHOSPHATE
7758-11-4
PHOSPHORIC ACID, MONOSODIUN SALT,MONOHYDRATE
10049-21-5
SODIUM AZIDE
26628-22-8
1/17/2013 SODIUM CHLORIDE
7647-14-5
SODIUM AZIDE
26628-22-8
1/14/2013 NONE- LESS THAN1% OF ANY HAZADOUS
1/25/2013 NONE- LESS THAN1% OF ANY HAZADOUS
1/25/2013 NONE- LESS THAN1% OF ANY HAZADOUS
1/23/2013 SODIUM HYDROXIDE
1310-73-2
1/14/2013 NONE- LESS THAN1% OF ANY HAZADOUS
IRRITANT
SENSITIZING MATERIAL
IRRITANT
TARGET ORGAN EFFECTS
IRRITANT
TARGET ORGAN EFFECTS
IRRITANT
TARGET ORGAN EFFECTS
IRRITANT
IRRITANT
TARGET ORGAN EFFECTS
IRRITANT
TARGET ORGAN EFFECTS
IRRITANT
TARGET ORGAN EFFECTS
IRRITANT
TOXIC MATERIAL
TARGET ORGAN EFFECTS
IRRITANT
IRRITANT
CAL SET A
2517
7/1/2011 PROPRIETARY
NA
IRRITANT
7027
CAL SET F
41274
7/1/2011 PROPRIETARY
NA
IRRITANT
7027
CONTROLS MULTIPACK
35644
4/1/2011 PROPRIETARY
NA
IRRITANT
7027
DEPROTEINIZING
7027
SOLN
12704
6/1/2010 SODIUM HYPOCHLORITE
7681-52-9
IRRITANT
Page 55 of 66
CHEMICAL LIST
4/15/2015
7027-CENTRAL LAB CHEMISTRY
7027
SOAKING SOLN
13409
6/1/2010 SODIUM HYPOCHLORITE
7681-52-9
IRRITANT
7027
CCX COOX CAL
41549
6/1/2010 HYPOCHLOROUS ACID
T681-52-9
IRRITANT
7027
CONDITIONING
7027
SOLN
6/1/2008 HYDROCHLORIC ACID
7647-01-0
IRRITANT
7027
7027 CONTROLS
CO-OX CONTROLS
LIQUICHEK SPINAL FLUID
751
NA
IRRITANT
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027
7027 CONTROLS
7027
7027 OSOM
7027
7027
7027
7027
7027
BIO-RAD
LIQUID UNASSAYED
MULTIQUAL
06857
38281
697
IMMUNOASSAY PLUS 362
ETHANOL/AMMONIA 544
URINE CHEMISTRY
397
PEDIATRIC CONTROL 354
IMMUNOLOGY CONTROL
591
URINE TOXICOLOGY 438
SPECIALTY IMMUNOASSAY
359
WB IMMUNOSUPPRESSANT
274
DIABETES
171
CARDIAC MARKERS PLUS
146
TUMOR MARKERS
547
HOMOCYSTEINE
288
THERMO SCIENTIFIC
MAS UA CONTROL
92771
MAS DOA TOTAL
DOA_TOTAL
ADVANCED
OSOM 290 STANDARD 3MA029
INSTRUMENTS
OSOM 50 STANDARD 3MA005
OSOM 850 STANDARD 3MA085
OSOM 1500 STANDARD 3LA151
OSOM 2000 STANDARD 3LA201
LINEARITY SET
3LA028
4/1/2011 PROPRIETARY
8/6/2013
NONE- LESS THAN1% OF ANY HAZADOUS
2/27/2013
NONE- LESS THAN1% OF ANY HAZADOUS
2/27/2013
2/19/2013
12/16/2013
2/20/2014
1/20/2014
2/20/2014
2/27/2013
12/16/2013
2/27/2013
12/13/2014
11/30/2012
4/25/2013
3/11/2008
6/10/2011
4/9/2013
NONE- LESS THAN1% OF ANY HAZADOUS
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
26172-55-4
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
26172-55-4
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
SODIUM CHLORIDE
7647-14-5
2-HYDROXYBIPHENYL SODIUM SALT TETRAHYDRATE132-27-4
Page 56 of 66
IRRITANT
IRRITANT
IRRITANT
7028-RAPID CARE RICHLAND
DEPT TEST NAME
VENDOR
7028
CLEANING
THERMO
7028
7028
CLEANING
STERIS
7028
CLEANING
TEXWIPE CO
7028
CLEANING
THERMO
7028
CLEANING
CLOROX
7028
COMPANY
7028
CLEANING
3M COMPANY
7028
7028
7028
7028
CLEANING
MEDLINE
7028
INDUSTRIES
7028
CLEANING
METREX
7028
RESEARCH
7028
CORPORATION
7028
CLEANING
BAXTER
7028
7028 PIPETTE CALIBARTEL, INC.
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
CBC
SYSMEX
7028
XE2100
7028
7028
7028
7028
7028
7028
CBC
CONTROLS
7028
7028
CBC
SYSMEX
7028
XE2100
7028
CBC
SYSMEX
7028
XE2100
7028
CBC
SYSMEX
7028
XE2100
7028
CBC
SYSMEX
4/15/2015
REAGENT
SOFTCIDE
HAND SOAP
SOFT N SURE
MICRODUSTER
SOFTGUARD
ULTRA CLOROX
PRODUCT #
12-544-09
MSDS
7/14/2005
HAZARDOUS INGREDIANT
P-CHLORO-M-XYLENOL
1119
TX2500
11002-24-001
7286
1/1/2001
4/1/1994
3/27/2008
9/1/2004
3M AVAGARD
FOAM
ANTISEPTIC
9251
3/27/2009
ALCOHOL PREP
PADS
CAVICIDE
CAVIWIPES
51088
2/21/2002
NONE- LESS THAN1% OF ANY HAZADOUS
CHLORODIFLUOMETHANE
NONE- LESS THAN1% OF ANY HAZADOUS
Sodium Hypochlorite
SODIUM HYDROXIDE
Ethyl alcohol
water
emollients
Dimethicone Surfactant
Isopropyl Alcohol
131024
Jul-07
M6015
5/2/2008
67-63-0
64-19-7
25322-68-3 IRRITANT
10125-13-0
99-76-3
122-99-6
64-02-8
5/20/2009 Aqueous phthalate buffer
Ponceau S (Acid red 112)
Methyl 4-hydroxybenzoate
2-phenoxyethanol
EDTA
EXEMPT
NONE- LESS THAN1% OF ANY HAZADOUS
2/23/2010
N/A
6226-79-5
99-76-3
122-99-6
64-02-8
SP BRAND LENS
CLEANER
PCS BLANK
SOLUTION
PCS CALIB
SOLUTIONS
PCS SAMPLE
RANGE
SOLUTIONS
PCS-231
PCS-600
PCS-221
CELLPACK
CELLSHEATH
RET SEARCH (II)DIL
STROMATOLYSER 4DL
STROMATOLYSER FB
STROMATOLYSER NR
SUFOLYSER
e-CHECK XE
SCS-1000
STROMATOLYSER-NR
DYE
STROMATOLYSER-IM
PK-30L
SE-90L
RED-300
FFD-200A
FBA-200A
SNR-200
SLS-220A
201-6001-0
STROMATOLYSER -4DS
DYE
RET-SEARCH (II) DYE
Isoproponal
Ethylene glycol monobutyl ether
ISOPROPANOL
ACETIC ACID
5/20/2009 POLYETHYLENE GLYCOL
Copper (II) chloride dihydrate
Methyl 4-hydroxybenzoate
2-phenoxyethanol
EDTA
5/20/2009 NONE- LESS THAN1% OF ANY HAZADOUS
CAS #
88-04-0
HAZARD
IRRITANT
75-45-6
MAY CAUSE FROSTBITE
7681-52-9
1310-73-2
64-17-5
7732-18-5
trade secret
102783-01-7
67-63-0
CORROSIVE
67-63-0
111-76-2
EXEMPT
NONE- LESS THAN1% OF ANY HAZADOUS
SNR-800
12/31/2010
ETHYLENE GLYCOL
107-21-1
SIM-220A
6/12/2009
SODIUM HYDROXIDE
1310-73-2
FFS-8001
2/22/2011
RED-800
11/12/2010
ETHYLENE GLYCOL
METHANOL
ETHYLENE GLYCOL
107-21-1
67-56-1
107-21-1
Page 57 of 66
FLAMMABLE
NERVOUS SYSTEM
IRRITANT
FLAMMABLE
IRRITANT
FLAMMABLE
IRRITANT
BLINDNESS
FLAMMABLE
IRRITANT
IRRITANT
COMBUSTIBLE
TOXIC
CORROSIVE
IRRITANT
COMBUSTIBLE
TOXIC
COMBUSTIBLE
7028-RAPID CARE RICHLAND
7028
7017
7017
7017
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
CBC
EOSA
SEO
XE2100
PROTOCOL
WRIGHT-GIEMSA
STAIN
264-983
9/10/2012
METHANOL
GLYCERIN
METHYL ALCOHOL
67-56-1
56-81-5
67-56-1
TOXIC
FLAMMABLE
TOXIC
IRRITANT
METHANOL
67-56-1
IRRITANT
FLAMMABLE
TOXIC
FLAMMABLE
IRRITANT
CBC
THERMO
METHANOL
9600-1
9/5/2006
CBC
THERMO
RESOLVE IMMERSION
OIL
HIGH VISCOSITY
LOW VISCOSITY
M5004
2/2/2012
CBC
IMMUCOR
0002327
IO17-10
4/9/2012
6/14/2006
2/19/2009
2/19/2009
1/26/2012
1/26/2012
1/26/2012
3/6/2012
SED
SED
FLD
PFS
ASAPF
P2Y12
TEG
FIB
DDI
AT3
PTINR
PTT
THRO
MO
MALARIA
4/15/2015
BOVINE ALBUMIN
SOLUTION 22%
STRECK
ESR VACUUM TUBES
STRECK
ESR -CHEX
STRECK
CELL-CHEX
SIEMENS
PFA TRIGGER SOLUTION
COLLAGEN/ADP
COLLAGEN/EPI
ACCRIVA
ASPIRIN
PRU
WQC
GREINER BIO-ONE
BLUE TOP
HAEMOSCOPE
HEPARINASE CUPS
KAOLIN
RAPID TEG REAGENT
LEVEL 1/2 CONTROLS
ACTIVATORF A-P1
ARACHIDONIC ACID AA-P3
ADP-P2
FUNCTIONAL FIBRINOGEN
DIAGNOSTICA
STA CaCl2
STAGO
STA CLEANER SOLN
STA COAG CONT N&ABN
STA FIBRINOGEN
STA LIATEST N&P
STA LIATEST D-Di
STA NEOPLASTINE CL
STA OWREN-KOLLER
STA PTT A
STA THROMBIN
STA DESORB U
FISHER SCIENTIFIC SURE-VUE MONO
ALERE
MALARIA RAPID TEST
SF10A1001-1
SF10A1000-7
SF10A1000-7
B4170-50
B4170-21A
B4170-20A
2203033
2203050
2203011
9NC
6212;6005
6300
07-032
8001/8002
07-014
07-014
07-014
07-034
00367
00973
00676
00674
00526
00515
00667
00360
00595
00611
00975
3/7/2011
6/1/2007
6/1/2007
3/27/2007
6/1/2007
6/1/2007
6/1/2007
6/1/2007
6/1/2007
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
12/21/2011
6/7/2010
2303817
665-025
13/3/97
6/1/2012
WHITE MINERAL OIL
POLYPHENYLS
HYDROGENATED TERPHENYLS
POLYBUTENE
TERPHENYLS
BOVINE ALBUMIN
SODIUM AZIDE
SODIUM CITRATE DIHYDRATE
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
CITRIC ACID TRISODIUM DIHYDRATE
HEPARINASE I FROMFLAVOBACTERIUM
KAOLIN-CHINA CLAY
RAPID TEG REAGENT
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
POTASSIUM HYDROXIDE
SODIUM HYPOCHLORIDE
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
Page 58 of 66
8042-47-5
68956-74-1
61788-32-7
9003-29-6
26140-60-3
9048-46-8
26628-22-8
4/3/6132
4/3/6132
NA
NA
NA
NA
1310-58-3
7681-52-9
IRRITANT
IRRITANT
IRRITANT
IRRITANT
TOXIC
TOXIC
CORROSIVE
IRRITANT
7028-RAPID CARE RICHLAND
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
GROUP A
STREP
RAFLU
MALARIA POSITIVE CTL
665-010
10/20/2014 SODIUM AZIDE
SOFIA STREP A FIA
20253
6/12/2013 SODIUM NITRITE
REAGENT SOLUTION
ACETIC ACID
SOFIA INFLUENZA
20218
1/15/2014 NONE- LESS THAN1% OF ANY HAZADOUS
A+B
UNI-TRANS-RT
UT-116
11/13/2013 NONE- LESS THAN1% OF ANY HAZADOUS
SOFIA RSV FIA
20242
8/6/2012 NONE- LESS THAN1% OF ANY HAZADOUS
QUIDEL
QUIDEL
PURITAN
QUIDEL
RSV
UA
FCC
CCSP
UA
IRIS
IRIS
PROCALCITONIN
BIOMERIEUX
IRIS DILUENT
IRIS SYSTEM CLEANER
IQ CALIBRATOR
IRISPEC CA
IRISPEC CB
IRISPEC CC
IQ FOCUS
IQ LAMINA
SG CALIBRATOR LOW
SG CALIBRATOR HIGH
VELOCITY CHEMISTRY STRIPS
IQ NEGATIVE CONTROL
IQ POSITIVE CONTROL
IQ BODY FLUID LYSE
VELOCITY CALCHECK
VELOCITY WASH SOLN
BRAHMS PCT
PROCALCITONIN
AUDIT MICRO
CONTROLS
BHYD
SIGMA-ALDRICH
BHYD
ABBOTT
BHYD
RNA MEDICAL
PCT VALIDATION
SET
PCT LINEARITY SET
B-HYDROXYBUTYRIC
ACID SODIUM SALT
MEDISENSE BRAND
GLUCOSE AND
KETONE CONTROL
Glucose and β-Ketone
Calibration Verification
Control set,
800-3202
800-3203
800-3103
800-0074
800-0074
800-7702
800-3104
800-3102
AX-2480
AX-4280
800-7212
800-3104
800-3104
800-3213
800-7703
800-7704
3045-01
K842M-25
10/5/2011
NONE- LESS THAN1% OF ANY HAZADOUS
10/5/2011
SODIUM HYPOCHLORIDE
10/5/2011
NONE- LESS THAN1% OF ANY HAZADOUS
7/1/2011
NONE- LESS THAN1% OF ANY HAZADOUS
7/1/2011
ACETONE
7/1/2011
NONE- LESS THAN1% OF ANY HAZADOUS
10/5/2011
NONE- LESS THAN1% OF ANY HAZADOUS
10/5/2011
NONE- LESS THAN1% OF ANY HAZADOUS
2/1/2004
NONE- LESS THAN1% OF ANY HAZADOUS
2/1/2004
NONE- LESS THAN1% OF ANY HAZADOUS
11/14/2011
NONE- LESS THAN1% OF ANY HAZADOUS
10/5/2011
NONE- LESS THAN1% OF ANY HAZADOUS
10/5/2011
NONE- LESS THAN1% OF ANY HAZADOUS
11/14/2011
NONE- LESS THAN1% OF ANY HAZADOUS
10/5/2011
NONE- LESS THAN1% OF ANY HAZADOUS
10/29/2009
NONE- LESS THAN1% OF ANY HAZADOUS
4/5/2008 DIETHANOLAMINE
SODIUM AZIDE
3/2/2009 NONE- LESS THAN1% OF ANY HAZADOUS
K841M-5
H6501
3/2/2009 NONE- LESS THAN1% OF ANY HAZADOUS
11/4/2011
NONE- LESS THAN1% OF ANY HAZADOUS
BIOMSDS
59
Acetaminophen SIEMENS
ACTM FLEX
CARTRIDGE
K5088
ALB
ALB FLEX
CARTRIDGE
K1013
SIEMENS
ALB-SENSITIVESIEMENS
s ALB FLEX
10/9/2009
NONE- LESS THAN1% OF ANY HAZADOUS
Jun-11
NONE- LESS THAN1% OF ANY HAZADOUS
DEDM0322 TROMETAMOL
POLYETHYLENE GLYCOL #1540
O-CRESOL
DEDM0292 SODIUM ACETATE
ACETIC ACID
2-CHLORACETAMIDE
MRDV0040 NONE- LESS THAN1% OF ANY HAZADOUS
Page 59 of 66
4/15/2015
26628-22-8 IRRITANT
7632-00-0 TOXIC
64-19-7
CORROSIVE
7681-52-9
CORROSIVE
67-64-1
IRRITANT
111-42-2
IRRITANT
26628-22-8 TARGET ORGAN EFFECTS
77-86-1
25322-68-3
95-48-7
127-09-3
64-19-7
79-07-2
IRRITANT
TOXIC MATERIAL
CORROSIVE
IRRITANT
7028-RAPID CARE RICHLAND
7028 ALP
7028
ALP i
ALP CALIBRATOR
K2115
KC330
7028 ALT
SIEMENS
ALT i
K2143
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
AMMONIA
SIEMENS
AMON FLEX
K3019
AMYLASE
SIEMENS
AMY FLEX
CARTRIDGE
K3017
AST
SIEMENS
AST FLEX
CARTRIDGE
K1021
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
Bilirubin,Direct SIEMENS
Bilirubin,Total
SIEMENS
BUN
SIEMENS
βhCG
SIEMENS
Calcium
Chloride
Cholesterol
CK
CKMB
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
DBIL FLEX
CARTRIDGE
BILI
CALIBRATOR
T/DBIL CALIB
TBIL FLEX
CARTRIDGE
BUN FLEX
CARTRIDGE
K2125
KC210
DEDM0414 NONE- LESS THAN1% OF ANY HAZADOUS
DEDM0125 NONE- LESS THAN1% OF ANY HAZADOUS
POLY,α-HYDRO-w-HYDROXY-ETHANE-1,2DIOL
DEDM0399 ETHOXYLATED
2-AMINO-2-(HYDROXYMETHYL)PROPANE-1,3-DIOL
HYDROCHLORIDE
DEDM0296 GLYCERIN
MANNITOL,DDEDM0297 POTASSIUM THIOCYANATE
SODIUM CHLORIDE
SODIUM AZIDE
DEDM0298 DISODIUM L-ASPARTATE
2-AMINO-2-(HYDROXYMETHYL)PROPANE1,3-DIOL HYDROCHLORIDE
TROMETAMOL
POLYETHYLENE GLYCOL #135
DEDM0329 HYDROGEN CHLORIDE
SODIUM NITRITE
DEDM0073 NEOMYCIN, SULFATE
GENTAMICIN, SULFATE
25322-68-3 IRRITANT
1185-53-1
56-81-5
69-65-8
333-20-0
7647-14-5
22628-22-8
5598-53-8
K1167
K1021
DEDM0301
BHCG FLEX
CARTRIDGE
K6430
DEDM0138
BHCG CALIBRATOR
KC632
DEDM0198
CA FLEX CART.
K1023
CHOL FLEX
CK i
CARTRIDGE
CK CALIBRATOR
K1027
K2038
DEDM0302
SEE V-LYTE
DEDM0248 SODIUM CHLORIDE
DEDM0287 NONE- LESS THAN1% OF ANY HAZADOUS
DEDM0126 SUCROSE
AMMONIUM SULPHATE
DEDM0250 GLYCEROL
POLYETHYLENE GLYCOL #1540
MAGNESIUM DI(ACETATE)
Page 60 of 66
IRRITANT
IRRITANT
IRRITANT
IRRITANT
1185-53-1
77-86-1
25322-68-3
7647-01-0 CARCINOGEN
7632-00-0
1405-10-3
1405-41-0
ACETAMIDE,2,2-DICHLORO-N-(BETA-HYDROXYALPHA-(HYDROXYMETHYL)-P-NITROPHENETHYL),D-(-)-THREO
56-75-7
NONE- LESS THAN1% OF ANY HAZADOUS
SODIUM ACETATE
127-09-3
CAFFEINE
58-08-2
GLYCERIN
56-81-5
MANNITOL,D69-65-8
POLY(OXY-1,2-ETHANEDIYL),ALPHA,-HYDRO-,
OMEGA,-HYDROXY25322-68-3
SODIUM CHLORIDE
7647-14-5
NEOMYCIN, SULFATE
1405-10-3
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
55965-84-9
NEOMYCIN, SULFATE
1405-10-3
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
55965-84-9
SODIUM GLYCINATE
6000-44-8
DEDM0184
DEDM0273
CKMB FLEX
CARTRIDGE
4/15/2015
7647-14-5
SENSITIZING MATERIAL
IRRITANT
IRRITANT
IRRITANT
SENSITIZING MATERIAL
IRRITANT
SENSITIZING MATERIAL
IRRITANT
IRRITANT
57-50-1
IRRITANT
7783-20-2
56-81-5
CARCINOGEN
25322-68-3 IRRITANT
142-72-3
7028-RAPID CARE RICHLAND
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
MASS CKMB
ISOENZYME
CALIBRATOR
MBI FLEX
CARTRIDGE
CO2 FLEX
CARTRIDGE
KC672
SODIUM CHLORIDE
GLYCINE,N,N'-1,2-ETHANEDIYLBIS
ETHANOL
DEDM0340 TROMETAMOL
DEDM0238 NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0141 NONE- LESS THAN1% OF ANY HAZADOUS
K3032
DEMD0288 NONE- LESS THAN1% OF ANY HAZADOUS
K1137
107-21-1
IRRITANT
7791-18-6
26628-22-8
ECREA FLEX
CARTRIDGE
ECREA CALBRATOR
K1270
DEDM0251 ETHANEDIOL
MAGNESIUM CHLORIDE,HEXAHYDRATE
SODIUM AZIDE
DEDM0230 NONE- LESS THAN1% OF ANY HAZADOUS
1405-10-3
CREA FLEX
CARTRIDGE
CRP FLEX CARTRIDGE
hs CRP FLEX
CARTRIDGE
hs CRP CON L
hs CRP CON H
DIG FLEX
CARTRIDGE
K1033
DEDM0056 NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0253 SODIUM HYDROXIDE
K7032
K7046
MRDV0009 SUCROSE
MRDV0008 SUCROSE
57-50-1
57-50-1
KC755
KC757
K4036
DIGXN FLEX
LOCI DIGOXIN
K6435
ETOH FLEX
CARTRIDGE
GENT FLEX
CARTRIDGE
K5022
GGT FLEX
CARTRIDGE
K2045
MRDV0011 NONE- LESS THAN1% OF ANY HAZADOUS
MRDV0012 NONE- LESS THAN1% OF ANY HAZADOUS
DEDM0258 CHROMIN DIOXIDE
ETHANEDIOL
POLYETHYLENE GLYCOL #1540
SODIUM CHLORIDE
STREPTOMYCIN SULPHATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0369 SODIUM CHLORIDE
STREPTOMYCIN SULPHATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0201 TROMETAMOL
SODIUM 4-MORPHOLIN-1-YLETHYLSULPONATE
DEDM0187 SODIUM CHLORIDE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
BORIC ACID
DEDM0264 2-CHLORACETAMIDE
CKMB VERIFIER
MMB FLEX
CARTRIDGE
CO2
SIEMENS
Creatinine
SIEMENS
CRP
DIGOXIN
SIEMENS
SIEMENS
ETOH-Alcohol SIEMENS
GENTAMICIN SIEMENS
GGT
SIEMENS
4/15/2015
K6420
K4012
Page 61 of 66
7647-14-5
10378-23-1
64-17-5
77-86-1
IRRITANT
1405-10-3 SENSITIZING MATERIAL
55965-84-9
SENSITIZING MATERIAL
55965-84-9
1310-73-2 CORROSIVE
SENSITIZING MATERIAL
12018-01-8
107-21-1
IRRITANT
25322-68-3 SENSITIZING MATERIAL
7647-14-5
3810-74-0
55965-84-9
7647-14-5 SENSITIZING MATERIAL
3810-74-0
55965-84-9
77-86-1
IRRITANT
71119-23-8
7647-14-5 IRRITANT
SENSITIZING MATERIAL
55965-84-9
1405-10-3
10043-35-3
79-07-2
IRRITANT
SENSITIZING MATERIAL
7028-RAPID CARE RICHLAND
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
GLUCOSE
SIEMENS
LACTIC ACID SIEMENS
LDH
LIPASE
SIEMENS
SIEMENS
MAGNESIUM SIEMENS
PHENYTOIN
SIEMENS
PHOSPHORUS SIEMENS
Potassium
SIEMENS
SALICYLATE SIEMENS
SODIUM
SIEMENS
TOTAL PROTEIN
SIEMENS
URINARY/CSF SIEMENS
PROTEIN
GLUCOSE FLEX
CARTRIDGE
LA FLEX
CARTRIDGE
LDH FLEX
CARTRIDGE
LDI FLEX
CARTRIDGE
LIPL FLEX
CARTRIDGE
LIP FLEX
CARTRIDGE
MG FLEX
CARTRIDGE
PTN FLEX
CARTRIDGE
K1039
DEDM262
K3016
DEDM0232 GLYCERN
HYDRAZINE, SULFATE
1,3-PROPANEDIOL,2-AMINO-2-HYDROXYMETHYL
AMMONIUM HYDROGEN SULPHATE
POLY(OXY-1,2-ETHANEDIYL),ALPHA,-HYDRO-,
OMEGA,-HYDROXYNEOMYCIN, SULFATE
DEDM0234 1,3-PROPANEDIOL,2-AMINO-2-HYDROXYMETHYL
1,3-PROPANEDIOL,2-AMINO-2-HYDROXYMETHYL
HYDROCHLORIDE
DEDM0328 SODIUM CHLORIDE
K2054
NONE- LESS THAN1% OF ANY HAZADOUS
K3056
DEDM0219 NONE- LESS THAN1% OF ANY HAZADOUS
K3057
DEDM0188 1,3-PROPANEDIOL,2-AMINO-2-HYDROXYMETHYL
1,3-PROPANEDIOL,2-AMINO-2-HYDROXYMETHYL
HYDROCHLORIDE
POLY(OXY-1,2-ETHANEDIYL),ALPHA,-HYDRO-,
OMEGA,-HYDROXYSUCROSE
DEDM0237 SODIUM METABORATE,ANHYDROUS
K4064
PHOS FLEX
CARTRIDGE
DEDM0268 NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0266 SULPHURIC ACID
SODIUM BISULFITE
DISODIUM MOLYDBATE
TP FLEX
CARTRIDGE
K1073
SEE V-LYTE
DEDM0269 IRON (III) NITRATE, NONAHYDRATE
NITRIC ACID
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
SEE V-LYTE
DEDM0277 COPPER SULPHATE
UCFP FLEX
CARTRIDGE
K3026
DEDM0190 METHANOL
UCFP CALIBRATOR
KC260
DEDM0247 NONE- LESS THAN1% OF ANY HAZADOUS
SAL FLEX
CARTRIDGE
K5020
4/15/2015
Page 62 of 66
56-81-5
IRRITANT
13464-80-7 TOXIC MATERIAL
77-86-1
SENSITIZING MATERIAL
7783-20-2
25322-68-3
1405-10-3
77-86-1
IRRITANT
1185-53-1
7647-14-5
TARGET ORGAN EFFECTS
77-86-1
IRRITANT
1185-53-1
TARGET ORGAN EFFECTS
25322-68-3
57-50-1
7775-19-1 IRRITANT
TARGET ORGAN EFFECTS
1405-10-3 IRRITANT
SENSITIZING MATERIAL
55965-84-9
7664-93-9 IRRITANT
7631-90-5 TOXIC MATERIAL
7631-95-0 SENSITIZING MATERIAL
CORROSIVE
CARCINOGEN
TARGET ORGAN EFFECTS
7782-61-8
7697-37-2
1405-10-3
SENSITIZING MATERIAL
CORROSIVE
CARCINOGEN
TARGET ORGAN EFFECTS
55965-84-9
7758-98-7
67-56-1
IRRITANT
TOXIC MATERIAL
TARGET ORGAN EFFECTS
IRRITANT
TOXIC MATERIAL
TARGET ORGAN EFFECTS
7028-RAPID CARE RICHLAND
7028
7028
7028
7028
7028
7028
7028
7028
7027
7027
7027
7027
7027
7027
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
TROPONIN
SIEMENS
CTNI FLEX
CARTRIDGE
CTNI
CALIBRATOR
TSH
SIEMENS
K6421
SIEMENS
VANCOMYCIN SIEMENS
SIEMENS
ELECTROLYTES
DIMENSION
VISTA
SIEMENS
SIEMENS
SYSTEM
REAGENTS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
7647-14-5
1405-10-3
1405-10-3
V-LYTE IMT
CARTRIDGE
V-LYTE
STANDARD A
V-LYTE
STANDARD B
V-LYTE
V-LYTE DILUENT
V-LYTE
DILUENT CHECK
VISTA ENZ 5
CALIBRATOR
VISTA ENZ 6
CALIBRATOR
MULTI 2
SAMPLE DILUENT
K800A
K820
DEMD0115 NONE- LESS THAN1% OF ANY HAZADOUS
K825
DEMD0116 NONE- LESS THAN1% OF ANY HAZADOUS
K835
DEDM0118 NONE- LESS THAN1% OF ANY HAZADOUS
K840
DEDM0220 NONE- LESS THAN1% OF ANY HAZADOUS
NEOMYCIN, SULFATE
DEDM0312 GENTAMICIN, SULFATE
DEDM0350 SUCROSE
CHEM 1
CALIBRATOR
KC110
K6412
TSH SDIL
VALPROIC
ACID
DEDM0256 SODIUM CHLORIDE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0255 NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0084 SODIUM CHLORIDE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0077vsNEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEMD0281 SODIUM CHLORIDE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
DEDM0191 SODIUM CHLORIDE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
BORIC ACID
DEDM0390 NONE- LESS THAN1% OF ANY HAZADOUS
TSH FLEX
CARTRIDGE
KC678
VALP FLEX
CARTRIDGE
VANC FLEX
CARTRIDGE
CHEM 2
CALIBRATOR
CHEM 3
K4078
K4086
KC350
KC360
KD694
KC120
4/15/2015
DEDM0393 5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
DEDM0112 5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
DEDM0246 AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
Page 63 of 66
TARGET ORGAN EFFECTS
SENSITIZING MATERIAL
55965-84-9
55965-84-9 SENSITIZING MATERIAL
7647-14-5 IRRITANT
55965-84-9 TARGET ORGAN EFFECTS
1405-10-3 SENSITIZING MATERIAL
55965-84-9
7647-14-5 IRRITANT
55965-84-9 TARGET ORGAN EFFECTS
1405-10-3 SENSITIZING MATERIAL
7647-14-5 IRRITANT
55965-84-9 TARGET ORGAN EFFECTS
1405-10-3 SENSITIZING MATERIAL
10043-35-3
1405-10-3
1405-41-0
57-50-1
SENSITIZING MATERIAL
TARGET ORGAN EFFECTS
55965-84-9 IRRITANT
1405-10-3 SENSITIZING MATERIAL
55965-84-9 IRRITANT
1405-10-3 SENSITIZING MATERIAL
55965-84-9 IRRITANT
1405-10-3 SENSITIZING MATERIAL
7028-RAPID CARE RICHLAND
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
CALIBRATOR
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
CHEM 4
CALIBRATOR
CUVETTE
WASH SOLUTION
DRUG 1
CALIBRATOR
DRUG 2
CALIBRATOR
DRUG 4
CALIBRATOR
ENZYME 1
CALIBRATOR
ENZYME 2
CALIBRATOR
ENZYME
DILUENT
LOCI 1
CALIBRATOR
4/15/2015
KC130
DEDM0072 AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
ETHANOL
55965-84-9 SENSITIZING MATERIAL
64-17-5
CARCINOGEN
KC140
KS805
IRRITANT
55965-84-9 SENSITIZING MATERIAL
KC410
DEDM0128 NONE- LESS THAN1% OF ANY HAZADOUS
DEDM0120 5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
DEDM0259 NONE- LESS THAN1% OF ANY HAZADOUS
KC420
DEDM0075 GENTAMICIN, SULFATE
1405-41-0
SENSITIZING MATERIAL
KC460
DEDM0152 NONE- LESS THAN1% OF ANY HAZADOUS
KC310
DEDM0123 NONE- LESS THAN1% OF ANY HAZADOUS
KC320
DEDM0124 AMMONIUM SULPHATE
7783-20-2
ED
DEDM0260 SODIUM CHLORIDE
7647-14-5
IRRITANT
TARGET ORGAN EFFECTS
IRRITANT
TARGET ORGAN EFFECTS
KC660
DEDM0109 5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
DEDM0136 5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
DEDM0207 5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
DEDM0286 5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
AND 2-METHYL-2H-ISOTHIAZIOL-3 -ONE
NEOMYCIN, SULFATE
ETHANOL
DEDM0141 NONE- LESS THAN1% OF ANY HAZADOUS
LOCI 4
CALIBRATOR
KC640
LOCI 5
CALIBRATOR
KC600
LOCI 8
CALIBRATOR
KC646
MMB
CALIBRATOR
PROT1
CON H
PROT1
CON L
PROT1
KC672
KC717
KC715
KC706
MRDV0016 SODIUM CHLORIDE
SODIUM AZIDE
MRDV0014 SODIUM CHLORIDE
SODIUM AZIDE
MRDV0015 SODIUM CHLORIDE
Page 64 of 66
55965-84-9 IRRITANT
1405-10-3 SENSITIZING MATERIAL
55965-84-9 IRRITANT
1405-10-3 SENSITIZING MATERIAL
55965-84-9 IRRITANT
1405-10-3 SENSITIZING MATERIAL
55965-84-9 TARGET ORGAN EFFECTS
1405-10-3 SENSITIZING MATERIAL
64-17-5
CARCINOGEN
7647-14-5 TARGET ORGAN EFFECTS
26628-22-8
7647-14-5 TARGET ORGAN EFFECTS
26628-22-8
7647-14-5 TARGET ORGAN EFFECTS
7028-RAPID CARE RICHLAND
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
7028
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SIEMENS
SPILL KITS
FEF
CA+
CONTROLS
PND CORP
ADEZA
NOVA
BIO-RAD
CON M
PROT 2
CALIBRATOR
PROT 2
CON H
PROT 2
CON L
PROT 3
CON
PROT 1
CALIBRATOR
REAGENT
PROBE CLEANER
SAMPLE
PROBE CLEANER
7028
HEMMOCULT BECKMAN COULTER
SODIUM AZIDE
MRDV0020 2-PYRROLIDONE
SODIUM AZIDE
MRDV0021 2-PYRROLIDONE
SODIUM AZIDE
MRDV0022 2-PYRROLIDONE
SODIUM AZIDE
MRDV0019 NONE- LESS THAN1% OF ANY HAZADOUS
26628-22-8
616-45-5
TOXIC MATERIAL
26628-22-8
616-45-5
TOXIC MATERIAL
26628-22-8
616-45-5
TOXIC MATERIAL
26628-22-8
7647-14-5 TARGET ORGAN EFFECTS
26628-22-8
KS806
MRDV0013 SODIUM CHLORIDE
SODIUM AZIDE
DEDM0121 NONE- LESS THAN1% OF ANY HAZADOUS
KS807
DEDM0122 SODIUM HYPOCHLORIDE CL ACTIVE
7681-52-9
CORROSIVE
IRRITANT
TARGET ORGAN EFFECTS
NA
NA
NA
IRRITANT
IRRITANT
IRRITANT
7681-52-9
7681-52-9
T681-52-9
IRRITANT
IRRITANT
IRRITANT
7647-01-0
NA
IRRITANT
IRRITANT
KC780
KC787
KC785
KC775C
KC710C
SYSTEM
KS804
DILUENT
UNI-SAFE
RAPID Ffn
CAL SET A
CAL SET F
CONTROLS MULTIPACK
DEPROTEINIZING
SOLN
SOAKING SOLN
CCX COOX CAL
CONDITIONING
SOLN
06857
CO-OX CONTROLS
LIQUICHEK SPINAL FLUID751
LIQUID UNASSAYED
MULTIQUAL
697
IMMUNOASSAY PLUS
362
ETHANOL/AMMONIA
544
URINE CHEMISTRY
397
PEDIATRIC CONTROL
354
IMMUNOLOGY CONTROL 591
7028
7028
7028
7028
7028
7028
7028
7028 CONTROLS
THERMO SCIENTIFIC MAS UA CONTROL
7028
MAS DOA TOTAL
7028
FCC
SIGMA ALDRICH
HYALURONIDASE
7028
CYTOLOGY
CYTYC
CYTOLYT SOLN
7028
HEMOCULT
7028
SENSA
7028
DEVELOPER
4/15/2015
DEDM0119 NONE- LESS THAN1% OF ANY HAZADOUS
2517
41274
35644
2/3/2011
4/3/2009
7/1/2011
7/1/2011
4/1/2011
12704
13409
41549
6/1/2010 SODIUM HYPOCHLORITE
6/1/2010 SODIUM HYPOCHLORITE
6/1/2010 HYPOCHLOROUS ACID
38281
6/1/2008 HYDROCHLORIC ACID
4/1/2011 PROPRIETARY
8/6/2013
NONE- LESS THAN1% OF ANY HAZADOUS
2/27/2013
2/27/2013
2/19/2013
12/16/2013
2/20/2014
1/20/2014
92771
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
PROPRIETARY
PROPRIETARY
PROPRIETARY
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
NONE- LESS THAN1% OF ANY HAZADOUS
26172-55-4 IRRITANT
3/11/2008 NONE- LESS THAN1% OF ANY HAZADOUS
H3506
85092-001
11/3/2011
7/1/2002
395009
1/30/2003
NONE- LESS THAN1% OF ANY HAZADOUS
METHANOL
HYDROGEN PEROXIDE
ETHANOL-METHANOL MIX
Page 65 of 66
67-56-1
FLAMMABLE
TOXIC
7722-84-1 FLAMMABLE
8013-52-3 IRRITANT
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.008.01 SAFETY DATA SHEETS ONLINE
1.0
PRINCIPLE A safety data sheet (SDS) is a form containing data regarding the properties of
a particular substance. An important component of product stewardship and workplace safety,
it is intended to provide workers and emergency personnel with procedures for handling or
working with that substance in a safe manner, and includes information such as physical data
(melting point, boiling point, flash point, etc.), toxicity, health effects, first aid, reactivity,
storage, disposal, protective equipment, and spill handling procedures. SDS information may
include instructions for the safe use and potential hazards associated with a particular
material or product
2.0
PROCEDURE:
2.1
Laboratory staff may obtain Safety Data Sheets from online
by following these basic steps.
2.2
Accessing the Internet – the internet can be accessed by clicking on the
Internet Explorer icon. This will bring up MyPal screen. Click on
Richland (Baptist, Baptist Parkridge, or Easley) in the blue box.
Scroll down to Services. Choose Global Safety Data Sheet.
Page 51 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.3
SDS Search - To conduct a search simply
2.3.1 Select from the drop down box to Search for:
Product Name, Manufacturer Name, or Manufacturer Part #.
2.3.2 Choose your criteria your want from: contains, equals, or begins
with.
2.3.3 A second drop down box will appear. Choose this drop down box
and select the criteria you desire.
2.3.4 Type in the 3rd box the chemical name.
Page 52 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.3.5
2.3.6
Choose the correct chemical name from the list.
Click the search button.
Page 53 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.4
A list will be displayed based on the search criteria you entered. Select
with the manufacturers’ name that matches your chemical.
Click on the page icon.
Page 54 of 150
the entry
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.5
RESULTS : this will open the SDS image in a new browser window using Adobe
Acrobat® Reader. To return to the Search page simply close this new browser window.
2.6
Printing a Safety Data Sheet - To print a safety data sheet you will need
to click the printer icon in the document.
Initial Author/Date: Fay Parker-Brown
Revised By Author/Date: Fay Parker-Brown, MBA, SM(ASCP) 9/3/09
Barbara Morrison, MA, MT(ASCP) 2/9/10
Mary B. Paoli MT(ASCP)SBB 6/17/14
Page 55 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.009.01 SPILL CLEAN UP PROCEDURE
1.0
2.0
3.0
4.0
PRINCIPLE: Spills have the potential for causing serious hazards. It is important to be
familiar with the spilled material's hazardous characteristics. Some laboratory spills
require outside assistance because of the spill's size or its unusual hazards. Trained
hazardous material spill responders have learned that it is much better to be overly
cautious in responding to a spill than to risk lives for something that "shouldn't be too
dangerous." Do not downplay the seriousness of potentially hazardous spills.
EMERGENCY PREPAREDNESS: To prepare for spills, you should:
2.1
Learn about the hazards of the chemicals, and biological fluids in your
laboratory.
2.2
Know the location of the nearest spill kit.
2.3
Know the components of the spill kit and how they are used.
2.4
Know who to call for help with complex spills.
Hospital Safety Program Manager: Michael P latt 434-3125.
Dial “0” for the hospital operator and ask for the Administrator on Duty.
Laboratory Safety Officer: Mary Paoli 434-2048.
KNOW YOUR HAZARDS
Before using any chemicals, you should evaluate the consequences of potential spills and
develop appropriate response procedures. Consult Material safety data sheets for response
planning. Additionally, communicate potential hazards to other workers in your area. When
planning laboratory work and preparing for potential problems, determine the hazard class of
all the chemicals to be used. The following chemical properties are of most concern when
preparing for possible chemical spills:
3.1
flammability
3.2
reactivity to air or water
3.3
corrosion
3.4
high toxicity
3.5
health hazard
FIRST STEPS WHEN A SPILL OCCURS: Communication and Determination
4.1
Whenever you spill a laboratory chemical or discover a spill or release, tell your
colleagues and laboratory safety officer (or laboratory supervisor/manager/lead
tech) -no matter how small or insignificant the spill or release appears.
4.2
When a spill occurs, you and others should move well away from the area when
determining the appropriate response. There are two types of spills: simple spills,
which you can clean up yourself, and complex spills, which require outside
assistance.
4.2.1 A simple spill is defined as one that does not spread rapidly, does not
endanger people or property except by direct contact, and does not
endanger the environment.
Page 56 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
4.2.2
4.3
4.4
Three basic steps should be taken to determine whether a spill is simple
or complex: (A) evaluating the spill's risks;
(B) evaluating quantities; and
(C) evaluating the spill's potential impact.
4.2.3 The first step in evaluating whether a spill is "simple" is to estimate the
risks created by the spill. In spill response, the key risks of concern are
human health effects, property damage, and environmental damage.
Human Health Effects
4.3.1 Potential health effects is the most important hazard category to consider
when deciding whether or not to attempt a spill cleanup. Some chemical
releases may result in health hazards such as fires or explosions. Other
chemical releases may present health threats because of their ability to
spread rapidly and enter the body readily. A spill is not "simple" if it
presents these risks.
4.3.2 If the potential for fire or explosion exists, seek outside assistance from
trained emergency responders by calling the hospital safety officer.
Releases of flammable chemicals (liquid or solid) can present significant
fire and explosion risks when one or more of the following is present:
volatile vapors, water reactive or air reactive chemicals, ignition sources,
oxidizers, and significant quantities of combustible materials.
4.3.3 Toxic vapors and dust are also hazardous. Avoid direct contact with such
hazards because they spread quickly, are easily absorbed through the
skin, and may damage tissue.
4.3.4 A chemical spill is not a health risk if it has a low toxicity (especially if it
is not volatile or a dust), is not highly corrosive, and is not a strong
oxidizer. Such spills may be considered "simple" only if physical
damage or environmental factors are absent. When a spilled chemical's
toxicity is unknown, treat the spill like a potential human health
hazard by avoiding exposure and seeking outside assistance.
4.3.5 Biological spills may contain hazardous materials but are best cleaned up
by the person working in the area where the spill has occurred. These
spills also require decontamination with an appropriate hospital
disinfectant; Clavicide or a 1:10 bleach solution.
Physical Damage to Property:
The potential for physical damage to property (equipment, building materials,
structures, or cleanup materials) also is important when determining whether you
have a simple spill. Remember-a common first response to a spill is to try to
protect equipment and property, but any real threat to such items will also
threaten the persons cleaning up the spill. Do not attempt to protect property if
there are any human health or fire/explosion hazards present.
4.4.1 In addition to potential fire and explosion hazards, strong corrosives and
oxidizers typically fall under the property damage category. If any
Page 57 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
5.0
6.0
hazards are present that would damage property, treat the spill as
complex and contact the appropriate authorities.
4.5
Environmental Threats: Some laboratory spills have the potential for escaping
into the environment. Spills may release into the atmosphere, discharge into the
sewer system, or leak directly into soils or surface water. While few laboratory
spills present environmental threats, it is necessary to notify the appropriate
authorities if a spill has the potential to cause environmental damage. If you can
do so safely, it may be prudent to take interim measures before the hazardous
materials response team arrives, such as blocking a spreading spill with
absorbents or covering a floor drain with a rubber mat. Though small amounts of
some chemicals pose environmental problems, most environmental risks are
presented by large-quantity releases of materials. A large-quantity release that
threatens the environment is not a simple spill, but requires the attention of
trained responders.
EVALUATE QUANTITIES
The next step to take when determining whether a spill is "simple" is to evaluate the
quantity of material released.
5.1
If a spilled chemical is not hazardous, its cleanup (without the assistance of an
emergency response team) is dependent on the ability to control the spill, as well
as the availability of sufficient spill control materials (e.g., an absorbent for
liquids). Factors that may complicate a cleanup effort (such as the unique
characteristics of a spill's surroundings or the restricted access to a spill) must be
determined on a case-by-case basis.
5.2
If the spilled chemical is hazardous, the threshold quantity for a simple spill
cleanup depends on the spilled chemical's physical properties and hazards. This
quantity depends on situational factors such as the training and experience of
laboratory personnel, the availability of spill control materials, the availability of
personal protective equipment, and the physical layout of the spill location. The
more toxic, corrosive, or flammable a material is, the less likely that the spill can
be defined as "simple". Thresholds for flammable liquids and solids, as well as
volatile toxics, should be relatively low. Spills of reactive chemicals should only
be managed by trained responders (who may be in-house). In general, simple
spill thresholds for liquids will be lower than the thresholds for solids.
Additionally, simple spill thresholds for volatiles will be lower than the
thresholds for non-volatiles.
EVALUATE POTENTIAL IMPACTS: The third step to take when deciding whether a
spill can be managed as a simple spill is to evaluate the potential broader impacts of the spill.
A chemical spill in an area where its potential risks are magnified by specific situations (such
as physical situations or the presence of a large number of people) should not be managed as a
simple spill. For instance, the presence of boxes, chemicals, and other ignition sources would
magnify the impact of a one-gallon release of acetone. Since acetone is highly flammable and
volatile, this situation would be immediately dangerous to both human health and property, and
cleanup should be handled by an emergency responder. Other factors that may magnify a spill's
impact and require emergency response are:
Page 58 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
6.1
6.2
6.3
6.4
6.5
6.6
6.7
6.8
6.9
6.10
7.0
The possibility that hazardous vapors or dusts might enter the building's
ventilation system (and be distributed to other areas).
The possibility that spilled liquids might flow into other areas, thus expanding
the threat of harm (such as reaching ignition sources, exposing other people,
damaging delicate equipment).
The presence of incompatible chemicals.
The proximity of classrooms or offices containing people who could be harmed
by the spill's consequences.
Spills in sinks that might be connected to other sinks through the plumbing
system.
When evaluating potential impacts, a prompt response can minimize adverse
consequences. On the other hand, an inappropriate response can turn a simple
spill into a complex situation.
To determine whether a spill is simple or complex (which is often the hardest
part of spill response), you need to know (1) the hazard(s) posed by the spilled
chemical and (2) the spill's potential impact. Both these factors are, in large part,
determined by the spill's size.
The following information will help you determine whether you have a simple
spill: the type of chemical(s) spilled, the amount, the hazardous characteristics of
the spilled chemical(s), the location, the proper method for c leaning up the spill,
the personal protective equipment available, and the training of the laboratory's
personnel.
If the spill is determined to be a “simple” spill you may clean it up using the spill
kit and continue with your work.
If the spill is “complex” you should call for help.
RECOMMENDED PROCEDURES FOR CLEANING UP SIMPLE SPILLS
7.1
Wear PPE: disposable gown, chemical goggles from spill kit, chemical gloves
from spill kit, disposable foot coverings from spill kit.
7.1.1 Often it is a good idea to wear two sets of gloves: one as the primary
barrier, the second as a thin inner liner in the event the primary barrier
fails. When the cleanup is completed, be sure to wash hands and other
potentially affected skin surfaces.
7.2
Absorb the bulk of the spill using the absorbent mats from the spill kit or the
granular absorbent. Spill sox or pillows may be used to stop the spill from
spreading.
7.2.1 For spills of biological materials; blood, body fluids, culture fluids,
analyzer waste, absorbs the bulk of the spill using the absorbent mats
prior to using disinfectant on the spill.
7.2.1.1 After removing the absorbent material cover the spill area with
disinfectant, allow the appropriate contact time before cleaning up
the disinfectant.
Page 59 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
7.2.2
7.3
7.4
If responding to a broken tube or other specimen container in a
centrifuge, do not open the centrifuge for 30 minutes to avoid any aerosol
or droplet formation.
7.2.2.1 Disinfect the centrifuge chamber before returning it to use.
7.2.3 All absorbent material used on a biological spill must be placed in the
Biohazard Waste for disposal.
If there is broken glass mixed with the spill use caution when absorbing the
spilled material.
7.3.1 Use the dustpan and scoop from the spill kit or other device, not your
hands to pick up broken glass. Make sure any broken glass from a spill
goes into a “sharps” container.
Place all used absorbent material in a separate bag for disposal. Refer to spilled
material’s MSDS for any special disposal requirements.
8.0
RECOMMENDED PROCEDURES FOR CLEANING UP COMPLEX SPILLS
8.1
Evacuate any people from the area, isolate the area and call for assistance.
8.1.1 Call the Hospital Safety Officer or hospital switchboard for the
Administrator On Duty. Be ready to tell them the location, the nature of
the spill and approximate amount of spilled material.
8.2
Establish site security to prevent access while cleanup is in progress.
8.3
Be ready to assist the spill response team as necessary.
9.0
COMPLETE THE SPILL REPORT
After cleaning up a spill, a simple write-up should be prepared to document what happened,
why, what was done, and what was learned. Such documentation can be used to avoid similar
instances in the future. Major incidents are almost always preceded by numerous near misses.
9.1
Complete the spill report.
9.2
The laboratory safety officer will review the completed form and take corrective
action if indicated.
Initial Author/Date: Mary B. Paoli MT(ASCP)SBB 5/1/2012
Revised: Mary B. Paoli MT(ASCP)SBB 3/6/13
Page 60 of 150
Palmetto Health Laboratories
S1.009.0:F1
S1.009.01:F1 SPILL REPORT
DATE/TIME OF SPILL
LABORATORY AREA
SPILL KIT USED
yes
USE PPE FOR ALL SPILL CLEAN UP
TYPE OF SPILL
no
BLOOD/ BODY FLUIDS/OTHER BIOLOGICALS
DESCRIBE
APPROXIMATE AMOUT
BLSL3 AGENT
yes
AREA EVACUATED
yes
BIOAEROSOLS PRESENT
yes
BROKEN GLASS OR SHARPS yes
ABSORB BULK OF SPILL
yes
DISINFECTANT APPLIED
yes
SITE CLEANED
yes
USED MATERIALS IN BIOHAZARD WASTE
yes
no
no
no
no
no
no
no
no
CHEMICAL SPILL
DESCRIBE
APPROXIMATE AMOUT
MSDS FOUND
IS MATERIAL FLAMMABLE?
yes
yes
no
no
yes
yes
yes
WHO NOTIFIED
WHEN
yes
no
no
no
IF YES, REMOVE IGNITION SOURCE
HEALTH HAZARD?
EXPLOSIVE ?
IF YES- EVACUATE AREA
LAB/HOSPITAL SAFETY OFFICER CALLED
ANYONE INJURED?
BRIEF DESCRIPTION
no
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective date: 04.01.2014
S1.010.01 Hazardous Waste Training in the Laboratory
1.0 Principle
Appropriate waste handling procedures at Palmetto Health are based on compliance with
OSHA regulations for protection of personnel who have to handle the waste and with other
federal and state regulations. The lab generated waste is integrated with the overall
hospital plan.
2.0 Definitions
2.1
Hazardous waste- is considered as hazardous if it is listed as a hazardous waste in
the Title 40 Code of Federal Regulations (CFR) Part 261, Subpart D. Or any of
the characteristics listed.
2.2
Ignitable- flammable or spontaneously combustible. Has a flash point of less than 140
degrees Fahrenheit or an alcohol content of 24% or more.
2.3
Corrosive- burns the skin or corrodes metals. Liquids with a pH of 2 or lower or 12.5 or
higher are corrosive.
2.4
Reactive- unstable and may explode or react violently with water or other
materials.
2.5
Toxic- contains heavy metals above specific concentrations, such as lead, mercury,
cadmium or toxic organic chemicals.
3.0
4.0
Identifying hazardous waste
3.1
Review Safety Data Sheet (SDS) with lab safety officer for approval before bringing in
chemicals.
3.2
Review all product labels.
3.3
Compare product and process information to hazardous waste characteristics listed in
the federal regulations.
3.4
Some non-hazardous materials may become hazardous waste due to contaminants
added during use.
Training
4.1
All laboratory staff will be trained on how to handle hazardous waste initially and then
annually with the mandatory training.
4.2
Information to be included in training:
4.2.1 Identifying waste in lab
4.2.2 Data Safety Sheet
4.2.3 Container labeling
4.2.4 Working with chemicals, waste, PPE, disposal
4.2.5 Chemical Hygiene Plan, Laboratory Safety Manual
Page 61 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
5.0
Provisions addressed
5.1
Designation of wastes requiring special handling
5.1.1 Regulated waste
5.1.2 Biohazardous waste
5.1.3 Chemical waste
5.1.4 Hazardous waste
5.2
Waste segregation
5.2.1 Waste will be separated at point of origin into correct containers
5.3
Packaging
5.3.1 Waste is packaged in a manner that protects patients, healthcare workers, waste
management workers, all involved from possible exposures.
5.3.2 The container must hold its integrity though handling, storage, transportation,
and treatment.
5.3.3 Sharps should be discarded immediately into containers that are
5.3.3.1 Closable
5.3.3.2 Puncture resistant
5.3.3.3 Leak proof on sides and bottom
5.3.3.4 Labeled or color coded as a biohazard
5.3.3.5 Easily accessible
5.3.3.6 maintained upright throughout use
5.3.3.7 Replaced routinely and not allowed to overfill
5.3.4 Other regulated waste should be placed in containers that are
5.3.4.1 Closable
5.3.4.2 Constructed to contain all contents and prevent leakage of substances
during handling, storage, transport, or shipping
5.3.4.3 Labeled or color-coded as a biohazard
5.3.4.4 Closed prior to removal to prevent spillage or protrusion of contents
during handling, storage, transport or shipping
5.4
Storage
5.4.1 The lab has temporary holding rooms. The waste is there only for a brief time
until and picked up by a Disposal Company.
5.4.2 The lab staff takes chemicals to be discarded to the Chemical Hygiene/Safety
Officer.
5.4.3 The Safety Officer will notify the contracted disposal company and package the
chemical for pickup.
5.4.4 Tracking invoices are given to the Hospital Safety Officer.
6.0
Typical Hazardous Wastes
6.1
Acids/Bases (corrosive)
6.1.1 Acetic acid
6.1.2 Ammonium hydroxide
6.1.3 Hydrochloric acid
6.1.4 Nitric acid
6.1.5 Oleum
Page 62 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
6.2
6.3
6.4
6.5
6.1.6 Potassium hydroxide
6.1.7 Sodium hydroxide
6.1.8 Sulfuric acid
Reactives
6.2.1 Calcium metal
6.2.2 Dry picric acid
6.2.3 Potassium cyanide
6.2.4 Potassium metal
6.2.5 Sodium sulfide
6.2.6 Stannic chloride
Oxidizers (Ignitables)
6.3.1 Ammonium chromate
6.3.2 Chromium trioxide
6.3.3 Lead chromate
6.3.4 Manganese dioxide
6.3.5 Silver nitrate
6.3.6 Sodium bromate
6.3.7 Sodium chromate
Solvents (Ignitables)
6.4.1 Acetone
6.4.2 Benzene
6.4.3 Ethanol
6.4.4 Ethyl ether
6.4.5 Formaledhyde
6.4.6 Hexane
6.4.7 Isopropanol
6.4.8 Methanol
6.4.9 Methylene ethyl ketone
6.4.10 Pentane
6.4.11 Pyridine
6.4.12 Tetrahydrofuran
6.4.13 Toluene
6.4.14 Xylene
Toxics
6.5.1 Acetaldehyde
6.5.2 Ally alcohol
6.5.3 Barium
6.5.4 Carbon disulfide
6.5.5 Carbon tetrachloride
6.5.6 Chloroform
6.5.7 Chromium
6.5.8 Hydrazine
6.5.9 Lead
6.5.10 Mercury
Page 63 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
7.0
8.0
6.5.11 Naphthalene
6.5.12 Sodium azide
Storage of chemicals
7.1
See Chemical Hygiene Plan S.072. in the Safety manual
7.2
All chemicals should always be labeled
7.3
Store according to class
Procedure for new chemicals
8.1
The SDS sheets are obtained and reviewed by the Lab Safety Officer to see what class it
fits in, any special PPE needed, and disposal.
9.0
Laboratory Waste Streams
Category
Description
Broken Glass
NonSharp Plastic
contaminated
Non-recyclable
Broken glass
glass
Plastic
Serological
pipettes, glass,
light bulbs,
sharps
Empty Chemical Intact, clean
Containers
triple-rinsed
glass and plastic
containers
without caps
Lab Trash
Noncontaminated
Gloves, bench
paper,
packaging, small
boxes, paper
towels, weigh
boats, bottle
caps, plastic
wrappers
Normal house
hold trash
Container
Red puncture
proof containers
Location
All areas of the
lab
Handling
Taken to the lab
waste room for
pickup
Large EVS bins
Storage room
EVS picks up
Standard waste
baskets
In lab areas
EVS picks up
Page 64 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
REGULATED
MEDICAL
WASTE
All Sharps
Biological Waste
Infectious Waste
Infectious Waste
Glass pipettes,
needles,
syringes, scalpel
blades, slides,
coverslips, loops,
picks, used vitek
cards, glass
tubes, etc
Culture plates,
KB plates, Titer
plates, Slants,
identification
plates, stock
cultures
Red puncture
proof containers
Lab
Placed in lab
waste room for
pickup by
contractor
Designated
autoclave bags
Lab
Autoclaved by
techs, placed in
waste boxes
Specimens
including blood,
fluids, urines, etc
Red puncture
proof containers
Pathological
waste, human
blood and blood
products
Red biohazard
bags
Lab
Air cans, sprays
Can must be
completely
emptied
Lab
Place in regular
waste can when
completely
emptied
Buffer solutions,
liquid media,
broths,
neutralized
solutions,
chemicals on the
non-haz list
Container
Lab
Down drain to
sanitary sewer
Placed in lab
waste room for
pickup by
contractor
Placed in lab
waste room for
pickup by
contractor
Aerosol cans
CHEMICAL
WASTE
Non-hazardous
chemical liquids
Page 65 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Hazardous
Chemicals listed Closed original
Lab
Give to Safety
chemical waste
as hazardous
containers
Officer to notify
liquids and solids
contractor
11.
References
11.1 M29-A2 Protection of Laboratory Workers for Occupationally Acquired Infections;
Approved Guideline- 2nd Edition, Vol. 25, No. 10 Clinical and Laboratory Standards
Institute, Wayne, PA.
Initial Date/Author: Fay Parker-Brown, MBA (ASCP) 10/15/10
Revised: Fay Parker-Brown, MBA (ASCP) 11/23/10,
Mary B. Paoli MT(ASCP)SBB 6/17/14, 1/28/15
Page 66 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.011.01 LATEX ALLERGY
1.0
PRINCIPLE
Latex gloves are effective in preventing transmission of many infectious diseases to health care
workers. Through the years, many workers have developed allergic reactions.
2.0
LATEX ALLERGY INFORMATION
2.1
Latex allergy can result from repeated exposures to protein in natural
rubber latex through skin contact or inhalation.
2.2
Reactions usually begin within minutes of exposure to latex.
2.3
Reactions may be minor or severe with skin rashes, inflammation,
respiratory irritation, asthma, and in rare cases shock.
2.4
The amount of exposure needed to sensitize individuals to natural rubber
latex is not known, but reductions in exposure to latex proteins have been
reported to be associated with decreased sensitization and symptoms.
2.5
People at increased risk for developing latex allergy include workers with
ongoing latex exposure, persons with a tendency to have multiple allergic
conditions, and persons with spina bifida.
2.6
Latex allergy is associated with allergies to certain foods such as
avocados, potatoes, bananas, tomatoes, chestnuts, kiwi fruit, and papaya.
3.0
SAFETY PRECAUTIONS
To prevent harm to our employees, patients, and others, the following procedures are in place.
3.1
In our laboratory, latex gloves are not used.
3.2
All gloves purchased are nitrile or vinyl.
3.3
Phlebotomy uses latex free gloves and tourniquets.
3.4
Phlebotomy follows protocol (see policy Latex Allergy Protocol in
Phlebotomy Manual).
3.5
All employees are screened and educated about latex allergies during pre
employment workup.
3.6
Hospital Latex policy implemented.
Page 67 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Listed below are products that have been removed:
DO NOT USE
 Latex gloves
 Syringes with latex

Band-Aids with latex


Latex tourniquets
Latex balloons
ALTERNATIVE FOUND
 Vinyl or nitrile gloves
 BD latex free syringes
 Plastic, silk, paper tape, or
steri-strips
 Latex free tourniquets
 Mylar balloons
Initial Author/Date: Fay Parker-Brown MBA, SM (ASCP) 7/26/05
Revised By Author/Date: Fay Parker-Brown, MBA SM(ASCP) 8/24/09
Page 68 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.012.01 UV LIGHT SAFETY
1.0
PRINCIPLE
Ultra-violet light (UV) is defined as electromagnetic radiation in the spectral region between
180 and 400 nanometers (nm). Immediate or prolonged exposure to UV light can result in
painful eye injury, skin burn, premature skin aging, or skin cancer. Individuals who work with
or in areas where UV sources are used are at risk for UV exposure if the appropriate shielding
and protective equipment are not used.
UV or ultraviolet lamps are used in biological safety cabinets, light boxes, and crosslinkers in
many laboratories and some patient care rooms. One of the problems in working with UV
radiation is that the symptoms of overexposure are not immediately felt so that persons exposed
do not realize the hazard until after the damage is done.
UV radiation is that radiation just outside the visible range, or under 400
nanometers (nm). There are three ranges of UV
MECHANISM –
HIGH
EXPOSURES
UV-A
UV-B
RANGE IN nm
HAZARD
POTENTIAL
DAMAGE
NEAR UV 320-400
MID UV 290-320
LOWEST
MID TO HIGH
UV-C
FAR UV 190-290
HIGEST
CATARACTS
SKIN OR EYE
BURNS
INCREASE RISK
OF SKIN CANCER
SKIN OR EYE
BURNS
INCREASE RISK
OF SKIN CANCER
2.0
HEALTH EFFECTS
2.1
The health effects of exposure to UV light are familiar to anyone who has
had sunburn. However, the UV light levels around some UV equipment
greatly exceed the levels found in nature.
2.2
Acute (short-term) effects include redness or ulceration of the skin.
2.3
At high levels of exposure, these burns can be serious.
2.4
For chronic exposures, there is also a cumulative risk of harm. This risk
depends upon the amount of exposure dur ing your lifetime.
Page 69 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.5
The long-term risk for large cumulative exposure includes premature
aging of the skin and even skin cancer.
2.6
UV exposure is not immediately felt, the user may not realize a hazard
until after the damage is done.
2.7
The eyes are also susceptible to UV damage. Like the skin, the covering of
the eye or the cornea, is epithelial tissue, too.
2.8
The danger to the eye is enhanced by the fact that light can enter from all
angles around the eye and not only in the direction you are looking.
2.9
The lens can also be damaged, but since the cornea acts as a filter, the
chances are reduced.
2.10 This should not lessen the concern over lens damage however, because
cataracts are the direct result of lens damage.
2.11 Burns to the eyes are usually more painful and serious than a burn to the
skin. Make sure your eye protection is appropriate for this work. There are
specially-made safety glasses for the different UV ranges.
2.12 NORMAL EYEGLASSES OR CONTACTS OFFER VERY LIMITED
PROTECTION!!
2.13 You must not forget to protect the rest of your face. Severe skin burns can
happen in a very short time, especially under your chin (where most
people forget to cover).
2.14 Full-face shields are really the only appropriate protection when working
with UV light boxes for more than a few seconds.
2.15 Be sure to protect your arms and hands by wearing a long-sleeve lab coat
and gloves.
3.0
FIRST AID
3.1
The symptoms of UV overexposure to the skin are well known and
characteristically called sunburn. However, the symptoms of overexposure to the eyes
are not widely known. Such as:
3.1.1 a burning and painful sensation in the eye
3.1.2 a sensitivity to light
3.1.3 the sensation of a foreign object in the eye, sometimes described as
sand in the eye tearing
3.2
These symptoms usually develop several hours after the overexposure
occurred.
3.3
If an eye or skin injury is suspected, the individual should be examined by
a physician.
4.0
EQUIPMENT USES
4.1
Germicidal lamps emit radiation almost exclusively in the far-UV range of
254 nm, and are commonly used in Laminar Air Flow hoods or biological
safety cabinets and should be treated with extreme caution.
4.1.1 DO NOT expose yourself to these lights!
Page 70 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
4.2
4.3
The UV light box is another source in use in some laboratories. This
instrument is literally a box with a glass top and a UV lamp inside. Some
units have multiple lamps that allow a choice of wavelength.
Most of these instruments are stationary, but there are a few hand held
types that carry the same hazards as the stationary models.
5.0
SAFETY MEASURES
The UV lamp should never be left on when the hood is open. Even a small opening at the
bottom of the cabinet can exceed occupational exposure standards several feet away.
6.0
REFERENCES:
6.1
University of Washington, Environmental Health and Safety,201 Hall
Health Center, MS 354400,Seattle, Washington 98195-4400
6.2
Princeton University Health and Safety Guide
Initial Author/Date: Mary Sue Sawyer 8/7/03
Revised By Author/Date: Fay Parker-Brown, 8/24/09
Page 71 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.013.01 GLASSWARE SAFETY
1.0
PRINCIPLE
Glass breakage is the most common cause of injury producing accidents in the
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1.9
1.10
Use only glassware that is in good condition.
Discard pieces with chips or cracks.
When using glass tubing, fire polish all ends.
Lubricate tubing with glycerin or water before inserting into rubber
stoppers or rubber tubing.
Protect hands with gloves or towel when inserting the glass tubing.
Hold both elbows close to the body to limit movement.
Heavy glass articles must not be stored on high shelves.
Whenever practical. Polyethylene bottles should be used instead of glass.
Broken glassware must not be picked up directly with the hands. It must
be cleaned up using mechanical means, such as a brush and dust pan, a
vacuum cleaner, tongs, cotton swabs, or forceps.
All broken glassware should be disposed in separate puncture-resistant
containers, sharps containers.
Initial Author/Date: Mary Sue Sawyer, MBA, MT(ASCP) before 1998
Revised By Author/Date: Fay Parker-Brown MBA SM(ASCP) 7/25/05, 7/27/06, 8/24/09
Page 72 of 150
laboratories.
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.014.01 CENTRIFUGE SAFETY
1.0
PURPOSE AND/OR PRINCIPLE
Centrifuges are to be handled with care and operated properly to prevent accidents.
2.0
IMPORTANT TIPS:
2.1
All centrifuges should have lockable lids which should not be opened
when the rotor is moving.
2.2
In normal use, when there is no tube breakage, airborne particles may be
generated during centrifugation.
2.3
Tubes should be properly capped and sealed before insertion into the
centrifuge.
2.4
If an unusual condition (such as noise or vibration) occurs, the centrifuge
should be stopped immediately.
2.4.1 The operator should check to be sure that heads are symmetrically
loaded, tube caps are correctly seated and swinging buckets are
symmetrically placed.
2.4.2 Particular attention should be given to verify that swing-out cups
are supported correctly.
2.5
Keep hair, beard, ties, hair ribbons or other dangling items out of the way.
2.6
Do not centrifuge uncovered tubes or specimens or flammable chemicals.
2.7
Centrifugation creates a vacuum and causes liquids to volatilize. This
makes contaminated specimens become aerosols and flammable liquids to
become potential bombs. Use caps or parafilm.
2.8
The maximum speed rating for the rotor must not be exceeded.
2.9
Plastic tubes used in ultra-centrifuges are subject to great pressure which
sometimes causes them to break. Such tubes should not be used.
2.10 A tube to be used in angle-head centrifuges must never be filled to the
point that liquid is in contact with the lip of the tube when it is placed in
the rotor. High G forces will drive the liquid past the cap seal and over the
outside of the tube.
2.11 All cultures of specimens with infectious agents or specimens with
infectious agents (i.e. AFB) should be centrifuged within sealed centrifuge
tubes.
3.0
POST BREAKAGE PROCEDURES:
3.1
If a tube breaks in the centrifuge, the operator should put on the
appropriate personal protective equipment, open the lid and remove
broken pieces using a hemostat or other appropriate device.
Page 73 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
3.2
3.3
3.4
4.0
All remaining intact tubes removed from the unit should be considered
contaminated and should be decontaminated accordingly.
The centrifuge is thoroughly cleaned before using again.
All debris should be carefully removed from carriers and bowl.
REFERENCES
4.1
Approved Guideline. NCCLS, M29-A, Dec. 1997.
Initial Author/Date: Mary Sue Sawyer 9/4/01
Revised By Author/Date: Fay Parker-Brown 8/27/04, 5/31/05, 7/27/06, 8/24/09
Page 74 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective date: 04.01.2015
S1.015.01 Glove Safety
1.0
Purpose
OSHA requires Palmetto Health Laboratory to provide all employees with gloves.
2.0
Key Points for Proper Glove Safety:
2.1
Examine them for defects before work.
2.2
They should never be washed or reused.
2.3
Change them when a task is completed or becomes soiled, tear, or has
perforations.
2.4
Always wash hands after removing gloves
2.5
Remove gloves before leaving the lab.
3.0
Proper technique for removing gloves:
3.1 Keep in mind that the outside of your glove is contaminated and the inside is clean.
Throughout the procedure, contaminated should touch only contaminated areas and noncontaminated touch only non-contaminated areas.
3.2 Grasp the palm of your right glove with your left hand. (It doesn’t matter which glove is
removed first; consistency is the key. If you reverse the hands in one step, be sure to reverse
them in all.)
3.3 Slowly pull off the right glove, inside out.
3.4 Wash hands.
Revised: Mary B. Paoli MT(ASCP)SBB 06.13.2014
Page 75 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.016.01 ELECTRICAL SAFETY
1.0
PURPOSE AND/OR PRINCIPLE
Clinical and Pathology laboratories are the source of many potential electrical hazards present
in the laboratory. For this reason, it is imperative to become familiar with the following
general guidelines in the use and handling of electrical equipment. Specific instructions for
handling electrical hazards in each lab are found under safety procedures for that section.
Significant physical harm or death may result from its misuse. With direct current, a person
can detect a “tingling” feeling at 1mA and the median “let-go” threshold (the current at which
one cannot release the conductor) is 76mA. For 60 Hertz alternating current, the values are
0.4mA and 16mA, respectively. Women are more sensitive to the effects of electrical current;
approximately 2/3 of the current is needed to produce the same effect. Higher currents produce
respiratory inhibition, then ventricular fibrillation, and ultimately cardiac arrest.
2.0
REFRIGERATORS:
2.1
If they are used for the storage of organic solve nts should be explosion
proof (safe). All electrical parts are located outside the storage area
to prevent sparks from igniting any fumes that might form as a result of
the storage of these materials.
2.2
All other refrigerators shall have signs posted on the front door stating that
they are NOT SUITABLE FOR THE STORAGE OF FLAMMABLE
MATERIALS.
3.0
HOTPLATES:
3.1
Hot plates used in the evaporation of organic solvents should be
explosion-proof with a remote control located outs ide the hood. This
prevents sparks from reacting with vapors.
4.0
PRE-USAGE TESTING:
4.1
All new equipment shall be checked for electrical safety before being put
into use and after repair or modification to ensure proper functioning of
electrical components.
4.2
If any repairs need to be made, they shall be done only by qualified
personnel.
5.0
INSPECTION:
5.1
Turn off the power to equipment before inspecting it. Turn off circuit breakers or
unplug the equipment.
5.2
All electrical outlets in all areas of the labs and the morgue, will be tested once a year for
proper grounding and frayed, split or worn wiring by Clinical Engineering.
Page 76 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
5.3
5.4
Replace all frayed, split, or worn wiring BEFORE using equipment.
The results will be recorded and kept on file for two years by the Engineering or the
Lab Safety Officer.
6.0
REPAIRS:
6.1
All equipment shall be unplugged before attempting any repairs.
6.2
Unplug by pulling the plug not the cord.
6.3
Remember that parts such as batteries, condensers and capacitors store
electricity and pose a hazard even with the piece of equipment unplugged.
6.4
Read instructions carefully before attempting any repair.
6.5
DO NOT attempt to make any electrical repairs.
6.6
This should be performed by clinical engineering or a qualified
serviceman.
6.7
A record will be kept of all instrument repairs by the department.
7.0
CLEANING:
7.1
Unplug instrument before any cleaning.
7.2
Do not use alcohol to clean any electrical equipment. Alcohol could cause
damage to the insulation varnish or other insulating material
and affect the electrical value of the component. Other organic solvents
also damage the instrument and the finish of the instrument cabinet.
8.0
SPILLS:
8.1
Avoid spills on electrical equipment.
8.2
If a spill does occur:
8.2.1 Turn the instrument off and unplug immediately.
8.2.2 Dry and leave unplugged until thoroughly dry.
8.2.3 Tag the instrument so that others will know the kind of hazard
involved and tell all other personnel about the spill and the
possible length of time the instrument will be out of use.
8.3
DO NOT handle electrical equipment with wet hands or when standing in
or near water.
8.4
DO NOT place hands on metal sink or any other grounded metal when
working with electrical equipment. A shortage could result in a serious
injury or electrocution.
9.0
FUSES:
9.1
ALWAYS turn the equipment off and disconnect before inserting a fuse.
9.2
It is dangerous to place a fuse in a live circuit.
9.3
Replace a fuse with the same type and size as the one being removed.
9.4
If an instrument repeatedly blows a fuse, determine the cause. Have
Clinical Engineering or the Service Representative check to see if there is
a short circuit or overload.
Page 77 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
10.0
SHOCKS:
10.1
Any shock (no matter how minute) from any laboratory equipment is a
warning of a potentially hazardous condition.
10.2 The equipment should be disconnected at once and the cause of the
situation should be found and remedied before the equipment is used
again.
11.0
EXTENSION CORDS: Extension cords are not allowed in the Lab.
12.0
CIRCUITS AND OUTLET BOXES:
12.1 UL approved outlet strips or distribution boxes which are fuses or
equipped with a circuit breaker are to be used if there is a need for more
outlets. DO NOT use multiple outlet adapters!!!
12.2 Electrical Engineering is to install any strips.
12.3 Lab employees should know the location of circuit boxes and know which
circuit breaker controls the electrical power supply to the equipment in
their department.
12.4 Circuit breakers will be identified and listed in each section to enable
laboratory personnel to identify which breaker might be involved in an
electrical equipment accident.
13.0
ELECTRICAL GROUNDING:
13.1 For individual safety, all electrical equipment shall be properly grounded
from exposed metal parts by using a three prong plug and receptacle.
14.0
PROCEDURE FOR HANDLING OF ELECTRICAL ACCIDENTS:
14.1 Electrical Injuries:
14.1.1 DO NOT TOUCH a person “frozen” to any electrical instrument or
line until the source of electricity is disconnected.
14.1.2 Call a physician immediately.
14.2
15.0
Electrical Burns:
14.2.1 Immediately disconnect or isolate the source of current.
14.2.2 Refer the employee to Employee Health or the Emergency Room
as the situation dictates.
STORAGE WARNING
15.1 Do not use or store highly flammable solvents near electrical equipment.
Initial Author/Date: Mary Sue Sawyer
Revised By Author/Date: Fay Parker-Brown 4/12/93, 9/4/01, 7/22/05, 11/6/08
8/24/09, 8/3/10, Mary B. Paoli 6/12/14, 08.08.2014
Page 78 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date : 04.01.2015
S1.017.01 Back Safety
1.0
Purpose
Preventing a back injury is easier than repairing one.
2.0
Ways of Preventing Back Injury:
2.1 Exercise to strengthen your back and reduce stress.
2.2 Lose excess weight.
2.3 Maintain good posture.
3.0 Lifting Correctly:
3.1
Think about the weight of the object you will be moving and the distance you will be
moving it. Be sure there is enough space for movement.
3.2
Position yourself in front of the load.
3.3
Your feet should straddle the load, shoulder width
apart.
3.4
One foot slightly in front of the other for balance.
3.5
Slowly squat down by bending your knees – not your
back and stomach.
3.6
Using both hands, firmly grab the load and bring it as
close to your body as you can. This will help distribute the weight of the load over your
feet and make the move easier.
3.7
Once the load is close to the body, slowly straighten out your legs until you are standing
upright.
3.8 Then, proceed to your destination.
Page 79 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
3.12
3.9
By reversing the lift, you can reduce the strain on your back and stomach muscles.
Squat down by bending your knees and position the load out in front of you. Maintain
contact until you are sure the load is secure.
3.10
If the load is too heavy, bulky, or awkward for you to lift alone, be sure to get help.
3.11
When possible, use mechanical equipment to move heavy items.
Quick Review Tips
1. Bend to lift an object – don’t stoop.
2. Keep your back straight by tucking in your chin.
3. Lift with the strong leg muscles, not the weaker back muscles.
Initial Author/Date: Fay Parker-Brown 02.10.2010,
Revised By: Mary B. Paoli 6/12/14, 08.08.2014
Page 80 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.018.01 COMPRESSED GASES: STORAGE AND HANDLING
1.0
PRINCIPLE
Users of compressed gases must be familiar with the pertinent equipment and the characteristics
of the gases. Compressed gases constitute several hazards both mechanical and physical. All
cylinders must be stored and handled properly to safeguard employees, visitors and patients. If
the cylinder valve is accidentally broken, a standard 330 cubic foot cylinder at approximately
2600 psi becomes a rocket attaining speeds of several miles per hour.
The contents of the cylinder may represent additional hazards due to flammability, reactivity,
toxicity or asphyxiation. Exposure to corrosive gases such as chlorine, ammonia, and nitrogen
dioxide can do irreparable damage to the lungs. Cryogenic gases such as liquid nitrogen can
cause tissue damage from extreme cold.
2.0
GENERAL STANDARDS:
Cylinders of compressed gas must be secured in racks, on approved transport carts or chained
to the wall, in an upright position at all times, so they cannot fall. Major explosions can occur
if cylinder falls.
2.1
Valve safety covers shall be left on until pressure regulators or needle
valves are ready to be attached.
2.2
Containers must be marked clearly with the name of the contents. Color
codes alone or tags hung around the necks of the cylinders are not
acceptable. Cylinders lacking proper identification must not be accepted
from the vendors.
2.3
Insure the protective cap is in place and securely strap the cylinder to the hand trucks or
dollies must be used in moving cylinders.
2.4
Never roll or drag cylinders!
2.5
Do not attempt to repair cylinders or cylinder valves or to force stuck or
frozen cylinder valves.
2.6
The use of oil, grease or lubricants on valves, regulators, or fittings is
prohibited. These substances may be reactive with some gases such as
oxygen. Regulators used with oxidizing agents must be carefully cleaned
to avoid the possibility of explosion due to contact of the gas with any reducing agent or
oil.
2.7
Cylinders should never be dropped or permitted to strike each other
violently.
2.8
A small amount of gas must be left in the cylinders and the cylinder valves
must be closed to prevent contamination of the inside of the cylinders.
Page 81 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.9
2.10
2.11
2.12
2.13
2.14
2.15
2.16
2.17
2.18
Any gas cylinder with a broken valve head becomes a missile capable of
penetrating walls.
Cylinders must not be stored with or near flammable materials.
Piped lines should be thoroughly checked for leaks before use and
periodically, to verify safe operating conditions.
Cylinders should be kept out of high traffic areas.
Storage areas used for cylinders should be well ventilated, cool and dry.
Do not expose cylinders to an open flame or to any temperature above 125°F.
Attach the regulator securely before opening the valve. Open cylinder valves slowly. Do
not use a wrench to open or close a wheel type valve. If it cannot be operated by hand, it
should be repaired by the vendor or qualified individuals. Spring loaded pressure relief
regulators should be used.
Never leave cylinder valves open when not in use. Segregate empty cylinders from full.
When the cylinder is no longer in use, shut off the valves, relieve the pressure in the gas
regulators, remove the regulator and cap the cylinder.
Cylinders should never be emptied to a pressure lower than 25 psi because the residual
contents may be contaminated with air if the valve is left open.
If a cylinder leaks and the leak cannot be stopped by tightening a valve gland or packing
nut, close the leaking valve, replace the valve cap and move the cylinder to a well
ventilated area. Tag the cylinder as dangerous, rope the area off and notify a supervisor
and engineering.
3.0
FLAMMABLE COMPRESSED GASES:
Because of the fire and explosive hazards that can result when these products are used in confined
spaces, special care must be used.
3.1
No more than two cylinders should be manifold together. However, several
instruments or outlets may be operated from a single cylinder.
3.2
Stand-by cylinders (full or empty) must not be stored in the laboratory.
3.3
Cylinder size is limited to 200 cubic feet.
3.4
Piping must be compatible with the gas, e.g., no copper for acetylene, no
plastic tubing in any high pressure portion of a system, etc.
3.5
Flammable gases should never be stored with oxygen or other gases
supporting combustion.
4.0
PRESSURE REGULATORS AND NEEDLE VALVES:
4.1
Needle valves and regulators are designed specifically for different families
of gases.
4.2
USE ONLY THE PROPERLY DESIGNED FITTINGS.
4.3
Threads and surfaces must be clean and tightly fitted. Do not lubricate.
4.4
Tighten regulators and valves firmly with the proper size wrench. (Do not
use adjustable wrenches or pliers. They damage the nuts.) Do not force
tight fits.
4.5
Open valves slowly to prevent rupturing the diaphragm in the regulator.
Do not force valves that "stick".
Page 82 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
4.6
4.7
4.8
4.9
Check for leaks at connections. Leaks are usually due to damaged faces at
connections or improper fittings. Do not attempt to force an improper fit.
It may only damage a previously undamaged connection and compound the
problem.
Valve handles must be left attached to the cylinders.
The maximum rate of flow should be set by the high pressure valve on the
cylinder. Fine tuning of flow should be regulated by the needle valve.
Shut off cylinders when not in use.
5.0
LEAK TESTING:
5.1
Cylinders should be tested by "snoop" or a soap solution.
5.2
Test the cylinders first, before regulators are attached.
5.3
Test again after the regulators or gauges are attached.
6.0
EMPTY CYLINDERS:
6.1
Must be marked empty and remain in an upright position.
6.2
Empty or unused cylinders must be returned properly.
6.3
Replace valve safety caps.
Initial Author/Date: Mary Sue Sawyer before 1998
Revised By Author/Date: Fay Parker-Brown 1/12/01, 5/14/03, 8/12/06, 9/20/07, 8/24/09, 7/6/10
Page 83 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Gas Cylinders
Fasten cylinders securely.
Protect cylinder valve with cap.
Transport cylinders on hand truck- don’t roll.
DO NOT drop cylinders, can cause an explosion.
Mark cylinders when empty.
Page 84 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.019.01 NOISE MONITORING
3.0
Policy Statement / Purpose
Palmetto Health Laboratories will monitor noise levels and protect employees from
excessive noise levels in the workplace.
2.0
Guidelines / Topics
2.1
Work related hearing loss
2.1.1 Hearing loss is a critical workplace safety and health issue.
2.1.2 Noise induced hearing loss is 100 percent preventable.
2.1.3 Once acquired, hearing loss is permanent and irreversible.
2.1.4 Prevention measures must be taken by employers and
workers to ensure the workers’ hearing.
2.2
When information indicates that any employee’s exposure may equal or
exceed an 8-hour time-weighted average of 85 decibels, the employer
shall develop and implement a monitoring program.
2.2.1 All laboratory employees will be protected against the detrimental
effects of excessive noise exposure.
2.2.2 Removing hazardous noise from the workplace through
engineering controls is the most effective way to prevent noiseinduced hearing loss.
2.2.3 Hearing protectors such as ear plugs and ear muffs should be used
when it is not feasible to otherwise reduce noise to a safe level.
2.2.4 OSHA provides a table for noise levels. When employees are
subjected to sound exceeding those listed in the Table G-16
feasible administrative or engineering controls shall be utilized.
TABLE G-16 – PERMISSIBLE NOISE EXPOSURES
DURATION PER DAY, HOURS
8………………………………..
6………………………………..
4………………………………..
3………………………………..
2………………………………..
1 ½……………………………..
1………………………………..
½……………………………….
¼ or less……………………….
SOUND LEVEL dBA SLOW
RESPONSE
90
92
95
97
100
102
105
110
115
Page 85 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.3
2.4
2.5
2.7
Responsibilities of Supervisor
2.3.1 Maintain an awareness of the approximate noise levels in work places for which
he/she is responsible.
2.3.2 Request a survey/ monitoring from the lab safety officer when a change in
equipment or procedure may increase employee exposure to noise.
Responsibilities of Employee
2.4.1 Complies with the recommendations of the Lab Safety Officer and
Administration for controlling noise exposure.
2.4.2 Makes proper use of the hearing protection devices provided by Lab
Administration.
2.4.3 Reports any suspected change in noise levels of equipment to Lab
Administration.
2.4.4. Participates in audiometric testing or other hearing conversation programs as
required by the lab policy.
Responsibilities of Lab Safety Officer and or Administration
2.5.1 Performs noise surveys when appropriate.
2.5.1.1 The Lab Safety Officer will screen for excessive noise on an annual
basis, when laboratory instrumentation changes, or on request from
employees, section managers or supervisors.
2.5.1.2 The noise screen will consist of using the noise meter on MIN/MAX
mode for a period of 15 minutes.
2.5.1.3 If the Max level exceeds 85 dBA a continuous monitoring will be set up.
2.5.1.4 The Noise Continuous Monitor will record the noise level each minute
and average noise will be documented for each 8 hour shift.
2.5.1.5 If the average noise in an eight hour shift exceeds 85dBA, employees
working in that area will be notified and hearing protection provided
until the problem can be corrected.
2.5.2 Places warning signs in areas where sound levels exceed those in
table G-16 from the OHSA regulations.
2.5.3 Approves and issues all hearing protection devices used by lab
employees.
2.5.3.1 Provides instruction on the proper use, care and
maintenance of these devices.
2.5.4 Consults Facilities and Engineering departments for engineering
methods for controlling noise levels when such measures are
considered feasible.
2.5.5 Makes arrangements for audiometric tests as required by OSHA
regulations and lab policy.
Each employee will be informed of monitoring results when exposed at or above the
action level.
Page 86 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.7.3
2.7.4
2.7.5
2.7.6
Audiometric testing- Audiometric testing shall be made available
to all employees who have 8-hour time weighted average exposure
levels of 85dBA or higher.
2.7.3.1 Follow-up will be done and compared to the baseline
annually.
Training shall be provided at least annually to those that have been
exposed to time weighted averages of 85dBA and above.
Noise exposure measurement records shall be kept for two years
Audiometric test results for the duration of a worker’s
employment.
3.0
References
3.1
NIOSH, Work-Related Hearing Loss, DHHS Publication No. 2001-103
3.2
OSHA, Regulations (Standards – 29 CFR), Occupational noise
exposure. – 1910.95.
3.3
U. S. Department of Labor, Occupational Safety & Health Administration:
http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=9735&p_table
4.0
Initial Author/Date: Karen W. Sullivan MT(ASCP)10.01.2014
Revised By Mary B. Paoli BS,MT(ASCP)SBB, 01.15.2015
Page 87 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.020.01 EYE AND FACE PROTECTION
1.0
Policy Statement/ Purpose
Facial barrier protection should be used if there is a reasonably anticipated potential for
splattering or splashing blood or body substances or any liquid suspected of containing
infectious agents. A plastic face shield provides the best facial protection as it covers the eyes
and mucous membranes of the nose and mouth. Splashguards (stationary shields) are an
acceptable alternative to the plastic face shield. In situations where there is an anticipation of
aerosol production the work should be performed in a certified Biological Safety Cabinet
(BSC). Ordinary prescription glasses and contact lenses are not adequate eye protection for
preventing exposure to splashes. All employees are required to wear face shields if it has been
determined that there is a reasonably anticipated potential for splattering or splashing by risk
analysis performed by their supervisor.
Chemical splashes to the eyes and face are best avoided by handling all hazardous
chemical in a certified chemical fume hood. Face shields do not protect from chemical fumes
and some chemicals may react or interact with contact lenses.
If an employee has a chemical or biological splash to the eyes they must use the laboratory
eyewash. Eye Wash stations are located in every area. Eyewash has a dual wide angle spray
head that delivers a soft steady flow of water to the eyes. Eyes should be washed for a
minimum of 15 minutes.
2.0
Responsibilities
2.1
Laboratory Director
2.1.1 Provide all employees PPE including plastic face shields.
2.1.2 Maintain certification of all BSCs and chemical fume hoods.
2.2
Department Supervisors and Managers
2.2.1 Maintain a list of their employees who wear contact lenses at work.
If a contact lens wearing employee has a splash or chemical
exposure to the eyes they may need addition medical aid to remove
the contact lens.
2.2.2 Ensure that the eyewash stations in their departments are tested
weekly and are maintained in proper working order.
2.2.3 Ensure all employees have the appropriate PPE available and it is
used according to the department risk assessment.
2.3
Laboratory Safety Officer
2.3.1 Review all accidental splashes to the eyes and faces of employees
for root cause and preventative measures that may be needed.
2.3.2 Review department risk assessments to determine if employees
are adequately protected from splashes to the eyes and face.
Page 88 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.4
Employees
2.4.1 Protect mucous membranes of the eyes, nose and mouth during
processes that are likely to generate splashes from infectious
materials wear a face shield, work behind a bench top shield or
work within a BSC.
.
2.4.2 Handle hazardous chemicals in a chemical fume hood when
possible or wear a face shield.
2.4.3 Use the eyewash station in the event of eye contamination.
2.4.3.1 Activate the eye wash.
2.4.3.2 Wash spills to the eyes for a full 15 minutes.
2.4.3.3 Call for assistance and follow the accident reporting
procedure.
2.4.3.4 Contact Lens Wearers: Tell treating personal that you were
wearing contact lenses at the time of the splash.
3.0
References
3.1
M29-A4 Protection of Laboratory Workers for Occupationally Acquired
Infections; Approved Guideline- 4TH Edition, Vol. 34, No. 8 Clinical and
Laboratory Standards Institute, Wayne, PA.
3.2
Contact Lenses in a Chemical Environment, Weissman, B.R.,
Occupational Health & Safety, October 2005.
4.0
Initial Author/Date: Mary B. Paoli BS,MT(ASCP)SBB, 11.03.2014
Revised By Author/Date:
Page 89 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
EFFECTIVE DATE: 04.01.2015
S1.021.01
EYEWASH FUNCTION CHECKS
1.0
PRINCIPLE
An eyewash has a dual wide angle spray head that delivers a soft steady flow of water to the
eyes. In the event of eye contamination, the laboratory worker should hold his/her eye open
and rinse for a minimum of 15 minutes, then seek medical attention. Contact lenses provide
no protection from caustic splashes. They can concentrate caustic material against the cornea
or prevent tears from washing a caustic substance away. They will absorb solvents and vapors;
therefore constituting a hazard during splashes or spills. Each department supervisor should
know which of their employees wears contacts so that they may get appropriate care should a
splash to the eyes occur. Each department is responsible for the weekly function checks of all
the eyewashes in their department. The department supervisor (or designee) will review the
weekly function check forms (Form 1), and retain the completed records in their
department.
2.0
REQUIREMENTS
The laboratory has adequate plumbed or self-contained emergency eyewash facilities in every
area where there are hazardous chemicals as defined by the laboratory's chemical hygiene plan
(e.g. chemicals that are irritating, corrosive, toxic by contact or absorption, etc.).
The eyewash facility includes the following:
2.1
No greater than 10 seconds travel distance from areas in the laboratory where
hazardous chemicals are present
2.2
Capable of delivering 1.5 liters/minute for 15 minutes
2.3
Flow is provided to both eyes simultaneously
2.4
Nozzles or covers to protect from airborne contaminants
2.5
Hands-free flow once activated
2.6
Signage for location of eyewash
2.7
Unobstructed path with unlocked doors opening in the direction of the eyewash
2.8
Plumbed systems are protected from unauthorized shut off
2.9
Tepid fluid temperature
2.10 Plumbed systems are activated weekly
3.0
FUNCTION CHECKS- WEEKLY
3.1
Ensure eye wash is clear of obstructions and easily visible from all
directions (adequate signage).
3.2
Flush weekly and record on the eyewash form S1.021.01:F1.
3.2.1 Run the eyewash for 3-5 minutes to clear the lines and check the
pressure.
3.3
What to check when flushing:
Page 90 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
3.3.1
3.4
Eyewash protection caps must be in place and in good condition.
Activate the eye wash, the covers should open or get pushed off by the
water stream.
3.3.2 The ON/OFF valves must be operational, activated by a single
motion.
3.3.3 Water flow remains ON when the operator removes his/her hand.
3.3.4 Water flows freely and is directed at the proper angles to flush the
eyes.
3.3.5 The running water must be clear.
3.3.6 The temperature of the water should be tepid ( neither hot nor cold).
After function check wipe down the eyewash, clean and replace the caps.
4.0
FUNCTION CHECKS- ANNUAL
4.1
Once a year each eyewash will be checked for adequate flow rates.
4.1.1 The Laboratory Safety Officer or designee will check each eyewash by
activating the eyewash and timing how long it takes to fill a bucket up to
the 1.5 liter mark.
4.1.2 The time to fill the 1.5 liter volume must be less than one minute.
4.1.3 If the flow is inadequate the hospital maintenance department will be
called to repair the eyewash.
4.1.3.1 Repaired eyewashes will be re-tested for adequate flow rate.
4.2
Annual Flow Rate Checks S1.021.01:F02 will be reviewed and retained by the
Laboratory Safety Officer.
5.0
PROCEDURES- chemical splashes to the eyes.
5.1
Avoid rubbing eyes if they become contaminated.
5.2
Move immediately to closest plumbed eye wash station.
5.3
Push lever to activate water.
5.4
Remove contact lenses if present.
5.5
Place face and eyes over stream of water so that both eyes are being flushed with
streams of water.
5.6
Hold eye lids open and flush both eyes for at least 15 minutes or more using
copious amounts of water.
5.7
Employee to immediately go to Employee Health for further evaluation and
treatment. Notify employee health if contacts are still in place.
6.0
REFERENCES
6.1
American National Standard Institute (ANSI) Z358.1 – 1998 Emergency
Eyewash and Shower Equipment.
6.2
Clinical Laboratory Safety; Approved Guideline, GP17A, NCCLS.
Initial Author/Date: Jestine B. Witherspoon 7/91
Revised By Author/Date: Mary B. Paoli MT (ASCP) SBB 02.23.2009, 05.10.2013, 03.05.2015
Page 91 of 150
Palmetto Health Laboratories
S1.021.01:F01
USE ONE FORM FOR EACH EYEWASH
x OR √
EYEWASH NUMBER
LOCATION
MONTH
WEEK 1
CAPS
FLOW
TEMP
TECH #
YEAR
WEEK 2
CAPS
FLOW
TEMP
TECH#
MONTH
WEEK 1
CAPS
FLOW
TEMP
TECH #
MONTH
WEEK 1
CAPS
FLOW
TEMP
TECH #
MONTH
MONTH
WEEK 3
CAPS
FLOW
TEMP
TECH#
REVIEW
WEEK 4
CAPS
FLOW
TEMP
TECH#
WEEK 5
CAPS
FLOW
TEMP
TECH#
WEEK 3
CAPS
FLOW
TEMP
TECH#
REVIEW
WEEK 4
CAPS
FLOW
TEMP
TECH#
WEEK 5
CAPS
FLOW
TEMP
TECH#
WEEK 3
CAPS
FLOW
TEMP
TECH#
REVIEW
WEEK 4
CAPS
FLOW
TEMP
TECH#
WEEK 5
CAPS
FLOW
TEMP
TECH#
WEEK 3
CAPS
FLOW
TEMP
TECH#
REVIEW
WEEK 4
CAPS
FLOW
TEMP
TECH#
WEEK 5
CAPS
FLOW
TEMP
TECH#
WEEK 3
CAPS
FLOW
TEMP
TECH#
REVIEW
WEEK 4
CAPS
FLOW
TEMP
TECH#
WEEK 5
CAPS
FLOW
TEMP
TECH#
YEAR
WEEK 2
CAPS
FLOW
TEMP
TECH#
MONTH
WEEK 1
CAPS
FLOW
TEMP
TECH #
WEEK 5
CAPS
FLOW
TEMP
TECH#
YEAR
WEEK 2
CAPS
FLOW
TEMP
TECH#
WEEK 1
CAPS
FLOW
TEMP
TECH #
REVIEW
WEEK 4
CAPS
FLOW
TEMP
TECH#
YEAR
WEEK 2
CAPS
FLOW
TEMP
TECH#
WEEK 1
CAPS
FLOW
TEMP
TECH #
WEEK 3
CAPS
FLOW
TEMP
TECH#
YEAR
WEEK 2
CAPS
FLOW
TEMP
TECH#
YEAR
WEEK 2
CAPS
FLOW
TEMP
TECH#
CORRECTIVE ACTION
INDICATES SATISFACTORY
Palmetto Health Laboratories
S1.021.01:F02
S=SATISFACTORY
U= UNSATISFACTORY
DATE
EYEWASH # LOCATION
TIME TO FILL 1.5 L
TECH
S OR U
DATE
EYEWASH # LOCATION
TIME TO FILL 1.5 L
TECH
S OR U
DATE
EYEWASH # LOCATION
TIME TO FILL 1.5 L
TECH
S OR U
DATE
EYEWASH # LOCATION
TIME TO FILL 1.5 L
TECH
S OR U
DATE
EYEWASH # LOCATION
TIME TO FILL 1.5 L
TECH
S OR U
DATE
EYEWASH # LOCATION
TIME TO FILL 1.5 L
TECH
S OR U
DATE
EYEWASH # LOCATION
TIME TO FILL 1.5 L
TECH
S OR U
DATE
EYEWASH # LOCATION
TIME TO FILL 1.5 L
TECH
S OR U
DATE
EYEWASH # LOCATION
TIME TO FILL 1.5 L
TECH
S OR U
DATE
EYEWASH # LOCATION
TIME TO FILL 1.5 L
TECH
S OR U
DATE
EYEWASH # LOCATION
TIME TO FILL 1.5 L
TECH
S OR U
DATE
EYEWASH # LOCATION
TIME TO FILL 1.5 L
TECH
S OR U
DATE
EYEWASH # LOCATION
TIME TO FILL 1.5 L
TECH
S OR U
DATE
EYEWASH # LOCATION
TIME TO FILL 1.5 L
TECH
S OR U
CORRECTIVE ACTION
REVIEW
DATE
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.022.01 SAFETY SHOWER FUNCTION VERIFICATION
1.0
PRINCIPLE
The safety shower delivers a soft yet even spray pattern that flushes chemical
contaminants away from affected areas. This check is done to assure proper function and flush
the system of any rust collected.
2.0
FUNCTION CHECKS
2.1
Ensure shower is clear of obstructions and easily visible from all
directions (adequate signage).
2.2
Flush Monthly.
2.3
What to check when flushing:
2.3.1 Pulling the ring instantly activates shower.
2.3.2 Water flow remains ON when the operator removes his/her hand.
2.3.3 The temperature of the water should be tepid (lukewarm).
3.0
PROCEDURES
3.1
In the event of gross contamination
3.1.1 Remove contaminated clothing
3.1.2 Activate the safety shower by pulling down on the lever
3.1.3 Stand under the flow for a minimum of 15 minutes
3.1.4 Seek medical attention
4.0
REFERENCES
4.1
American National Standard Institute (ANSI) Z358.1 – 1998 Emergency
Eyewash and Shower Equipment.
4.2
Clinical Laboratory Safety; Approved Guideline, GP17A, NCCLS.
5.0
Initial Author/Date: Mary B. Paoli MT (ASCP) SBB 03.05.2015
Revised By Author/Date:
Page 92 of 150
Palmetto Health Laboratories
S1.022.01:F02
YEAR
S=SATISFACTORY
U= UNSATISFACTORY
JAN
UNOBSTRUCTED ACTIVATION WATER REMAINS ON TEMP = TEPID
TECH
REVIEW
FEB
UNOBSTRUCTED ACTIVATION WATER REMAINS ON TEMP = TEPID
TECH
REVIEW
MARCH UNOBSTRUCTED ACTIVATION WATER REMAINS ON TEMP = TEPID
TECH
REVIEW
APRIL
UNOBSTRUCTED ACTIVATION WATER REMAINS ON TEMP = TEPID
TECH
REVIEW
MAY
UNOBSTRUCTED ACTIVATION WATER REMAINS ON TEMP = TEPID
TECH
REVIEW
JUNE
UNOBSTRUCTED ACTIVATION WATER REMAINS ON TEMP = TEPID
TECH
REVIEW
JULY
UNOBSTRUCTED ACTIVATION WATER REMAINS ON TEMP = TEPID
TECH
REVIEW
AUG
UNOBSTRUCTED ACTIVATION WATER REMAINS ON TEMP = TEPID
TECH
REVIEW
SEPT
UNOBSTRUCTED ACTIVATION WATER REMAINS ON TEMP = TEPID
TECH
REVIEW
OCT
UNOBSTRUCTED ACTIVATION WATER REMAINS ON TEMP = TEPID
TECH
REVIEW
NOV
UNOBSTRUCTED ACTIVATION WATER REMAINS ON TEMP = TEPID
TECH
REVIEW
DEC
UNOBSTRUCTED ACTIVATION WATER REMAINS ON TEMP = TEPID
TECH
REVIEW
CORRECTIVE ACTION
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.023.01 SAFE SPECIMEN TRANSPORT
1.0
2.0
PURPOSE
To ensure safe transport of laboratory specimens from the hospital patient care floors to the
rapid care and central laboratories. All specimens should be submitted in an appropriately
labeled and well constructed container with a secure lid to prevent leakage during transport.
EQUIPMENT
2.1 Transport Carriers
2.2 Foam Inserts
2.3 Biohazard bags- self-seal “speci-guard” with pocket
2.4 Courier Bags
3.0
PROCEDURE
3.1 Packaging for Tube System: Refer to SP 2.012.06 Pevco Pneumatic TubeSystem.
Proper packaging is essential to avoid contamination and the resulting downtime of the system.
3.1.1
Collect specimen in approved container.
3.1.2
Verify lid is secure to prevent leakage.
3.1.3
Identify all specimens properly with computer generated label (or backup
procedure).
3.1.4
Place in biohazard self-seal safety bag. Any paperwork should be placed in
outside pocket of bag to prevent contamination. Bags must be sealed.
3.1.5
Inspect carrier for visible contamination. If carrier shows signs of
contamination, remove from service.
3.1.6
Foam liners must be used with all lab specimens.
3.1.7
Biohazard symbol must show on clear side of carrier.
3.1.8
Close carrier firmly – both latches closed. Carrier must not be overloaded and
nothing should hang out of the carrier. Weight limit – 3lbs.
3.1.9
Specimens received from the tube system with signs of leakage in the sealed
biohazard bag should not be removed from the bag. Notify the sender of the
unacceptable condition of the sample and request a new sample be submitted.
Page 93 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
3.2
The engineering department is responsible for system decontamination in the event of
biohazardous spills. Call ENGINEERING to report the spill, discontinue using the
system until engineering has finished decontamination.
3.2.1
3.3
3.4
4.0
5.0
Report any broken carriers to supervisor or lead tech, remove them from service.
Transport from outreach locations: refer to LO2.012.01 Specimen Transport
All specimens picked up by a courier to be transported to the laboratory must
be packaged in a sealed biohazard bag by the client. The specimen is to be labeled with
the patient’s name and date of birth and have appropriate paperwork/ ordering
information accompanying it in the outside pocket.
3.3.1 All specimens will be transported in a courier bag labeled with a biohazard
symbol.
Specimens sent to outside reference laboratories will be packaged according to the
reference laboratories requirements and in accordance with IATA Dangerous Goods
Regulations and the US Dept. of Transportation (US DOT). DOT regulations are found
in the Code of Federal Regulations, 49 CFR 173.
3.4.1 Training for employees, who will package and/or offer infectious substances for
transport. This training information is provided by the Bureau of Laboratories
(DHEC- the Bureau of Laboratories in Columbia, SC) to train employees to ship
infectious substances, category A & B.
3.4.2 Training is required every two years.
3.4.3 The employer must provide employee training and determine when the
employee is adequately trained. When meeting IATA regulations, the employer
must then issue a certificate stating that the employee has passed a test and is
certified to ship the types of dangerous goods covered by the training.
REFERENCES
4.1
Occupational Safety and Health Administration: 29CFR Part 1910.1030, 29 CFR Part
1910.1200(e)
4.2
National Committee for Clinical Laboratory Standards: NCCLS M29-T2
4.3
National Institutes of Health, Department Bio-Safety
4.4
Centers for Disease Control, Hospital Infection Program
Initial date: Fay Parker-Brown 03.28.1994
Revised:
Fay Parker-Brown 10.12.2000, 07.22.2005, 08.05.2010
Mary B. Paoli MT(ASCP)SBB 06.20.2014
Page 94 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.024.01 LABORATORY ERGONOMICS
1.0
PURPOSE AND/OR PRINCIPLE
Laboratory workers are at risk for repetitive motion injuries during routine laboratory
procedures such as pipetting, working at microscopes, operating microtomes, using cell
counters and video display terminals. Standing and working in awkward positions in
laboratory hoods/biological safety cabinets can also present ergonomic problems.
The purpose of the procedure is to inform lab personnel about how laboratory risk factors can
be controlled, how they can improve their level of comfort when performing their jobs and
reduce the risk of acquiring occupational injuries.
2.0
REPETITIVE PIPETTING
Pipetting is one of the most common tasks performed in the laboratory. It involves several
ergonomic stressors - thumb force, repetitive motions, and awkward over-reaching postures,
especially of the wrists, arms, and shoulders. The following are recommendations for
ergonomics hazards associated with the use of
pipettes:
2.1
Use pipettes that fit comfortably in the user’s hand.
2.2
For tasks such as mixing or aliquotting, use an electronic pipetter with
mixing functions.
2.3
Use a multichannel pipettor for large aliquotting tasks.
2.4
Use shorter pipettes. This decreases hand elevation and consequent
awkward postures.
2.5
Use low profile waste receptacles for used tips. They should be no higher
than the top of the tubes being filled.
2.6
Take micro-breaks of 3-5 minutes for every 20-30 minutes of pipetting.
2.7
Clean pipetters on a regularly scheduled basis - this reduces "sticking" and
improves quality of work.
2.8
Adjust the workstation so the individual doesn’t have to work with their
arms in an elevated position. Work with arms close to the body.
2.9
Use thin-wall pipette tips that fit correctly and are easy to eject.
2.10 Use minimal force when applying pipette tips.
2.11 Keep samples and instruments within easy reach.
2.12 Use an adjustable stool or chair when sitting at a lab bench.
2.13 If is necessary to stand for long periods of time during pipetting, provide
anti-fatigue matting.
2.14 make sure head and shoulders are kept in a neutral position. Bend forward no more than
30 degrees.
2.15 Perform work only at appropriate heights.
Page 95 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
3.0
COMPUTER WORKSTATION
Many laboratorians spend 50% or more of their day entering data with their keyboard and
mouse resting on a lab bench. The following are recommended for control of ergonomic
hazards associated with the use of computers in the lab:
3.1
Install adjustable keyboard platforms under lab benches which
accommodate use of the mouse beside the keyboard.
3.2
Where possible, position computer workstations in corners or other areas
away from doors, entrances, and passageways.
3.3
Provide fully adjustable seating.
3.4
Place monitors so the user’s viewing distance is between 18 and 30".
3.5
Place monitor so the top of the screen is approximately eye level. This
allows the eyes to naturally gravitate toward the center of the screen.
3.6
Use a document holder placed adjacent to and in the same plane as the
computer screen.
3.7
Provide foot rests, where possible, for individuals in order for them to
change leg positions throughout the day.
3.8
Provide for a choice of keyboards and mouse or other input devices for
individuals who have existing musculoskeletal pr oblems.
3.9
Encourage mini-breaks of 3 to 5 minutes for every 20 - 30 minutes of
keyboarding or mouse work.
3.10 Stretch, look away from your work, get up, do other tasks to alter work routines
throughout the day.
4.0
MICROSCOPY
The workstation should be made as adjustable as possible. Operating a microscope for long
hours puts strain on the neck, shoulders, eyes, lower back, wrists and arms. Ideally, the person
at the microscope should be able to adjust the height of his or her chair, work surface, and
microscope. The following are recommended for control of ergonomic hazards associated with
the use of microscopes:
4.1
Don’t use a microscope for more than 5 hours per day avoiding long
uninterrupted periods of microscope work.
4.2
Try pulling the microscope toward the edge of the work surface to position
the operator in a more upright posture.
4.3
If possible, try elevating the microscope or placing it at an angle so you
can look directly into the eyepiece. This can help position the operator in a
more upright posture and reduce rounding of the shoulders and neck.
4.4
Maintain neutral spine.
4.5
Provide arm rests to support the operator’s forearms while using
adjustment knobs.
4.6
Use an ergonomically designed chair that provides adequate back support,
adjustable height, and adjustable seat angle.
4.7
Make sure there is adequate room under the work surface so the operator
can pull the chair up to the ocular(s).
4.8
Provide footrests and discourage the use of foot rings on stools.
Page 96 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
4.9
4.10
4.11
4.12
4.13
Provide sit-stand seats for areas where there is restricted leg room.
Encourage frequent breaks from microscopy work as well as stretching
exercises.
Do not work with elbows winged. Keep elbows close to sides, below 45 degree angle.
Use proper sitting posture and positioning.
Ensure that sufficient knee and leg space is available.
5.0
BIOSAFETY CABINETS AND LABORATORY WORKBENCHES
Biosafety cabinets and laboratory workbenches present similar ergonomic hazards
which are mostly due to lack of adjustability and leg room. The following are
recommended for control of ergonomic hazards associated with the use of biosafety cabinets
and laboratory workbenches:
5.1
Use an ergonomically designed chair that provides adequate back support,
adjustable seat angle, and height adjustability between 28 inches to 33
inches.
5.2
Use footrests for individuals whose feet do not rest comfortably on the
floor.
5.3
Remove drawers, supplies, refrigerators, etc. from under the workbenches
and cabinet doors from under biosafety cabinets in order to provide leg
room.
5.4
Position materials in the cabinet and on the bench top as close as possible
to avoid extende d reaching without compromising containment of the
cabinet.
5.5
Use anti-fatigue matting for laboratory personnel who must stand for
extended periods of time.
6.0
MICROTOME & CRYOSTAT WORK
The following are recommended for control of ergonomic hazards associated with the use of a
microtome or cryostat:
6.1
Lower the workstation to keep arms closer to body.
6.2
Apply padding to the front edge of work surface to eliminate sharp edges
and increase the amount of blood flow to the hands.
6.3
Retrofit the existing handle with an adapter that will allow the operator to
use the handwheel in a pistol grip position. This will alleviate repetitive
wrist flexion and extension.
6.4
Avoid placing utensils such as forceps inside the cryostat.
6.5
Use an ergonomically designed chair.
7.0
OVERHEAD LIFTING
Due to lack of space in the laboratory, many laboratory workers must store equipment and
supplies on overhead shelves. This is recognized by NIOSH as a risk factor for ergonomically
related disorders. The following are recommended for control of ergonomic hazards
associated with overhead lifting:
Page 97 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
7.1
7.2
7.3
7.4
8.0
REFERENCES:
8.1
9.0
Store heavy objects on shelves below shoulder height whenever possible.
Use a stable footstool or stepladder to reach objects that are stored on
shelves.
Avoid asymmetric lifting (twisting while lifting). The object to be lifted
should be directly in front of the worker.
Store materials that are frequently used on shelving units which are
located higher than shoulder height.
URL: http://www.cdc.gov/od/ohs, Office of the Director/Administrator
Centers for Disease Control and Prevention, and Agency for Toxic
Substances and Disease Registry, Atlanta, GA
Initial Author/Date: Mary Sue Sawyer, MBA, MT(ASCP) 8/7/03
Revised By Author/Date: Fay Parker-Brown, MBA, SM(ASCP) 7/27/06, 9/14/07,
8/24/09, 8/5/2010
Mary.B.Paoli BS MT(ASCP)SBB 08.08.2014
Page 98 of 150
PALMETTO HEALTH LABORATORIES
S1.024.01:F01 ERGONOMICS TIPS
Task
Seating
Body positions/postures
Work Practices/ Processes
Avoid sitting at the edge of the seat, sit all the way back into
Use a footrest if feet do not reach the floor
footrest
the seat to provide back support
If back support is not adequate or if the seat pan is
Chair should provide adequate low back
Get out of chair at least every half hour to help relieve stress
too long, try a rolled up towel or a back support
and thigh support
on back
cushion to provide support.
Front edge of chair should not press up
Before starting work, make sure chair is properly adjusted.
Remove or adjust armrests that hinder work
against back of knees.
Pipetting
Proper equipment
Feet should rest flat on the floor or a
activities
Maintain straight wrists
Keep waste bins, beakers, etc., as close as possible
Use shorter pipetters and pipette tips
Keep elbows close to body
Take frequent microbreaks away from pipetting (at least
Choose pipetters that require minimal hand and
every 15-30 minutes)
finger effort
Share workload between right and left hands
For highly repetitive jobs, utilize automated
Rotate pipetting tasks with other employees as feasible
processes or multi-channel pipetters where feasible.
Occasionally alternate activities to avoid continuous
See seating
pipetting for long periods
Test Tube
Maintain straight wrists
Arrange tubes to minimize reaching/ twisting
Use upside-down containers to raise tube racks
Handling
Work w/ elbows close to body
Share workload between right and left hands
when needed
Avoid reaching upward or stooping
Take adequate breaks away from handling activity (even
Use vortexer mixer rack instead of holding tubes by
low
short several second "micro-breaks" help
hand
Use both hands to open tubes
Use cap removers to help minimize pinch gripping
To avoid forearms resting on sharp edges, pad
edges or use a cushion to pad forearm.
Microscope
Maintain straight wrists
Take frequent microbreaks to rest eyes (momentarily close
Raise and stand microscope at a slight tilt to allow a
Use
Avoid tilted head/ neck postures
eyes or focus on far away objects to vary focal length)
more upright head/ neck posture
Hand Tool Use
Maintain straight wrists
Avoid pinch gripping tools when
possible
Keep scopes clean and in good condition
To avoid forearms resting on sharp edges, pad
Spread microscope work throughout the day or rotate
edges or use a cushion to pad forearm.
microscope work among several employees as feasible
See seating (above)
Take occasional microbreaks away from tool use (at least
Choose the right tool for the job
every 15-30 minutes)
Ensure tools are in proper working order
Share workload between right and left hands
Increase size of tool handles where possible to
minimize gripping effort
General Work
Tips
Minimize use of awkward body postures
For any continuous/ repetitive task, take frequent
When purchasing equipment, models
microbreaks away from the primary activity
that adjust in size are preferable
Arrange work scheduling to allow occasional alternating of tasks
Use the proper equipment for the task
Rotate tasks intermittently between left and right hands to
Know how to properly use the equipment
avoid overuse of any one side
Where feasible, use automated processes to
For highly continuous/ repetitive tasks, consider a rotation
reduce/ eliminate high repetition or forces
of employees to help safely distribute workload
Report any injury or recurring discomfort to your supervisor
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.025.01 TUBERCULOSIS EXPOSURE CONTROL PLAN
1.0
PRINCIPLE
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis. It is
contagious and potentially life threatening. In the mid 1980s there was a significant
resurgence of tuberculosis in the United States, which was primarily associated with foreignborn individuals from areas of the world that have a high prevalence of TB; homeless persons;
medically undeserved populations; injecting drug users; the elderly and especially individuals
who are immune compromised as a result of HIV infection or chronic renal failure, diabetes
mellitus or immunosuppressive therapy. Mycobacterium tuberculosis and M. bovis infections
are a proven hazard to laboratory personnel as well as others that may be exposed to infectious
aerosols in the laboratory. Staffs who work in laboratories that handle clinical specimens
experience risk not typically present in other areas of the health care setting. The incidence of
tuberculosis in laboratory personnel working with M. tuberculosis has been reported to be
three times higher than those not working with the agent.
In our laboratory administrative measures are used to reduce the risk of exposing susceptible
individuals to persons who have infectious TB. Written policies and protocols are in place to
ensure rapid identification, isolation and treatment of persons with TB. Effective work
practices are implemented such as good biological safety procedures. The use of adequate
respiratory protection is used when necessary. Employees are trained and educated about
hazards of working with tuberculosis during their initial lab orientation and when training in the
particular areas. Microbiology Lab staff working with TB are trained in methods that minimize
the production of aerosols and their competency is checked periodically. All employees are
screened annually through Health Works.
2.0
TRANSMISSION AND PATHOGENESIS
2.1
M. tuberculosis is carried in airborne viable particles referred to as droplet nuclei which
can be generated when persons who have active tuberculosis coughs, sneezes, speaks,
sings or laughs.
2.2
The particles generated by these actions are relatively large but by
evaporation small particles in the size range of one to five microns are
formed.
2.3
These particles can remain airborne for extended periods of time
and be carried throughout a room or building by air currents.
2.4
Infection occurs when a susceptible person inhales droplet nuclei
containing M. tuberculosis and these particles pass through the mouth or
nasal passages, upper respiratory tract and bronchi to reach the alveoli of
the lung.
Page 99 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.5
2.6
2.7
2.8
Usually within two to ten weeks after initial infection the immune system
limits the reproduction and spread of the organism but some of the bacilli
remain dormant for many years. This condition is known as latent TB
infection.
TB is preventable and in most cases treatable.
It usually attacks the respiratory system, but can also attack other body parts such as the
kidney, spine and brain.
If TB is not treated properly it can result in death.
3.0
LABORATORY HAZARDS:
3.1
Tubercle bacilli may be present in sputum, gastric lavage fluids,
cerebrospinal fluid, urine, and in lesions from a variety of tissues.
3.2
Exposure to laboratory –generated aerosols is the most important hazard
encountered.
3.3
Tubercle bacilli may survive in heat-fixed smears and may be aerosolized
in the preparation of frozen sections and during manipulation of liquid
cultures.
3.4
Because of the low infective dose of M. tuberculosis for humans and in
some laboratories a high rate of isolation of acid fast organisms from
clinical specimens, sputa and other clinical specimens from suspected or
known cases of tuberculosis must be considered potentially infectious and
handled with appropriate precautions.
3.5
Assessment of Occupational Risk: See the Exposure Determination
Procedure and the Biosafety Guidelines for Microbiology Procedure.
4.0
CONTROLS IN PLACE
4.1
Infection control practices can help reduce the risk of TB transmission.
4.2
There is timely availability of laboratory to processing, testing and reporting to
physicians, Infection Control and the State TB Control.
4.3
Coordinating efforts with our State Lab.
4.4
Use of proper respiratory protection.
4.5
Biological Safety hood with a hepa filter used to conduct all aerosol-generating
activities, including culture media inoculation, opening centrifuge cups, setting up
biochemicals and performing sonication.
4.6
Ultra violet lights in safety hood. Research has demonstrated that uses of the lights are
effective in killing or inactivating M. tuberculosis under experimental conditions.
4.7
For all procedures disposable gloves should be worn and disposed of when work is
complete, gloves are contaminated or the integrity of the glove is compromised.
4.8
Face protection is worn when processing and any time there is manipulation outside of
the hood.
4.9
Positive smears are reported within 24hours of receipt.
Page 100 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
5.0
RECOMMENDED PRECAUTIONS:
5.1
Biosafety Level 2 practices, containment equipment and facilities are
required for activities at American Thoracic Society (ATS) laboratory
level I, preparation of acid-fast smears, and culturing of sputa or other
clinical specimens, provided that aerosol generating manipulations of such
specimens are conducted in a Class I or II biological safety cabinet.
5.2
Liquefaction and concentration of sputa for acid-fast staining may also be
conducted safely on the open bench by first treating the specimen (in a
Class I or II safety cabinet) with an equal volume of 5% sodium
hypochlorite solution and waiting 15 minutes before centrifugation.
5.3
Biosafety Level 3 practices, containment equipment and facilities are
required for laboratory activities of ATS levels II and III in the
propagation and manipulation of cultures of M. tuberculosis or M. bovis.
5.4
Skin testing with purified protein deviate (PPD) of previously skin-testednegative laboratory personnel can be used as a surveillance procedure.
5.5
In general, a laboratory procedure for culturing M. tuberculosis and for
examining certain specimens from infected patients follows the CDC
biosafety guidelines.
5.6
Engineering controls are used to eliminate the risks. Procedures are
conducted using Class II Biological Safety Cabinets and in accordance
with the latest recommendations on working safely with M. tuberculosis
published by the CDC. Work is only done using these requirements.
5.7
The use of special containment vessels, sealed rotors or safety cups are in
place for processing high concentrations or high volumes of infectious
agents and specimens suspected of containing airborne agents, M.
tuberculosis.
5.7.1 Sealed rotors or safety cups are opened only inside biosafety
cabinet when centrifuging is complete.
5.8
Concentration of infectious agents is a potentially hazardous procedure, as
the inoculum size will be increased if an exposure occurs.
5.8.1
Class II biological safety cabinets should be used.
5.9
Care should be taken during transfer or aliquoting operations to avoid
aerosol production. It should be done in a biological safety cabinet to
contain aerosols.
5.10 Protective garments are removed before going out of the TB room.
6.0
AUTOPSY ROOMS
6.1
Autopsy rooms should be at negative pressure with respect to adjacent
areas and the room air should be exhausted directly to the outside of the
building.
6.1.1 ASHRAE recommends that autopsy rooms have ventilation that
provides airflow of 12 changes per hour.
6.1.2 Other provisions could include recirculation of air within the room
through HEPA filters.
Page 101 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
6.2
6.3
7.0
REFERENCES
7.1
Guidelines for preventing the transmission of Mycobacterium tuberculosis in healthcare settings, 2005. MMWR 2005; 54 (no.RR-17).
7.2
8.0
Personnel while performing autopsies on individuals who may have
infectious TB should wear respiratory protective devices.
Any exposures or potential exposures should be handled according to the
Microbiology guidelines. Health Works would initiate any treatment or follow-up.
www.cdc.gov/tb/topic/laboratory/default.htm.
Initial Author/Date: Fay A. Parker-Brown 9/14/01
Revised By: Fay Parker-Brown, 8/4/03, 10/10/06, 9/3/09, 9/7/10
Mary B. Paoli BS, MT(ASCP)SBB 03.05.2015
Page 102 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.026.01 FORMALDEHYDE EXPOSURE CONTROL
1.0
2.0
PRINCIPLE
The Occupational Safety and Health Administration (OSHA) promulgated a final rule on May
27, 1992 for occupational exposure to formaldehyde, Title 29 of the Code of Federal
Regulations (CFR) Part 1910.1048. The risk of exposure in histology laboratories is great
without proper engineering controls and good work practices. To reduce this risk, affected
laboratory employees must have access to properly functioning fume hoods or ventilation as
well as appropriate work practices to keep exposure to formaldehyde below the “action level”
of 0.5 parts per million (ppm) for an hour period and a short-term exposure limit (STEL) of 2
ppm for 15 minutes of exposure. The action level remains at 0.5 ppm as per 29 CFR section
1910.1048.
Histology has been outsourced to PPS. They perform training, monitoring and follow up.
They follow regulations.
DESCRIPTION:
2.1
Formaldehyde solution is a colorless, aqueous solution containing not less
than 37% formaldehyde (CH2O).
2.2
In histology, it is also known as formalin and is diluted to 10% for use as a
tissue preservative.
2.3
Formaldehyde has a powerful effect on all kinds of tissue; therefore it is
an ideal preservative for surgical pathology, histology and autopsy
laboratories.
2.4
It hardens the samples and kills bacteria or inhibits their growth.
2.5
It is an excellent germicide and more penetrable than phenols.
2.6
WARNING: Formaldehyde is a carcinogen, is highly poisonous, is a skin
irritant and sensitizer, all eye and respiratory irritant.
2.7
It can also be absorbed through the skin.
2.8
High exposures are associated with cough and bronchial spasms as well as
central nervous system (CNS) effects such as headache and dizziness.
2.9
Immunogenic response includes dermatitis and asthma.
2.10 Acute overexposure can lead to pneumonitis and death.
2.11 Formaldehyde has been linked with neuropsychiatric disturbances
including headache, irritability and depression.
2.12 Ingestion of formaldehyde can be fatal, and long term exposure to low levels in the air
or on the skin can cause asthma-like respiratory problems and skin irritation such as
dermatitis and itching.
2.13 Concentrations of 100 ppm are immediately dangerous to health or life.
Page 103 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
3.0
EXPOSURE MONITORING:
3.1
Exposure monitoring is conducted twice a year.
3.1.1 Once by Risk Tech using a representative sampling strategy
measuring sufficient exposures within job classifications when
formaldehyde concentrations are relatively constant.
3.1.2 Secondly by formaldehyde monitoring badges provided by
SENSORS Corporation.
3.2
The monitoring will he repeated each time there is a change in production,
equipment process, personnel or control measures that result in new or
additional exposure to formaldehyde.
3.3
If reports of signs and symptoms of respiratory or dermal conditions
associated with formaldehyde exposure occur, the affected employee’s
exposure will he promptly monitored.
3.4
If last monitoring results reveal employee exposure at or above the
permissible exposure limitt (PEL) of 0.75 ppm or at or above the short
term exposure limit (STEL) of 2 ppm, the following actions are taken:
3.4.1 Engineering checks department ventilation
3.4.2 10% Formaldehyde concentrations used by operating and
emergency room are verified.
3.4.3 Repeat testing is scheduled every three months until the
monitoring results fall below the action level for two consecutive
sampling periods that are at least seven days apart.
3.5
Each staff member reviews his/her monitoring results with supervisor
within 15 days of receiving the results.
3.6
Each tested employee verifying their review and understanding the results,
signs off on said results.
3.7
When the PEL is more than 0.75 ppm, a written plan to reduce employee
exposure is given to each employee that describes the corrective action
being taken to decrease the exposure.
4.0
REGULATED AREAS:
4.1
Posted as a precautionary message and safety practice, which is not
intended to mean that the PEL & STEL is exceeded, all entrances and
access ways have signs bearing the following information:
DANGER
FORMALDEHYDE
IRRITANT & POTENTIAL CANCER HAZARD
AUTHORIZED PERSONNEL ONLY
4.2
Access to regulated areas is limited to authorized persons who have been
trained to recognize the hazards of formaldehyde.
Page 104 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
5.0
ENGINEERING CONTROLS & WORK PRACTICES:
5.1
Easily accessible sinks with eye washes.
5.2
POLYFORM-F Spill Control agent is used in the event of a formaldehyde
spill LESS than 1 pint.
5.3
Spills MORE than 1 pint; a CODE YELLOW is implemented. Histology
personnel are evacuated from the area, all doors are closed and the
hospital operator is notified of the spill in Histology.
5.4
An exhaust system is installed in the Histology lab that draws
formaldehyde flumes from, the counter surface. This prevents flumes from
reaching the face of the Histology personnel while they are gross ing and
performing staining procedures.
5.5
There are approximately 30 air changes per hour for the entire room and
4.3 outside air changes per hour.
6.0
PROTECTIVE EQUIPMENT & CLOTHING:
6.1
Personal protective equipment and clothing are provided at no cost to the
employee.
6.2
For performing gross examinations of tissue wear:
6.2.1 Cover gown made of chemically resistant material
6.2.2 Face shield
6.2.3 Gloves
6.3
For disposal of specimens and changing processor, wear:
6.3.1 Cover gown made of chemically resistant material
6.3.2 Face shield
6.3.3 Gloves.
6.4
Only persons trained by Palmetto Health Richland according to training
protocol (see Training) to recognize the hazards of formaldehyde are to
remove the contaminated material from the storage area for purposes of
cleaning, laundering or disposal.
6.5
No employee takes home equipment or clothing that is contaminated with
formaldehyde.
6.6
Palmetto Health Richland informs any person who launders, cleans, or
repairs such clothing or equipment of formaldehyde’s potentially harmful
effects and procedures to safely handle the clothing and equipment.
8.0
RECORD KEEPING:
8.1
Environmental monitoring records are kept for 30 years and include:
8.1.1 Date of measurement
8.1.2 Operation being monitored
8.1.3 Methods of sampling and analysis and evidence of their accuracy
and precision
8.1.4 Number, durations, (STEL or TWA), time, and results of samples
taken
8.1.5 Types of protective devices worn
Page 105 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
8.1.6
Names, job classifications, social security numbers and exposure
estimates of the employees whose exposures are represented by the
actual monitoring results.
9.0
REFERENCES:
9.1
Budavari, S. MD et al. The Merck Index. Merck & Company, I Edition,
1989, p. 4148.
9.2
Emmett. LA Ed. Occupational Medicine Sate of the Art, Health Problems
of Health Care Workers. Vol. 2 No. 3 July-September 1987 Hanley &
Belfus, Inc., pp. 570-571 and 645.
9.3
LaDou, J MD., Occupational Medicine. Appleton & Long 1990 pp 340342.
9.4
Rosenstock, L MD., Cullen, MR MD. Clinical Occupational Medicine.
WE Saunders, Co. 986, pp 222-223.
9.5
US Department of Labor, final rule Part II. Federal Register. 29 CFR
1910. 1048 Occupational Exposures to Formaldehyde May 27, 1992.
9.6
Lott, AL PhD, CIH & Greenblatt. M MD. Formaldehyde Regulations:
What You Need to Know. Vol. 7 No. 4 April 1993. CAP Today, pp 32-35.
10.0
Initial Author/Date: Terri Gorin, BHS, HT(ASCP)
Revised By Author/Date: Fay Parker-Brown, MBA, SM(ASCP)10/12/04,
9/3/09,10/6/10
Page 106 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
FORMALDEHYDE MONITORING MEDICAL QUESTIONAIRE
(From 29 CFR section 1910.1 048— Formaldehyde)
INITIAL EMPLOYMENT QUESTIONAIRE (page 1)
Date:
Employee Name:
Emp. ID:
SSN
Job Title:
DOB:
Age:
Sex:
Height:
Weight:
MEDICAL HISTORY
Have you ever been hospitalized as a patient?
Yes
No
If yes, what kind of problems were you having?
Have you ever had any kind of operation?
Yes No
If yes, what kind?
_____________
Do you take any kind of medicine regularly?
Yes No
If yes what kind?
Are you allergic to any drugs, foods or chemicals? Yes No
If yes, what kind of allergy?
What causes
the allergy?
Have you ever been told that you have asthma, hay fever, or sinusitis? Yes No
Have you ever been told you have emphysema, bronchitis, or any other respiratory problems?
Yes
No
If yes, explain:
Have you ever been told you have Hepatitis?
Cirrhosis?
Yes No
Cancer?
Yes No
Arthritis?
Yes No
Joint Pain?
Yes No
High Blood Pressure?
Yes No
Mean Trouble?
Yes No
Do you smoke?
Yes
No
If yes, How much and for how long?
Do you drink alcohol in any form? Yes No
If yes, how much, how often and for how long?
Yes
No
Do you wear glasses or contact lenses? Yes No
Which?
Do you get any physical exercise other than that required to do your job? Yes
If yes, explain:
No
Do you have any hobbies or “side jobs” that require you to use chemicals, such as furniture -stripping,
sand blasting, insulation, or manufacturer of urethane foam, furniture, etc? Yes No
If so, please describe, giving type of business or hobby, chemicals used and length of exposures:
Page 107 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
FORMALDEHYDE MONITORING MEDICAL QUESTIONAIRE
(From 29 CFR section 1910.1 048— Formaldehyde)
INITIAL EMPLOYMENT QUESTIONAIRE (page 2)
Date:
Employee Name:
Do you experience any shortness of breath? Yes
No
If yes, do you have to rest alter climbing several flights of stairs? Yes No
If yes, when you walk with people your own age, do you walk slower than they do?
Yes No
If yes, if you have to walk slower than norma l pace, do you have to limit the distance that you walk?
Yes
No
If yes do you have to stop and rest while bathing or dressing? Yes No
Do you cough as much as three months out of the year?
Yes No
If yes, have you had this cough for more than two year?
Yes No
If yes, do you ever cough anything up from your chest?
Yes No
Do you ever have a feeling of smothering, unable to take a deep breath, or tightness in your chest?
Yes No
If so, do you notice that this occurs on any particular day of the week? Yes No
If so, which day?
If yes, do you notice that this occurs at any particular place? Yes No
If yes, do you notice that this is worse after you have returned to work after being off for several days?
Yes No
Have you ever noticed any wheezing in your chest?
Yes No
If yes, is this only with colds or other infections?
Yes No
Is this caused by exposure to any kind of dust or other material? Yes No
If yes, what kind?
Have you noticed any sore or burning throat or itchy or burning nose when you are at work?
Yes
No
If yes, explain circumstances:
Have you noticed any stuffiness or dryness of your nose? Yes No
Do you ever have swelling of the eye lids or face? Yes No
Have you ever been jaundiced?
Yes No
If yes was this accompanied by any pain? Yes
No
Have you ever had a tendency to bruise easily or bleed excessively Yes
No
Do you have frequent headaches that are not relieved by aspirin or Tylenol? Yes No
If yes, do they occur at any particular time of the day or week? Yes No
If yes, when do they occur?
Do you have frequent episodes of nervousness or irritability? Yes No
Do you tend to have trouble concentrating or remembering? Yes No
Do you ever feel dizzy, light-headed, and excessively drowsy or like you have been drugged?
Yes
No
Does your vision ever become blurred?
Yes No
Do you have numbness or tingling of the hands or feet or other parts of your body?
Yes No
Have you over had chronic weakness or fatigue?
Yes No
Page 108 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
FORMALDEHYDE MONITORING MEDICAL QUESTIONAIRE
(From 29 CFR section 1910.1 048— Formaldehyde)
INITIAL EMPLOYMENT QUESTIONAIRE (page 3)
Date:
Employee Name:
Have you ever had any swelling of your feet or ankles to the point where you could not wear your
shoes? Yes No
Are you bothered by heartburn or indigestion? Yes No
Do you ever have itching, dryness, or peeling and scaling of the hands? Yes No
Do you ever have a burning sensation in the hands, or reddening of the skin? Yes No
Do you ever have cracking or bleeding of the skin on your hands? Yes No
Are you under a physician’s care? Yes No
If yes, for what re you being treated?
Do you have any physical complaints today? Yes
If yes, explain:
No
Page 109 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
OCCUPATIONAL HISTORY
How long have you worked for your present employer?
What jobs have you held with this employer?
In each of these jobs, how many hours a day were you exposed to chemicals?
What chemicals have you worked with most of the time?
Have you ever noticed any type of skin rash you feel was related to your work? Yes No
Have you ever noticed any kind of chemical that:
Makes you cough?
Yes
No
Wheeze?
Yes
No
Become short of breath?
Yes No
Cause your chest to become tight? Yes No
Are you exposed to any dust or chemicals at home? Yes No
If yes, please explain:
In other jobs, have you had exposure to:
Wood dust? Yes No
Nickel or chromium? Yes No
Silica (foundry, sand blasting)?
Yes No
Arsonic or asbestos? Yes No
Organic Solvents?
Yes No
Urethane foams?
Yes No
OCCUPATIONAL HISTORY UPDATE
Are you working on the same job this year as you were last year? Yes No
If not, how has your job changed?
What chemicals are you exposed to on your job?
How many hours a day are you exposed to chemicals?
Have you noticed any skin rash within the pact year you feel was related to your work?
Yes
No
If yes, explain circumstances:
Have you noticed that any chemical makes you cough, be short of breath or wheeze?
Yes
No
If yes, can you identify it?
Page 110 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
FORMALDEHYDE EXPOSURE MONITORING
MEDICAL HISTORY UPDATE
Date:
Employee Name:
Emp. ID:
Have you been in the hospital as a patient any tine within the past year? Yes No
If yes, for what condition?
Have you been under the care of a physician during the past year? Yes No
If yes, for what condition?
Is there any change in your breathing since last year?
Yes No
Is your general health different this year from last year?
Yes No
Have you in the past year or are you now taking any medication on a regular basis?
Yes No
Name(s) of medication:
Condition(s) being treated:
Page 111 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.027.01 XYLENE EXPOSURE CONTROL PLAN
1.0
PRINCIPLE
Xylene is a colorless, clinically non-reactive solution that contains 17% ethyl benzene. Xylene
is used in the tissue processors, auto-stainer, and automated cover-slipper in Histology. It is
most commonly used as a clearing reagent in the processing and staining processes. (Histology
has been outsourced to PPS)
WARNING: Xylene contains benzene which is a known Carcinogen. It is also an eye
and skin irritant that affects the central nervous system (CNS).
1.1
Conditions contributing to instability: heat, sparks, or open flame
1.2
Incompatibilities: contact with strong oxidizers may cause fires and explosions
2.0
EXPOSURE MONITORING:
2.1
Exposure monitoring is conducted yearly by AZIMUTH, Inc. or other certified
company by using a representative sampling strategy measuring sufficient exposures
within job classifications when xylene concentrations are relatively constant.
2.2
The monitoring will he repeated each time there is a change in production
equipment, process, personnel, or control measures that result in new or
additional exposure to xylene.
2.3
If reports or signs and symptoms respiratory or dermal conditions
associated with xylene exposure occur, the affected employee’s exposure
will be promptly monitored.
2.4
If the last monitoring results reveal employee exposure at or above the
permissible exposure limit (PEL) of l00ppm the following actions are
taken:
2.4.1 Department ventilation is checked by engineering.
2.4.2 Repeat testing is scheduled every 3 months until the monitoring
results fall below the action level for 2 consecutive sampling
periods that am at least 7 days apart.
2.4.3 Employee monitoring results are reviewed by hospital safety
officer within 15 days of receiving and distributed to the
appropriate lab personnel.
2.4.4 These results are distributed for employee review and signature.
3.0
ENGINEERING CONTROLS AND WORK PRACTICES
3.1
Easily accessible sinks and eye washes
3.2
Room ventilation
Page 112 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
4.0
PROTECTIVE EQUIPMENT & CLOTHING
4.1
Personal protective equipment and clothing are provided at no cost to the
employee. These include impermeable gowns, face shields, arid gloves.
5.0
SPILLS
5.1
Xylene spills will only be wiped up with disposable cleaning items.
5.2
Spills LESS than one gallon:
5.2.1 Wear personal protective equipment (gown, gloves, face shield)
5.2.2 Ventilate area of spill.
5.2.3 Dike the spill.
5.2.4 Absorb with dry sand.
5.2.5 Dispose of with the hazardous waste.
5.3
Spills MORE than one gallon:
5.3.1 Evacuate personnel from the area.
5.3.2 Close doors.
5.3.3 Call Operator notify her of a CODE YELLOW. Be certain to give
her your location.
5.3.4 Notify Lab Safety Officer or Hospital Safety Officer of occurrence.
5.3.5 Inform Healthworks of an employee exposure.
6.0
STORAGE
6.1
Xylene should be stored in a cool, dry well-ventilated area
6.2
Store in tightly sealed containers that are labeled according to OSHA’s standards.
6.3
Storage must be in standard flammable cabinets.
7.0
RECORD KEEPING
7.1
Environmental monitoring records are kept by the Hospital Safety Officer
and include:
7.1.1 Date of measurement.
7.1.2 Level of exposure.
8.0
Initial Author/Date: Terri Gorin, BHS, HT(ASCP) before 2004
Revised By Author/Date: Fay Parker-Brown, 10/04/04, 9/3/09, 9/2/10, 10/11/10
Page 113 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective date:04.01.2015
S1.028.01 SAFETY GUIDELINES FOR HANDLING OF POSSIBLE
CREUTZFELDT-JAKOB DISEASE
(SUBACUTE SPONGIFORM ENCEPHALOPATHY)
1.0
2.0
3.0
4.0
5.0
Principle
Creutzfeldt-Jakob disease (CJD) is a degenerative neurological disorder of humans with an
incidence in the United States of approximately one case/million population/year. The disease
is most likely caused by a proteinaceous infectious agent or prion. The disease is rapidly
progressive and always fatal. It afflicts both men and women between the ages of 50 to 75. A
new variant form has been identified in much younger population in the United Kingdom. The
incubation period varies from months to decades but once symptoms develop the majority of
the patients die within a year of onset. The agent that causes the disease is resistant to
sterilization and the disinfection processes routinely used in healthcare settings.
Infection Control has a policy on guidelines for CJD.
Symptoms patients present with:
2.1 Dementia
2.2 Ataxia
2.3 Behavior changes
2.4 visual deficits
2.5 Involuntary movements
Diagnosis
No single test available
3.1 Rule out dementia such as encephalitis or chronic meningitis
3.2 Neurological exam
3.3 Spinal tap
3.4 Electroencephalogram
3.5 MRI
3.6 Trying develop test detects protein markers
Cause
4.1 Possible unusual slow virus or another organism
4.2 Never been able to isolate virus or other organism in people with the disease
4.3 It is difficult to kill, does not appear to contain genetic information in the form of nucleic
acids
4.4 Long incubation period
Disease and Transmission
5.1 CJD is not considered to be contagious in the traditional sense.
5.2 Cannot be transmitted through the air, through touching or most casual forms of contact
Page 114 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
6.0
7.0
8.0
9.0
10.0
5.2 Exposure to brain tissue and spinal cord fluid from infected individuals should be avoided to
prevent transmission of the disease through these materials.
5.3 CJD has spread from grafts of dura mater, transplanted corneas, implantation of
inadequately sterilized electrodes in the brain, and injections of contaminated pituitary
growth hormone derived from human pituitary glands from cadavers.
5.4 Some animal studies suggest that contaminated blood and related products may transmit the
disease.
Disease categories
6.1 The CDC recommends that contaminated specimens be grouped according to the level of
risk.
6.2 High risk includes tissues from the brain, spinal cord and eye.
6.3 Low risk infectious tissues and fluid include cerebrospinal fluid, lung, kidney, liver, spleen,
placenta, and lymph node.
6.4 No risk infectious fluids and tissue include all other specimens such as blood, urine, sputum
and tears.
Confirmation
7.1Only way is by brain biopsy or autopsy
Precautions
8.1 Follow standard precautions as with all samples. Gloves should be worn to hand blood and
body fluids. Masks, gowns, and protective eyewear should be worn if exposure to mucous
membranes or skin to blood or other material that is potentially infectious is anticipated.
8.2 Blood and body fluids maybe disposed of in the sanitary sewer system.
8.3 Standard precautions are routine disinfection procedures are all that is needed for low risk
specimens.
8.4 The most important precaution is to avoid injury from instruments used in examination and
contact between contaminated material and non-intact skin.
8.5 CSF received for special testing should go to Send Outs
8.6 Pathology, Lab Safety is informed.
8.7 Communicate with Infectious Disease to make sure there is approval or consultation before
the sample is accepted by the lab.
8.8 Histology has specific instructions for working with CJD cases.
8.9 CJD is a DHEC reportable disease.
References
9.1 M29-A2 Protection of Laboratory Workers for Occupationally Acquired Infections;
Approved Guideline- 2nd Edition, Vol. 25, No. 10 Clinical and Laboratory Standards
Institute, Wayne, PA.
9.2 Murray, P.R., 8th Ed., Manual of Clinical Microbiology Volume 1, ASM press,
Washington D.C., 2003, pages 100-101.
Initial Author/Date : Fay Parker-Brown 09.09.2010
Revised By Author/Date:
Page 115 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.029.01
LABORATORY GUIDELINES FOR HANDLING
SPECIMENS FROM PATIENTS WITH SUSPECTED OR CONFIRMED
EBOLA VIRUS DISEASE
1.0
Principle
Ebola, previously known as Ebola hemorrhagic fever, is a severe, often fatal disease in humans
and nonhuman primates (such as monkeys, gorillas, and chimpanzees). Ebola is a rare and
deadly disease caused by infection with a virus of the family Filoviridae, genus Ebolavirus.
Ebola is found in several African countries. The first Ebola species was discovered in 1976
near the Ebola River in what is now the Democratic Republic of the Congo. Since then,
outbreaks have appeared sporadically in Africa. The natural reservoir host of Ebola remains
unknown. However, on the basis of available evidence and the nature of similar viruses,
researchers believe that the virus is animal-borne with bats being the most likely reservoir.
When an infection does occur in humans, the virus can be spread in several ways to others.
Ebola is spread through direct contact (through broken skin or mucous membranes in, for
example, the eyes, nose, or mouth) with blood or body fluids (including but not limited to
urine, saliva, sweat, feces, vomit, breast milk, and semen) of a person who is sick with Ebola
objects (like needles and syringes) that have been contaminated with the virus.
Ebola is not spread through the air or by water. There is no evidence that mosquitos or other
insects can transmit Ebola virus. Only mammals (for example, humans, bats, monkeys, and
apes) have shown the ability to become infected with and spread Ebola virus.
Healthcare providers caring for Ebola patients and the family and friends in close contact with
Ebola patients are at the highest risk of getting sick because they may come in contact with
infected blood or body fluids of sick patients.
1.1
Suspected Case: A person who has both consistent symptoms and risk factors as
follows:
1.1.1 Clinical criteria, which includes fever of greater than 38.0 degrees Celsius or
100.4 degrees Fahrenheit, and additional symptoms such as severe headache,
muscle pain, vomiting, diarrhea, abdominal pain, or unexplained hemorrhage;
AND
1.1.2 Epidemiologic risk factors within the past 21 days before the onset of
symptoms, such as contact with blood or other body fluids or human remains of
a patient known to have or suspected to have EVD; residence in—or travel to—
an area where EVD transmission is active; or direct handling of bats or nonhuman primates from disease-endemic areas.
1.2
High risk exposures
A high risk exposure includes any of the following:
1.2.1 Percutaneous (e.g., needle stick) or mucous membrane exposure to blood or
body fluids of EVD patient
Page 116 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
1.2.2
Direct skin contact with, or exposure to blood or body fluids of, an EVD patient
without appropriate personal protective equipment (PPE)
1.2.3 Processing blood or body fluids of a confirmed EVD patient without appropriate
PPE or standard biosafety precautions
1.2.4 Direct contact with a dead body without appropriate PPE in a country where an
EVD outbreak is occurring.
1.3
Low risk exposures
A low risk exposure includes any of the following
1.3.1 Household contact with an EVD patient
1.3.2 Other close contact with EVD patients in health care facilities or community
settings. Close contact is defined as being within approximately 3 feet (1 meter)
of an EVD patient or within the patient’s room or care area for a prolonged
period of time (e.g., health care personnel, household members) while not
wearing recommended personal protective equipment, and contact precautions.
1.3.4 Having direct brief contact (e.g., shaking hands) with an EVD patient while not
wearing recommended personal protective equipment.
1.3.5 Brief interactions, such as walking by a person or moving through a hospital, do
not constitute close contact.
For the purpose of these guidelines, a suspected Ebola Virus Disease (EVD) patient is a patient
who reports either a Low or High Risk exposure, for whom a definitive diagnosis has not yet
been, determined, should be tested for Ebola virus after approval by both the state health
department (DHEC) as well as the Centers for Disease Control and Prevention (CDC).
This procedure will describe the Personal Protective Equipment (PPE) needed to handle
specimens collected from suspected patients for definitive EVD testing. Personnel packing
these specimens must be certified for Shipping Category A Infectious Specimens.
2.0 Equipment:
2.1
Ebola PPE Box: contents
Fluid resistant disposable gown
Disposable nitrile gloves with long cuffs
N95 mask
Head cover
Face shield
Shoe covers
Permanent marking pen
Bleach- full strength
Bottled water
Bleach wash bottle, marked for bleach volume and water volume
Wypall cloths
Biohazard bags with zip ties
2.2
Paperwork in folder on top of Ebola PPE box
CDC guidelines for putting on and removing PPE
Specimen handling log
Page 117 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
3.0
CDC test request form
Packaging instructions for Category A infectious disease specimens.
2.3
Category A-Infectious disease specimen shipping box UN2814 with specimen
container.
Procedure:
3.1
When the notification is received that the isolation unit has drawn a specimen to be sent
to the CDC for Ebola testing get one of the Ebola PPE boxes.
3.1.1 Specimens; 2-4 mL purple top tubes will be collected by the isolation unit
nursing personnel.
3.1.2 Collected specimens will be labeled by the collector with the proper patient
identifiers. A piece of transparent tape will be placed over the label.
3.1.3 The collector will spray disinfectant solution onto a cloth and wipe the exterior
of each tube. Do not spray the tubes directly.
3.1.4 The tubes will then be placed into a biohazard bag and the bag sealed.
3.1.5 The bag containing the tubes will be passed out of the isolation unit.
3.1.6 The receiving personnel will wipe off the outside of the bag with disinfectant
sprayed onto a cloth, then place the cleaned bag into a second biohazard bag and
sealed.
3.1.7 The double bagged specimens will be placed into a transport case (igloo cooler)
for transport to the laboratory. Do not tube the specimens in the pneumatic tube
system.
3.2
Remove and review the paperwork in the folder. Give the Specimen log to a second
person (not involved with handling the specimen). This second person will record the
name and contact information for the person dropping off the specimen as well as the
tech packing the specimen for shipment. This log is then removed from the area to
prevent contamination.
3.3
Dress in the PPE according to the CDC guidelines.
3.4
Prepare the 10% bleach solution using the straight bleach, the bottled water and the
bleach squirt bottle which is marked for the volume of bleach and water.
3.5
Once the specimen has been delivered, disinfect the outside of the biohazard bag with
the fresh 10% bleach solutions prayed onto a cloth.
3.6
Package the specimen in the UN2814 box according to the instructions.
See diagram next page.
3.6.1 A cold pack must be added to the outer container to maintain temperature during
transport. Do not place the cold pack in the inner container as it might break the
specimen tubes. Never add dry ice to these containers.
3.7
Place the required paperwork in the shipping container, seal and label the shipping
container (use permanent marker).
3.8
Disinfect the outside of the shipping container with the fresh 10% bleach solutions
prayed onto a cloth.
3.9
Remove PPE according to the CDC instructions.
3.10 Place all used PPE, bleach, water, squirt bottle into a biohazard bag, close with ziptie
3.11 Place closed biohazard bag into second biohazard bag, close with zip tie.
3.12 Wash hands.
Page 118 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
3.13
Deliver the biohazard bag to the autoclave room where it will be autoclaved before
disposal.
4.0
Transportation of packaged specimens
4.1
Preliminary testing for suspected Ebola patients will be done by DHEC.
4.2
Complete the DHEC requisition (see attachments) in the special pathogens
section enter” rule out Ebola”.
4.2.1 See attachments for the proper labeling of the package to go to DHEC.
4.2.2 The Shippers name, address, and a contact person’s name and telephone
number must be completed on the package.
4.3
A Shippers Declaration for Dangerous Goods must also be completed and
accompany the specimen (see attachments).
4.3.1 Use the terms “Suspected Category A infectious Substance” on the form
DO NOT use “Ebola specimen”.
Page 119 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
4.3.2
4.4
4.5
5.0
An emergency (24 hour) contact number must be entered on the bottom
of the form.
4.3.3 The form must be signed by the person packing the sample this person
must be certified in shipping infectious substances.
If DHEC laboratories get a positive result on their initial test, they will forward
the specimen to the CDC for confirmation testing.
If CDC confirms the positive Ebola test they will want additional samples set
directly to them for viral load monitoring.
4.5.1 Additional specimens will be collected according to the CDC
instructions.
4.5.2 Complete the CDC test request form, A Shippers Declaration for
Dangerous Goods, and the World Courier form.
4.5.3 World Courier’s phone number is 1-800-221-6600 and the account
number is 21025.
4.5.4 World courier will have more instructions and forms when the call for
the pickup is made.
Initial Author / Date: Mary B.Paoli BS MT(ASCP)SBB 11.05.2014
Page 120 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Page 121 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Page 122 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Page 123 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Page 124 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Page 125 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Page 126 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective date: 04.01.2013
S1.030.01 CHEMICAL EXPOSURE/TERRORISM RESPONSE PLAN
NOTE: ALSO SEE M10.001.03 BIOTERRORISM READINESS PLAN FOR PALMETTO
HEALTH MICROBIOLOGY LABORORY
1.0
PRINCIPLE
An incident of biological or chemical exposure/terrorism might range from dissemination
of aerosolized anthrax spores to food product contamination, and predicting when and how
such an exposure/attack might occur is not possible. Terrorist incidents in the United States
and elsewhere involving bacterial pathogens, nerve gas, and a lethal plant toxin (e.g, ricin) have
demonstrated that the United States is vulnerable to biological and chemical threats as well as
explosives.
Because the initial detection of a biological or chemical release will probably occur at the
local level, disease surveillance systems at state and local health agencies must be capable
of detecting unusual patterns of disease or injury, including those caused by unusual or
unknown threat agents.
Chemical exposure/terrorism events are likely to be overt because the effects of chemical
agents absorbed through inhalation or by absorption through the skin or mucous membranes are
usually immediate and obvious. Such attacks elicit immediate response from police, fire, and
EMS personnel.
2.0
PALMETTO HEALTH’S RESPONSIBILITIES
The Emergency Department (ED) physicians are responsible for identifying possib le
chemical exposure/terrorism events.
Chemical agents that might be used by terrorists or cause accidental exposures range from
warfare agents to toxic chemicals commonly used in industry. Criteria for determining high
threat chemical agents include
chemical agents already known to be used as weaponry;





availability of chemical agents to potential terrorists;
chemical agents likely to cause major morbidity or mortality;
potential of agents for causing public panic and social disruption; and
agents that require special action for public health preparedness. Categories of chemical
agents include
nerve agents,
— tabun (ethyl N,N-dimethylphosphoramidocyanidate),
— sarin (isopropyl methylphosphanofluoridate),
— soman (pinacolyl methyl phosphonofluoridate),
— GF (cyclohexylmethylphosphonofluoridate),
— VX (o-ethyl-[S]-[2-diisopropylaminoethyl]-methylphosphonothiolate);
Page 127 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________



blood agents,
— hydrogen cyanide,
cyanogen chloride;
blister agents,
— lewisite (an aliphatic arsenic compound, 2-chlorovinyldichloroarsine),
— nitrogen and sulfur mustards,

heavy metals,
— phosgene oxime;
— arsenic,
— lead,
— mercury;






Volatile toxins,
— benzene,
— chloroform,
— trihalomethanes;
pulmonary agents,
— phosgene,
— chlorine,
— vinyl chloride;
incapacitating agents,
— BZ (3-quinuclidinyl benzilate);
pesticides, persistent and nonpersistent;
dioxins, furans, and polychlorinated biphenyls (PCBs);
explosive nitro compounds and oxidizers,
— ammonium nitrate combined with fuel oil;



flammable industrial gases and liquids,
— gasoline,
— propane;
poison industrial gases, liquids, and solids,
— cyanides,
— nitriles; and
corrosive industrial acids and bases,
— nitric acid,
— sulfuric acid.
Because of the increasing number of chemicals that are being synthezied, treating exposed
persons by clinical syndrome rather than by specific agent is more useful for public health
planning and emergency medical response purposes. Public health agencies and first
responders might render the most aggressive, timely, and clinically relevant treatment
possible by using treatment modalities based on syndromic categories (e.g., burns and
trauma, cardiorespiratory
failure, neurologic damage, and shock). These treatment activities must be linked with
authorities responsible for environmental sampling and decontamination to effectively
respond to an event.
Page 128 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
2.1
2.2
2.3
3.0
The ED physicians, working with other first responders and local/state officials, w ill
contact DHEC.
Chemical Threat Event Contact number at DHEC: 1-803-767-8112.
Once DHEC has been alerted to a possible chemical exposure/terrorism event the
chemical exposure/terrorism response plan will be put into effect.
LABORATORY RESPONSE NETWORK FOR CHEMICAL THREATS (LRN-C)
3.1
The South Carolina Department of Health and Enviromental Control (DHEC) Bureau of
Laboratories has a Chemical Exposure Laboratory (CEL) that is part of the CDC’s
Laboratory Response Network
3.1.1
Chemicals the CEL can detect in blood and urine:
Metals
Small Molecules
Arsenic
Lewisite Metabolite
Barium
Cyanide
Berylium
Volatile Organic Compounds (VOCs)
Cadmium
Tetramine
Lead
Organophosphate Nerve Agent Metabolites
Mercury
Nitrogen Mustard Metabolite
Thallium
Sulfur Mustard Metabolite
Uranium
Metabolic Toxins
Ricinine and Abrine
Tetranitromethane Metabolite
3.2
The CEL was developed to provide rapid laboratory response to chemical
terrorism/exposure events. The CEL provides:
3.2.1
24 hour response to chemical terrorism/exposure incidents.
3.2.2
Training and direction on sample collection and packaging
Page 129 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
4.0
3.2.3
Sample pickup and transportation
3.2.4
Rapid analysis of specimens and result reporting.
CLINICAL LABORATORY’S RESPONSIBILITY
4.1
Collection of blood and urine samples for chemical analysis at the LRN-C
laboratories will be done by ED personnel.
4.1.1
The ED physicians will start the process by identifying the patients whose
samples require LRN-C testing.
4.1.2
ED personnel will enter the required data on the
“CT LABORATORY SAMPLE CHAIN OF CUSTODY FORM”
(COCF)
4.1.3
4.2
4.3
Chemical Exposure/Terrorism Event Specimen Collection protocols will be
followed. See attachments.
Blood and/or urine specimens will be collected and packaged separately.
4.2.1
The Palmetto Health Richland laboratory will supply the ED with additional
blood collection tubes and urine cups if necessary.
4.2.2
Each sample type, from each patient, must be accompanied by a COCF.
4.2.3
The samples will be placed in Biohazard Bags with absorbent, the COCF in
the outside pocket. The bags are then sealed securing the samples and the
COCF.
4.2.4
The sealed bags are then transported to the Laboratory Referral Testing
(Send Outs) Department.
Laboratory Referral Testing (Send Outs) Department personnel or Laboratory Lead
Techs will be responsible for storage of the collected samples until they can be
picked up by DHEC CEL personnel.
4.3.1
Blood samples [DO NOT remove from sealed biohazard bags] are placed
in a monitored refrigerator for storage at 2-8°C.
Page 130 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
4.3.2
Urine samples [DO NOT remove from sealed biohazard bags] will be
placed in a monitored -70°C freezer.
DO NOT FREEZE BLOOD SAMPLES.
4.4
In the event that the ED is overwhelmed by possible chemical terrorism
victims/patients, or the patients are already admitted to the hospital floors, specimen
collection and packaging may have to be performed by Laboratory phlebotomists.
4.4.1
4.5
5.0
The laboratory has a CT Response Kit with the required COCF and
packaging materials as well as the specimen collection protocols located in
the Referral Laboratory section.
To arrange for pickup of specimens, call the DHEC CEL Emergency Cell Phone
(803-767-8112) or during normal business hours, the CEL office phone (803-8960886).
ATTACHMENTS
5.1
5.2
5.3
5.4
5.5
CT LABORATORY SAMPLE: CHAIN-OF-CUSTODY FORM
CDC Chemical Terrorism Event Specimen Collection chart
CDC Shipping Instructions for Specimens Collected from People Who May Have
Been Exposed to Chemical-Terrorism Agents (7 pages).
DHEC CT: Materials and Paperwork for Urine Specimens(2 pages).
DHEC CT: Materials and Paperwork for Blood Specimens (2 pages)
6.0
REFERENCES:
6.1
MMWR Biologicl and Chemical Terroris m Strategic Plan for Preparedness and
Response. April 21, 2000/Vol.49/No.RR-4. U.S. Department of Health and Human
Services, CDC, Atlanta, GA 30333
7.0
Initial Author/Date: Mary B. Paoli MT(ASCP)SBB 2/6/13
Revised By Author/Date:
Page 131 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective date: 04.01.2015
S1.031.01 Safe Work Practices Review
1.0
Safe Work Practices Review
There is documented periodic review (at least annually) of safe work
practices to reduce hazards.
NOTE: Review must include bloodbor ne hazard control and chemical
hygiene.
Evidence of Compliance:
✓
Safety committee minutes OR records of regular safety inspections OR
incident reports and statistics OR another method defined by the
laboratory director
2.0
Evaluation Methods:
2.1
Review of Accident Reports
2.2
Periodic Safety Audits by Safety Committee
2.3
Periodic Audit by Safety Officer
2.4
Environment of Care Audits
2.5
The annual consideration and implementation of appropriate
commercially available and effective safer medical devices designed to
eliminate or minimize occupational exposure.
2.6
Seek new ways to improve the Chemical Hygiene Program.
2.7
Annual review/revision of department chemical inventories.
2.8
Annual review of each departments risk assessments, and the monitoring
of control measures for effectiveness.
3.0
Report:
3.1
Accident reports: analysis of cause, ways to prevent re-occurrence.
3.2
Monthly Environment of Care Audits by Safety Committee: summary of
findings.
3.3
Safety Officer Audits: summary of findings.
3.4
Hospital Environment of Care Rounds: summary of findings, corrective
actions.
3.5
Review and update Chemical Hygiene Plan annually.
4.0
Initial Author/Date: Mary B. Paoli, BS, MT(ASCP)SBB 09.02.2014
Revised By Author/Date
Page 145 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.033.01 MANDATORY TRAINING FIRE SAFETY
1.0
PRINCIPLE It's easy to remember how to use a fire extinguisher if you can remember the
acronym PASS, which stands for Pull, Aim, Squeeze, and Sweep.
Revised By Author/Date: Fay Parker-Brown, 10/12/04, 9/3/09
Pull the pin of the extinguisher.
This pin is in place to prevent accidental discharge. Removal unlocks the trigger mechanism.
This will allow you to discharge the extinguisher.
Aim at the base of the fire
The base is where the fuel is actually burning.
Squeeze the top handle or lever
This depresses a button that releases the pressurized extinguishing agent in the extinguisher.
X.XXX FORMALDEHYDE REGULATION
Document
Supervisor Review
Date
Pathologist Review
Date
Initial
Annual
Revision
Rev ID
Sweep from side to side
until the fire is complete ly out. Start using the extinguisher from a safe distance away, then
Page 146 of 150
move forward. Once the fire is out, keep an eye on the area in case it re-ignites. It is better to
use too much extinguisher than too little.
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
1.1
2.0
3.0
If you run out of extinguishing agent before the fire is put out, or if the fire spreads or
grows, GET OUT. Don’t endanger yourself further if your first attempt is unsuccessful.
FIRE CLASSIFICATIONS:
Fires are classified based on the type of fuel that is burning.
2.1 Class A - Wood, paper, cloth, trash and plastics
(solid combustible materials that are not metals)
2.2 Class B - Flammable liquids such as gasoline, oil, kerosene and solvents
2.3 Class C - Electrical equipment
(as long as it's "plugged in" it is considered a Class C fire)
2.4 Class D - Combustible Metals such as magnesium, potassium and sodium as well as
organometallic reagents such as alkyllithiums, Grignards, and diethylzine.
TYPES OF FIRE EXTINGUISHERS:
3.1 Pressurized Water - Class A fire only
3.2 Water stored under air pressure - 2.5 gallon cylinder
3.3 Discharge approximately 1 minute, with a range of 10-20 feet
3.4 Extinguishes the fire by removing heat
3.5 WATER-FILLED EXTINGUISHERS ARE NOT ACCEPTABLE FOR
LABORATORY USE. If you have a water-filled extinguisher, have it
replaced immediately.
4.0
DRY CHEMICAL - Class A, B & C fires
4.1 Dry chemical powder (ABC - Ammonium phosphate, BC - Sodium or potassium
bicarbonate) stored under nitrogen pressure
4.2 Discharge approximately 8 to 15 seconds, with a range of 6-15 feet
4.3 Extinguishes fire by removing the oxygen through smothering
4.4 Dry chemical fire extinguishers are suitable for labs, but can cause a tremendous mess.
Dry chemical powder can infiltrate sensitive electrical
equipment and ruin optics, mirrors
and other laboratory equipment.
5.0
CARBON DIOXIDE (CO2) - Class B & C fires
5.1 CO2 stored under pressure
5.2 Discharge approximately 8 to 15 seconds, range 3-5 feet
5.3 Extinguishes fire by reducing the amount of oxygen around the fire
5.4 WARNING: CO2 can cause severe chemical burns and freezing of
body parts. DO NOT HOLD THE HORN - grip the handle part of
the extinguisher.
5.5 WARNING: CO2 can reduce the percent of oxygen in air when in a
confined area. Use only in well ventilated areas.
Page 147 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
6.0
7.0
DRY POWDER (SODIUM CHLORIDE/SAND) - Class D fires
6.1 This agent can be stored in both extinguishers and storage bins. The agent is applied
gently at a sufficient amount to cover the burning metal
6.2 Extinguishes fires by forming a crust over the burning metal, thus smothering it.
FIRE DRILLS: fire drills are held to educate the occupants in a building as to the fire safety
features and evacuation routes.
7.1 New employees must be shown the location of the fire alarm pulls, the
location of fire extinguishers in their area and the evacuation route and
meeting place they should use in the event of a fire or fire drill.
7.2 Physical evaluation of the escape route must be performed annually to ensure
that fire exit corridors and stairwells are clear and that all fire exit doors open
properly.
7.3 Elevators are never used in the event of a fire or fire drill.
7.4 Fire safety knowledge is tested as part of the annual laboratory safety training.
8.0
FIRE RESPONSE: in the event of a fire R.A.C.E. helps you remember what to do.
8.1 R= rescue any patient/employee/visitor in the area of the fire.
8.2 A= alarm, pull the fire alarm in the area.
8.3 C= contain the fire by shutting the closest fire doors
8.4 E= escape from the area using your predetermined evacuation routes
E can also mean extinguish the fire, if possible, using the fire extinguisher in
the area.
9.0
Initial Author/Date: Fay Parker-Brown MBA, SM(ASCP)
Revised By Author/Date: Fay Parker-Brown, MBA, SM(ASCP) 9/3/09
Mary B. Paoli BS,MT(ASCP)SBB 10/17/14
Page 148 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
Effective Date: 04.01.2015
S1.034.01 RADIATION SAFETY IN THE LABORATORY
1.0
PRINCIPLE
None of the procedures performed in the Palmetto Health Laboratories involve handling
radioactive isotopes but laboratory workers may come in contact with radiation in other ways.
Workers should be familiar with the radiation symbol and radiation safety policies.
2.0
PRECAUTIONS IN DEALING WITH RADIOACTIVE PATIENTS
Patients receiving Iodine-125 seeds are radioactive and time with them should be minimized.
The patient’s blood and urine are not radioactive and can be handled like any other specimen.
Read any instructions on the patient’s door before entering. Refer to Palmetto Health
Radiation Safety Policy 278.
3.0
SENTINEL NODE BIOPSY PROCEDURE
Biopsy samples from patients that have radioactive seeds placed in their tissues do not require
special handling due to the small amount of radioactivity.
Refer to Palmetto Health Radiation Safety Policy 279.
4.0
HANDLING OF BODIES CONTAINING RADIOACTIVE MATERIAL
In general handling of a body containing only a diagnostic quantity of any radioactive material
for nuclear medicine procedure will not present a significant health hazard. Whenever an
autopsy is requested on a patient who has radioactive materials the Radiation Safety Officer
must be notified.
Refer to Palmetto Health Radiation Safety Policy 276 & 278.
Page 149 of 150
Palmetto Health Laboratories
SAFETY MANUAL
_______________________________________________________________________
5.0
IRRADIATION OF BLOOD PRODUCTS- BLOOD BANK RADIATION SAFETY
The Blood Bank at Palmetto Health Richland operates the IBL 437C Blood Irradiator with
three radioactive Cesium-137 sources. Refer to Blood Bank policy B2.017.04, and Palmetto
Health Radiation Safety Policy 251.
5.1
Only individuals trained in the proper operation of the irradiator are allowed to operate
it.
5.2
Radiation monitors are in place to monitor any potential exposure.
5.3
Dosimetry reports are maintained by the Radiation Safety Department.
6.0
Initial Author/Date: Mary B. Paoli BS,MT(ASCP)SBB 03.16.2015
Revised By Author/Date:
Page 150 of 150
Was this manual useful for you? yes no
Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project